Document:

EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 
  

SIXTH OMNIBUS AMENDMENT 

This SIXTH OMNIBUS AMENDMENT is made as of November 18, 2016 (this “Amendment”), among CHS RECEIVABLES FUNDING, LLC, a
Delaware limited liability company (“Receivables Funding”), as Borrower and as the Company, THE BANK OF NOVA SCOTIA (“Scotia”), as a Committed Lender and as a Managing Agent, CRÉDIT AGRICOLE CORPORATE AND
INVESTMENT BANK (“CA-CIB”), as a Committed Lender, as a Managing Agent and as Administrative Agent, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD. (“BTMU”), as a Committed
Lender and as a Managing Agent, ATLANTIC ASSET SECURITIZATION LLC (“Atlantic”), as a Conduit Lender, LIBERTY STREET FUNDING LLC (“Liberty Street”), as a Conduit Lender, VICTORY RECEIVABLES CORPORATION
(“Victory”), as a Conduit Lender, CHSPSC, LLC (as successor-by-conversion to Community Health Systems Professional Services Corporation) (“Professional Services”), a Delaware limited liability company, as
Collection Agent under each of the Receivables Loan Agreement, Contribution Agreement, and Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement, the “Authorized Representative”), CHS/COMMUNITY HEALTH
SYSTEMS, INC., a Delaware corporation (“CHS”), as Transferor, as Buyer and individually (as the provider of a performance undertaking) and EACH OF THE OTHER PERSONS IDENTIFIED AS ORIGINATORS ON THE SIGNATURE PAGES HERETO AFFILIATED
WITH CHS/COMMUNITY HEALTH SYSTEMS, INC., as Originators. All capitalized terms used herein without reference shall have the meanings assigned to such terms in the Receivables Loan Agreement, Contribution Agreement or Sale Agreement (as each is
defined below), as applicable, in each case after giving effect to this Amendment. 
 WHEREAS, Receivables Funding, as
Borrower, Scotia, as a Committed Lender and as a Managing Agent, CA-CIB, as a Committed Lender, as a Managing Agent and as Administrative Agent, BTMU, as a Committed Lender and as a Managing Agent, the other Lenders party thereto and Professional
Services, as Collection Agent, have entered into the Receivables Loan Agreement, dated as of March 21, 2012 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Receivables Loan Agreement”);

 WHEREAS, CHS, as Transferor, Receivables Funding, as the Company, and Professional Services, as Collection Agent
thereunder, have entered into the Receivables Purchase and Contribution Agreement, dated as of March 21, 2012 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Contribution Agreement”);

 WHEREAS, the Originators, Professional Services, as Collection Agent and Authorized Representative thereunder, and CHS,
as Buyer, have entered into the Receivables Sale Agreement, dated as of March 21, 2012 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Sale Agreement”); and 

WHEREAS, the parties hereto desire to amend certain provisions of the Receivables Loan Agreement, the Contribution Agreement
and the Sale Agreement, pursuant to Section 10.01 of the Receivables Loan Agreement, Section 9.01 of the Contribution Agreement and Section 9.01 of the Sale Agreement, and take the other actions set forth herein, and have agreed to do so subject to
the terms and conditions of this Amendment. 

 NOW, THEREFORE, in consideration of the agreements hereinafter set forth, and
for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 

SECTION 1.    Modifications to Receivables Loan Agreement.  Subject to all of the terms
and conditions set forth in this Amendment, effective as of the Amendment Effective Date, the Receivables Loan Agreement (including Schedules and Exhibits) is hereby amended in its entirety to read in the form of such Receivables Loan Agreement
(including Schedules and Exhibits) attached hereto as Annex A. 
 SECTION 2.    Modifications
to Contribution Agreement.  Subject to all of the terms and conditions set forth in this Amendment, effective as of the Amendment Effective Date, the Contribution Agreement (including Schedules and Exhibits) is hereby amended in its
entirety to read in the form of such Contribution Agreement (including Schedules and Exhibits) attached hereto as Annex B. 

SECTION 3.    Modifications to Sale Agreement.     Subject to all of the
terms and conditions set forth in this Amendment, effective as of the Amendment Effective Date, the Sale Agreement (including Schedules and Exhibits) is hereby amended in its entirety to read in the form of such Sale Agreement (including Schedules
and Exhibits) attached hereto as Annex C. 
 SECTION 4.    Conditions to
Effectiveness.     This Amendment shall become effective upon the date (the “Amendment Effective Date”) on which the following conditions have been satisfied (in form and substance reasonably acceptable
to the Administrative Agent): 
 (a)        The Administrative Agent shall have
received counterparts of this Amendment duly executed by each of the Borrower, the Company, the Collection Agent (as Collection Agent under each of the Receivables Loan Agreement, the Contribution Agreement, and the Sale Agreement), the Authorized
Representative, the Transferor, the Buyer, CHS individually, the Originators, the Managing Agents, the Committed Lenders, the Conduit Lenders and the Administrative Agent. 

(b)        The Administrative Agent shall have received the items listed in
Schedule I hereto. 
 (c)        All fees and expenses required to be paid on
the date hereof or prior to an Advance under the Receivables Loan Agreement (as amended by this Amendment) pursuant to (i) the Receivables Loan Agreement (as amended by this Amendment), (ii) the Fee Letter (as amended and restated on the
date hereof) and (iii) any other Facility Document shall have been paid. 

(d)        Each Managing Agent and the Administrative Agent shall have completed
satisfactory due diligence and obtained the requisite credit approvals. 
 SECTION
5.    Representations and Warranties.
 (a)      Each of the CHS
Parties represents and warrants as of the date hereof that (i) it has taken all necessary action to authorize the execution, delivery and performance of this 

  
 2 

 
Amendment and the performance of the Receivables Loan Agreement, Contribution Agreement, Sale Agreement and the other Facility Documents, each as amended hereby, and (ii) no consent, approval,
authorization or order of, or filing, registration or qualification with, any court or governmental authority or third party is required in connection with the execution, delivery or performance by such Person of this Amendment other than such as
has been met or obtained and are in full force and effect. 
 (b)      Each of the CHS
Parties represents and warrants as of the date hereof that each of this Amendment and each Facility Document (as amended by this Amendment or otherwise as of the date hereof, as applicable) constitutes such Person’s legal, valid and binding
obligation, enforceable against such person in accordance with its terms, except as such enforceability may be subject to (A) bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting
creditors’ rights generally and (B) general principles of equity (regardless of whether such enforceability is considered in a proceeding at law or in equity). 

(c)      The Borrower hereby makes each of the representations and warranties contained in
Sections 4.01 and 4.03 of the Receivables Loan Agreement as of the date hereof, in each case after giving effect to this Amendment, except for those representations and warranties that refer to specific dates, which are made as of the dates
indicated therein. 
 (d)      The Collection Agent hereby makes each of the representations
and warranties contained in Section 4.02 of the Receivables Loan Agreement as of the date hereof, in each case after giving effect to this Amendment, except for those representations and warranties that refer to specific dates, which are made as of
the dates indicated therein. 
 (e)      Each of the Borrower and the Collection Agent
further represents and warrants that, both before and after giving effect to this Amendment, no event has occurred and is continuing which constitutes an Event of Default, or would, with the passage of time or the giving of notice, constitute an
Event of Default. 
 SECTION 6.    Facility Document.  This Amendment shall constitute
a Facility Document under the terms of the Receivables Loan Agreement as amended hereby. 
 SECTION
7.    Further Assurances.     The Borrower and the Collection Agent agree to promptly take such action, upon the reasonable request of the Administrative Agent, as is necessary to carry out the
intent of this Amendment. 
 SECTION 8.    Confirmation of Agreements.  On and after
the date hereof, all references to each of the Receivables Loan Agreement, the Contribution Agreement, and the Sale Agreement in the Facility Documents and the other documents and instruments delivered pursuant to or in connection with such Facility
Documents shall mean, respectively, (i) the Receivables Loan Agreement as amended by this Amendment, and as hereafter modified, amended or restated in accordance with its terms, (ii) the Contribution Agreement as amended by this Amendment, and as
hereafter modified, amended or restated in accordance with its terms, and (iii) the Sale Agreement as amended by this Amendment, and as hereafter modified, amended or restated in accordance with its terms. Except as herein expressly amended,
each of 

  
 3 

 
the Receivables Loan Agreement, the Contribution Agreement and the Sale Agreement are ratified and confirmed in all respects and shall remain in full force and effect in accordance with each
agreement’s respective terms. For the avoidance of doubt, all information and other calculations reported on the Monthly Report for the Collection Period ending November 30, 2016, and on each Monthly Report for each Collection Period
thereafter, shall be determined after giving effect to the express modifications set forth in Annex A to this Agreement. 

SECTION 9.    Confirmation of Undertaking.      CHS, as undertaking
party under the Collection Agent Performance Undertaking, dated as of March 21, 2012 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Performance Undertaking”), in favor of CA-CIB as
administrative agent on behalf of the Lenders, hereby consents to the amendments to (i) the Receivables Loan Agreement set forth in Section 1 of this Amendment, (ii) the Contribution Agreement set forth in Section 2 of this Amendment, and (iii) the
Sale Agreement set forth in Section 3 of this Amendment, and hereby confirms and agrees that, notwithstanding the effectiveness of this Amendment, the Performance Undertaking heretofore executed and delivered by it is, and shall continue to be, in
full force and effect in accordance with its terms and shall apply to the Receivables Loan Agreement, Contribution Agreement and Sale Agreement, each as amended by this Amendment, and the Performance Undertaking is hereby so ratified and confirmed.

 SECTION 10. GOVERNING LAW.        THIS AMENDMENT SHALL, IN ACCORDANCE WITH
SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH OF THE PARTIES HERETO HEREBY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE
AND FEDERAL COURTS OF THE UNITED STATES AND THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN NEW YORK COUNTY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AMENDMENT, ANY OTHER FACILITY DOCUMENT,
ANY OTHER DOCUMENT DELIVERED PURSUANT HERETO OR THERETO, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH OF THE PARTIES HERETO HEREBY WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS THE MAINTENANCE OF ANY SUCH ACTION OR PROCEEDING
AND CONSENTS TO THE GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED APPROPRIATE BY SUCH COURT. 
 SECTION 11.
Execution in Counterparts.    This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all
of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Amendment by facsimile or by electronic mail in portable document format (pdf) shall be effective as
delivery of a manually executed counterpart of this Amendment. 
 SECTION 12. Severability of
Provisions.   Any provision of this Amendment which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the
remaining provisions hereof or affecting the validity or enforceability of such provision in any other jurisdiction. 

SECTION 13. Headings. Section headings used herein are for convenience of reference only, are not part of this
Amendment and shall not affect the construction of, or be taken into consideration in interpreting, this Amendment. 
  

[Signature Pages Follow] 

  
 4 

 IN WITNESS WHEREOF, this Amendment has been duly executed as of the date first
written above. 
  

									
		 		 	 CHS RECEIVABLES FUNDING, LLC,

		 		 	 as Borrower and as Company

					
		 		 	 By:
	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	 Name: Edward W. Lomicka
	 	
		 		 		 	 Title:   Vice President and Treasurer
	 	
			
		 		 	 CHSPSC, LLC,

		 		 	as Collection Agent under each of the Receivables Loan Agreement, Contribution Agreement and Sale Agreement and as Authorized Representative
					
		 		 	 By:
	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	 Name: Edward W. Lomicka
	 	
		 		 		 	 Title:   Vice President and Treasurer
	 	

  

Signature Page to Sixth Omnibus Amendment 

 
									
		 		 	CHS/COMMUNITY HEALTH SYSTEMS, INC.,
		 		 	as Transferor, as Buyer and individually
					
		 		 	 By:
	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	 Name: Edward W. Lomicka
	 	
		 		 		 	 Title:   Vice President and Treasurer
	 	

  

Signature Page to Sixth Omnibus Amendment 

 
									
		 		 	CRÉDIT AGRICOLE CORPORATE AND INVESTMENT BANK, as Administrative Agent,
		 		 	as a Managing Agent and as a Committed Lender
					
		 		 	 By:
	 	 /s/ Kostantina Kourmpetis
	 	
		 		 		 	 Name: Kostantina Kourmpetis
	 	
		 		 		 	 Title:   Managing Director
	 	
					
		 		 	 By:
	 	 /s/ Sam Pilcer
	 	
		 		 		 	 Name: Sam Pilcer
	 	
		 		 		 	 Title:   Managing Director
	 	
			
		 		 	ATLANTIC ASSET SECURITIZATION LLC,
		 		 	as a Conduit Lender
				
		 		 	 By:
	 	CRÉDIT AGRICOLE CORPORATE AND INVESTMENT BANK, as attorney-in-fact
					
		 		 	  By:	 	 /s/ Kostantina Kourmpetis
	 	
		 		 		 	 Name: Kostantina Kourmpetis
	 	
		 		 		 	 Title:   Managing Director
	 	
					
		 		 	  By:	 	 /s/ Sam Pilcer
	 	
		 		 		 	 Name: Sam Pilcer
	 	
		 		 		 	 Title:   Managing Director
	 	

  

Signature Page to Sixth Omnibus Amendment 

 
									
		 		 	THE BANK OF NOVA SCOTIA, as a Managing Agent and as a Committed Lender
					
		 		 	 By:
	 	 /s/ Diane Emanuel
	 	
		 		 		 	 Name: Diane Emanuel
	 	
		 		 		 	 Title:   Managing Director
	 	
			
		 		 	LIBERTY STREET FUNDING LLC,
		 		 	as a Conduit Lender
					
		 		 	 By:
	 	 /s/ Bernard J. Angelo
	 	
		 		 		 	 Name: Bernard J. Angelo
	 	
		 		 		 	 Title:   Vice President
	 	

  

Signature Page to Sixth Omnibus Amendment 

 
									
		 		 	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,

as a Managing Agent

					
		 		 	 By:
	 	 /s/ Luna Mills
	 	
		 		 		 	 Name: Luna Mills
	 	
		 		 		 	 Title:   Managing Director
	 	
			
		 		 	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,

as a Committed Lender

					
		 		 	 By:
	 	 /s/ Luna Mills
	 	
		 		 		 	 Name: Luna Mills
	 	
		 		 		 	 Title:   Managing Director
	 	
			
		 		 	 VICTORY RECEIVABLES CORPORATION,
 as
a Conduit Lender

					
		 		 	 By:
	 	 /s/ David V. DeAngelis
	 	
		 		 		 	 Name: David V. DeAngelis
	 	
		 		 		 	 Title:   Vice President
	 	

  

Signature Page to Sixth Omnibus Amendment 

											
		 		 	ORIGINATORS:
			
		 		 	AFFINITY HOSPITAL, LLC
		 		 	BERWICK HOSPITAL COMPANY, LLC
		 		 	BLUEFIELD HOSPITAL COMPANY, LLC
		 		 	BLUFFTON HEALTH SYSTEM LLC
		 		 	BULLHEAD CITY HOSPITAL CORPORATION
		 		 	CARLSBAD MEDICAL CENTER, LLC
		 		 	CLEVELAND TENNESSEE HOSPITAL
		 		 	COMPANY, LLC
		 		 	COATESVILLE HOSPITAL CORPORATION
		 		 	CRESTVIEW HOSPITAL CORPORATION
		 		 	DEACONESS HEALTH SYSTEM, LLC
		 		 	DUKES HEALTH SYSTEM, LLC
		 		 	DYERSBURG HOSPITAL CORPORATION
		 		 	EMPORIA HOSPITAL CORPORATION
		 		 	FOLEY HOSPITAL CORPORATION
		 		 	FRANKLIN HOSPITAL CORPORATION
		 		 	GADSDEN REGIONAL MEDICAL CENTER, LLC
		 		 	GRANBURY HOSPITAL CORPORATION
		 		 	GREENBRIER VMC, LLC
		 		 	HOSPITAL OF MORRISTOWN, INC.
		 		 	JACKSON, TENNESSEE HOSPITAL
		 		 	COMPANY, LLC
		 		 	JOURDANTON HOSPITAL CORPORATION
		 		 	KAY COUNTY OKLAHOMA HOSPITAL COMPANY, LLC
		 		 	LAKE WALES HOSPITAL CORPORATION
		 		 	LANCASTER HOSPITAL CORPORATION
		 		 	LAS CRUCES MEDICAL CENTER, LLC
		 		 	LEA REGIONAL HOSPITAL, LLC
		 		 	MARTIN HOSPITAL CORPORATION
		 		 	MARY BLACK HEALTH SYSTEM LLC
		 		 	MCNAIRY HOSPITAL CORPORATION
		 		 	MCSA, L.L.C.
		 		 	MOBERLY HOSPITAL COMPANY, LLC
		 		 	NATIONAL HEALTHCARE OF LEESVILLE, INC.
		 		 	NORTHAMPTON HOSPITAL COMPANY, LLC
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Sixth Omnibus Amendment 

  

											
		 		 	    ORIGINATORS (CONT.):

 

											
		 		 	NORTHWEST HOSPITAL, LLC
		 		 	ORO VALLEY HOSPITAL, LLC
		 		 	PETERSBURG HOSPITAL COMPANY, LLC
		 		 	PHOENIXVILLE HOSPITAL COMPANY, LLC
		 		 	POTTSTOWN HOSPITAL COMPANY, LLC
		 		 	PORTER HOSPITAL, LLC
		 		 	QHG OF ENTERPRISE, INC.
		 		 	QHG OF SOUTH CAROLINA, INC.
		 		 	ROSWELL HOSPITAL CORPORATION
		 		 	RUSTON LOUISIANA HOSPITAL COMPANY, LLC
		 		 	SCRANTON HOSPITAL COMPANY, LLC
		 		 	SHELBYVILLE HOSPITAL CORPORATION
		 		 	SILOAM SPRINGS ARKANSAS HOSPITAL COMPANY, LLC
		 		 	SPOKANE VALLEY WASHINGTON HOSPITAL COMPANY, LLC
		 		 	SPOKANE WASHINGTON HOSPITAL COMPANY, LLC
		 		 	ST. JOSEPH HEALTH SYSTEM LLC
		 		 	TOMBALL TEXAS HOSPITAL COMPANY, LLC
		 		 	WARREN OHIO HOSPITAL COMPANY, LLC
		 		 	WARREN OHIO REHAB HOSPITAL COMPANY, LLC
		 		 	WARSAW HEALTH SYSTEM LLC
		 		 	WEATHERFORD TEXAS HOSPITAL COMPANY, LLC
		 		 	WESLEY HEALTH SYSTEM, LLC
		 		 	WEST GROVE HOSPITAL COMPANY, LLC
		 		 	WILKES-BARRE HOSPITAL COMPANY, LLC
		 		 	WOMEN & CHILDREN’S HOSPITAL, LLC
		 		 	YOUNGSTOWN OHIO HOSPITAL COMPANY, LLC
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	 Name:
	 	Edward W. Lomicka
		 		 		 	 Title:
	 	Vice President and Treasurer

  

Signature Page to Sixth Omnibus Amendment 

  

											
		 		 	    ORIGINATORS (CONT.):

 

											
		 		 	KIRKSVILLE MISSOURI HOSPITAL COMPANY, LLC
		 		 	LUTHERAN MUSCULOSKELETAL CENTER, LLC
		 		 	OAK HILL HOSPITAL CORPORATION
		 		 	SALEM HOSPITAL CORPORATION
		 		 	SCRANTON QUINCY HOSPITAL COMPANY, LLC
		 		 	WOODWARD HEALTH SYSTEM, LLC
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Sixth Omnibus Amendment 

											
		 		 	    ORIGINATORS (CONT.):

 

											
		 		 	AMORY HMA, LLC
		 		 	ANNISTON HMA, LLC
		 		 	BILOXI H.M.A., LLC
		 		 	BRANDON HMA, LLC
		 		 	CAMPBELL COUNTY HMA, LLC
		 		 	CARLISLE HMA, LLC
		 		 	CHESTER HMA, LLC
		 		 	CITRUS HMA, LLC
		 		 	CLARKSDARE HMA, LLC
		 		 	CLINTON HMA, LLC
		 		 	COCKE COUNTY HMA, LLC
		 		 	DURANT H.M.A., LLC
		 		 	EAST GEORGIA REGIONAL MEDICAL CENTER, LLC
		 		 	FORT SMITH HMA, LLC
		 		 	HAINES CITY HMA, LLC
		 		 	HERNANDO HMA, LLC
		 		 	HMA FENTRESS COUNTY GENERAL
		 		 	HOSPITAL, LLC
		 		 	HMA SANTA ROSA MEDICAL CENTER, LLC
		 		 	JACKSON HMA, LLC
		 		 	JEFFERSON COUNTY HMA, LLC
		 		 	KEY WEST HMA, LLC
		 		 	LANCASTER HMA, LLC
		 		 	LEBANON HMA, LLC
		 		 	MADISON HMA, LLC
		 		 	MARSHALL COUNTY HMA, LLC
		 		 	MELBOURNE HMA, LLC
		 		 	METRO KNOXVILLE HMA, LLC
		 		 	MIDWEST REGIONAL MEDICAL CENTER, LLC
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Sixth Omnibus Amendment 

											
		 		 	    ORIGINATORS (CONT.):

 

											
		 		 	NORTHWEST ARKANSAS HOSPITALS, LLC
		 		 	PASCO REGIONAL MEDICAL CENTER, LLC
		 		 	POPLAR BLUFF REGIONAL MEDICAL CENTER, LLC
		 		 	PORT CHARLOTTE HMA, LLC
		 		 	PUNTA GORDA HMA, LLC
		 		 	RIVER OAKS HOSPITAL, LLC
		 		 	ROCKLEDGE HMA, LLC
		 		 	ROH, LLC
		 		 	ROSE CITY HMA, LLC
		 		 	SEBASTIAN HOSPITAL, LLC
		 		 	SEBRING HOSPITAL MANAGEMENT ASSOCIATES, LLC
		 		 	SEMINOLE HMA, LLC
		 		 	STATESVILLE HMA, LLC
		 		 	TRIAD OF ALABAMA, LLC
		 		 	TULLAHOMA HMA, LLC
		 		 	TUNKHANNOCK HOSPITAL COMPANY LLC
		 		 	VENICE HMA, LLC
		 		 	VICKSBURG HEALTHCARE, LLC
		 		 	YAKIMA HMA, LLC
		 		 	YORK PENNSYLVANIA HOSPITAL COMPANY, LLC
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Sixth Omnibus Amendment 

											
		 		 	    ORIGINATORS (CONT.):

 

											
		 		 	BROWNWOOD HOSPITAL, L.P.	 	
		 		 	By:	 	Brownwood Medical Center, LLC	 	
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	
				
		 		 	COLLEGE STATION HOSPITAL, L.P.	 	
		 		 	By:	 	College Station Medical Center, LLC	 	
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	
				
		 		 	IOM HEALTH SYSTEM, L.P.	 	
		 		 	By:	 	Lutheran Health Network Investors, LLC
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	

  

Signature Page to Sixth Omnibus Amendment 

											
		 		 	    ORIGINATORS (CONT.):

 

											
		 		 	LAREDO TEXAS HOSPITAL COMPANY, L.P.
		 		 	By:	 	Webb Hospital Corporation	 	
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	
			
		 		 	LONGVIEW MEDICAL CENTER, L.P.
		 		 	By:	 	Regional Hospital of Longview, LLC
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	
				
		 		 	NAVARRO HOSPITAL, L.P.	 	
		 		 	By:	 	Navarro Regional, LLC	 	
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	

  

Signature Page to Sixth Omnibus Amendment 

											
		 		 	    ORIGINATORS (CONT.):

 

											
		 		 	PINEY WOODS HEALTHCARE SYSTEM, L.P.
		 		 	By:	 	Woodland Heights Medical Center, LLC
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	
			
		 		 	REHAB HOSPITAL OF FORT WAYNE
		 		 	GENERAL PARTNERSHIP	 	
		 		 	By:	 	Lutheran Health Network Investors, LLC
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	
				
		 		 	SAN ANGELO HOSPITAL, L.P.	 	
		 		 	By:	 	San Angelo Community Medical Center, LLC
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	
				
		 		 	VICTORIA OF TEXAS, L.P.	 	
		 		 	By:	 	Detar Hospital, LLC	 	
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer	 	

  

Signature Page to Sixth Omnibus Amendment 

											
		 		 	    ORIGINATORS (CONT.):

 

											
		 		 	ARMC, L.P.	 	
		 		 	By:	 	Triad-ARMC, LLC	 	
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer
				
		 		 	CRESTWOOD HEALTHCARE, L.P.	 	
		 		 	By:	 	Crestwood Hospital, LLC	 	
		 		 	Its:	 	General Partner	 	
					
		 		 	By:	 	 /s/ Edward W. Lomicka
	 	
		 		 		 	Name:	 	Edward W. Lomicka	 	
		 		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Sixth Omnibus Amendment 

 Schedule I 

Condition Precedent Documents 

As required by Section 4 of the Amendment, each of the following items must be delivered to the
Administrative Agent prior to the effectiveness of the Amendment. Unless otherwise indicated, each of the documents below is dated as of November 18, 2016: 
  

			
	  

Document/Action
  

	 	 
	 1.

 
	 	 Amendment

 

	 	 
	 	 	Schedules to Amendment
	 	 
	 	 	
Schedule I        Condition Precedent Documents (Closing
List)

	 	 
	 	 	Annexes to Amendment
	 	 
	 	 	
Annex A          Receivables Loan Agreement

	 	 
	 	 	
Annex B          Contribution Agreement

	 	 
	 	 	
Annex C          Sale Agreement

	 	 
	 2.
	 	Fifth Amended and Restated Fee Letter
	 	 
	 3.
	 	 Officer’s Certificate of CHS concerning the
requirements of Section 6.05(b)(ii) of the Parent Credit Agreement
  

	 	 
	 4.
	 	 Approval of Parent Credit Agreement Administrative
Agent under Section 6.05(b)(ii) of the Parent Credit Agreement
  

	 	 
	 5.
	 	 Secretary’s Certificate certifying and
attaching (or certifying no changes to) (i) the certificate of incorporation or formation, as amended through the date hereof, certified by the applicable Secretary of State, (ii) the operating agreement, by-laws or partnership agreement, as
applicable, as amended through the date hereof, (iii) the resolutions adopted, (iv) the names and signatures of the officers authorized on its behalf to execute the agreements to be delivered by it and (v) in the case of Borrower, Collection Agent
and CHS, a copy of the good standing certificate, for each of:
  

	 	 
	 	 	
(a)      Borrower

 

	 	 
	 	 	
(b)      Collection Agent

 

	 	 
	 	 	
(c)      Each of the Originators

 

	 	 
	 	 	
(d)      CHS

 

	 	 
	6. 	 	 Opinion of Bass, Berry & Sims PLC, counsel for
the Borrower, Collection Agent, and CHS, as to existence and good standing, due authorization and execution, and enforceability
  

  

Schedule I to Sixth Omnibus Amendment 

			
	  

Document/Action
  

	  

7.
	 	  

Opinion of in-house counsel for Borrower, Collection Agent, Originators and CHS regarding additional corporate matters

 

	  

8.
	 	  

Delivery of the most recent monthly report on or before October 20, 2016 with respect to the September 2016 collection period

 

	  

9.
	 	  

Funding Request, if any, dated November 17, 2016 (or such later date and at such later time than as provided in the Receivables Loan Agreement as may be
approved by each Lender, in its respective sole discretion)
  

	  

10.
	 	  

Forms of UCC-3 Financing Statements continuing each UCC-1 Financing Statement previously filed on or about the Closing Date which forms shall be filed on or
prior to the Amendment Effective Date
  

	  

11.
  
	 	  

Payment of fees and expenses
  

  

Schedule I to Sixth Omnibus Amendment 

 ANNEX A 

US $700,000,000 
 RECEIVABLES LOAN
AGREEMENT 
 Dated as of March 21, 2012 (as amended through November 18, 2016), 

Among 
 CHS RECEIVABLES FUNDING,
LLC, 
 as the Borrower, 
 THE
SEVERAL COMMERCIAL PAPER CONDUITS PARTY HERETO, 
 as Conduit Lenders, 

and 
 THE SEVERAL FINANCIAL
INSTITUTIONS PARTY HERETO, 
 as Committed Lenders, 

and 
 THE SEVERAL FINANCIAL
INSTITUTIONS PARTY HERETO, 
 as Managing Agents, 

and 
 CREDIT AGRICOLE CORPORATE
AND INVESTMENT BANK, 
 as the Administrative Agent, 

and 
 CHSPSC, LLC (as
successor-by-conversion to Community Health Systems Professional 
 Services Corporation), 

as the Collection Agent 

 TABLE OF CONTENTS 
  

							
	 	  	Page	 
		
	 Article I DEFINITIONS
	  	 	2	  
	 SECTION 1.01.
	 	Certain Defined Terms	  	 	2	  
	 SECTION 1.02.
	 	Other Terms	  	 	37	  
	 SECTION 1.03.
	 	Accounting Terms and Principles	  	 	37	  
	 SECTION 1.04.
	 	Computation of Time Periods	  	 	38	  
	 SECTION 1.05.
	 	Computation of Ratios	  	 	38	  
		
	 Article II THE LOAN FACILITY
	  	 	38	  
	 SECTION 2.01.
	 	Advances; Interest	  	 	38	  
	 SECTION 2.02.
	 	Security for Obligations	  	 	41	  
	 SECTION 2.03.
	 	Extension of the Facility	  	 	44	  
	 SECTION 2.04.
	 	Optional Reduction in Facility Limit; Optional Prepayments and Mandatory Prepayments	  	 	44	  
	 SECTION 2.05.
	 	Selection of Fixed Periods	  	 	45	  
	 SECTION 2.06.
	 	Fees, Interest, Payments and Computations, Etc.	  	 	46	  
	 SECTION 2.07.
	 	Payment and Collection Procedures Generally	  	 	48	  
	 SECTION 2.08.
	 	Trigger Event and Termination Date Payment Procedures	  	 	49	  
	 SECTION 2.09.
	 	Updated Borrowing Base	  	 	51	  
	 SECTION 2.10.
	 	Late Payments, Payments on other than Business Day	  	 	51	  
	 SECTION 2.11.
	 	Increased Costs; Capital Adequacy; Illegality	  	 	52	  
	 SECTION 2.12.
	 	Taxes	  	 	53	  
	 SECTION 2.13.
	 	Assignment of the Sale Agreement and the Contribution Agreement	  	 	57	  
	 SECTION 2.14.
	 	Sharing of Payments	  	 	57	  
	 SECTION 2.15.
	 	Defaulting Lender	  	 	58	  

  
 i 

							
	 	  	Page	 
		
	 Article III CONDITIONS OF ADVANCES
	  	 	59	  
	 SECTION 3.01.
	 	Conditions Precedent to Initial Advance	  	 	59	  
	 SECTION 3.02.
	 	Conditions Precedent to All Advances	  	 	59	  
		
	 Article IV REPRESENTATIONS AND WARRANTIES
	  	 	60	  
	 SECTION 4.01.
	 	Representations and Warranties of the Borrower	  	 	60	  
	 SECTION 4.02.
	 	Representations and Warranties of the Collection Agent	  	 	67	  
	 SECTION 4.03.
	 	Article 9 Representations and Warranties	  	 	70	  
		
	 Article V GENERAL COVENANTS
	  	 	70	  
	 SECTION 5.01.
	 	Covenants of the Borrower	  	 	70	  
	 SECTION 5.02.
	 	Covenants of the Collection Agent	  	 	77	  
		
	 Article VI ADMINISTRATION, COLLECTION AND MONITORING OF ASSETS
	  	 	84	  
	 SECTION 6.01.
	 	Appointment and Designation of the Collection Agent	  	 	84	  
	 SECTION 6.02.
	 	Collection of Receivables by the Collection Agent; Extensions and Amendments of Receivables	  	 	85	  
	 SECTION 6.03.
	 	Distribution and Application of Collections	  	 	86	  
	 SECTION 6.04.
	 	Other Rights of the Administrative Agent	  	 	86	  
	 SECTION 6.05.
	 	Records	  	 	88	  
	 SECTION 6.06.
	 	Receivable Reporting	  	 	88	  
	 SECTION 6.07.
	 	Collections and Lock-Boxes	  	 	88	  
	 SECTION 6.08.
	 	UCC Matters; Protection and Perfection of Collateral	  	 	89	  
	 SECTION 6.09.
	 	Obligations With Respect to Receivables	  	 	90	  
	 SECTION 6.10.
	 	Applications of Collections	  	 	90	  
	 SECTION 6.11.
	 	Annual Servicing Report of Independent Audit Firm	  	 	90	  
	 SECTION 6.12.
	 	Indemnities by the Collection Agent	  	 	91	  
		
	 Article VII EVENTS OF DEFAULT
	  	 	92	  
	 SECTION 7.01.
	 	Events of Default	  	 	92	  
	 SECTION 7.02.
	 	Volcker Extension	  	 	97	  
		
	 Article VIII INDEMNIFICATION
	  	 	97	  
	 SECTION 8.01.
	 	Indemnities by the Borrower	  	 	97	  

  
 ii 

							
	 	  	Page	 
		
	 Article IX THE ADMINISTRATIVE AGENT; MANAGING AGENTS
	  	 	99	  
	 SECTION 9.01.
	 	Authorization and Action	  	 	99	  
	 SECTION 9.02.
	 	Agent’s Reliance, Etc.	  	 	100	  
	 SECTION 9.03.
	 	Administrative Agent and Affiliates	  	 	101	  
	 SECTION 9.04.
	 	Resignation of the Administrative Agent	  	 	101	  
	 SECTION 9.05.
	 	Payments	  	 	101	  
	 SECTION 9.06.
	 	Managing Agents	  	 	102	  
		
	 Article X MISCELLANEOUS
	  	 	103	  
	 SECTION 10.01.
	 	Amendments and Waivers	  	 	103	  
	 SECTION 10.02.
	 	Notices	  	 	104	  
	 SECTION 10.03.
	 	Electronic Transmissions	  	 	105	  
	 SECTION 10.04.
	 	Right of Setoff	  	 	105	  
	 SECTION 10.05.
	 	No Waiver; Remedies	  	 	105	  
	 SECTION 10.06.
	 	Binding Effect; Assignability	  	 	106	  
	 SECTION 10.07.
	 	Term of this Agreement	  	 	108	  
	 SECTION 10.08.
	 	GOVERNING LAW; CONSENT TO JURISDICTION; WAIVER OF OBJECTION TO VENUE; SERVICE OF PROCESS	  	 	108	  
	 SECTION 10.09.
	 	WAIVER OF JURY TRIAL	  	 	109	  
	 SECTION 10.10.
	 	Costs, Expenses and Taxes	  	 	109	  
	 SECTION 10.11.
	 	Waiver of Consequential Damages	  	 	109	  
	 SECTION 10.12.
	 	Recourse Against Certain Parties; No Proceedings	  	 	110	  
	 SECTION 10.13.
	 	Execution in Counterparts; Severability; Integration	  	 	111	  
	 SECTION 10.14.
	 	Confidentiality	  	 	111	  
	 SECTION 10.15.
	 	Acknowledgment and Consent to Bail-In of EEA Financial Institutions	  	 	113	  

  
 iii 

 LIST OF SCHEDULES AND EXHIBITS 

 

			
	SCHEDULES 	 	
		
	 SCHEDULE I
	 	Lenders
		
	 SCHEDULE II
	 	Condition Precedent Documents (Closing List)
		
	 SCHEDULE III
	 	[Intentionally Omitted]
		
	 SCHEDULE IV
	 	Non-Governmental Entity Obligor Concentration Percentages
		
	 SCHEDULE V
	 	Jurisdiction of Organization, Principal Place of Business and Chief Executive Office, and Location of Records
		
	 SCHEDULE VI
	 	Specified Originators
		
	EXHIBITS	 	
		
	 EXHIBIT A
	 	Form of Monthly Report
		
	 EXHIBIT B
	 	Form of Performance Undertaking
		
	 EXHIBIT C-1
	 	Form of Funding Request
		
	 EXHIBIT C-2
	 	Form of Borrower Notice
		
	 EXHIBIT D
	 	Form of Business Associate Agreement
		
	 EXHIBIT E
	 	Form of Assignment of Agreements
		
	 EXHIBIT F-1
	 	Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Not Partnerships For U.S. Federal Income Tax Purposes)
		
	 EXHIBIT F-2
	 	Form of U.S. Tax Compliance Certificate (For Foreign Participants That Are Not Partnerships For U.S. Federal Income Tax Purposes)
		
	 EXHIBIT F-3
	 	Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Partnerships For U.S. Federal Income Tax Purposes)
		
	 EXHIBIT F-4
	 	Form of U.S. Tax Compliance Certificate (For Foreign Participants That Are Partnerships For U.S. Federal Income Tax Purposes)

  
 iv 

 THIS RECEIVABLES LOAN AGREEMENT is dated as of March 21, 2012 (as amended through
November 18, 2016), among: 
 (1)      CHS RECEIVABLES FUNDING, LLC, a Delaware limited
liability company (the “Borrower”); 
 (2)      ATLANTIC ASSET
SECURITIZATION LLC, a Delaware limited liability company (“Atlantic”), as a Conduit Lender; 

(3)      LIBERTY STREET FUNDING LLC, a Delaware limited liability company (“Liberty
Street”), as a Conduit Lender; 
 (4)      VICTORY RECEIVABLES CORPORATION, a
Delaware corporation (“Victory”), as a Conduit Lender; 
 (5)      THE BANK
OF NOVA SCOTIA (“Scotia”), as a Managing Agent and as a Committed Lender; 

(6)      CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK (“CA-CIB”), as a Managing Agent and as a Committed Lender; 

(7)      THE BANK OF TOKYO-MITSUBISHI UFJ, LTD. (“BTMU”), as a Managing Agent
and as a Committed Lender; 
 (8)      CREDIT AGRICOLE CORPORATE AND INVESTMENT BANK, as
administrative agent (in such capacity, the “Administrative Agent”); and 

(9)      CHSPSC, LLC (as successor-by-conversion to Community Health Systems Professional
Services Corporation), a Delaware limited liability company (“Professional Services”), in its capacity as the initial Collection Agent hereunder. 

PRELIMINARY STATEMENTS. 

WHEREAS, the Originators, the Collection Agent and the Buyer have entered into the Sale Agreement, relating to the sale of
certain Receivables originated by the Originators to the Buyer. 
 WHEREAS, the Transferor, the Collection Agent and the
Company have entered into the Contribution Agreement, relating to the sale and capital contribution of the Transferor of certain Receivables purchased by the Transferor (in its capacity as Buyer under the Sale Agreement) to the Company. 

WHEREAS, the Borrower, may from time to time request Advances from the Lenders secured by, among other things, the
Receivables received by the Borrower as contributions to its capital (in its capacity as the Company under the Contribution Agreement) on the terms and conditions of this Agreement. 

 WHEREAS, as security for the Obligations, the Borrower desires to grant to the
Administrative Agent, for the benefit of the Secured Parties, a security interest in and a lien on all of its Collateral. 

IT IS AGREED as follows: 

ARTICLE I 
 DEFINITIONS 

SECTION 1.01.        Certain Defined Terms. 

(a)      Certain capitalized terms used throughout this Agreement are defined above or in this
Section 1.01. 
 (b)      As used in this Agreement and its
exhibits, the following terms shall have the following meanings (such meanings to be equally applicable to both the singular and plural forms of the terms defined). 

“AccessOne Program Receivables” means any Receivable that is subject to, and has not been repurchased
pursuant to the terms of, (i) that certain Amended and Restated Receivables Purchase Agreement, dated October 19, 2004, between QHG of South Carolina, Inc. and HRA Financial Services, Inc., (ii) that certain Amended and Restated Receivables Purchase
Agreement, dated October 15, 2004, between Mary Black Health System LLC and HRA Financial Services, Inc., as amended, restated, supplemented or modified from time to time, (iii) that certain Amended and Restated Receivables Purchase Agreement, dated
October 12, 2004, between QHG of Enterprise, Inc. and AccessOne Medcard, Inc., as amended, restated, supplemented or modified from time to time, (iv) that certain Amended and Restated Receivables Purchase Agreement, dated October 12, 2004, between
Carlsbad Medical Center, LLC and HRA Financial Services, Inc., as amended, restated, supplemented or modified from time to time, (v) that certain Amended and Restated Receivables Purchase Agreement, dated October 13, 2004, between Lea Regional
Hospital, LLC and HRA Financial Services, Inc., as amended, restated, supplemented or modified from time to time, or (vi) that certain Amended and Restated Receivables Purchase Agreement, dated October 15, 2004, between Las Cruces Medical Center,
LLC and HRA Financial Services, Inc., as amended, restated, supplemented or modified from time to time. 

“Adjusted Eurodollar Rate” means, with respect to any Fixed Period and any Revolving Principal Balance
related thereto, an interest rate per annum (expressed as a decimal and rounded upwards, if necessary, to the nearest one hundredth of a percentage point) equal to the London-Interbank Offered Rate administered by ICE Benchmark Administration
(or any other person that takes over administration of such rate) appearing on the Reuters screen that displays such rate (or other commercially available source designated by the Administrative Agent) for deposits in a principal amount of not less
than $1,000,000 for such Fixed Period as of 11:00 A.M., London time, two Business Days before the first day of such Fixed Period; provided, that if such rate is not available on any date when it is to be determined, then the rate shall be an
interest rate per annum determined by the Administrative Agent equal to the rate at which it would offer deposits in United States Dollars to prime banks in the London interbank market for a period equal to such Fixed Period and in a
principal amount of not less than $1,000,000 at or about 11:00 A.M. (London time) on the second Business Day before (and for value on) the first day of such Fixed Period. 

  
 2 

 “Administrative Agent” has the meaning assigned to that term in
the Recitals. 
 “Advance” has the meaning assigned to that term in
Section 2.01. 
 “Affected Party” has the meaning assigned to that term in
Section 2.11(a). 
 “Affiliate” when used with respect to a Person means any
other Person controlling, controlled by or under common control with such Person. 
 “Aggregate Excess
Concentration” means, for any Obligor that is an Insurer, at any time, the amount by which the aggregate Expected Net Value of all Eligible Receivables owing by such Obligor exceeds a percentage equal to the “Obligor Concentration
Percentage” with respect to such Obligor determined in accordance with Schedule IV of the aggregate Expected Net Value of all Eligible Receivables. 

“Agreement” means this Receivables Loan Agreement, including the Preliminary Statements, Schedules and
Exhibits hereto, as the same may be amended, restated, supplemented or otherwise modified from time to time. 

“Alternative Rate” means, with respect to any Fixed Period and any Revolving Principal Balance related
thereto, an interest rate per annum equal to (x) the Adjusted Eurodollar Rate plus (y) 1.30%; provided, however, that the “Alternative Rate” for any such Revolving Principal Balance and Fixed Period shall be the Base
Rate (a) if on or before the first day of such Fixed Period, a Lender, Managing Agent or the Administrative Agent shall have determined that a Eurodollar Disruption Event has occurred or (b) from and after the date on which a Liquidity Agent has
purchased the interests of the related Conduit Lender in Advances following an Event of Default. 

“Anti-Corruption Laws” means all laws, rules, and regulations of any jurisdiction applicable to the CHS
Parties or their respective Subsidiaries from time to time concerning or relating to bribery or corruption, including, without limitation, the Foreign Corrupt Practices Act of 1977, as amended, and any applicable law or regulation implementing the
OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions. 

“Applicable Law” means, as to any Person, all statutes, laws, ordinances, rules, and regulations of any
Governmental Entity, in each case applicable to or binding upon the Person or any of its property or to which the Person or any of its property is subject. 

“Assignment and Acceptance” means an assignment and acceptance pursuant to which the assignee agrees to take
an assignment of Revolving Principal Balance from a Lender and become a party to this Agreement, in form and substance satisfactory to the Administrative Agent, entered into by the Lender and such assignee pursuant to
Section 10.06. 

  
 3 

 “Assignment of Agreements” means that certain Assignment of
Agreements, dated as of the Closing Date, among the Buyer, the Borrower and the Administrative Agent in the form attached hereto as Exhibit E, as such agreement may be amended, restated, supplemented or otherwise modified from time to time.

 “Atlantic” has the meaning assigned to that term in the Recitals. 

“Atlantic Lender Group” means the Lender Group for which Atlantic acts as Conduit Lender. 

“Availability” means, at any time, the amount, if positive, by which (a) the lesser of (i) the
Facility Limit in effect or (ii) the Borrowing Base exceeds (b) the aggregate Revolving Principal Balance outstanding hereunder. 

“Bail-In Action” means the exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution
Authority in respect of any liability of an EEA Financial Institution. 
 “Bail-In Legislation” means,
with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the
EU Bail-In Legislation Schedule. 
 “Bankruptcy Law” means the United States Bankruptcy Reform Act of
1978 (11 U.S.C. §§ 101, et seq.) as amended from time to time, or any successor statute, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership,
insolvency, reorganization, or similar debtor relief laws of the United States or other applicable U.S. jurisdictions from time to time in effect and affecting the rights of creditors generally. 

“Base Rate” means, on any day, a fluctuating rate of interest per annum equal to the higher of
(i) the per annum rate of interest equal to the PRBKCHMN Index as published by Bloomberg (or other commercially available source designated by the Administrative Agent) and (ii) 0.50% per annum above the Federal Funds Rate.

 “Borrower” has the meaning assigned to that term in the Recitals. 

“Borrower Notice” means a written notice of the Borrower to the Administrative Agent and each Managing
Agent, in substantially the form attached hereto as Exhibit C-2. 
 “Borrowing
Base” means, at any time, an amount equal to the (i) the Net Receivables Balance minus (ii) the Total Reserves. 

“Borrowing Base Deficiency” means, at any time, the amount, if positive, by which the aggregate Revolving
Principal Balance outstanding hereunder exceeds the lesser of (i) the Facility Limit or (ii) the Borrowing Base. 

“BTMU” has the meaning assigned to that term in the Recitals. 

  
 4 

 “Business Associate Agreement” means an agreement in
substantially the form of Exhibit D, as such agreement may be amended, restated, supplemented or otherwise modified from time to time. 

“Business Day” means a day of the year other than a Saturday or a Sunday on which (a) banks are
required to be open in New York City and (b) if the term “Business Day” is used in connection with the Adjusted Eurodollar Rate, dealings in dollar deposits are carried on in the London interbank market. 

“Buyer” means CHS in its capacity as the buyer under the Sale Agreement. 

“CA-CIB” has the meaning assigned to that term in the
Recitals. 
 A “Change in Control” shall be deemed to have occurred if (a) any “person” or
“group” (within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934 as in effect on the Closing Date), shall own, directly or indirectly, beneficially or of record, shares representing more than 40% of the aggregate ordinary
voting power represented by the issued and outstanding capital stock of the Parent, (b) a majority of the seats (other than vacant seats) on the board of directors of the Parent shall at any time be occupied by persons who were neither
(i) nominated by the board of directors of the Parent nor (ii) appointed by directors so nominated, (c) any change in control (or similar event, however denominated) with respect to the Parent or the Collection Agent (if it is an Affiliate of
the Borrower, any Originator or the Parent) shall occur under and as defined in any indenture or agreement in respect of Material Indebtedness to which such Person is a party (other than, under any indenture or agreement in respect of Material
Indebtedness assumed in connection with a permitted acquisition or any change in control triggered by the permitted acquisition pursuant to which such Material Indebtedness was assumed), or (d) the Parent shall cease to own, directly or indirectly,
beneficially and of record, (i) 100% of the issued and outstanding equity interests of CHS, the Borrower, any Originator (other than the Specified Originators) or the Collection Agent (if it is an Affiliate of the Borrower, any Originator or the
Parent), or (ii) the percentage of the issued and outstanding equity interests of any Specified Originator listed on Schedule VI hereto or such other percentage that is not less than 5% below such percentage listed on Schedule VI. 

“CHS” means CHS/Community Health Systems, Inc., a Delaware corporation. 

“Closing Date” means March 21, 2012. 

“CMS” means the Centers for Medicare and Medicaid Services of the United States Department of Health and
Human Services. 
 “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any
successor and the regulations promulgated and rulings issued thereunder. 
 “Collateral” has the meaning
assigned to such term in Section 2.02. 
 “Collateral Documents” means,
collectively, this Agreement, the Assignment of Agreements, each Control Agreement, each Deposit Account Notification Agreement (Government Healthcare Receivables), and all other security agreements, pledge agreements,

  
 5 

 
guarantees and other similar agreements, and all amendments, restatements, modifications or supplements thereof or thereto, by or between any one or more of the Borrower, and any Lender or the
Administrative Agent for the benefit of the Administrative Agent and the Secured Parties now or hereafter delivered to the Administrative Agent pursuant to or in connection with the transactions contemplated hereby, and all financing statements
against any such Person as debtor in favor of any Lender or the Administrative Agent for the benefit of the Secured Parties, as any of the foregoing may be amended, restated and/or modified from time to time. 

“Collection Account” means an account that is (i) maintained at a bank or other financial institution in the
name of an Originator for the purpose of receiving Collections and (ii) subject to a Deposit Account Notification Agreement (Government Healthcare Receivables). 

“Collection Account Bank” means a bank or other financial institution holding one or more Collection
Accounts, which on the Closing Date shall be Bank of America, N.A., and on the Second Omnibus Amendment Effective Date and thereafter shall be Bank of America, N.A., or Fifth Third Bank, as context requires. 

“Collection Agency Receivable” means a Receivable that has been referred to a third party secondary
collection agency by the Collection Agent. 
 “Collection Agent” means, at any time, the Person or Persons
then authorized pursuant to Article VI to service, administer and collect Receivables, initially Professional Services, in such capacity. 

“Collection Date” means the date following the Termination Date applicable to all Lender Groups then party
hereto on which the aggregate outstanding Revolving Principal Balance under this Agreement has been reduced to zero, all Obligations (other than indemnities that are contingent as to liability) have been paid in full and the Commitments are
terminated. 
 “Collection Period” means a calendar month. 

“Collections” means, with respect to any Receivable, all cash collections and other cash proceeds of such
Receivable, including insurance payments under any insurance policy and all cash proceeds of the Related Security with respect to such Receivable. 

“Commercial Paper” means, with respect to any Conduit Lender, the short-term unsecured promissory notes,
denominated in U.S. Dollars, issued by or on behalf of such Conduit Lender. 
 “Commitment” means, with
respect to each Committed Lender, the commitment of such Committed Lender to make Advances hereunder expressed as a U.S. Dollar amount representing the maximum Revolving Principal Balance for such Committed Lender hereunder (without regard to the
Borrowing Base at any time), as such commitment may be (a) reduced or increased from time to time in accordance with Section 2.04 or Section 10.01 and (b) reduced or increased from time to time, pursuant to assignments
by or to such Committed Lender pursuant hereto. Each Committed Lender’s Commitment is set forth on Schedule I, or in the Assignment and Acceptance pursuant to which such Committed Lender shall have assumed its
Commitment. As of the Third Omnibus Amendment Effective Date, the aggregate amount of the Commitments 

  
 6 

 
is $700,000,000. In the event that the Scheduled Termination Date shall occur solely under clause (a) of such defined term, then on such Scheduled Termination Date the aggregate Commitments
of the Lenders in the Lender Group for which such Scheduled Termination Date has occurred shall be reduced to zero. 

“Committed Lender” means each Person set forth as such in Schedule I to this
Agreement (as such Schedule I may be amended, supplemented or otherwise modified and in effect). 

“Company” means CHS Receivables Funding, LLC, in its capacity as the purchaser and contributee under the
Contribution Agreement. 
 “Concentration Account” means an account, subject to a Control Agreement and
maintained in the name of the Borrower at a Concentration Account Bank for the purpose of receiving transfers from the applicable Collection Accounts and for transacting all banking activities in accordance with the Facility Documents. 

“Concentration Account Bank” means Bank of America, N.A., Fifth Third Bank or, with the prior written
consent of the Administrative Agent, another bank or financial institution. 
 “Conduit Lender” means,
with respect to any Lender Group, the member in such Lender Group which is, or is funded by, a multi-seller commercial paper conduit (and if more than one member in such Lender Group is, or is funded by, a multi-seller commercial paper conduit,
“Conduit Lender” shall mean such members collectively). 
 “Conforming Funding Period”
means any period in the Revolving Period other than during a Deferred Funding Period. 
 “Conforming
Lender” means a Committed Lender other than a Deferred Funding Lender. 
 “Conforming Lender
Group” means a Lender Group other than a Deferred Funding Lender Group. 
 “Contract” means an
insurance policy, contract or other instrument obligating an Obligor to make payment with respect to a Receivable. 

“Contractual Allowances” means, with respect to any Receivable, an amount determined by the Collection Agent
(or, subject and pursuant to Section 6.04(b), the Administrative Agent or any agent designated by the Administrative Agent), set forth in the Monthly Report and approved by the Administrative Agent and Managing Agent in accordance with
Section 6.06 or as otherwise agreed in accordance with Section 2.09(b), by which such Receivable, consistent with the applicable Originator’s historical collection experience, is expected to be reduced prior to payment
thereof by the Obligor, as such amount may be adjusted, upwards or downwards, in the discretion of the Collection Agent. 

  
 7 

 “Contribution Agreement” means that certain Receivables
Purchase and Contribution Agreement dated as of the Closing Date, among the Transferor, the Company and the Collection Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment, the Third Omnibus Amendment, the Fourth Omnibus
Amendment, the Fifth Omnibus Amendment and the Sixth Omnibus Amendment, and as the same may be further amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof, together with all
instruments, documents and agreements executed by any of the CHS Parties party thereto in connection therewith, in each case, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms
thereof and hereof. 
 “Control Agreement” means (a) that certain Deposit Account Control Agreement, dated
as of the Closing Date, among the Borrower, the Administrative Agent and Bank of America, N.A., as the Concentration Account Bank, (b) that certain Deposit Account Control Agreement, dated as of the Second Omnibus Amendment Effective Date, among the
Borrower, the Administrative Agent and Fifth Third Bank, as the Concentration Account Bank, and (c) each other Deposit Account Control Agreement entered into among the Borrower, the Administrative Agent and a Concentration Account Bank, in each case
in form and substance satisfactory to the Administrative Agent, as each such agreement may be amended, modified, supplemented or restated in accordance with its terms and the terms hereof. 

“CP Breakage” means, for any Revolving Principal Balance with respect to a Fixed Period (computed without
regard to any shortened duration of such Fixed Period as a result of the occurrence of the Termination Date applicable to all Lender Groups then party hereto) during which such Revolving Principal Balance is reduced as a result of an Optional
Prepayment or a Mandatory Prepayment, the amount, if any, by which (a) the additional Interest (calculated without taking into account any CP Breakage) which would have accrued on the reduction of such Revolving Principal Balance during such
Fixed Period (as so computed) if such reductions had remained as Revolving Principal Balance or if the applicable Interest Rate had remained unchanged, as the case may be, exceeds (b) the sum of (i) Interest actually received by a Lender
in respect of such Revolving Principal Balance for such Fixed Period and (ii) if applicable, the income, if any, received by such Lender from such Lender’s investing the proceeds of reductions of Revolving Principal Balance. 

“CP Costs” means, with respect to any Conduit Lender, for each day, the sum of (i) discount or interest
accrued on Pooled Commercial Paper for such Conduit Lender on such day that is allocated, in whole or in part, by the related Managing Agent to fund or maintain the Revolving Principal Balance of such Conduit Lender, plus (ii) any and all
accrued commissions in respect of placement agents and dealers, and issuing and paying agent fees incurred, in respect of such Pooled Commercial Paper for such day, plus (iii) other costs associated with funding small or odd-lot amounts with
respect to all receivable purchase or financing facilities which are funded by Pooled Commercial Paper for such day to the extent such Pooled Commercial Paper is allocated, in whole or in part, by the related Managing Agent to fund or maintain the
Revolving Principal Balance of such Conduit Lender. 
 “CP Disruption Event” means the inability of any
Conduit Lender, at any time, whether as a result of a prohibition, a contractual restriction or any other event or circumstance whatsoever, to raise funds through the issuance of its commercial paper notes (whether or not constituting
“Commercial Paper” hereunder) in the United States commercial paper market. 

  
 8 

 “CP Rate” means, with respect to any Conduit Lender for any
Fixed Period and any Revolving Principal Balance with respect thereto, the per annum rate that, when applied to such Revolving Principal Balance for the actual number of days elapsed in such Fixed Period, would result in an amount of accrued
interest equivalent to such Conduit Lender’s CP Costs for such Fixed Period. 
 “Credit and Collection
Policy” means the credit, contracting and collection policies and practices relating to Contracts and Receivables of the Originators previously provided to each Managing Agent, as modified in compliance with Section 6.02(c) of this
Agreement and provided to or accessible to each Managing Agent in electronic format. 
 “Critical Accounting
Policy” means the “Critical Accounting Policy” (as such term is defined in the annual report on Form 10-K of the Parent). 

“Debt” of any Person means (a) indebtedness of such Person for borrowed money, (b) obligations of
such Person evidenced by bonds, debentures, notes or other similar instruments, (c) obligations of such Person to pay the deferred purchase price of property or services beyond ordinary course of business payment terms for trade payables,
(d) obligations secured by a valid Lien upon property or assets owned by such Person, even though such Person has not assumed or become liable for the payment of such obligations and (e) obligations of such Person under direct or indirect
guaranties in respect of, and obligations (contingent or otherwise) to purchase or otherwise acquire, or otherwise to assure a creditor against loss in respect of, indebtedness or obligations of others of the kinds referred to in clauses
(a) through (d) above. 
 “Default” means any event or circumstance that but for notice or
lapse of time or both would constitute an Event of Default. 
 “Default Ratio” means, in respect of any
Collection Period, the ratio (expressed as a percentage) computed as of the Determination Date, by dividing 

(a)      the aggregate Expected Net Value of all Receivables that were Specified
Defaulted Receivables as of the last day of such Collection Period by 

(b)      the aggregate Expected Net Value of all Receivables as of the last day
of such Collection Period. 
 “Defaulted Receivable” means a Receivable: 

(a)      as to which, as of the date that is 150 days after the Last Service
Date, the amount paid thereon is less than the Expected Net Value of such Receivable (other than as a result of a miscalculation by the Collection Agent of Contractual Allowances), 

(b)      as to which the Obligor thereof is currently the subject of an
Insolvency Proceeding, or 

  
 9 

 (c)      which, consistent with the
Credit and Collection Policy, has been or should be written off the Borrower’s or an Originator’s books as uncollectible. 

“Defaulting Lender” means, subject to Section 2.15(b), any Committed Lender that, as determined by
the Administrative Agent or any Managing Agent that is not part of the Lender Group of such Committed Lenders, (a) has failed to fund any portion of an Advance within three Business Days of the date required to be funded by it thereunder, (b) has
notified the Administrative Agent or any Managing Agent in writing that it does not intend to comply with any of its funding obligations under this Agreement or has made a public statement to the effect that it does not intend to comply with its
funding obligations under this Agreement, (c) has failed, within three Business Days after request by the Administrative Agent or a Managing Agent, to confirm that it will comply with its funding obligations hereunder, or (d) has, or has a direct or
indirect parent company that has, (i) become the subject of an Insolvency Proceeding, (ii) had a receiver, conservator, trustee or custodian appointed for it or (iii) become the subject of a Bail-In Action; provided that a Committed Lender shall not
be a Defaulting Lender solely by virtue of the ownership or acquisition of any equity interest in that Committed Lender or any direct or indirect parent company thereof by a Governmental Entity so long as such ownership interest does not result in
or provide such Committed Lender with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Committed Lender (or such Governmental Entity) to
reject, repudiate, disavow or disaffirm any contracts or agreements made with such Committed Lender. 
 “Deferred
Funding Advance Shortfall” means the amount of the Advance that a Deferred Funding Lender Group was requested to fund in a Funding Notice and was not funded on the related Funding Date as a result of the provisions set forth in Section
2.01(h) with respect to Deferred Funding Lenders. 
 “Deferred Funding Amount” means, with respect to
any Deferred Funding Lender and determined as of any Deferred Funding Settlement Date, an amount equal to the Deferred Funding Advance Shortfall. 

“Deferred Funding Certificate” means an Officer’s Certificate delivered by a Managing Agent to the
Collection Agent and the Administrative Agent certifying that a Lender in (or an Affiliate of) such Managing Agent’s Lender Group: (i) is incurring (or expects to incur) charges with respect to its Commitment hereunder in connection with
the calculation of the “liquidity coverage ratio” under Basel III, and (ii) is in good faith seeking to exercise or has exercised a delayed funding option in transactions similar to the transactions contemplated hereunder. 

“Deferred Funding Date” means a Funding Date during a Deferred Funding Period. 

“Deferred Funding De-Designation Date” has the meaning assigned to that term in Section 2.01(h)(i).

 “Deferred Funding De-Designation Notice” has the meaning assigned to that term in
Section 2.01(h)(i). 

  
 10 

 “Deferred Funding Lender” means a Committed Lender that
delivers a Deferred Funding Certificate in accordance with to Section 2.01(h)(i). 
 “Deferred Funding Lender
Agent” means the Managing Agent of a Deferred Funding Lender Group. 
 “Deferred Funding Lender
Group” means any Lender Group that includes a Deferred Funding Lender. 
 “Deferred Funding
Period” means a period in the Revolving Period during which one or more Lender Groups is then currently a Deferred Funding Lender Group. 

“Deferred Funding Settlement Date” means, with respect to unpaid Deferred Funding Amounts of any Deferred
Funding Lender Group, the earlier to occur of (i) a Business Day selected by the applicable Deferred Funding Lender Agent and indicated in its Deferred Funding Certificate that is 32 days (or, if such
32nd day is not a Business Day, not more than the number of days to the next Business Day following such 32nd day) from the applicable Deferred
Funding Date (even if such date occurs following the end of the Revolving Period); and (ii) the Deferred Funding De-Designation Date applicable to such Deferred Funding Lender Group. 

“Delinquency Ratio” means, in respect of any Collection Period, the ratio (expressed as a percentage)
computed as of the Determination Date, by dividing 
 (a)      the
aggregate Expected Net Value of all Delinquent Receivables as of the last day of such Collection Period by 

(b)      the aggregate Expected Net Value of all Receivables as of the last day
of such Collection Period. 
 “Delinquent Receivable” means a Receivable, other than a Defaulted
Receivable, as to which, as of the date that is 120 days after the Last Service Date, the amount paid thereon is less than the Expected Net Value of such Receivable (other than as a result of a miscalculation by the Collection Agent of Contractual
Allowances). 
 “Deposit Account Notification Agreement (Government Healthcare Receivables)” means (a)
that certain Deposit Account Notification Agreement (Government Healthcare Receivables), dated as of the Closing Date, among the Originators party thereto, the Administrative Agent, Bank of America, N.A., as the Collection Account Bank, and, solely
for purposes of Section 11 thereof, CHS, (b) that certain Deposit Account Instructions and Service Agreement, dated as of the Second Omnibus Amendment Effective Date, among the Originators party thereto, the Administrative Agent and Fifth Third
Bank, as the Collection Account Bank, and (c) each other agreement entered into by one or more Originators, the Administrative Agent and a Collection Account Bank providing for, among other things, standing revocable instructions by such Originators
to transfer Collection Account funds to a Concentration Account and notification to the Administrative Agent of any change in such instructions, in each case in form and substance satisfactory to the Administrative Agent, in each case as such
agreement may be amended, modified, supplemented or restated in accordance with its terms and the terms hereof. 

  
 11 

 “Determination Date” means with respect to any Collection
Period, the last day of such Collection Period. 
 “DSO” means, as of the last day of any Collection
Period, the product of (a) the amount obtained by dividing (i) the daily average of the Net Receivables Balance of all Receivables for such Collection Period and the prior two Collection Periods, by (ii) the sum of the cumulative
gross sales of the Originators net of Contractual Allowances for such Collection Period and the prior two Collection Periods, multiplied by (b) 90. 

“EEA Financial Institution” means (a) any credit institution or investment firm established in any EEA
Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution
established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent. 

“EEA Member Country” means any of the member states of the European Union, Iceland, Liechtenstein, and
Norway. 
 “EEA Resolution Authority” means any public administrative authority or any person entrusted
with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution. 

“Electronic Transmission” means each document, instruction, authorization, file, information and any other
communication transmitted, posted or otherwise made or communicated by e-mail (including an “excel” spreadsheet file or PDF file attached to an e-mail) to the extent confirmed received by such recipient thereof, or other equivalent service
acceptable to the Administrative Agent. 
 “Eligible Obligor” means, at any time, an Obligor which is:

 (a)      not an Affiliate of the Borrower, CHS or any Originator; 

(b)      a resident of the United States; 

(c)      not the Obligor of Defaulted Receivables having an Expected Net Value
in an aggregate amount of 25% or more of the aggregate Expected Net Value of all Receivables of such Obligor; 

(d)      not the subject of any Insolvency Proceeding; and 

(e)      an Insurer or a Governmental Entity. 

For the avoidance of doubt, an Obligor that is ineligible pursuant to two or more clauses above shall be counted as ineligible under this
Agreement once, without duplication. 

  
 12 

 “Eligible Receivable” means, at any time, a Receivable: 

(a)      the Obligor of which is an Eligible Obligor; 

(b)      which is not a Delinquent Receivable, a Defaulted Receivable or a
Collection Agency Receivable; 
 (c)      which (i) is an
“account”, including a health-care-insurance receivable, or a general intangible within the meaning of the UCC and is not evidenced by any instrument or chattel paper, (ii) unless it is an Unbilled Receivable, has been invoiced by the
applicable Originator and as to which all performance and other action required to be taken in connection therewith by the applicable Originator (and, if applicable, the Borrower) for the Obligor has been so performed or taken, (iii) is
denominated and payable only in U.S. Dollars, (iv) that has not been compromised in any manner that would reduce the amount payable with respect thereto in any manner not reflected in the Total Reserves or the Contractual Allowances with respect
thereto (including by extension of time of payment) and, in any event, is payable in an amount approximating its Expected Net Value by the Obligor or Obligors identified by the applicable Originator in its records as being obligated to do so,
(v) is net of any deductible limitations, commissions, fees, or other discounts, (vi) is based on an actual and bona fide rendition of services or sale of goods to the patient by the applicable Originator in the ordinary course of business,
(vii) to the extent required under Applicable Law, is subject to a Patient Consent Form executed by the applicable patient, and (viii) satisfies all applicable requirements of, and, in the case of Receivables owed by Governmental Entities or
Insurers, was originated and processed in accordance with, the Credit and Collection Policy or the Critical Accounting Policy, as applicable, and the billing requirements of the applicable Obligor except in any Immaterial Respect; 

(d)      which was transferred to the Buyer under the Sale Agreement by an
Originator that (i) was not at the time of transfer and currently is not the subject of any Insolvency Proceeding and (ii) has not been the subject of a Removal; 

(e)      which was transferred to the Borrower under the Contribution Agreement
by Transferor, who was not at the time of transfer and currently is not the subject of any Insolvency Proceeding; 

(f)      which is not the subject of any action, suit, proceeding or dispute
(pending or threatened), setoff, counterclaim, defense, abatement, suspension, deferment, deductible, reduction or termination by the Obligor thereof (except for statutory rights of Governmental Entities that are not pending or threatened) unless,
in the case of a Receivable from a Governmental Entity, Medicare/Medicaid Cost Report Liability Reserves have been established with respect thereto in an amount in compliance with the Critical Accounting Policy and otherwise reasonably satisfactory
to the Administrative Agent; 
 (g)      which is not based on any cost report
settlement or expected settlement due from any Governmental Entity; 

  
 13 

 (h)      the invoice for the goods
and services constituting the basis for which, has been prepared, delivered and is in a form such that, after application of all relevant Contractual Allowances adjustments have been applied to such Receivable and the invoiced balance thereunder,
the expected payments for the invoiced goods and services will be in an amount approximating the Expected Net Value of such Receivable; 

(i)      the financing of which hereunder is made in good faith and without
actual intent to hinder, delay or defraud present or future creditors of the Borrower or any Originator; 

(j)      the assignment of which (including the grant of a perfected security
interest therein and the assignment of any Related Security) does not contravene or conflict in any material respect with any Applicable Law or any contractual or other restriction, limitation or restriction with regard to confidentiality; 

(k)      the Obligor with respect to which has been directed to make payments on
such Receivable to a Lock-Box or Collection Account; 
 (l)      the Contract
with respect to which, (i) together with such Receivable, does not contravene in any material respect any Applicable Law (including laws, rules and regulations relating to truth in lending, fair credit billing, fair credit reporting, equal credit
opportunity, fair debt collection practices and privacy) and with respect to which no party to the Contract related thereto is in violation of any such Applicable Law in any material respect, (ii) does not contain any provision prohibiting the grant
of a Lien in such payment obligation from the patient to the Originator, from the Originator to the Transferor, from the Transferor to the Borrower or from the Borrower to the Administrative Agent, (iii) has been duly authorized and, together with
such Receivable, constitutes the legal, valid and binding obligation of the Obligor, and (iv) was in full force and effect and applicable to the customer or patient at the time the goods or services constituting the basis for such Receivable were
sold or performed; 
 (m)      with respect to which no consents by any third
party to the grant of a security interest therein are required other than consents previously obtained in writing by the Borrower; 

(n)      as to which the Administrative Agent has not notified the Borrower and
the Collection Agent that the Administrative Agent has determined, in its reasonable business judgment exercised in good faith, that the inclusion of such Receivable (or class of Receivables (other than Medicare or Medicaid)) would have a material
adverse effect on the program; 
 (o)      (i) which, prior to the grant
of an interest therein pursuant to this Agreement, is owned by the Borrower free and clear of any Lien (other than Permitted Liens), and (ii) with respect to which, from and after the grant of an interest therein pursuant to this Agreement, the
Administrative Agent has a properly perfected first priority security interest therein, free and clear of any Lien (other than Permitted Liens) (which, for clarity, will exclude Receivables originated by Kay County Oklahoma Hospital Company, LLC as
“Eligible Receivables” until such time as the Kay County Lien is released and terminated in full); 

  
 14 

 (p)      which is not an Ineligible
Receivable; 
 (q)      which, if it is an Unbilled Receivable, is not within
10 days of the statutory limit for billing and collection applicable to the Obligor thereof and is not aged more than 30 days from its Last Service Date; 

(r)      except for an Unbilled Receivable, all information set forth in the
bill and supporting claim documents with respect to which is true, complete and correct except in any Immaterial Respect, and if additional information is requested by the Obligor, the Borrower (or related Originator) has or will promptly provide
(or cause to be provided) the same, and if any error has been made with respect to such information, the Borrower (or related Originator) will promptly correct the same and, if necessary, rebill such Receivable; 

(s)      with respect to which the Originator’s Medicare or Medicaid cost
reports have been examined and audited or “final settled” or for which a Notice of Program Reimbursement (“NPR”) has been issued by (i) as to Medicaid, the applicable state agency or other CMS designated agent or agents of
such state agency, charged with such responsibility, or (ii) as to Medicare, the Medicare intermediary or other CMS designated agents charged with such responsibility, and there is no basis for any Governmental Entity to assert an offset with
respect to such Receivable, including as the result of any unpaid amounts, with respect to any audit, financial settlement or NPR, except to the extent covered by Medicare/Medicaid Cost Report Liability Reserves; 

(t)      which is not an AccessOne Program Receivable; and 

(u)      which is not an Illinois Medicaid Receivable. 

For the avoidance of doubt, (i) a Receivable or portion of a Receivable that is ineligible pursuant to two or more clauses above shall be
counted as ineligible under this Agreement once, without duplication, (ii) so long as no Default or Event of Default is continuing, an Eligible Receivable that becomes ineligible under any clause hereunder may be resubmitted as an Eligible
Receivable at a future date if and to the extent all qualifications under this definition are satisfied as of the date of resubmission (including curing the basis for the initial determination of ineligibility hereunder). 

“ENV Event” means the date the ENV Ratio falls below 95% for three consecutive Collection Periods.

 “ENV Period” means the period from the first day of the Collection Period commencing immediately after
the occurrence of an ENV Event to the day on which the Collection Agent delivers the updated Monthly Report required by Section 2.09(b). 

“ENV Ratio” means, as of the last day of any Collection Period and set forth in each Monthly Report, the
percentage equivalent of a fraction, the numerator of which is “CHS Collections” received and the denominator of which is “CHS Adjusted Net Revenue” for all hospitals of CHS and its Subsidiaries, in aggregate, on a rolling
twelve-month basis. 

  
 15 

 For the purpose of this definition: 

“CHS Collections” means, as of the last day of any Collection Period, cash collections
actually received by CHS and its Subsidiaries for the 12 month period ended on such date. 
 “CHS
Adjusted Net Revenue” means, as of the last day of any Collection Period, net revenue less bad debt expense (as such terms are used in the consolidated financial statements of Parent and its Subsidiaries) for CHS and its Subsidiaries for
the 12 month period ended on the last day of the immediately preceding Collection Period. 
 “ERISA” means
the Employee Retirement Income Security Act of 1974, as the same may be amended from time to time. 
 “ERISA
Affiliate” means any trade or business (whether or not incorporated) that, together with the Borrower, is treated as a single employer under Section 414(b) or (c) of the Code, or, solely for purposes of Section 302 of ERISA and Section 412
of the Code, is treated as a single employer under Section 414 of the Code. 
 “ERISA Event” means (a) any
“reportable event”, as defined in Section 4043 of ERISA or the regulations issued thereunder, with respect to a Plan (other than an event for which the 30-day notice period is waived), (b) a failure by any Plan to meet the minimum funding
standards (within the meaning of Sections 412 or 430 of the Code or Section 302 of ERISA) applicable to such Plan, in each case whether or not waived, (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA, of an
application for a waiver of the minimum funding standard with respect to any Plan, (d) a determination that any Plan is, or is expected to be, in “at-risk” status (as defined in Section 303(i)(4) of ERISA or Section 430(i)(4) of the Code),
(e) the incurrence by the Borrower or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan or the withdrawal or partial withdrawal of the Borrower or any of its ERISA Affiliates from
any Plan or Multiemployer Plan, (f) the receipt by the Borrower or any of its ERISA Affiliates from the PBGC or a plan administrator of any notice relating to the intention to terminate any Plan or Plans or to appoint a trustee to administer any
Plan, (g) the receipt by the Borrower or any of its ERISA Affiliates of any notice, or the receipt by any Multiemployer Plan from the Borrower or any of its ERISA Affiliates of any notice, concerning the imposition of Withdrawal Liability or a
determination that a Multiemployer Plan is, or is expected to be, insolvent or in reorganization, within the meaning of Title IV of ERISA or in endangered or critical status, within the meaning of Section 432 of the Code or Section 305 of ERISA, (h)
the occurrence of a non-exempt “prohibited transaction” with respect to which the Borrower or any of the Subsidiaries is a “disqualified person” (within the meaning of Section 4975 of the Code) or with respect to which the
Borrower or any such Subsidiary could otherwise be liable or (i) any other event or condition with respect to a Plan or Multiemployer Plan that could result in liability of the Borrower or any Subsidiary. 

  
 16 

 “EU Bail-In Legislation Schedule” means the EU Bail-In
Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time. 

“Eurodollar Disruption Event” means, with respect to any Revolving Principal Balance and any Fixed Period,
any of the following: (a) a determination by any Lender that it would be contrary to law or to the directive of any central bank or other governmental authority (whether or not having the force of law) to obtain U.S. Dollars in the London
interbank market to make, fund or maintain any Advance for such Fixed Period, (b) the inability of CA-CIB to obtain timely information for purposes of determining the Adjusted Eurodollar Rate or
(c) the inability of any Lender to obtain U.S. Dollars in the London interbank market to make, fund or maintain any Advance for such Fixed Period. 

“Event of Default” has the meaning assigned to that term in Section 7.01. 

“Expected Net Value” means, with respect to any Receivable, the sum of (a) the gross unpaid amount of such
Receivable on the date of creation thereof minus (b) all Contractual Allowances with respect to such Receivable; provided that the amount deducted pursuant to clause (b) shall be increased by 25% (i) during an ENV Period or (ii)
if a Monthly Report is not delivered when due in accordance with Section 6.06, during the period from the first Business Day after the date on which such Monthly Report was required to have been delivered until the first Business Day
immediately following the date such Monthly Report is delivered in accordance with Section 6.06. 

“Expected Receivables Default Rate” means, in respect of any Collection Period, the highest three-Collection
Period rolling average Receivables Default Rate over the twelve most recently ended Collection Periods. 

“Facility Documents” means this Agreement, the Collateral Documents, the Sale Agreement, the Contribution
Agreement, the Fee Letter, the Performance Undertaking and all other certificates, instruments, financing statements, registrations, reports, notices, agreements and documents executed or delivered under or in connection with this Agreement, in each
case as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with this Agreement. 

“Facility Limit” means $700,000,000, as such amount may be adjusted from time to time pursuant to
Section 2.04, provided, however, that at all times, on or after the Termination Date applicable to all Lender Groups then party hereto, the “Facility Limit” shall mean the aggregate outstanding
Revolving Principal Balance hereunder. In the event that the Scheduled Termination Date shall occur solely under clause (a) of such defined term, then on such Scheduled Termination Date the Facility Limit shall be reduced by the aggregate
Commitments of the Lenders in the Lender Group for which such Scheduled Termination Date has occurred (as such Commitments were in effect immediately prior to such Scheduled Termination Date).

“FATCA” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or
successor version that is substantively comparable) and any current or future regulations or official interpretations thereof. 

  
 17 

 “Federal Funds Rate” means, for any day, a fluctuating interest
rate per annum equal to the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers, as published for such day (or, if such day is not a Business Day,
for the next preceding Business Day) by the Federal Reserve Bank of New York, or, if such rate is not so published for any day which is a Business Day, the average of the quotations for such day for such transactions received by the Administrative
Agent from three Federal funds brokers of recognized standing selected by it. 
 “Fee Letter” means that
certain fee letter executed among the Borrower, each Managing Agent and the Administrative Agent, dated on or about the Closing Date, as the same may be amended, restated, supplemented or otherwise modified from time to time. 

“Fifth Omnibus Amendment” means that certain Fifth Omnibus Amendment, made as of the Fifth Omnibus Amendment
Effective Date, among the Borrower, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, CA-CIB, as a Managing Agent, as a Committed Lender
and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as Transferor, as
Buyer and individually (as a performance undertaking party), the Originators party thereto and such other parties as are named therein. 

“Fifth Omnibus Amendment Effective Date” means November 13, 2015. 

“Financial Covenant Cure Period” has the meaning assigned to that term in
Section 7.01(r). 
 “First Omnibus Amendment” means that certain First Omnibus
Amendment, made as of July 30, 2012, among the Borrower, as Borrower and as the Company, Scotia, as a Managing Agent, CA-CIB, as a Managing Agent and as Administrative Agent, the Collection Agent, as
Collection Agent under each of this Agreement, the Contribution Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as Transferor and as Buyer, and each of the Initial Originators, as
Originators. 
 “Fitch” means Fitch, Inc., and any successor thereto. 

“Fixed Period” means, for any outstanding Revolving Principal Balance, (a) if Interest in respect of
all or any part thereof is computed by reference to the CP Rate, a period of 1 to and including 31 days, (b) if Interest in respect thereof is computed by reference to the Adjusted Eurodollar Rate, a period of one month and (c) if Interest
in respect thereof is computed at the Alternative Rate, a period of 1 to and including 31 days; provided, however, that (i) any Fixed Period (other than of one day) which would otherwise end on a day which is not a Business Day shall be
extended to the next succeeding Business Day (provided, however, if Interest in respect of such Fixed Period is computed by reference to the Adjusted Eurodollar Rate, and such Fixed Period would otherwise end on a day which is not a Business
Day, and there is no subsequent Business Day in the same calendar month as such day, such Fixed Period shall end on the next preceding Business Day) and (ii) any Fixed Period which commences before the Termination Date applicable to all Lender
Groups then party hereto and would otherwise end on a date occurring after the Scheduled Termination Date applicable to all Lender Groups then party hereto shall end on such Scheduled Termination Date. 

  
 18 

 “Foreign Lender” means any Lender that is organized under the
laws of a jurisdiction other than that in which the Borrower is resident for tax purposes. For purposes of this definition, the United States of America, each State thereof and the District of Columbia shall be deemed to constitute a single
jurisdiction. 
 “Fourth Omnibus Amendment” means that certain Fourth Omnibus Amendment, made as of the
Fourth Omnibus Amendment Effective Date, among the Borrower, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, CA-CIB, as a Managing
Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale
Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), the Originators party thereto and such other parties as are named therein. 

“Fourth Omnibus Amendment Effective Date” means March 31, 2015. 

“Funding Date” has the meaning assigned to that term in Section 2.01(c). 

“Funding Request” means a written request of the Borrower to the Administrative Agent and each Managing
Agent, in substantially the form attached hereto as Exhibit C-1. 
 “GAAP” means
the generally accepted accounting principles in the United States in effect from time to time including, at any time after the adoption thereof in the United States, the generally accepted accounting standards from time to time developed and
approved by the International Accounting Standards Board. 
 “Governmental Entity” means the United States
of America, any state thereof, any political subdivision of a state thereof and any agency or instrumentality of the United States of America or any state or political subdivision thereof and any entity exercising executive, legislative, judicial,
regulatory, or administrative functions of or pertaining to government. Payments from Governmental Entities will be deemed to include payments governed under the Social Security Act (42 U.S.C. §§ 1395 et seq.), including payments
under Medicare, Medicaid and TRICARE/CHAMPUS, and payments administered or regulated by CMS; provided that for purposes of the definition of “Eligible Obligor”, Governmental Entities with respect to Medicaid-related and
Medicare-related Receivables shall be treated as separate entities in the manner identified in the Monthly Report. 

“Healthcare Laws” means all applicable statutes, laws, ordinances, rules, and regulations of any
Governmental Entity with respect to regulatory matters primarily relating to patient healthcare, healthcare providers, and healthcare services (including Section 1128B(b) of the Social Security Act, as amended, 42 U.S.C. § 1320a 7(b)
(Criminal Penalties Involving Medicare or State Health Care Programs), commonly referred to as the “Federal Anti-Kickback Statute,” HIPAA and the Social Security Act, as amended, Section 1877, 42 U.S.C. § 1395nn (Prohibition Against
Certain Referrals), commonly referred to as “Stark Statute”). 

  
 19 

 “HHS Compliance Date” the date established by the United States
Department of Health and Human Services on and after which certain health care entities, including the CHS Parties, are required to have implemented the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) for
diagnosis coding, including the Official ICD-10-CM Guidelines for Coding and Reporting, and the International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for inpatient hospital procedure coding, including the
Official ICD-10-PCS Guidelines for Coding and Reporting. 
 “HIPAA” means the Health Insurance Portability
and Accountability Act of 1996, Pub. L. No. 104-191, the Privacy Standards, the Security Standards, and the Privacy provisions (Subtitle D) of the Health Information Technology for Economic Clinical Health Act, Division A, Title XIII of
Pub. L. 111-5, and its implementing regulations. 
 “Illinois Medicaid Receivable” means any
Receivable with respect to which the Obligor is the State of Illinois or any agency or instrumentality thereof acting through Illinois’ Medicaid agency that arises out of charges reimbursable under Medicaid. 

“Immaterial Respect” means, with respect to (1) any eligibility criteria relating to a Receivable included
in a Funding Request as an Eligible Receivable, any non-compliance with such eligibility criteria that does not result in (i) the diminution in any amount whatsoever (x) in the timely payment or, (y) of the Expected Net Value of such Receivable, or
(ii) the impairment exclusion, elimination or limitation of any material rights, remedies or benefit that otherwise would be available to obtain Collections on such Receivable, or (2) any representation or warranty hereunder, any breach of a
representation or warranty that does not result in (i) the diminution in any amount whatsoever (x) in the timely payment or, (y) of the Expected Net Value of such Receivable, or (ii) the impairment exclusion, elimination or limitation of any
material rights, remedies or benefit that otherwise would be available to obtain Collections on the Receivables. 

“Indemnified Amounts” has the meaning assigned to that term in Section 8.01. 

“Indemnified Parties” has the meaning assigned to that term in Section 8.01. 

“Independent Director” has the meaning assigned to that term in
Section 5.01(h)(ii). 
 “Ineligible Receivable” means a Receivable on the books
and records of an Originator in one of the following financial classes from the list of all financial classes categorized by the Originators set forth on the schedule of financial classes provided to the Administrative Agent on the Closing Date: (i)
Early-Out Blue Cross, (ii) Early-Out HMO/PPO, (iii) Early-Out Other Insurance, (iv) Champus, (v) Workers Comp., (vi) Other Governmental, (vii) Schip Standards, (viii) Schip Nonstandard, (ix) Industrial, (x) Auto Insurance Liability, or (xi) Other
Non-Government. 

  
 20 

 “Initial Originators” means each of the Persons affiliated with
the Parent and party to the Sale Agreement as of the Closing Date as an originator collectively, and “Initial Originator” means any of them individually. 

“Insolvency Proceeding” means, with respect to any Person, any of the following events: (a) any
proceeding shall be instituted by such Person seeking to adjudicate it as bankrupt or insolvent, or seeking liquidation, winding up, reorganization, dissolution, stay of proceedings, arrangement, adjustment, protection, relief, or composition of it
or its debts under any Bankruptcy Law or (b) any proceeding shall be instituted against such Person seeking to adjudicate it a bankrupt or insolvent, or seeking liquidation, dissolution, stay of proceedings, winding up, reorganization, arrangement,
adjustment, protection, relief, or composition of it or its debts under any Bankruptcy Law, and such proceeding (other than with respect to the Borrower) shall remain unstayed for a period of 60 days, or the requested adjudication, relief or other
action sought thereby shall have been made, granted or taken. 
 “Insurer” means any Person (other than a
Governmental Entity) which in the ordinary course of its business or activities agrees to pay for healthcare goods and services received by individuals, including commercial insurance companies, nonprofit insurance companies (such as the Blue Cross,
Blue Shield entities), employers or unions which self insure for employee or member health insurance, prepaid health care organizations, preferred provider organizations, health maintenance organizations or any other similar
Person. “Insurer” includes insurance companies issuing health, personal injury, workers’ compensation or other types of insurance but does not include any individual guarantor. 

“Interest” means, with respect to any Revolving Principal Balance and any Fixed Period, the product of 

 

					
		 	IRP x C x ED	 	
		 	DC	 	

 where: 
  

					
	 C
	    	 =  
	    	 such Revolving Principal Balance as of the last day of such Fixed Period,

			
	 DC
	    	 =  
	    	 360, if the Interest Rate is based on Adjusted Eurodollar Rate or CP Rate, and 365/366 if the Interest Rate is based on the
Base Rate,

			
	 ED
	    	 =  
	    	 the actual number of days elapsed during such Fixed Period, and

			
	 IRP
	    	 =  
	    	 the Interest Rate for such Fixed Period;

 provided, however that (a) no provision of this Agreement shall require the payment or
permit the collection of Interest in excess of the maximum permitted by Applicable Law and (b) Interest shall not be considered paid by any distribution if at any time such distribution is rescinded or must otherwise be returned for any reason.

  
 21 

 “Interest Rate” means, for any Fixed Period and any Revolving
Principal Balance related thereto: 
 (a)      for each day during such Fixed
Period to the extent a Lender will be funding the applicable Advance on such day through the issuance of commercial paper, a rate equal to the CP Rate for such Fixed Period; 

(b)      for each day during such Fixed Period to the extent a Lender will not
be funding or maintaining the applicable Advance on such day through the issuance of commercial paper, a rate equal to the Alternative Rate for such Fixed Period or, at the Administrative Agent’s request, such other rate as the Administrative
Agent, each Managing Agent and the Borrower shall agree to in writing; and 

(c)      during the occurrence of an Event of Default, a rate equal to the sum
of the Base Rate for such Fixed Period plus 2.0%. 
 “Investment” means, with respect to any
Person, any direct or indirect loan, advance or investment by such Person in any other Person, whether by means of share purchase, capital contribution, loan or otherwise, excluding the acquisition of Receivables, Related Security, Collections and
other proceeds thereof (and interests therein) pursuant to the Sale Agreement and the Contribution Agreement and excluding commission, travel and similar advances to officers, employees and directors made in the ordinary course of business. 

“Investment Company Act” means the Investment Company Act of 1940, as amended. 

“IRS” shall mean the Internal Revenue Service and any Person succeeding to the functions thereof. 

“Kay County Lien” means (a) the tax lien evidenced by (i) the Notice of Federal Tax Lien filed against Kay
County Oklahoma Hospital Company, LLC, for a total amount of $9,594,943.55, prepared and signed at Nashville, Tennessee, on October 2, 2012, filed at the Kay County Clerk in the State of Oklahoma and recorded in Book F17, Page 95 on October 9, 2012,
and (ii) the Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital Company, LLC, for a total amount of $9,594,943.55, prepared and signed at Nashville, Tennessee, on October 2, 2012, filed at the Oklahoma County Clerk, in the
state of Oklahoma under filing no. 20121009030027290 on October 9, 2012; and (b) the tax lien evidenced by (i) the Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital Company, LLC, for a total amount of $1,191,207.26, prepared and
signed at Nashville, Tennessee, on November 15, 2012, filed at the Kay County Clerk in the State of Oklahoma and recorded in Book F17, Page 104 on November 26, 2012, and (ii) the Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital
Company, LLC, for a total amount of $1,191,207.26, prepared and signed at Nashville, Tennessee, on November 15, 2012, filed at the Oklahoma County Clerk in the State of Oklahoma under filing no. 20121126030032200 on November 26, 2012. 

“Last Service Date” means, with respect to any Receivable, the date on which the related patient was
discharged from the care of the applicable Originator. 

  
 22 

 “Lender Group” means the Conduit Lender(s) administered by a
financial institution, the related Committed Lenders and their related Managing Agent, as set forth on Schedule I to this Agreement (as such Schedule I may be amended, supplemented or otherwise
modified and in effect). 
 “Lender Group Limit” means, for each Lender Group, the sum of the Commitments
of the Committed Lenders in such Lender Group. 
 “Lender Group Percentage” means, with respect to any
Lender Group, the percentage equivalent of a fraction the numerator of which is the sum of the Commitments held by the Committed Lenders members of such Lender Group and the denominator of which is the sum of all Commitments outstanding. If the
Commitments have terminated or expired, the Lender Group Percentages shall be the percentage equivalent of a fraction the numerator of which is the aggregate Revolving Principal Balance held by the Lenders members of such Lender Group and the
denominator of which is the total Revolving Principal Balance. 
 “Lenders” means collectively, the
Conduit Lenders, the Committed Lenders and any other Person that agrees, pursuant to the pertinent Assignment and Acceptance (other than any such Person that ceases to be a party hereto pursuant to an Assignment and Acceptance), to fund Advances
pursuant to this Agreement (other than any such Person that ceases to be a party hereto as a result of the occurrence of the Scheduled Termination Date solely under clause (a) of such defined term, the payment in full of the Obligations owing to its
related Lender Group and the termination of the Commitments made by its related Lender Group hereunder). 

“Liberty Street” has the meaning assigned to that term in the Recitals. 

“Liberty Street Lender Group” means the Lender Group for which Liberty Street acts as Conduit Lender. 

“Lien” means a lien, assignment, mortgage, pledge, hypothecation, privilege, title retention, security
interest, charge, hypothec, encumbrance or other right or claim of any Person. 
 “Liquidity Agreement”
means an agreement between a Conduit Lender and a Liquidity Provider evidencing the obligation of such Liquidity Provider to provide liquidity or asset purchase facilities in connection with the issuance by such Conduit Lender of Commercial Paper or
the borrowing by such Conduit Lender of the proceeds of Commercial Paper. 
 “Liquidity Provider” means
the Person or Persons who provide liquidity support to a Conduit Lender in connection with the issuance by such Conduit Lender of Commercial Paper or the borrowing by such Conduit Lender of the proceeds of Commercial Paper and each guarantor of any
such Person. Each Liquidity Provider shall be a Committed Lender hereunder, unless the Administrative Agent and the Borrower shall have otherwise consented to such Liquidity Provider in writing (such consent not to be unreasonably withheld).

 “Lock-Box” means a post office box to which Collections are remitted for retrieval by a Collection
Account Bank and deposited by such Collection Account Bank into a Collection Account. 

  
 23 

 “Loss Horizon” means, in respect of any Collection Period, a
ratio equal to (a) the cumulative gross sales of the Originators over the four most recently ended Collection Periods over (b) the Net Receivables Balance at the end of such Collection Period. 

“Loss Reserve” means, at any time, the product of (a) the Loss Reserve Percentage for the most recently
ended Collection Period multiplied by (b) the Net Receivables Balance. 
 “Loss Reserve Percentage”
means, (x) in respect of any Collection Period occurring during the Temporary Trigger Relief Period, the greater of (a) the product of (i) Temporary Trigger Relief Related Expected Receivables Default Rate multiplied by (ii) the
Loss Horizon multiplied by (iii) the Stress Factor and (b) the Loss Reserve Percentage Floor, and (y) in respect of any other Collection Period, the greater of (a) the product of (i) Expected Receivables Default Rate multiplied
by (ii) the Loss Horizon multiplied by (iii) the Stress Factor and (b) the Loss Reserve Percentage Floor. 

“Loss Reserve Percentage Floor” means 20%. 

“Managing Agent” means (i) for the Atlantic Lender Group,
CA-CIB, (ii) for the Liberty Street Lender Group, Scotia, and (iii) for the Victory Lender Group, BTMU. 

“Majority Lenders” means (i) at any time that there are three or less Committed Lenders, 100% of the
Committed Lenders hereunder, and (ii) at all other times, Committed Lenders holding more than 50% of the Commitments hereunder. 

“Mandatory Prepayment” has the meaning given in Section 2.07(e). 

“Material Adverse Effect” means a material adverse change since December 31, 2011 in, or a material adverse
effect upon, (a) the operations, business, properties or financial condition of (i) the Originators taken as a whole, the Borrower or the Collection Agent or (ii) the Parent and its subsidiaries, taken as a whole, (b) the ability of the
Borrower, the Collection Agent, the Parent, CHS or any Material Originator to perform in any material respects their respective obligations under this Agreement or any other Facility Document to which it is a party, or (c) (i) the
legality, validity, binding effect or enforceability of any Facility Document, or (ii) the perfection or priority of any Lien granted under any of the Collateral Documents (other than with respect to an immaterial amount of Collateral and which
the Borrower, applicable Originator, Collection Agent or CHS is diligently disputing by appropriate proceedings). 

“Material Indebtedness” means any Debt (other than any Debt incurred under the Facility Documents) of any
one or more of the Parent or the Collection Agent in an aggregate principal amount exceeding $50,000,000. 

“Material Originator” means, as of any date of determination, any Originator or group of Originators,
collectively, the Receivables of which constitute at least 7.5% of the average of the Net Receivables Balances determined as of the last day of each of the three consecutive Collection Periods occurring immediately prior to such date of
determination. 

  
 24 

 “Medicaid” means the medical assistance program established by
Title XIX of the Social Security Act (42 U.S.C. § 1396 et seq.) and any statutes succeeding thereto. 

“Medicaid Concentration Limit” means, at any time, an amount equal to 20% of the aggregate Expected Net
Value of all Eligible Receivables at the end of the most recent Collection Period; provided that the Medicaid Concentration Limit may be subject to adjustment, upward or downward by the Managing Agents in their sole discretion, following the
implementation of any change in Applicable Law, including Healthcare Law. 
 “Medicaid Excess
Concentration” means, at any time, the amount by which the aggregate Expected Net Value of all Eligible Receivables owing by Governmental Entities under Medicaid at such time exceeds the Medicaid Concentration Limit. 

“Medicare” means the health insurance program for the aged and disabled established by Title XVIII of the
Social Security Act (42 U.S.C. § 1395 et seq.) and any statutes succeeding thereto. 
 “Medicare Concentration
Limit” means, at any time, an amount equal to 45% of the aggregate Expected Net Value of all Eligible Receivables at the end of the most recent Collection Period; provided that the Medicare Concentration Limit may be subject to
adjustment, upward or downward by the Managing Agents in their sole discretion, following the implementation of any change in Applicable Law, including Healthcare Law. 

“Medicare Excess Concentration” means, at any time, the amount by which the aggregate Expected Net Value of
all Eligible Receivables owing by Governmental Entities under Medicare at such time exceeds the Medicare Concentration Limit. 

“Medicare/Medicaid Cost Report Liability Reserve” means, at any time, all Medicare and Medicaid cost report
liabilities as shown on the financial statements of the Originators determined in accordance with the Critical Accounting Policy plus any additional reserves that the Administrative Agent may establish and maintain from time to time in its
reasonable discretion to reflect any claims asserted or threatened by an Obligor that is a Governmental Entity that may result in a setoff, recoupment or other reduction of amounts payable on Receivables. 

“Medicare/Medicaid Expected Net Value” means, at any time, (a) the aggregate Expected Net Value of all
Eligible Receivables owing by Governmental Entities under Medicare with financial class Medicare HMO plus (b) the aggregate Expected Net Value of all Eligible Receivables owing by Governmental Entities under Medicaid with financial class Medicaid
HMO. 
 “Monthly Report” means a report, in substantially the form of Exhibit A,
executed by a Responsible Officer of the Collection Agent and furnished to the Administrative Agent and each Managing Agent pursuant to Section 6.06 or Section 3.02. 

“Monthly Report Due Date” means, with respect to any Collection Period, the 20th day of the calendar month following such Collection Period, or, if such day is not a Business Day, the next succeeding Business Day. 

  
 25 

 “Moody’s” means Moody’s Investors Service, Inc., and
any successor thereto. 
 “Multiemployer Plan” means a multiemployer plan as defined in Section 4001(a)(3)
of ERISA that is contributed to by the Borrower or with respect to which the Borrower has any liability (including on behalf of any ERISA Affiliate). 

“Net Receivables Balance” means, at any time, the aggregate Expected Net Value of all Eligible Receivables,
minus the sum of, (a) in the case of each Obligor that is an Insurer, the applicable Aggregate Excess Concentration for each such Obligor plus (b) the Medicare Excess Concentration plus (c) the Medicaid Excess
Concentration plus (d) the Expected Net Value of all Unbilled Receivables in excess of 20% of the Expected Net Value of all Receivables. 

“Notice” means such notice letter or form delivered by an Originator to an Obligor directing such Obligor to
make payments on Receivables solely into a Collection Account. 
 “Obligations” means all obligations,
liabilities and Debt of every nature of the Borrower from time to time owing to any Secured Party, under or in connection with this Agreement or any other Facility Document, including all principal, interest, fees and Indemnified Amounts, if any, in
each case whether primary, secondary, direct, indirect, contingent, fixed or otherwise and including interest accruing at the rate provided in the applicable Facility Document on or after the commencement by or against the Borrower, the Parent or
any of its other Subsidiaries thereof of any proceeding under Bankruptcy Law naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding. 

“Obligor” means an Insurer or Governmental Entity, as applicable, who is responsible for the payment of all
or any portion of a Receivable. For the avoidance of doubt, the term “Obligor” shall not include any Person that is currently classified in a “self-pay” financial class by the Collection Agent. 

“Optional Prepayment” has the meaning assigned to that term in Section 2.04(d). 

“Originators” means each of the Persons affiliated with the Parent and party to the Sale Agreement as an
originator collectively, and “Originator” means any of them individually. 
 “Other
Taxes” has the meaning assigned to that term in Section 10.10(b). 
 “Parent” means
Community Health Systems, Inc., a Delaware corporation. 
 “Parent Credit Agreement” means that certain
Credit Agreement, dated as of July 25, 2007, as amended and restated as of November 5, 2010, February 2, 2012 and January 27, 2014, and as further amended as of March 9, 2015, among CHS, as borrower, the Parent, the lenders party thereto, and Credit
Suisse AG, as administrative agent and as collateral agent for the lenders, as such agreement may be further amended, modified, supplemented or restated from time to time in accordance with its terms. 

  
 26 

 “Participant Register” has the meaning assigned to that term in
Section 10.06(e)(iv). 
 “Patient Consent Form” means a form signed by each
patient for which a Receivable has been or will be created: (i) with respect to Receivables originated on or prior to September 30, 2012, that is in form and substance consistent in all material respects with those forms used by the applicable
Originator in the ordinary course of its business, and (ii) with respect to Receivables originated after September 30, 2012, that is in form and substance in compliance with Applicable Law to permit an Originator to disclose certain demographic and
health information with respect to each patient to the Originator’s servicing agents and by such servicing agents and to any other Person (including the Administrative Agent and any Collection Agent) in the manner required or otherwise
contemplated under the Facility Documents, except that, to the extent Applicable Law requires the Patient Consent Form to list specific persons or entities who may receive such patient information, such Patient Consent Form need not list the
specific servicing agents or any other Person, including the Administrative Agent or any Collection Agent, in order to satisfy the requirements of this definition. 

“Payment Date” means the fifth Business Day of each month. 

“Payment Denial” means, as to any Receivable, any non-cash adjustment, including price adjustment, disputed
amount or other adjustment for any reason other than a credit related reason made to the Expected Net Value of such Receivable. 

“Payment Denial Rate” means, with respect to any Collection Period, the percentage equivalent of a fraction,
the numerator of which is the aggregate amount of Payment Denials occurring during such Collection Period and the denominator of which is the aggregate Expected Net Value of all Receivables as of the last day of such Collection Period. 

“PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor
entity performing similar functions. 
 “Performance Undertaking” means that certain Collection Agent
Performance Undertaking, dated as of the Closing Date, by CHS in favor of the Administrative Agent, substantially in the form of Exhibit B, as the same may be amended, restated or otherwise modified from time to time. 

“Permitted Investments” means (a) securities issued or directly and fully guaranteed or insured by the
United States government or any agency or instrumentality thereof having maturities of no more than 31 days from the date of acquisition (or, if earlier, maturing no later than the next occurring end of any Fixed Period), (b) time deposits and
certificates of deposit having maturities of no more than 31 days from the date of acquisition (or, if earlier, maturing no later than the next occurring end of any Fixed Period), maintained with or issued by any commercial bank having capital and
surplus in excess of $500,000,000 and having a short-term rating of not less than P-1 or the equivalent thereof from Moody’s, A-1 or the equivalent thereof from S&P, and F1 or the equivalent thereof from Fitch, (c) repurchase
obligations for underlying securities of the types described in clauses (a) or (b) above with a term of not more than 10 days (or, if earlier, the next occurring end of any Fixed Period), and (d) commercial

  
 27 

 
paper maturing within 31 days after the date of acquisition (or, if earlier, maturing no later than the next occurring end of any Fixed Period) and having a rating of not less than P-1 or the
equivalent thereof from Moody’s, A-1 or the equivalent thereof from S&P, and F1 or the equivalent thereof from Fitch. 

“Permitted Liens” means (i) liens for taxes, fees, assessments and other governmental charges that are
not delinquent and in respect of which adequate reserves have been established and (ii) any Lien created by or in connection with any Facility Document. 

“Person” means an individual, partnership, corporation (including a business trust), limited liability
company, joint stock company, trust, unincorporated association, joint venture, government (or any agency or political subdivision thereof) or other entity. 

“Plan” shall mean any employee pension benefit plan (other than a Multiemployer Plan) subject to the
provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, sponsored, maintained or contributed to by the Borrower, or with respect to which Borrower has any liability (including on behalf of any ERISA Affiliate). 

“Pledged Receivable” means any Receivable sold or contributed, or purported to have been sold or contributed
by the Transferor to the Borrower. 
 “Pooled Commercial Paper” means, for each of the Conduit Lenders,
the Commercial Paper notes of such Conduit Lender subject to any particular pooling arrangement by such Conduit Lender, but excluding Commercial Paper issued by such Conduit Lender for a tenor and in an amount specifically requested by any Person in
connection with any agreement effected by such Conduit Lender. 
 “Professional Services” has the meaning
assigned to such term in the Recitals. 
 “ratable”, “ratable share”,
“ratably” (and similar terms) means, the ratable interest of each Lender Group as determined by reference to its Lender Group Percentage. 

“Rating Agency” has the meaning assigned to such term in Section 10.01 of this
Agreement. 
 “Receivables” means all accounts (including health-care-insurance receivables), instruments
and general intangibles, whether now existing or hereafter arising, and all proceeds of any of the foregoing, in each case, consisting of rights of payment arising out of the rendition of medical, surgical, diagnostic or other professional medical
services or the sale of medical products by an Originator in the ordinary course of its business, including all third-party reimbursable portions or third-party directly payable portions of health-care-insurance receivables or general intangibles
owing (or in the case of Unbilled Receivables, to be owing) by an Obligor, including all rights to reimbursement from Obligors under any agreements with Obligors or other Persons and payments from Obligors, together with all books, records, ledger
cards, rights to access and use data processing records, rights to use computer software, and other property at any time used or useful in connection with, evidencing, embodying, referring to, or relating to any of the foregoing in which the
Borrower has acquired an interest pursuant to the Contribution Agreement. For the avoidance of doubt, this definition shall not include any Self Pay Obligation. 

  
 28 

 “Receivables Default Rate” means, in respect of any Collection
Period, the sum of (a) the Payment Denial Rate for such Collection Period plus (b) a fraction the numerator of which is (i) the aggregate Expected Net Value of all Receivables that are between 151 days and 180 days from the Last Service
Date plus (ii) the aggregate Expected Net Value of all Receivables which, consistent with the Credit and Collection Policy, have been written off the Borrower’s or an Originator’s books as uncollectible during such Collection Period
that were less than 151 days from the Last Date of Service, and the denominator of which is the gross sales of the Originators net of Contractual Allowances for the fifth Collection Period preceding such Collection Period. 

“Records” means all Contracts and other documents, books, records and other information (including computer
programs, tapes, disks, punch cards, rights to access and use data processing software and related property and rights) maintained with respect to Receivables and the related Obligors which the Borrower has itself generated, in which the Borrower
has acquired an interest pursuant to the Contribution Agreement or in which the Borrower has otherwise obtained an interest. 

“Register” has the meaning assigned to that term in Section 10.06(d). 

“Regulatory Change” means, relative to any Affected Party: 

(A)      the adoption, change, implementation, change in the phase-in or
commencement of effectiveness after the date hereof of: (i) United States Federal or state law or foreign law applicable to such Affected Party, (ii) regulation (including any applicable law, rule or regulation regarding capital
adequacy), interpretation, rule, directive, requirement or request (whether or not having the force of law) applicable to such Affected Party of (1) any court or government authority charged with the interpretation or administration of any law
referred to in clause (A)(i), or (2) any rating agency, fiscal, monetary or other authority having jurisdiction over such Affected Party, or (iii) GAAP, regulatory accounting principles or any other United States or foreign accounting
standards (or the issuance of any pronouncement, interpretation or release thereunder) by any accounting body or any other body charged with the promulgation or administration of accounting standards, including the Financial Accounting Standards
Board, the International Accounting Standards Board, the American Institute of Certified Public Accountants, the Federal Reserve Board of Governors and the Securities and Exchange Commission, applicable to such Affected Party and affecting the
application to such Affected Party of any law, regulation, interpretation, directive, requirement or request referred to in clause (A)(i) or (A)(ii) above; 

(B)      any change after the date hereof in the application to such Affected
Party of any existing law, regulation, interpretation, directive, requirement, request or accounting principles referred to in clause (A)(i), (A)(ii) or (A)(iii) above or any change in the interpretation, application or administration
thereof by any governmental authority, central bank or comparable agency charged with the interpretation or administration thereof, or compliance with any request or directive (whether or not having the force of law) of any such authority, central
bank or comparable agency; 

  
 29 

 (C)      the issuance, publication
or release after the date hereof of any regulation, interpretation, directive, requirement or request of a type described in clause (A)(ii) above to the effect that the obligations of any Liquidity Provider under the related Liquidity
Agreement are not entitled to be included in the zero percent category of off-balance sheet assets for purposes of any risk-weighted capital guidelines applicable to such Liquidity Provider or any related Affected Party; 

(D)      the compliance, whether commenced prior to or after the date hereof, by
any Affected Party with the requirements of (i) the final rule titled Risk-Based Capital Guidelines; Capital Adequacy Guidelines; Capital Maintenance: Regulatory Capital; Impact of Modifications to Generally Accepted Accounting Principles;
Consolidation of Asset-Backed Commercial Paper Programs; and Other Related Issues, adopted by the United States bank regulatory agencies on December 15, 2009, or any rules, regulations, guidance, interpretations or directives promulgated or
issued in connection therewith by such agency (whether or not having force of law), (ii) the Dodd-Frank Wall Street Reform and Consumer Protection Act adopted by Congress on July 21, 2010, or any existing or future rules, regulations,
guidance, interpretations or directives from the United States bank regulatory agencies relating thereto (whether or not having the force of law) or (iii) all requests, rules, guidelines or directives promulgated by the Bank for International
Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, regardless of the date enacted, adopted or issued, in each
case pursuant to this clause (D), regardless of the date enacted, adopted or issued; or 

(E)      the consolidation, for financial and/or regulatory accounting purposes,
of all or any portion of the assets and liabilities of a Conduit Lender that are the subject of this Agreement, a Liquidity Agreement or any other Facility Document with all or any portion of the assets and liabilities of a Committed Lender, a
Managing Agent or the Administrative Agent or any of their affiliates as a result of the existence of, or the occurrence of any change in, the accounting principles (or the interpretation thereof) referred to in clause (A)(iii) above. 

“Related Security” means with respect to any Receivable: 

(a)      all of the Borrower’s interest in the merchandise (including
returned, repossessed or foreclosed merchandise), if any, relating to the sale which gave rise to such Receivable; 

(b)      all other Liens and property subject thereto from time to time
purporting to secure payment of such Receivable, whether pursuant to the Contract related to such Receivable or otherwise; 

  
 30 

 (c)      the assignment to the
Administrative Agent, for the benefit of the Secured Parties, of all UCC financing statements or similar documents covering any collateral securing payment of such Receivable; 

(d)      all guarantees, indemnities, warranties, letters of credit, insurance
policies and proceeds and premium refunds thereof and other agreements or arrangements of whatever character from time to time supporting or securing payment of such Receivable whether pursuant to the Contract related to such Receivable or
otherwise; 
 (e)      all Records; and 

(f)      all present and future claims, demands, causes and choses in action in
respect of any or all of the foregoing and all payments on or under and all proceeds of every kind and nature whatsoever in respect of any or all of the foregoing, including all proceeds of the conversion, voluntary or involuntary, into cash or
other liquid property, all cash proceeds, accounts, accounts receivable, notes, drafts, acceptances, chattel paper, checks, deposit accounts, securities accounts, insurance proceeds, condemnation awards, rights to payment of any and every kind and
other forms of obligations and receivables, instruments and other property which at any time constitute all or part of or are included in the proceeds of any of the foregoing. 

“Removal” has the meaning set forth in the Sale Agreement. 

“Required Lenders” means (i) at any time that there are three or less Committed Lenders, 100% of the
Committed Lenders hereunder, and (ii) at all other times, Committed Lenders holding more than 80% of the Commitments hereunder. 

“Responsible Officer” means, with respect to any Person, its president, company controller, vice president,
treasurer or chief financial officer designated by resolution of such Person as being authorized to deliver notices, reports and certificates under this Agreement. 

“Revolving Period” means, the period beginning on the Closing Date when all conditions precedent to an
initial Advance have been satisfied and ending on the day preceding the Termination Date applicable to all Lenders then party hereto. 

“Revolving Principal Balance” means, with respect to any Lender at any time, the sum of the outstanding
principal amount of such Lender’s Advances at such time. 
 “Sale Agreement” means that certain
Receivables Sale Agreement, dated as of the Closing Date, among the Originators, the Buyer and the Collection Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment, the Third Omnibus Amendment, the Fourth Omnibus Amendment,
the Fifth Omnibus Amendment and the Sixth Omnibus Amendment, and as the same may be further amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof, together with all instruments,
documents and agreements executed by any of the Originators in connection therewith, in each case, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof. 

  
 31 

 “Sanctions” means economic or financial sanctions or trade
embargoes imposed, administered or enforced from time to time by the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of Treasury, the U.S. State Department, the U.S. Department of Commerce
or the U.S. Department of the Treasury. 
 “Sanctioned Country” means, at any time, a country or territory
that is itself the subject or target of any Sanctions (at the date of this Agreement, Cuba, Iran, North Korea, Sudan and Syria). 

“Sanctioned Person” means (a) any person listed in any Sanctions-related list of specially designated
foreign nationals or other persons maintained by the Office of Foreign Assets Control of the U.S. Department of Treasury, the U.S. State Department, the U.S. Department of Commerce or the U.S. Department of the Treasury or (b) any person controlled
by any such person. 
 “S&P” means Standard & Poor’s Ratings Services, a division of The
McGraw-Hill Companies, Inc., and any successor thereto. 
 “Scheduled Termination Date” means (a) solely
with respect to the Victory Lender Group, November 13, 2017 (provided that, under this clause (a), the Scheduled Termination Date shall occur solely with respect to the Lenders and Managing Agent that are members of such Lender Group on the
Sixth Omnibus Amendment Effective Date, without giving effect to any assignments made after such date in accordance with Section 10.06 of this Agreement, other than any assignment to a Liquidity Provider or to an Affiliate of a Lender in such
Lender Group), and (b) with respect to all other Lender Groups, November 13, 2018, as such date may be extended thereafter in accordance with Section 2.03(a) or Section 10.01. 

“Scotia” has the meaning assigned to that term in the Recitals. 

“Second Omnibus Amendment” means that certain Second Omnibus Amendment, made as of the Second Omnibus
Amendment Effective Date, among the Borrower, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, CA CIB, as a Managing Agent, as a
Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as
Transferor, as Buyer and individually (as a performance undertaking party), and each of the Originators party to the Sale Agreement as of the Second Omnibus Amendment Effective Date, as Originators. 

“Second Omnibus Amendment Effective Date” means March 7, 2013. 

“Secured Party” means, collectively, the Lenders, the Managing Agents, the Administrative Agent, and the
Liquidity Providers. 

  
 32 

 “Self Pay Obligations” means, as of any date, all accounts,
instruments and general intangibles, whether now existing or hereafter arising, that are payable by a Person other than an Obligor and classified in a “self pay” financial class by the Collection Agent as of such date and all proceeds of
any of the foregoing, in each case, consisting of rights of payment arising out of the rendition of medical, surgical, diagnostic or other professional medical services or the sale of medical products by an Originator in the ordinary course of its
business. 
 “Servicer Termination Event” means the occurrence of any of the following: 

(a)      any Event of Default; 

(b)      any withdrawal by the Collection Agent from a Collection Account or a
Concentration Account in contravention of or otherwise not in accordance with the terms of this Agreement or any other Facility Document; 

(c)      any failure on the part of the Collection Agent duly to comply in any
material respect with any of its duties, covenants or obligations hereunder or under any Facility Document or as “Collection Agent” under the Sale Agreement or Contribution Agreement, or under any Contract, any Applicable Law with respect
to any Receivable, or under the standards, duties and obligations set forth in the Credit and Collection Policy, in each case, as determined by the Administrative Agent in the exercise of its reasonable commercial judgment, which failure shall
continue uncured or unwaived for a period of 10 days (if such failure can be remedied) after the earlier to occur of (x) the date on which written notice of such failure shall have been given to the Collection Agent by the Administrative Agent or
the Borrower and (y) the date on which a Responsible Officer of the Collection Agent acquires knowledge thereof; 

(d)      the Collection Agent agrees to or otherwise permits to occur any
material change in the Credit and Collection Policy that is not in compliance with Section 6.02(c); 

(e)      Professional Services assigns its rights or obligations as
“Collection Agent” hereunder to any Person without the consent of the Administrative Agent and the approval of each Managing Agent (as required by Section 6.01); 

(f)      any financial or other information reasonably requested by the
Administrative Agent or any Managing Agent is not provided as requested within a reasonable amount of time following such request; or 

(g)      any representation or warranty made or deemed made by the Collection
Agent or any of its officers under or in connection with this Agreement or any other Facility Document shall have been false, incorrect or misleading in any material respect when made or deemed made. 

“Servicing Fee” has the meaning set forth in the Sale Agreement. 

“Servicing Fee Reserve” means, at any time, an amount equal to the sum of (a) all accrued and unpaid
Servicing Fee plus (b) the product of (i) the Servicing Fee Reserve Ratio and (ii) the aggregate Expected Net Value of all Receivables at such time. 

  
 33 

 “Servicing Fee Reserve Ratio” means the product of
(i) 1.0% multiplied by (ii) the Stress Factor multiplied by (iii) the DSO divided by 360. 

“Sixth Omnibus Amendment” means that certain Sixth Omnibus Amendment, made as of the Sixth Omnibus Amendment
Effective Date, among the Borrower, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, CA-CIB, as a Managing Agent, as a Committed Lender
and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as Transferor, as
Buyer and individually (as a performance undertaking party), the Originators party thereto and such other parties as are named therein. 

“Sixth Omnibus Amendment Effective Date” means November 18, 2016. 

“Specified Defaulted Receivables” means a Receivable: 

(a)      as to which, as of the date that is 150 days after the Last Service
Date, the amount paid thereon is less than the Expected Net Value of such Receivable (other than as a result of a miscalculation by the Collection Agent of Contractual Allowances) and which is between 151 days and 180 days from the Last Service
Date, 
 (b)      as to which the Obligor thereof is currently the subject of
an Insolvency Proceeding, or 
 (c)      which, consistent with the Credit and
Collection Policy, has been or should be written off the Borrower’s or an Originator’s books as uncollectible. 

“Specified Event” means the Events of Default listed in clause (h) or (i) of Section 7.01. 

“Specified Notice” means a notice by the Administrative Agent to the Borrower of the occurrence of a
Specified Event pursuant to Section 7.01. 
 “Specified Originators” means the Originators listed
on Schedule VI, which Schedule also sets forth the percentage ownership of the issued and outstanding equity interests of each such Originator that is held by CHS and its subsidiaries as of the Third Omnibus Amendment Effective Date. 

“Stress Factor” means, (i) for purposes of calculating the Medicare/Medicaid Cost Report Liability Reserve,
1.50, (ii) for purposes of calculating the Loss Reserve, (a) during the Temporary Trigger Relief Period, (x) if the DSO for any Collection Period occurring during the Temporary Trigger Relief Period exceeds 75 days, 3.00, and (y) if the DSO for
the applicable Collection Period and each other Collection Period that has occurred during the Temporary Trigger Relief Period is equal to or less than 75 days, 2.50, and (b) at all other times, 2.50, and (iii) for purposes of calculating the
Yield Reserve and the Servicing Fee Reserve, 7.50. 

  
 34 

 “Subsidiary” of a Person means a corporation, partnership,
joint venture, limited liability company or other business entity of which a majority of the shares of securities or other interests having ordinary voting power for the election of directors or other governing body (other than securities or
interests having such power only by reason of the happening of a contingency) are at the time beneficially owned, or the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such
Person. 
 “Taxes” has the meaning assigned to that term in Section 2.12(a).

 “Temporary Trigger Relief Period” means the period beginning on the Fifth Omnibus Amendment Effective
Date and ending on the Temporary Trigger Relief Period Termination Date, as such period may be extended thereafter in accordance with Section 7.01.

“Temporary Trigger Relief Period Termination Date” means October 31, 2016. 

“Temporary Trigger Relief Related Expected Receivables Default Rate” means, in respect of any
Collection Period, the highest Receivables Default Rate over the twelve most recently ended Collection Periods. 

“Termination Date” means the earliest of (a) the date of termination of the Facility Limit pursuant to
Section 2.04, (b) the date of the declaration or automatic occurrence of the Termination Date pursuant to Section 7.01, and (c) the Scheduled Termination Date (provided that if the
Scheduled Termination Date shall occur solely under clause (a) of such defined term, the Scheduled Termination Date shall occur solely with respect to the Lenders and Managing Agent in the Victory Lender Group on the Sixth Omnibus Amendment
Effective Date, without giving effect to any assignments made after such date in accordance with Section 10.06 of this Agreement, other than any assignment to a Liquidity Provider or to an Affiliate of a Lender in such Lender Group). 

“Termination Declaration Notice” has the meaning assigned to that term in
Section 7.01. 
 “Third Omnibus Amendment” means that certain Third Omnibus
Amendment, made as of the Third Omnibus Amendment Effective Date, among the Borrower, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender,
CA-CIB, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Sale Agreement, and as Authorized Representative (as defined
in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), each of the Originators party to the Sale Agreement as of the Third Omnibus Amendment Effective Date, as Originators, and such other parties
as are named therein. 
 “Third Omnibus Amendment Effective Date” means March 31, 2014. 

“Total Reserves” means, at any time, an amount equal to the sum of (a) the Loss Reserve plus (b) the
Yield Reserve plus (b) the Servicing Fee Reserve plus (d) the product of (i) the Medicare/Medicaid Cost Report Liability Reserve multiplied by (ii) the Stress Factor. 

  
 35 

 “Tranche” has the meaning assigned to that term in
Section 2.05(a). 
 “Transferor” means CHS in its capacity as the Transferor
under the Contribution Agreement. 
 “TRICARE/CHAMPUS” means the Civilian Health and Medical Program of
the Uniformed Service, a program of medical benefits covering former and active members of the uniformed services and certain of their dependents, financed and administered by the United States Departments of Defense, Health and Human Services and
Transportation and established pursuant to 10 USC §§ 1071-1106, and all regulations promulgated thereunder including (1) all federal statutes (whether set forth in 10 USC §§ 1071-1106 or elsewhere) affecting TRICARE/CHAMPUS, and
(2) all rules, regulations (including 32 CFR 199), manuals, orders and administrative, reimbursement, and other guidelines of all Governmental Entities (including the Department of Health and Human Services, the Department of Defense, the Department
of Transportation, the Assistant Secretary of Defense (Health Affairs), and the Office of TRICARE/CHAMPUS, or any Person or entity succeeding to the functions of any of the foregoing) promulgated pursuant to or in connection with any of the
foregoing (whether or not having the force of law) in each case as may be amended, supplemented or otherwise modified from time to time. 

“Trigger Event” means the occurrence of (i) a Default or an Event of Default, (ii) a Servicer
Termination Event or any event or circumstance that but for notice or lapse of time or both would constitute a Servicer Termination Event, or (iii) the date three Business Days following an ENV Event. 

“UCC” means the Uniform Commercial Code as from time to time in effect in the specified jurisdiction. 

“U.S. Dollars” or “US $” means the lawful currency of the United States of America. 

“Unbilled Receivable” means a Receivable in respect of which the goods have been shipped, or the services
rendered, to the relevant customer or patient, rights to payment thereon have accrued, but the invoice has not been rendered to the applicable Obligor. 

“United States” or “U.S.” means the United States of America. 

“Unused Fee” means the fee payable by the Borrower and identified as the “Unused Fee” in
the Fee Letter. 
 “Used Fee” means the fee payable by the Borrower and identified as the “Used
Fee” in the Fee Letter. 
 “Victory” has the meaning assigned to that term in the Recitals. 

“Victory Lender Group” means the Lender Group for which Victory acts as Conduit Lender. 

  
 36 

 “Volcker Event” means the occurrence of an Event of Default
pursuant to Section 7.01(v). 
 “Volcker Extension Period” has the meaning assigned to that term in
Section 7.02. 
 “Volcker Rule” means Section 619 of the Dodd-Frank Wall Street
Reform and Consumer Protection Act, Pub. L. 111-203 (2010), together with the interpretations, regulations, rules and pronouncements of any Governmental Authority with respect thereto. 

“Withdrawal Liability” shall mean liability to a Multiemployer Plan as a result of a complete or partial
withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA. 

“Write-Down and Conversion Powers” means, with respect to any EEA Resolution Authority, the write-down and
conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule. 

“Yield Reserve” means, at any time, an amount equal to the sum of (a) all accrued and unpaid Interest
plus (b) the product of (i) the Yield Reserve Ratio multiplied by (ii) the lesser of (x) the Borrowing Base and (y) the Facility Limit. 

“Yield Reserve Ratio” means the product of (i) the Base Rate multiplied by (ii) the Stress
Factor multiplied by (iii) the DSO divided by 360. 
 SECTION
1.02.      Other Terms. All terms used in Article 9 of the UCC in the State of New York, and not specifically defined herein are used herein as defined in such Article 9. The words
“herein,” “hereof,” and “hereunder” and other words of similar import refer to this Agreement as a whole, including the exhibits and schedules hereto, as the same may from time to time be amended or supplemented and not
to any particular section, subsection, or clause contained in this Agreement, and all references to Sections, Exhibits and Schedules shall mean, unless the context clearly indicates otherwise, the Sections hereof and the
Exhibits and Schedules attached hereto, the terms of which Exhibits and Schedules are hereby incorporated into this Agreement. Whenever appropriate, in the context, terms used herein in the singular also include the plural,
and vice versa. The words “including”, “included” and words of similar impact are not limiting. 

SECTION 1.03.      Accounting Terms and Principles. All accounting terms not
specifically defined herein shall be construed in accordance with GAAP, and all accounting determinations required to be made pursuant hereto and all financial statements prepared hereunder shall, unless expressly otherwise provided herein, be made
in accordance with GAAP. If there occurs after the date hereof any change in GAAP that affects in any respect the calculation of any financial ratio or covenant, the Administrative Agent, the Lenders and the Borrower shall negotiate in good
faith any amendment required in the Facility Documents with the intent of having the respective positions of the Administrative Agent, the Lenders and the Borrower after such change conform as nearly as possible to their respective positions as of
the date of this Agreement and, until any such amendments have been agreed upon, all calculations shall be made as if no change in GAAP has occurred. 

  
 37 

 SECTION 1.04.      Computation of Time
Periods. Unless otherwise stated in this Agreement, in the computation of a period of time from a specified date to a later specified date, the word “from” means “from and including” and the words “to” and
“until” each mean “to but excluding.” 
 SECTION
1.05.      Computation of Ratios. To the extent that any ratio, percentage or other amount hereunder is computed as a rolling average on the basis of data and computations for the current month or Collection
Period and a specified number of prior months or Collection Periods, and such prior months or Collection Periods include one or more months or Collection Periods ending prior to the Closing Date, the relevant ratio, percentage or other amount shall
be computed assuming that each such month or Collection Period preceding the Closing Date in fact fell after the Closing Date. 
 ARTICLE II

 THE LOAN FACILITY. 

SECTION 2.01.      Advances; Interest. 

(a)      On the terms and conditions hereinafter set forth, the Borrower may, by delivery of a
Funding Request to the Administrative Agent and each Managing Agent, from time to time on any Business Day during the Revolving Period, at its option, request that the Lenders make advances (each, an “Advance”) to the Borrower in an
amount which, at any time, shall not exceed the Availability in effect on the related Funding Date. Upon receipt of such Funding Request, each Managing Agent shall promptly forward such request to its related Lenders. All Advances will be
made in U.S. Dollars. The Borrower shall pay Interest with respect to each Advance or portion thereof for each day from and including the date such Advance is made to and excluding the date it is repaid in full in cash hereunder.

(b)      Each Funding Request shall: (i) specify the aggregate amount of the
requested Advance, which shall be in an amount equal to at least $1,000,000 with increments of $50,000 thereafter, (ii) specify the outstanding amount of Advances under this Agreement, and (iii) contain representations and warranties that
all conditions precedent for a funding have been met, including a representation by the Borrower that the requested Advance shall not, on the Funding Date thereof, exceed the Availability on such day. 

(c)      Such Funding Request shall be delivered not later than 12:00 noon (New York City time)
on the date which is one Business Day prior to the Business Day on which such Advance is requested to be made by Lenders not part of a Deferred Lending Group (each, a “Funding Date”) (or such lesser amount of time as may be approved
by each Lender, in its respective sole discretion). 
 (d)      A Funding Request shall be
irrevocable when delivered. 

  
 38 

 (e)      The applicable portion of the Advance
(i) may be made by the related Conduit Lender, in its sole discretion or (ii) if the related Conduit Lender does not fund, shall be made by the related Committed Lender, in each case, in accordance with its individual Commitment, if
applicable, and its Lender Group Percentage (subject to, during a Deferred Funding Period, the provisions of Section 2.01(h) below with respect to Deferred Funding Lenders). Notwithstanding anything contained in this
Section 2.01 or elsewhere in this Agreement to the contrary, no Lender shall be obligated to make any Advance in an amount that would result in the aggregate Advances then funded by the related Lender Group exceeding such
Lender Group’s Lender Group Limit then in effect. 
 (f)      The obligation of the
Lenders members of each Lender Group to remit such Lender Group’s Lender Group Percentage of any such Advance shall be several from that of each other Lender Group, and the failure of any Lender to so make such amount available to the Borrower
shall not relieve any other Lender of its obligation hereunder. 
 (g)      On each Funding
Date during a Conforming Period, following the satisfaction of the applicable conditions set forth in this Section 2.01 and Article III, each Lender shall make available to its related Managing
Agent, for deposit to the account of the Borrower or its designee in same day funds, at the account specified in the Funding Request, an amount equal to such Lender’s ratable share of the Advance then being made. During a Deferred Funding
Period, following the satisfaction of the applicable conditions set forth in this Section 2.01 and Article III (i) on each Deferred Funding Date, each Lender member of a Conforming Lender Group
shall make available to its related Managing Agent, for deposit to the account of the Borrower or its designee in same day funds, at the account specified in the Funding Request, an amount equal to such Lender’s ratable share of the Advance
then being made, and (ii) on each Deferred Funding Settlement Date, each Deferred Funding Lender shall make available Advances in accordance with the provisions of Section 2.01(h). Each Lender shall use commercially reasonable
efforts to initiate each wire transfer of an Advance to the Borrower no later than 12:00 noon (New York City time) on the applicable Funding Date, Deferred Funding Date or Deferred Funding Settlement Date, as applicable. Each Lender agrees that
either (i) no portion of any Advance shall be funded or held with “plan assets” of any “benefit plan investor” within the meaning of Section 3(42) of ERISA or (ii) the funding and holding of any portion of any Advance shall not
constitute or result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code. 

(h)      Special Provisions for Deferred Fundings. 

(i)      At any time, three Business Days after receipt by the Administrative Agent and the
Collection Agent of a Deferred Funding Certificate from a Managing Agent, the related Committed Lender shall become a “Deferred Funding Lender” and its related Lender Group shall become a “Deferred Funding Lender
Group”. Such designation shall remain in effect until such time as the related Deferred Funding Lender Agent issues a written notice to the Administrative Agent and the Collection Agent withdrawing such designation (a “Deferred
Funding De-Designation Notice”) effective as of the date such notice is delivered or as of such later date specified therein (such effective date, the “Deferred Funding De-Designation Date”). Effective as of the
Deferred Funding De-Designation Date, each Committed Lender that is a Deferred Funding Lender, and each related Lender Group that is a Deferred Funding Lender Group, shall cease to be a Deferred Funding Lender or a Deferred Funding Lender Group, as
applicable, and shall, for all purposes other than pursuant to the 

  
 39 

 
proviso hereto, be deemed to be a Conforming Lender and a Conforming Lender Group, as applicable; provided that in connection with any Advance outstanding as of the Deferred Funding
De-Designation Date for which any Deferred Funding Lender has not, as of such date, paid its Deferred Funding Amounts, such Deferred Funding De-Designation Date shall be deemed to be the Deferred Funding Settlement Date for such Advance and such
Deferred Funding Lender shall comply with its obligations pursuant to Section 2.01(h)(ii) and Section 2.01(h)(iii) for such Deferred Funding Settlement Date. 

(ii)      On each Deferred Funding Settlement Date, each Deferred Funding Lender shall make
available to its Managing Agent the Deferred Funding Amount, which amount (1) if such Deferred Funding Settlement Date occurs prior to the occurrence and continuance of an Event of Default or the Termination Date applicable to all Deferred Funding
Lenders hereunder, shall be deposited in the account of the Borrower or its designee as an Advance hereunder, and (2) if such Deferred Funding Settlement Date occurs following the occurrence and during the continuance of an Event of Default or the
Termination Date applicable to all Deferred Funding Lenders hereunder, shall be paid to the Administrative Agent for distribution on the same Business Day to the Lenders (including such Deferred Lender) ratably (calculated presuming that all
unfunded Deferred Funding Advance Shortfalls of any other Deferred Funding Lender Groups have been fully funded); provided that such Deferred Funding Lender shall not fund to the Administrative Agent and shall instead net out of its ratable portion
of the Deferred Funding Amount any amounts that it is entitled to receive from the Administrative Agent under this clause (h)(ii)(2); provided, in no event shall any such payment reduce the Revolving Principal Balance of any Lender or Lender
Group below zero. Upon the payment of the Deferred Funding Amount in accordance with the provisions of clause (ii)(2) above and without any further action on the part of such Deferred Funding Lender making such payment, the Borrower, the
Administrative Agent or the other Lenders, the Deferred Funding Lender making such payment will have acquired, and each Lender receiving a distribution of a portion of such payment will have granted to such Deferred Funding Lender, without
recourse or warranty, its portions of the Revolving Principal Balances that were reduced by application of the distribution of such Deferred Funding Amount by the Administrative Agent. The Revolving Principal Balance owing to each Lender member of a
Lender Group other than such Deferred Funding Lender’s Deferred Funding Lender Group shall be reduced by the amount of any portion of such payment received by such Lender and the Revolving Principal Balance owing to the Deferred Funding Lender
making such payment shall be increased by all amounts so paid such that the aggregate Revolving Principal Balance of all Lenders outstanding hereunder immediately prior to such payment and distribution shall be unchanged and shall continue to equal
to the aggregate Revolving Principal Balance of all Lenders outstanding hereunder immediately following such payment and distribution. 

(iii)      The obligation of each Deferred Funding Lender to fund the Deferred Funding Amount
on the related Deferred Funding Settlement Date is subject to any valid and timely claims of a Deferred Funding Lender under clause (iv) below, but is otherwise absolute and unconditional and shall not be affected by any circumstance
whatsoever, including (1) any setoff, counterclaim, recoupment, defense or other right which such Deferred Funding Lender may have against the Administrative Agent, the other Lenders, the Borrower, or any other Person for any reason whatsoever; (2)
the occurrence or continuance of an Default, Event 

  
 40 

 
of Default or Termination Date; (3) the termination of the Revolving Period, (4) the reduction or termination of any Commitments; or (5) any other occurrence, event, or condition, whether or not
similar to any of the foregoing (in each case, so long as such Advance does not result in the aggregate Advances then funded by the related Deferred Funding Lender Group exceeding such Deferred Funding Lender Group’s Lender Group Limit then in
effect. The funding or failure to fund the Deferred Funding Amount will not relieve or otherwise impair the obligation of the Borrower to repay the Revolving Principal Balance of each Lender, together with interest as provided in this
Agreement. 
 (iv)      A Deferred Funding Lender may not object to its funding obligation of
Deferred Funding Amounts under Section 2.01(g) and (h) on the basis of the failure of the Borrower to satisfy the conditions precedent set forth in this Section 2.01 and Article III
as of the Deferred Funding Date so long as all such conditions were satisfied as of the related Funding Date; provided that the absolute and unconditional funding obligations of a Deferred Funding Lender of Deferred Funding Amounts set forth
in this Section 2.01 do not constitute a waiver of any rights of such Deferred Funding Lender or of rights and remedies of the Administrative Agent and the Lenders (including such Deferred Funding Lender) against the Borrower, in each case,
as set forth hereunder. 
 (v)      Each Deferred Funding Lender acknowledges that the
Conforming Lender Groups have relied on the obligation of the Deferred Funding Lender to fund the Deferred Funding Amount in making Advances hereunder and is an intended beneficiary of such obligation. 

SECTION 2.02.      Security for Obligations. 

(a)      As security for the payment in full and performance of all Obligations, the Borrower
hereby pledges, grants a security interest in, and collaterally assigns to the Administrative Agent, for the benefit of the Lenders and the other Secured Parties, all of its right and title to and interest in all of its property of any kind and
nature, whether now owned or existing or hereafter arising or acquired and wheresoever located, including the following property and interests in property (collectively, the “Collateral”): 

(i)       all Receivables of the Borrower; 

(ii)      all Related Security relating to such Receivables; 

(iii)     all Collections with respect to, and other proceeds of, all such
Receivables; 
 (iv)     all of the Borrower’s rights, remedies, powers,
privileges and claims (as an initial assignee under the Assignment of Agreements) under or with respect to the Contribution Agreement (whether arising pursuant to the terms of the Contribution Agreement or otherwise available to the Borrower at law
or in equity), including the rights of the Borrower to enforce the Contribution Agreement and to give or withhold any and all consents, requests, notices, directions, approvals, extensions or waivers under or with respect to the Contribution
Agreement, each UCC financing statement filed by the Borrower against the Transferor under or in connection with the Contribution Agreement, and each UCC financing statement filed by the Transferor against the applicable Originators under or in
connection with the Sale Agreement; 

  
 41 

 (v)      all of the
Borrower’s rights, remedies, powers, privileges and claims under or with respect to the Sale Agreement (whether arising pursuant to the terms of the Sale Agreement or otherwise available to the Borrower by assignment at law or in equity),
including the rights of the Borrower to enforce the Sale Agreement and to give or withhold any and all consents, requests, notices, directions, approvals, extensions or waivers under or with respect to the Sale Agreement and each UCC financing
statement filed by the Borrower against the applicable Originator under or in connection with the Sale Agreement; 

(vi)     all of the Borrower’s rights, remedies, powers, privileges and claims
under or with respect to the Performance Undertaking (whether arising pursuant to the terms of the Performance Undertaking or otherwise available to the Borrower at law or in equity), including the rights of the Borrower to enforce the Performance
Undertaking and to give or withhold any and all consents, requests, notices, directions, approvals, extensions or waivers under or with respect to the Performance Undertaking; 

(vii)     to the maximum extent permitted by Applicable Law, all of the
Borrower’s rights, remedies, powers, privileges and claims under or with respect to each Concentration Account and each Collection Account and Lock-Box in which it has an interest (whether arising pursuant to the terms of the agreements
relating to such account or lock-box or otherwise available to the Borrower at law or in equity) including the rights of the Borrower to enforce its rights in and to the Concentration Accounts, the Collection Accounts and the Lock-Boxes and to give
or withhold any and all consents, requests, notices, directions, approvals, extensions or waivers with respect to any Concentration Account, any Collection Account or any Lock-Box, and all funds, financial assets and other property from time to time
on deposit in or credited to each Concentration Account, each Collection Account and each Lock-Box, and in all investments and proceeds thereof, but in each case excluding all collections on or proceeds of Self Pay Obligations on deposit therein or
credited thereto; 
   (viii)   all deposit accounts, securities accounts,
investment property, accounts, chattel paper, documents, goods, general intangibles, payment intangibles, instruments, letter-of-credit rights, inventory, contract rights, equipment, money, cash and cash equivalents, and all other personal property
of whatever kind or nature whatsoever; 
   (ix)     all books, records, and
other property related to or referring to any of the foregoing, including books, records, account ledgers, data processing records, computer software, and other property and general intangibles at any time evidencing or relating to any of the
foregoing; and 

  
 42 

   (x)      all present and
future claims, demands, causes and choses in action in respect of any or all of the foregoing and all payments on or under and all proceeds of every kind and nature whatsoever in respect of any or all of the foregoing, including all proceeds of the
conversion, voluntary or involuntary, into cash or other liquid property, all cash proceeds, accounts, accounts receivable, notes, drafts, acceptances, chattel paper, checks, deposit accounts, securities accounts, insurance proceeds, condemnation
awards, rights to payment of any and every kind and other forms of obligations and receivables, instruments and other property which at any time constitute all or part of or are included in the proceeds of any of the foregoing. 

(b)      The Borrower agrees that from time to time, at its expense, it will, and will direct
the Collection Agent, the Transferor pursuant to the Contribution Agreement and the applicable Originator pursuant to the Sale Agreement to promptly execute and deliver all further instruments and documents, and take all further action that the
Administrative Agent may reasonably request in order to perfect, protect or more fully evidence the interest in the Collateral acquired by the Administrative Agent, for the benefit of the Lenders and the other Secured Parties hereunder, or to enable
the Administrative Agent to exercise or enforce any of its rights hereunder. Without limiting the generality of the foregoing, the Borrower will upon the request of the Administrative Agent, and will direct the Collection Agent, the Transferor
and the applicable Originator to: (i) execute and file such financing or continuation statements, or amendments thereto or assignments thereof, and such other instruments or notices, as may be necessary or appropriate or as the
Administrative Agent may reasonably request, and (ii) mark its master data processing records evidencing such Receivables and related Contracts and other Related Security in a manner reasonably acceptable to the Administrative Agent, that
evidences that the Administrative Agent, on behalf of the Lenders and the other Secured Parties shall have acquired a security interest therein as provided in this Agreement. The Administrative Agent agrees that marking each financial class of
Receivables that does not fall under the definition of “Ineligible Receivable” shall be acceptable. 

(c)      The Borrower hereby authorizes the Administrative Agent to file one or more financing
or continuation statements, and amendments thereto and assignments thereof, relative to all or any of the Collateral now existing or hereafter arising without the signature of the Borrower where permitted by law, including any financing statement
describing the Collateral as “all assets” of the Borrower. The parties intend this Agreement to be a “security agreement” within the meaning of the UCC. 

(d)      Subject to Applicable Law, the Borrower shall, upon the request of the Administrative
Agent, at any time from and after an Event of Default and at the Borrower’s expense, notify the Obligors of Receivables, or any of them, or other obligors under any of the Collateral, of the Administrative Agent’s interest in the
Receivables and other Collateral, as applicable. 
 (e)      If the Borrower fails to perform
any of its agreements or obligations under this Section 2.02, the Administrative Agent may (but shall not be required to) itself perform, or cause performance of, such agreement or obligation, and the expenses of the
Administrative Agent incurred in connection therewith shall be payable by the Borrower upon the Administrative Agent’s demand therefor in accordance with Section 2.07 or 2.08, as applicable. 

  
 43 

 SECTION 2.03.      Extension of the
Facility. 
 (a)      The Borrower may, within 120 days, but no later than 60 days, prior
to each one-year anniversary of the Fifth Omnibus Amendment Effective Date, by written notice to the Administrative Agent, make written requests for the Lenders to extend the then-current Scheduled Termination Date applicable to such Lenders for an
additional 364 days. The Administrative Agent shall provide notice of such request promptly to each Managing Agent. 

(b)      Each Managing Agent shall give prompt notice to each of the Lenders in its related
Lender Group of its receipt of such request for extension of the Scheduled Termination Date. Each Lender shall make a determination, in its sole discretion and after a full review as to whether or not it will agree to extend the Scheduled
Termination Date; provided, however, that each Lender’s determination shall be made no later than 60 days after the date of the Borrower’s notice to the Administrative Agent of such request for extension; provided further
that the failure of any Lender to make a timely response to the Borrower’s request for extension of the Scheduled Termination Date shall be deemed to constitute a refusal by such Lender to extend the Scheduled Termination Date. 

(c)      In the event that any of the existing Lenders agree to extend the Scheduled
Termination Date, or to assign their Commitment prior to the Scheduled Termination Date to a Lender agreeing to extend the Scheduled Termination Date, the Borrower, the Collection Agent, the Administrative Agent and such extending Lenders shall
enter into such documents as the Administrative Agent and such Lenders may deem necessary or appropriate to reflect such extension, and all reasonable costs and expenses incurred by such Lenders and the Administrative Agent (including reasonable
attorneys’ and auditors’ fees) shall be paid by the Borrower. 
 SECTION
2.04.      Optional Reduction in Facility Limit; Optional Prepayments and Mandatory Prepayments. 

(a)      On any Payment Date (or, solely in the case of the reduction of the Facility Limit in
whole, on any Business Day), the Borrower shall be entitled at its option, to reduce the Facility Limit in whole or in part; provided that (i) the Borrower shall give written notice of such reduction to the Administrative Agent and each
Managing Agent at least three Business Days prior to the date of such reduction, (ii) no Borrowing Base Deficiency shall exist as a result of such reduction, (iii) any partial reduction of the Facility Limit shall be in an amount equal to
$25,000,000 with integral multiples of $5,000,000 above such amount, (iv) the Facility Limit shall not be reduced below $100,000,000 unless such reduction is in connection with the termination of all Commitments and the prepayment in full of
all Obligations (other than Obligations that are contingent as to liability) and (v) in the case of the reduction of the Facility Limit in whole on any date other than a Payment Date, the Borrower shall give written notice of its intent to reduce
the Facility Limit in whole at least thirty (30) days prior to the date of such reduction, which shall be followed by the notice to be made pursuant to clause (i) of this proviso confirming the date of such reduction. 

  
 44 

 (b)      The Lenders hereby agree that any
reduction in the Facility Limit shall reduce the Commitment of each Lender ratably in proportion to any such reduction in the Facility Limit; provided that, if there is a Defaulting Lender at the time of such reduction, the Borrower may at
its option direct that such reduction be applied first to reduce the Commitment of the Defaulting Lender to (but not below) the Revolving Loan Balance owing such Defaulting Lender and then applied to reduce the Commitments of the remaining Lenders
ratably; provided, further, that if such reduction is made pursuant to the last sentence of the defined term “Facility Limit” or otherwise as the result of the occurrence of the Scheduled Termination Date solely under clause
(a) of such defined term, such reduction shall be applied solely to reduce the aggregate Commitments of the Lenders in the Lender Group for which such Scheduled Termination Date has occurred (as such Commitments were in effect immediately prior to
such Scheduled Termination Date) unless a Trigger Event has occurred and is continuing or would result. 

(c)      Any request for a reduction or termination pursuant to this
Section 2.04 shall be irrevocable. 
 (d)      From time to time
during the Revolving Period, the Borrower may prepay (an “Optional Prepayment”) any portion or all of the Advances by the Borrower delivering a Borrower Notice to the Administrative Agent and each Managing Agent at least one
Business Day prior to the date of such Optional Prepayment (or, in each case, such later time as the applicable Lenders, in their respective sole discretion, may agree), specifying the date and amount of the Optional Prepayment. 

(e)      If the Borrower Notice relating to any Optional Prepayment is given, the amount
specified in the Borrower Notice shall be due and payable on the date specified therein. Payments of Interest accrued to the applicable payment date on the amount prepaid and any CP Breakage shall be made on the next Payment Date following such
repayment. Any partial Optional Prepayment by the Borrower of Advances hereunder, other than with respect to Mandatory Prepayments, shall be in a minimum amount of $1,000,000 with integral multiples of $100,000 above such amount. Any
amount so prepaid may, subject to the terms and conditions hereof, be reborrowed during the Revolving Period. A Borrower Notice relating to any such Optional Prepayment shall be irrevocable two Business Days prior to the date of prepayment
specified therein. 
 (f)      The aggregate outstanding Advances and all other Obligations
shall be repaid in accordance with Section 2.07, and shall be due and payable in full on the Termination Date applicable to all Lender Groups then party hereto. 

SECTION 2.05.      Selection of Fixed Periods. 

(a)      All Advances shall, for purposes of calculating Interest, be allocated to one or more
“Fixed Periods” as set forth in the definition of such term, and each such portion allocated to a particular Fixed Period is referred to herein as a “Tranche” (each, a “Tranche”). 

(b)      Each Tranche shall reflect the funding sources for the outstanding principal balance
of Advances associated therewith so that (i) there may be one or more Tranches, selected by the applicable Managing Agent, reflecting the portion of the outstanding principal balance of Advances funded by a funding made by a liquidity or credit
support provider 

  
 45 

 
to the Lender and (ii) there may be one or more Tranches allocated to the portion of the outstanding principal balance of Advances funded by the Commercial Paper of a Conduit
Lender. For avoidance of doubt, amounts outstanding in any Tranche may be combined with other Tranches from time to time in the discretion of the Managing Agent to reflect the applicable funding sources for such Tranches as described above.

 SECTION 2.06.      Fees, Interest, Payments and Computations, Etc. 

(a)      On the Closing Date, the Borrower paid to the Administrative Agent for its own benefit
and the benefit of each Managing Agent and each Lender, as applicable, the fees set forth in the Fee Letter in effect at such time that were due and payable on such date, including the upfront fee and reimbursement for all reasonable out-of-pocket
costs and expenses, including any legal fees and disbursements to the extent incurred, relating to the negotiation, preparation and closing of this Agreement and the other Facility Documents. 

(b)      On the Second Omnibus Amendment Effective Date, the Borrower paid to the
Administrative Agent for its own benefit and the benefit of each Managing Agent and each Lender, as applicable, the fees set forth in the Fee Letter in effect at such time that were due and payable on such date, including the upfront fee and
reimbursement for all reasonable out-of-pocket costs and expenses, including any legal fees and disbursements to the extent incurred, relating to the negotiation, preparation and closing of the Second Omnibus Amendment and the other Facility
Documents amended, restated, supplemented or otherwise modified as of such date. 

(c)      On the Third Omnibus Amendment Effective Date, the Borrower paid to the Administrative
Agent for its own benefit and the benefit of each Managing Agent and each Lender, as applicable, the fees set forth in the Fee Letter in effect at such time that were due and payable on such date, including the upfront fee and reimbursement for all
reasonable out-of-pocket costs and expenses, including any legal fees and disbursements to the extent incurred, relating to the negotiation, preparation and closing of the Third Omnibus Amendment and the other Facility Documents amended, restated,
supplemented or otherwise modified as of such date. 
 (d)      On the Fourth Omnibus
Amendment Effective Date, the Borrower paid to the Administrative Agent for its own benefit and the benefit of each Managing Agent and each Lender, as applicable, the fees set forth in the Fee Letter as amended and restated on such date that are due
and payable on such date, including the upfront fee and reimbursement for all reasonable out-of-pocket costs and expenses, including any legal fees and disbursements to the extent incurred, relating to the negotiation, preparation and closing of the
Fourth Omnibus Amendment and the other Facility Documents to be amended, restated, supplemented or otherwise modified as of such date. 

(e)      On the Fifth Omnibus Amendment Effective Date, the Borrower paid to the Administrative
Agent for its own benefit and the benefit of each Managing Agent and each Lender, as applicable, the fees set forth in the Fee Letter as amended and restated on such date that are due and payable on such date, including the upfront fee and
reimbursement for all reasonable out-of-pocket costs and expenses, including any legal fees and disbursements to the extent incurred, relating to the negotiation, preparation and closing of the Fifth Omnibus Amendment and the other Facility
Documents to be amended, restated, supplemented or otherwise modified as of such date. 

  
 46 

 (f)      On the Sixth Omnibus Amendment Effective
Date, the Borrower shall pay to the Administrative Agent for its own benefit and the benefit of each Managing Agent and each Lender, as applicable, the fees set forth in the Fee Letter as amended and restated on such date that are due and payable on
such date, including the upfront fee and reimbursement for all reasonable out-of-pocket costs and expenses, including any legal fees and disbursements to the extent incurred, relating to the negotiation, preparation and closing of the Sixth Omnibus
Amendment and the other Facility Documents to be amended, restated, supplemented or otherwise modified as of such date. 

(g)      On each Payment Date, the Borrower shall pay to the Administrative Agent, for its own
benefit and the benefit of each Managing Agent, for its benefit and the benefit of each related Lender, as applicable, certain fees with respect to the immediately preceding month in the amounts and on the dates set forth in the Fee Letter in effect
at such time (without duplication of amounts paid pursuant to Section 2.07 and subject to adjustment for a Defaulting Lender as provided in Section 2.15). 

(h)      On each Payment Date, the Borrower shall pay accrued and unpaid Interest for the
immediately preceding month to the Administrative Agent, for the benefit of each Managing Agent, for its benefit and the benefit of each related Lender, as applicable (without duplication of amounts paid pursuant to Section 2.07). 

(i)      On each Payment Date, the Collection Agent shall be entitled to receive the Servicing
Fee. The Servicing Fee shall be payable only from Collections pursuant to, and subject to the priority of payment set forth in, Sections 2.07 and 2.08 or, prior to the occurrence of an Event of Default, pursuant
to a capital contribution to the Borrower from CHS made in its sole discretion. 

(j)      If any Advance requested by the Borrower hereunder, or any selection of a subsequent
Fixed Period for any Revolving Principal Balance requested by the Borrower and approved by the applicable Managing Agent pursuant to Section 2.05 is not for any reason, other than the act or omission of a Lender, a Managing
Agent or the Administrative Agent (or their agents or employees) contrary to this Agreement, made or effectuated, as the case may be, on the date specified therefor, the Borrower shall indemnify each Lender against any loss, cost or expense incurred
by such Lender, including any loss (including loss of anticipated profits, net of anticipated profits in the reemployment of such funds in the manner determined by such Lender), cost or expense incurred by reason of the liquidation or reemployment
of deposits or other funds acquired by such Lender to fund or maintain such Advance, as the case may be, during such Fixed Period. Such loss, cost or expense shall be computed on a net basis (any indemnification payments under this Section
2.06(f) shall be without duplication to other amounts payable under Sections 2.04(e) or 2.06(g) hereof). 

  
 47 

 (k)      Without duplication of any payments
otherwise required hereunder, the Borrower shall pay to the applicable Managing Agent, within two Business Days after such Managing Agent’s written demand therefor for the benefit of the related Lenders, any CP Breakage payable hereunder. 

SECTION 2.07.      Payment and Collection Procedures Generally. 

(a)      To the extent not so previously instructed, the Collection Agent or the Borrower will,
or will cause each Originator to prepare, execute and deliver to each Obligor (or, in the case of a Governmental Entity, its fiscal intermediary) who is proposed to be a payor of Receivables, with copies to the Administrative Agent, a Notice, which
notice shall, among other things, instruct all Obligors to pay all Collections directly to a Lock-Box or Collection Account. 

(b)      The Collection Agent shall, or shall direct the Borrower to, take all actions
necessary and appropriate to ensure that (i) on each Business Day (whether or not the Termination Date has occurred) (x) all Collections received in the Lock-Boxes are deposited into a Collection Account and (y) all Collections received in or
deposited into the Collection Accounts are transferred in same day funds to the applicable Concentration Account and (ii) all Collections not received in a Lock-Box or a Collection Account are deposited into or transferred to the applicable
Concentration Account no later than two Business Days from receipt by the Collection Agent, the Borrower, the Transferor or an Originator, as the case may be. The Collection Agent or the Borrower shall promptly take, or direct the applicable
Originator to take, all such actions as are reasonably necessary in the Collection Agent’s or the Borrower’s discretion or reasonably requested by the Administrative Agent to ensure that future payments from any Obligor be made to a
Collection Account or Lock-Box. 
 (c)      So long as no Trigger Event exists or would
result from such proposed withdrawal, the Collection Agent may withdraw from any Concentration Account and distribute to the Borrower amounts deposited in such Concentration Account up to an amount such that the amount remaining in the Concentration
Accounts, collectively, at least equals the Interest, Used Fee, Unused Fee and Servicing Fee accrued through such date of withdrawal (which amount shall remain in the Concentration Accounts until the immediately following Payment Date); provided
that the foregoing shall not limit the ability of the Collection Agent to withdraw all proceeds of Self Pay Obligations from the Concentration Accounts at any time prior to the delivery by the Administrative Agent of the notice referred to in
Section 2.08(a), Section 6.04(a)(v) or Section 6.07(b) to any Concentration Account Bank, subject to the terms of this Agreement and the Control Agreements. 

(d)      On the Business Day immediately preceding each Payment Date to occur prior to the
Termination Date applicable to all Lender Groups then party hereto, the Collection Agent shall deposit (to the extent not previously deposited in accordance with clause (c) above) to a Concentration Account the amounts in
respect of Interest, Used Fee, Unused Fee and Servicing Fee accrued for the prior month and set aside as described in clause (c) above. Following deposit of such funds, the Collection Agent shall distribute the funds
as directed by the Administrative Agent, first, to the Managing Agents, for the benefit of the related Lenders, in full payment of the accrued and unpaid Interest for such month, second, to the Managing Agents, for the benefit of the
related Lenders and to the Administrative Agent, in full payment of the accrued and unpaid fees due to such Persons hereunder or under any other Facility Document for such month, third, to the Collection Agent, in full payment of any accrued
and unpaid Servicing 

  
 48 

 
Fee payable to the Collection Agent with respect to such month, and fourth, to the Administrative Agent or the Managing Agents, for the benefit of the related Lenders or other Indemnified
Persons, in full payment of all other unpaid Obligations accrued for such month. 

(e)      Notwithstanding anything to the contrary contained in this
Section 2.07 or any other provision in this Agreement, if on any Business Day prior to the Termination Date (other than a Termination Date that exists solely as a result of the occurrence of a Scheduled Termination Date
under clause (a) of such defined term) a Borrowing Base Deficiency exists, then, and in any event prior to any distribution to the Transferor or any Originator or other Affiliate under clause (c) above, in each case, the Borrower shall remit to the
Administrative Agent, for the benefit of the Lenders, no later than the close of business of the Administrative Agent on the second succeeding Business Day, a payment (each such payment, a “Mandatory Prepayment”) (to be applied
ratably among the Lenders by the Administrative Agent to outstanding Revolving Principal Balance allocated to Fixed Periods selected by the Administrative Agent, in its sole discretion) in such amount as may be necessary to reduce the outstanding
Revolving Principal Balance so that a Borrowing Base Deficiency no longer exists. Amounts other than principal owed in connection with such Mandatory Prepayment, including, (i) all Interest accrued and unpaid on the amount repaid to (but
excluding) the date of such repayment and (ii) any and all CP Breakage owed with respect to such repayment, shall be made on the next Payment Date following such repayment; provided, that, unless a Trigger Event has occurred and is
continuing or would result, if such Borrowing Base Deficiency exists solely as the result of the occurrence of the Scheduled Termination Date solely under clause (a) of such defined term, such Mandatory Prepayment shall be applied first to reduce
the outstanding Revolving Principal Balance of the Lenders in the Lender Group for which such Scheduled Termination Date has occurred to zero, and then applied in accordance with the foregoing paragraph; provided, further, that if such
Mandatory Prepayment is applied in accordance with the foregoing proviso, unless a Trigger Event has occurred and is continuing or would result, the Borrower shall remit to the Administrative Agent, for the benefit of the applicable members of the
Lender Group for which such Scheduled Termination Date has occurred, all accrued and unpaid Interest and fees applicable to the amounts so reduced and the Commitments of the Lenders in such Lender Group. 

(f)      All payments to be made by the Borrower or the Collection Agent under this Agreement
shall be made free and clear of any counterclaim, set-off, deduction or other defense, which such Person may have against any Lender, any Managing Agent, the Administrative Agent or against each other. 

SECTION 2.08.      Trigger Event and Termination Date Payment Procedures. 

(a)      On each Business Day after the occurrence of a Trigger Event and delivery by the
Administrative Agent of a notice in substantially the form attached to the Control Agreement transferring exclusive control of each Concentration Account to the Administrative Agent, funds shall be withdrawn from each Concentration Account solely
by, or at the direction of, the Administrative Agent to be applied by the Administrative Agent in the order of priority set forth in Section 2.07(d) and as set forth in Section 2.08(c). 

  
 49 

 (b)      On the Termination Date applicable to all
Lenders then party hereto and on each Business Day thereafter, the amounts set aside in each Concentration Account in accordance with Section 2.07 above shall be withdrawn from each Concentration Account, solely by, or at the direction of,
the Administrative Agent, to be applied by the Administrative Agent in the following order of priority: 

(i)      (A) First, to pay to the Collection Agent any accrued and unpaid
Servicing Fee (if the Collection Agent is a Person other than the Transferor, an Originator or an Affiliate thereof) which is then due and payable, and (B) second, to be retained in a Concentration Account to the extent of any daily accrued and
unpaid amounts of such Servicing Fee which are not then due and payable, until the next relevant payment date therefor, and not to be applied to any of the following items; 

(ii)      To pay, ratably among the Lenders, accrued and unpaid Interest which
is then due and payable; 
 (iii)      To pay, ratably among the Lenders,
accrued and unpaid Used Fee and Unused Fee which is then due and payable; 

(iv)      To pay, ratably among the Lenders, all Revolving Principal Balance
then outstanding; 
 (v)      To pay, ratably among the Lenders, the Secured
Parties and any other Indemnified Parties entitled thereto, the portion of any other accrued and unpaid Obligations which have not been paid pursuant to clauses (i) through (iv) above and which are then due and payable by the Borrower to any of
them under this Agreement; and 
 (vi)      (A) First, to pay to the
Collection Agent any accrued and unpaid Servicing Fee (if the Collection Agent is the Transferor, an Originator or an Affiliate of any thereof) which is then due and payable, and (B) second, to be retained in a Concentration Account to the extent of
any accrued and unpaid amounts of such Servicing Fee which are not then due and payable, until the next relevant payment date therefor. 

Following the Collection Date, the Collection Agent or the Administrative Agent, as the case may be, shall pay to the Borrower any remaining
Collections in the Concentration Accounts. 
 (c)      Following the delivery by the
Administrative Agent of the notice referred to in Section 2.08(a), Section 6.04(a)(v) or Section 6.07(b) to any Concentration Account Bank, the Borrower or the Collection Agent shall deliver to the Administrative Agent on
each Business Day a report identifying all amounts on deposit in each Concentration Account that constitute proceeds of Self Pay Obligations. Promptly following receipt of such report, but in any event no later than the next Business Day, the
Administrative Agent shall (i) provide instructions to each Concentration Account Bank directing the transfer of all proceeds of Self Pay Obligations so identified to an account specified by the Borrower or Collection Agent or (ii) raise any
concerns or objections with respect thereto with the Borrower. In the event of any dispute regarding the identification of proceeds of Self Pay Obligations, the parties agree to cooperate in good faith to promptly resolve such dispute. 

  
 50 

 SECTION 2.09.      Updated Borrowing Base.

 (a)      If on any day a Receivable in the Borrowing Base no longer qualifies as an
Eligible Receivable because (i) the Expected Net Value of any Receivable is either (x) reduced or adjusted as a result of any defective, rejected, returned, repossessed or foreclosed merchandise, any defective or rejected services, any failure
to provide services, any discount, rebate or any other adjustment made or performed by the Borrower or any other Person or (y) reduced or canceled as a result of a setoff in respect of any claim by the Obligor thereof against an Originator or
an Affiliate of an Originator, (ii) any of the representations or warranties in Section 4.01(h) is no longer true with respect to such Receivable or the Borrower or the Collection Agent discovers or is notified that such
Receivable was not an Eligible Receivable on the day it was included in the Borrowing Base or (iii) for any other reason pursuant to the terms hereunder, the Borrower or the Collection Agent shall recalculate the Borrowing Base as of such day after
giving effect to the removal of such Receivable or Receivables from the Borrowing Base calculation; provided, that the Collection Agent and the Borrower shall deliver an updated report with respect to the information in the Monthly Report
only to the extent that such reduction, adjustment, cancellation or disqualification would result in a Borrowing Base Deficiency. 

(b)      Promptly after the occurrence of an ENV Event, the Borrower shall deliver to the
Administrative Agent a Monthly Report updated as of such day, including a calculation of the Borrowing Base after giving effect to an adjustment to the Contractual Allowances, in an amount approved by the Administrative Agent and the Managing
Agents, to reflect such collection experiences. 
 (c)      If a Borrowing Base Deficiency
exists with respect to the revised Borrowing Base delivered pursuant to clause (a) or (b), then the Borrower shall make a Mandatory Prepayment in accordance with Section 2.07(e). 

SECTION 2.10.      Late Payments, Payments on other than Business Day. 

(a)      The payment or deposit of all amounts to be paid or deposited by the Borrower or the
Collection Agent hereunder shall be paid or deposited in accordance with the terms hereof no later than 12:00 P.M. (New York City time) on the day when due in lawful money of the United Stated in immediately available funds. The Borrower
shall, to the extent permitted by law, pay to the Administrative Agent interest on all amounts not paid or deposited when due hereunder (whether owing by the Borrower or by the Collection Agent) at 2.0% per annum above the Base Rate, payable
on demand; provided, however, that such interest rate shall not at any time exceed the maximum rate permitted by Applicable Law. Such interest shall be retained by the Administrative Agent except to the extent that such failure to make a
timely payment or deposit has continued beyond the date for distribution by the Administrative Agent of such overdue amount to the applicable Managing Agents, on behalf of the related Lenders, in which case such interest accruing after such date
shall be for the account of, and distributed by the Administrative Agent to such Managing Agents. All computations of interest and all computations of Interest (other than for Interest calculated in respect of the Base Rate, which shall be
computed on the basis of a year of 365/366 days), Servicing Fee, Used Fee, Unused Fee, CP Breakage and other fees hereunder shall be made on the basis of a year of 360 days for the actual number of days (including the first but excluding the last
day) elapsed. 

  
 51 

 (b)      Whenever any payment hereunder shall be
stated to be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day, and such extension of time shall in such case be included in the computation of payment of Interest, interest or any fee payable
hereunder, as the case may be; provided, however, that, if such extension would cause payment of Interest, or Revolving Principal Balance on which Interest accrues at the Adjusted Eurodollar Rate, to be made in the next following month, such
payment shall be made on the next preceding Business Day. 
 SECTION 2.11.      Increased
Costs; Capital Adequacy; Illegality. 
 (a)      If either (i) the introduction of
or any Regulatory Change (including any change by way of imposition or increase of reserve requirements) in any law, regulation, treaty or official directive, or in the interpretation or application thereof by any central bank or other governmental
agency or authority charged with the administration thereof (whether or not having the force of law), or (ii) the compliance by the Administrative Agent any Secured Party or any affiliate of either thereof (each of which, an “Affected
Party”) with any guideline or request from any central bank or other governmental agency or authority (whether or not having the force of law), (A) shall impose, modify or deem applicable any reserve requirement (including any reserve
requirement imposed by the Board of Governors of the Federal Reserve System, but excluding any reserve requirement, if any, included in the determination of Interest), special deposit or similar requirement against assets of, deposits with or for
the account of, or credit extended by, any Affected Party or (B) shall impose any other condition affecting the Collateral or any Lender’s rights or obligations hereunder, the result of which is to increase the cost to any Affected Party or to
reduce the amount of any sum received or receivable by an Affected Party under this Agreement, then within 10 days after demand by such Affected Party (which demand shall be accompanied by a statement setting forth the basis for such demand), the
Borrower shall pay directly to such Affected Party such additional amount or amounts as will compensate such Affected Party for such additional or increased cost incurred or such reduction suffered. 

(b)      If either (i) the introduction of or any change (including any change by way of
imposition or increase of reserve requirements) in any law, regulation, treaty or official directive, or in the interpretation or application thereof, in each case occurring after the date hereof, by any central bank or other governmental agency or
authority charged with the administration thereof (whether or not having the force of law), or (ii) the compliance by an Affected Party with any guideline or request from any central bank or other governmental agency or authority (whether or
not having the force of law) in each case promulgated after the date hereof, including compliance by an Affected Party with any request or directive regarding capital adequacy, or (iii) any Regulatory Change, has or would have the effect of reducing
the rate of return on the capital of any Affected Party as a consequence of its obligations hereunder or otherwise arising in connection herewith to a level below that which any such Affected Party could have achieved but for such introduction,
change or compliance by an amount deemed by such Affected Party to be material, then within 10 days after demand by such Affected Party (which demand shall be accompanied by a statement setting forth the basis for such demand), the Borrower shall
pay directly to such Affected Party such additional amount or amounts as will compensate such Affected Party for such reduction. 

  
 52 

 (c)      If as a result of any event or
circumstance similar to those described in Section 2.11(a) or 2.11(b), any Affected Party is required to compensate a bank or other financial institution providing liquidity support, credit enhancement or other
similar support to such Affected Party in connection with this Agreement or the funding or maintenance of Advances hereunder, then within 10 days after demand by such Affected Party, the Borrower shall pay to such Affected Party such additional
amount or amounts as may be necessary to reimburse such Affected Party for any amounts to be paid by it. 

(d)      In determining any amount provided for in this Section 2.11,
the Affected Party may use any reasonable averaging and attribution methods. Any Affected Party making a claim under this Section 2.11 shall submit to the Borrower a certificate as to the calculation of such additional
or increased cost or reduction, which certificate shall be conclusive absent manifest error. 

(e)      Failure or delay on the part of any Affected Party to demand compensation pursuant to
the foregoing provisions of this Section shall not constitute a waiver of such Affected Party’s right to demand such compensation, provided that the Borrower shall not be required to compensate any Affected Party pursuant to the
foregoing provisions of this Section for any increased costs incurred or reductions suffered more than six months prior to the date that such Affected Party notifies the Borrower of the circumstances giving rise to such increased costs or reductions
and of such Affected Party’s intention to claim compensation therefor (except that, if the Regulatory Change giving rise to such increased costs or reductions is retroactive, then the six-month period referred to above shall be extended to
include the period of retroactive effect thereof). The protections of this Section shall be available to the Affected Party regardless of any possible contention of the invalidity or inapplicability of the Regulatory Change that shall have
occurred or been imposed. 
 (f)      If any Managing Agent, on behalf of the related Lenders
shall notify the Administrative Agent that a Eurodollar Disruption Event has occurred, the Administrative Agent shall in turn so notify the Borrower, whereupon all Revolving Principal Balance in respect of which Interest accrues at the Adjusted
Eurodollar Rate for the then current Fixed Period shall immediately be converted into Revolving Principal Balance in respect of which Interest accrues at the Base Rate for the remainder of such Fixed Period. 

(g)      Without prejudice to the survival of any other agreement of the Borrower hereunder,
the agreements and obligations of the Borrower contained in this Section 2.11 shall survive the termination of this Agreement. 

SECTION 2.12.      Taxes. 

(a)      Any and all payments by the Borrower or the Collection Agent hereunder to any Lender,
any Managing Agent or the Administrative Agent shall be made free and clear of and without deduction for any and all present or future taxes, levies, imposts, deductions, charges or withholdings, and all liabilities with respect thereto, excluding,
(1) in the case of any Lender, 

  
 53 

 
any Managing Agent and the Administrative Agent, net income taxes and branch profits taxes that are imposed by the United States, (2) franchise taxes, net income taxes and branch profits taxes
that are imposed on such Lender, such Managing Agent or the Administrative Agent by the state or non-United States jurisdiction under the laws of which such Lender, such Managing Agent or the Administrative Agent (as the case may be) is organized or
conducts business or any political subdivision thereof, (3) in the case of a Foreign Lender, any withholding tax that is imposed on amounts payable to such Foreign Lender at the time such Foreign Lender becomes a party hereto (or designates a new
lending office), except to the extent that such Foreign was entitled, at the time of designation of a new lending office (or assignment), to receive additional amounts from the Borrower with respect to such withholding tax pursuant to this
Section 2.12(a), (4) any U.S. federal withholding Taxes imposed under FATCA, and (5) Taxes attributable to such recipient’s failure to comply with Section 2.12(c) (all such non-excluded taxes, levies, imposts, deductions, charges,
withholdings and liabilities being hereinafter referred to as “Taxes”). If the Borrower or the Collection Agent shall be required by law to deduct any Taxes from or in respect of any sum payable hereunder to any Lender, any
Managing Agent or the Administrative Agent, (i) the Borrower shall make an additional payment to such Lender, such Managing Agent or the Administrative Agent, as the case may be, in an amount sufficient so that, after making all required
deductions (including deductions applicable to additional sums payable under this Section 2.12), such Lender, such Managing Agent or the Administrative Agent (as the case may be) receives an amount equal to the sum it would
have received had no such deductions been made, (ii) the Borrower or the Collection Agent, as the case may be, shall make such deductions and (iii) the Borrower or the Collection Agent, as the case may be, shall pay the full amount
deducted to the relevant taxation authority or other authority in accordance with Applicable Law. Within 30 days after the date of any such payment of Taxes, the Borrower or the Collection Agent, as the case may be, will furnish to such Lender,
such Managing Agent or the Administrative Agent (as the case may be) the original or a certified copy of a receipt evidencing payment thereof. 

(b)      The Borrower will indemnify each Lender, each Managing Agent and the Administrative
Agent for the full amount of Taxes or Other Taxes (including any Taxes imposed by any jurisdiction on amounts payable under this Section 2.12) paid by such Lender, such Managing Agent or the Administrative Agent (as the
case may be) and any liability (including penalties, interest and expenses) arising therefrom or with respect thereto whether or not such Taxes or Other Taxes were correctly or legally asserted; provided that any Lender, any Managing Agent or
the Administrative Agent, as appropriate, making a demand for indemnity payment hereunder shall provide the Borrower with a certificate from the relevant taxing authority or from a responsible officer of such Lender, such Managing Agent and the
Administrative Agent stating or otherwise evidencing that such Lender, such Managing Agent or the Administrative Agent has made payment of such Taxes or Other Taxes and will provide a copy of or extract from documentation, if available, furnished by
such taxing authority evidencing assertion or payment of such Taxes or Other Taxes. This indemnification shall be made within 10 days from the date such Lender, such Managing Agent or the Administrative Agent (as the case may be) makes written
demand therefor. 
 (c)       

  
 54 

 (i)      Each Lender, each Managing
Agent and the Administrative Agent that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any this Agreement shall deliver to the Borrower and the Administrative Agent, at the time or times
reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a
reduced rate of withholding. In addition, each Lender, each Managing Agent and the Administrative Agent, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or
reasonably requested by the Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting
requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in Section 2.12(c)(ii)(A), (ii)(B) and
(ii)(C) below) shall not be required if in the Lender’s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or
commercial position of such Lender. 
 (ii)      Without limiting the
generality of the foregoing, in the event that the Borrower is a U.S. Person within the meaning of Section 7701(a)(30) of the Code, 

(A)      any Lender that is a U.S. Person shall deliver to the Borrower and the
Administrative Agent on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower or the Administrative Agent), executed originals of IRS Form W-9
certifying that such Lender is exempt from U.S. federal backup withholding tax; 

(B)      any Foreign Lender shall, to the extent it is legally entitled to do
so, deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter
upon the reasonable request of the Borrower or the Administrative Agent), whichever of the following is applicable: 

(i) in the case of a Foreign Lender claiming the benefits of an income tax treaty to which the United
States is a party (x) with respect to payments of interest under this Agreement, executed originals of IRS Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “interest” article of such
tax treaty and (y) with respect to any other applicable payments under this Agreement, IRS Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “business profits” or “other
income” article of such tax treaty; 
 (ii) executed originals of IRS Form W-8ECI; 

  
 55 

 (iii) in the case of a Foreign Lender claiming the benefits of
the exemption for portfolio interest under Section 881(c) of the Code, (x) a certificate substantially in the form of either Exhibit F-1 or Exhibit F-2 to the effect that such Foreign Lender is not a “bank” within the meaning
of Section 881(c)(3)(A) of the Code, a “10 percent shareholder” of the Borrower within the meaning of Section 881(c)(3)(B) of the Code, or a “controlled foreign corporation” described in Section 881(c)(3)(C) of the Code (a
“U.S. Tax Compliance Certificate”) and (y) executed originals of IRS Form W-8BEN; or 

(iv) to the extent a Foreign Lender is not the beneficial owner, or is a partnership, executed originals of
IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN, a U.S. Tax Compliance Certificate substantially in the form of Exhibit F-3 or Exhibit F-4, IRS Form W-9, and/or other certification documents from each beneficial owner
or direct or indirect partner, as applicable; 
 (C)      if a payment made to
a recipient under any this Agreement would be subject to U.S. federal withholding Tax imposed by FATCA if such recipient were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or
1472(b) of the Code, as applicable), such recipient shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such
documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and
the Administrative Agent to comply with their obligations under FATCA and to determine that such recipient has complied with such recipient’s obligations under FATCA or to determine the amount to deduct and withhold from such
payment. Solely for purposes of this clause (C), “FATCA” shall include any amendments made to FATCA after the date of this Agreement. 

Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any
respect, it shall update such form or certification or promptly notify the Borrower and the Administrative Agent in writing of its legal inability to do so. 

(d)      If the each Lender, each Managing Agent and the Administrative Agent determines, in
its sole discretion, that it has received a refund of any Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts pursuant to this Section, it shall pay to the Borrower an amount
equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this Section with respect to the Taxes giving rise to such refund), net of all out-of-pocket expenses of the such Lender,
Managing Agent, or Administrative Agent, as the case may be, and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund), provided that the Borrower, upon the request of such Lender,
Managing Agent, or the Administrative Agent, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Lender, Managing Agent, or Administrative Agent,
in the event the Lender, Managing Agent, or 

  
 56 

 
Administrative Agent, is required to repay such refund to such Governmental Authority. This paragraph shall not be construed to require the Administrative Agent, any Lender or the Managing
Agent to have any obligation to file for or otherwise pursue any refund of Taxes withheld or deducted from funds paid for the account of such Agent or Lender or make available its tax returns (or any other information relating to its taxes that it
deems confidential) to the Borrower or any other Person. 
 (e)      Without prejudice to the
survival of any other agreement of the Borrower hereunder, the agreements and obligations of the Borrower contained in this Section 2.12 shall survive the termination of this Agreement. 

SECTION 2.13.      Assignment of the Sale Agreement and the Contribution Agreement(a)
.. The Borrower hereby represents, warrants and confirms to the Administrative Agent that the Borrower has pledged to the Administrative Agent, for the benefit of itself and the Secured Parties hereunder, all of the Borrower’s right and
title to and interest in (i) the Contribution Agreement and (ii) as assignee thereof under the Assignment of Agreements, the Sale Agreement. The Borrower confirms and agrees that the Administrative Agent shall have pursuant to the Assignment of
Agreements, the sole right to enforce the Borrower’s rights and remedies under the Sale Agreement and the Contribution Agreement for the benefit of the Secured Parties hereunder, but without any obligation on the part of the Administrative
Agent, any Secured Party or any of their respective Affiliates, to perform any of the obligations of the Borrower under the Sale Agreement the Contribution Agreement. The Borrower further confirms and agrees that such assignment to the
Administrative Agent shall terminate upon the Collection Date; provided, however, that the rights of the Administrative Agent and the Secured Parties pursuant to the Assignment of Agreements with respect to rights and remedies in connection
with any indemnities and any breach of any representation, warranty or covenants made (i) by the Company under the Contribution Agreement, or (ii) by the applicable Originator under the Sale Agreement, which rights and remedies survive the
termination of the Sale Agreement and Contribution Agreement, shall be continuing and shall survive any termination of the Assignment of Agreements. 

SECTION 2.14.      Sharing of Payments(a) . If any Lender (for purposes of this
Section only, referred to as a “Recipient”) shall obtain payment (whether voluntary, involuntary, through the exercise of any right of setoff, or otherwise) on account of the Advances made by it in excess of its ratable share of
payments made on account of the Advances made by the Lenders (other than as a result of payments made to fewer than all of the Lenders as a result of the occurrence of a Scheduled Termination Date under clause (a) of such defined term), such
Recipient shall forthwith purchase from the Lenders which received less than their ratable share participations in the Advances made by such Persons as shall be necessary to cause such Recipient to share the excess payment ratably with each such
other Person; provided, however, that (a) if all or any portion of such excess payment is thereafter recovered from such Recipient, such purchase from each such other Person shall be rescinded and each such other Person shall repay to the
Recipient the purchase price paid by such Recipient for such participation to the extent of such recovery, together with an amount equal to such other Person’s ratable share (according to the proportion of (i) the amount of such other
Person’s required payment to (ii) the total amount so recovered from the Recipient) of any interest or other amount paid or payable by the Recipient in respect of the total amount so recovered and (b) the provisions of this Section shall not be
construed to apply to the application of funds arising from the existence of a Defaulting Lender. 

  
 57 

 SECTION 2.15.      Defaulting Lender. 

(a)      Notwithstanding anything to the contrary contained in this Agreement, if any Committed
Lender becomes a Defaulting Lender, then, until such time as such Committed Lender is no longer a Defaulting Lender, to the extent permitted by Applicable Law: 

(i)      Any payment of principal, interest, fees or other amounts received by
the Administrative Agent for the account of such Defaulting Lender (whether voluntary or mandatory, at maturity, pursuant to Section 2.07, Section 2.08, Article VII or otherwise, and including any amounts made available to the
Administrative Agent by such Defaulting Lender pursuant to Section 10.04), shall be applied at such time or times as may be determined by the Administrative Agent as follows: first, to the payment of any amounts owing by such
Defaulting Lender to the Administrative Agent or any Managing Agent hereunder; second, as the Borrowers may request (so long as no Default exists), to the funding of any Advance in respect of which such Defaulting Lender has failed to fund
its portion thereof as required by this Agreement, as determined by the Administrative Agent; third, if so determined by the Administrative Agent and the Borrower, to be held in a non-interest bearing deposit account and released in order to
satisfy obligations of such Defaulting Lender to fund Advances under this Agreement; and fourth, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction. Any payments, prepayments or other amounts paid or
payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender or to post cash collateral pursuant to this Section 2.15(a)(i) shall be deemed paid to and redirected by such Defaulting Lender, and each
Lender irrevocably consents hereto. 
 (ii)      Such Defaulting Lender shall
not be entitled to receive any Unused Fee for any period during which such Lender is a Defaulting Lender (and the Borrower shall not be required to pay any such fee that otherwise would have been required to have been paid to such Defaulting
Lender). 
 (b)      If the Borrower, the Administrative Agent and the Managing Agents each
agrees in writing in their respective sole discretion that a Defaulting Lender should no longer be deemed to be a Defaulting Lender, the Administrative Agent will so notify the parties hereto, whereupon as of the effective date specified in such
notice and subject to any conditions set forth therein, such Committed Lender will, to the extent applicable, purchase such portion of the outstanding Advances of the other Lenders, or take such other actions as the Administrative Agent may
determine to be necessary to cause the Lenders of such Committed Lender’s Lender Group to hold such Lender Group’s Lender Group Percentage of the Advances or as otherwise required by the terms of Section 2.01, whereupon such Lender
will cease to be a Defaulting Lender; provided that no adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of the Borrower while such Lender was a Defaulting Lender; and provided,
further, that except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from such Lender having
been a Defaulting Lender. 

  
 58 

 SECTION 2.16.      Terminating
Lender. If any Committed Lender shall be subject to an earlier Scheduled Termination Date hereunder than the Scheduled Termination Date applicable to all other Committed Lenders hereunder, Borrower, upon providing written notice to the
related Managing Agent and the Administrative Agent, shall have the right to require such Committed Lender and the related Conduit Lender to sell and assign in accordance with Section 10.06 of this Agreement, all, but not less than all, of
(A) such Committed Lender’s Commitment, without recourse, and (B) all of its respective interests, rights, and obligations under this Agreement to any assignee(s) permitted under such Section 10.06; provided, however, that (a) such
assignment shall not conflict with any statute, law, rule, regulation, order or decree of any governmental authority, (b) the assigning Committed Lender and Conduit Lender shall have received from such assignee(s) full payment in immediately
available funds of all amounts payable to it in respect of outstanding Advances, accrued and unpaid Interest and fees, and other amounts owing to it under or in connection with this Agreement and the other Facility Documents, (c) such assignment
shall be without representation or warranty (except to the extent set forth in the related Assignment and Acceptance) by the assigning Committed Lender and Conduit Lender and shall be at the sole expense of such assigning Committed Lender, and (d)
the assigning Committed Lender and Conduit Lender shall continue to have the benefit of all indemnities and other agreements under this Agreement which survive the termination of this Agreement.

ARTICLE III 
 CONDITIONS OF
ADVANCES 
 SECTION 3.01.      Conditions Precedent to Initial Advance. The
initial Advance hereunder is subject to the conditions precedent that (a) the Administrative Agent shall have received on or before the date of such Advance the items listed in Schedule II, each (unless otherwise
indicated) dated such date, in form and substance satisfactory to the Administrative Agent and each Managing Agent; provided, however, to the extent that any item is designated on Schedule II for delivery on or
before a specified date that is after the date of the initial Advance, delivery of such item shall not be a condition to the initial Advance, but the failure to deliver such item on or before the specified date shall constitute a breach of an
obligation of the Borrower hereunder which such breach shall give rise to an Event of Default under Section 7.01(d) hereof, (b) all fees and expenses required to be paid prior to the initial Advance pursuant to
(i) this Agreement and (ii) the Fee Letter have been paid, and (c) each Managing Agent and the Administrative Agent shall have completed satisfactory due diligence and obtained the requisite credit approvals. 

SECTION 3.02.      Conditions Precedent to All Advances. Each Advance (including the
initial Advance) to the Borrower by any Lender and the right of the Collection Agent to remit Collections to the Borrower pursuant to Section 2.07(c) shall be subject to the further conditions precedent that (a) with
respect to any such Advance, on or prior to the date of such Advance, the Collection Agent shall have delivered to the Administrative Agent, in each case in form and substance satisfactory to the Administrative Agent, a completed Monthly Report
dated on or before the most recent Monthly Report Due Date and (b) on the date of such Advance or remittance of Collections the following statements shall be true and the Borrower by accepting the amount of such Advance or remittance of
Collections shall be deemed to have certified that: 

  
 59 

  (i)       The
representations and warranties contained in Article IV are correct on and as of such day as though made on and as of such date, except for those that refer to specific dates, which shall be correct as of the dates indicated therein, 

 (ii)       No event has occurred and is continuing, or would result
from such Advance or remittance, which constitutes a Default or an Event of Default, 

 (iii)      On and as of such day, after giving effect to such Advance or
remittance, a Borrowing Base Deficiency does not exist, and 

 (iv)      No law or regulation shall prohibit, and no order, judgment or
decree of any federal, state or local court or governmental body, agency or instrumentality shall prohibit or enjoin, the making of such Advance by the Lenders in accordance with the provisions hereof. 

Notwithstanding the fact that any of the above-described conditions precedent may not have been satisfied in connection with
any Advance hereunder, prior to the Termination Date applicable to all Lender Groups then party hereto and as a result of the Borrower’s acceptance of the amount of any Advance the Borrower shall be deemed to have certified to the
Administrative Agent that such conditions precedent have, in fact, been satisfied. 
 ARTICLE IV 

REPRESENTATIONS AND WARRANTIES 

SECTION 4.01.      Representations and Warranties of the Borrower. The Borrower
represents and warrants to and, where applicable, agrees with each of the Secured Parties, that: 

(a)      The Borrower is a limited liability company duly formed, validly existing and in good
standing under the laws of the jurisdiction named at the beginning hereof and is duly qualified to do business, and is in good standing, in every jurisdiction in which the nature of its business requires it to be so qualified and the failure to do
so could reasonably be expected to have a Material Adverse Effect. 
 (b)      The execution,
delivery and performance by the Borrower of this Agreement, the Contribution Agreement and all other Facility Documents to be entered into by it, including the Borrower’s use of the proceeds of Advances and remittances of Collections, are
within the Borrower’s limited liability company powers, have been duly authorized by all necessary limited liability company action, do not contravene (i) the Borrower’s certificate of formation or limited liability company agreement,
(ii) any Applicable Law except where such contravention could not reasonably be expected to result in a Material Adverse Effect, (iii) any contractual restriction binding on or affecting the Borrower or its property other than such
restrictions that could not reasonably be expected to adversely affect the Collection Agent’s ability to perform its material obligations hereunder or, with respect to the transfer of the Receivables and Collections thereon, in any Immaterial
Respect, or (iv) any order, writ, judgment, award, injunction or decree binding on or affecting the Borrower or its property, and do not result in or require the creation of any Lien upon or with respect to any of its properties (other than
Permitted Liens and liens in favor of the Administrative Agent for the benefit of the 

  
 60 

 
Secured Parties with respect to the Collateral), and no transaction contemplated hereby or by the Contribution Agreement requires compliance with any bulk sales act or similar law. This
Agreement, the Contribution Agreement and each other Facility Document to be entered into by the Borrower have each been duly executed and delivered by the Borrower. 

(c)      No authorization or approval or other action by, and no notice to or filing with, any
governmental authority or regulatory body is required for the due execution, delivery and performance by the Borrower of this Agreement, the Contribution Agreement or any other Facility Document to be entered into by it, except for (i) the filing of
UCC financing statements, all of which financing statements have been duly filed and, to the Borrower’s knowledge, are in full force and effect, and (ii) such as have been obtained and are in full force and effect. 

(d)      This Agreement, the Contribution Agreement and each other Facility Document to be
entered into by the Borrower constitute the legal, valid and binding obligation of the Borrower enforceable against the Borrower in accordance with their respective terms subject to bankruptcy and similar laws affecting creditors generally and
general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law). 

(e)      (i)      The Borrower has furnished to the
Administrative Agent copies of the Parent’s audited consolidated balance sheet as at December 31, 2011, and the related audited consolidated statements of income and cash flow for the fiscal year of the Parent then ended reported on by
Deloitte & Touche LLP which financial statements present fairly in all material respects in accordance with GAAP the financial position of the Parent and its consolidated subsidiaries as at December 31, 2011, and the results of operations
of the Parent and its consolidated subsidiaries for the fiscal year of the Parent then ended, which financial statements present fairly in all material respects in accordance with GAAP the financial position of the Parent and its consolidated
subsidiaries as at such date, and the results of operations of the Parent and its consolidated subsidiaries for the fiscal year then ended; 

(ii)     Since December 31, 2011, (A) no material adverse change has occurred in the business,
assets, liabilities, financial condition or results of operations of the Parent and its subsidiaries taken as a whole, and (B) no event has occurred or failed to occur which has had or could reasonably be expected to result in, singly or in the
aggregate, a Material Adverse Effect; and 
 (iii)    The opening pro forma balance sheet of the
Borrower as at March 21, 2012, giving effect to the initial Advance to be made under this Agreement, a copy of which has been furnished to the Administrative Agent, present fairly in all material respects in accordance with GAAP the financial
position of the Borrower as at such date, and since January 23, 2012 no material adverse change has occurred in the business, assets, liabilities, financial condition or results of operations of the Borrower. 

(f)      There is no pending or, to the Borrower’s knowledge, threatened action or
proceeding affecting the Borrower before any court, governmental agency or arbitrator other than such actions and proceedings that the Collection Agent certifies to the Administrative Agent are, in the best judgment of the Collection Agent,
without legal merit as related to the Borrower and are being contested in good faith. The Borrower is not in default with respect to any order of any court, arbitrator or Governmental Entity, except in any Immaterial Respect. 

  
 61 

 (g)      No proceeds of any Advance will be used
by the Borrower (i) to acquire any security in any transaction which is subject to Section 13 or 14 of the Securities Exchange Act of 1934, as amended, or (ii) for any purpose other than to indirectly fund a purchase of Receivables
and related assets from an Originator and to make payments expressly contemplated under Section 3.1 of the Borrower’s operating agreement. 

(h)      Each Receivable, together with the Contract related thereto, shall, at all times, be
owned by the Borrower free and clear of any Lien (other than Permitted Liens), and the Administrative Agent shall have a valid and perfected first priority security interest in the property of the Borrower consisting of each Receivable then existing
or thereafter arising and in the Related Security and Collections with respect thereto, free and clear of any Lien (other than Permitted Liens); provided that the Borrower (acting directly or through the Collection Agent) shall have up to 10
days following actual knowledge thereof to remove any immaterial Lien that was improvidently filed without the consent of the Borrower or the Collection Agent; provided further that the Borrower (acting through the Collection Agent) shall
have the time period specified in Section 5.02(k) to remove and terminate the Kay County Lien. No effective financing statement or other instrument similar in effect with the Borrower as debtor, covering any Receivable or the
Related Security or Collections with respect thereto shall at any time be on file in any recording office except such as may be filed in favor of the Administrative Agent relating to this Agreement; provided that the Borrower (acting directly
or through the Collection Agent) shall have up to 10 days following actual knowledge thereof to remove any immaterial Lien that was improvidently filed without the consent of the Borrower or the Collection Agent; provided further that the
Borrower (acting through the Collection Agent) shall have the time period specified in Section 5.02(k) to remove and terminate the Kay County Lien. The contributions of the Receivables and related assets to the Borrower by the Transferor
under the Contribution Agreement constitute valid and “true contributions” and transfers for consideration (and not merely a pledge of such Receivables and assets for security purposes), enforceable against creditors of the Transferor, and
no such Receivables or related assets shall constitute property of Transferor. The purchases of the Receivables and related assets by Buyer from each Originator under the Sale Agreement constitute valid and true sales and transfers for
consideration (and not merely a pledge of such Receivables and assets for security purposes), enforceable against creditors of the Transferor and such Originator, and no such Receivables or related assets shall constitute property of the Transferor
or such Originator. 
 (i)      As of the close of business on each Business Day prior to the
latest Termination Date hereunder, a Borrowing Base Deficiency shall not exist. 

(j)      No Monthly Report or Funding Request (if prepared by the Borrower, the Collection
Agent or any Affiliate thereof, or to the extent that information contained therein is supplied by the Borrower, the Collection Agent or such Affiliate), information, exhibit, financial statement, document, book, record or report furnished or to be
furnished by the Borrower to the Administrative Agent or any Managing Agent in connection with this Agreement is or will be inaccurate in any material respect as of the date it is or shall be dated or (except as otherwise disclosed to the
Administrative Agent and the Managing Agents, as the case may be, at such 

  
 62 

 
time) as of the date so furnished or dated, and no such document contains or will contain any material misstatement of fact or omits or shall omit to state a material fact or any fact necessary
to make the statements contained therein not misleading; provided that to the extent any such information, report, financial statement, exhibit or schedule was based upon or constitutes a forecast or projection, the Borrower represents only
that it acted in good faith and utilized assumptions that the Borrower believed to be reasonable at the time made. 

(k)      The principal place of business and chief executive office of the Borrower and the
office where the Borrower keeps all of its Records are located at the address or addresses of the Borrower referred to in Section 10.02 hereof (or at such other locations as to which the notice and other requirements
specified in Section 6.08 shall have been satisfied). The Borrower is located in the jurisdiction of organization named at the beginning hereof for purposes of Section 9-307 of the UCC as in effect in the State of New
York, and the office in the jurisdiction of organization of the Borrower in which a UCC financing statement is required to be filed in order to perfect the security interest granted by the Borrower hereunder is Secretary of State of the State of
Delaware. The Borrower’s organizational identification number is 5099211.

(l)      The Borrower has no trade names, fictitious names, assumed names or “doing
business as” names or other names under which it has done or is doing business. 

(m)      The Contribution Agreement is the only agreement pursuant to which the Borrower
acquires Receivables, the Borrower has furnished to the Administrative Agent a true, correct and complete copy of the Contribution Agreement and the Sale Agreement, and the Contribution Agreement and the Sale Agreement are in full force and effect
and no “Event of Termination” under the Contribution Agreement or the Sale Agreement or event or circumstance that would with the passage of time or the giving of notice (or both) constitute an “Event of Termination” under the
Contribution Agreement or the Sale Agreement. 
 (n)      The Borrower was formed on January
23, 2012, and the Borrower did not engage in any business activities prior to the date of this Agreement. The Borrower has no subsidiaries. 

(o)      The Borrower shall have given reasonably equivalent value to the Transferor in
consideration for the transfer by the Transferor to the Borrower of the Receivables and Related Security under the Contribution Agreement, no such transfer shall have been made for or on account of an antecedent debt owed by the Transferor to the
Borrower, and no such transfer is or may be voidable or subject to avoidance under any section of the Bankruptcy Law. 

(p)      A copy of the Certificate of Formation of the Borrower as in effect on the date of
this Agreement has been provided to the Administrative Agent. 
 (q)      The Borrower is not
an insolvent person, in insolvent circumstances or on the eve of insolvency, as applicable (within the meaning of such term in the Bankruptcy Law) at the time of (and immediately after) each transfer of Receivables to the Borrower under the
Contribution Agreement, and at the time of (and immediately after) each Advance and remittance of Collections hereunder, the Borrower shall not have been an insolvent person, in insolvent circumstances or on the eve of insolvency, as applicable,
within the meaning of the 

  
 63 

 
Bankruptcy Law. The Borrower has entered into this Agreement for the purpose of indirectly financing its acquisition of Receivables and Related Security from the Originators, and not for the
purpose of defeating, hindering, delaying, defrauding or oppressing the rights and claims of creditors or others against the Borrower or for any other purpose relating in any way to the claims of creditors or others against the Borrower. 

(r)      The Borrower accounts for the transfers to it from the Transferor of interests in
Receivables, Related Security and Collections under the Contribution Agreement as “true” capital contributions and legal sales of such Receivables, Related Security and Collections in its books, records and financial statements, in
each case consistent with GAAP and with the requirements set forth herein. 
 (s)      The
sole and exclusive business of the Borrower is the acquisition of Receivables and Related Security pursuant to the Contribution Agreement for its own account, the borrowing of money pursuant to the terms of this Agreement, and making operational
cost payments expressly contemplated under Section 3.1 of the Borrower’s operating agreement. 

(t)      The Borrower is operated as an entity with assets and liabilities distinct from those
of the Transferor, each Originator and any Affiliates thereof, and the Borrower hereby acknowledges that the Administrative Agent, the Managing Agents and each Lender are entering into the transactions contemplated by this Agreement in reliance upon
the Borrower’s identity as a separate legal entity from, the Transferor, each Originator and from each such other Affiliate. 

(u)      The Borrower is not an “investment company” or a company controlled by an
“investment company” registered or required to be registered under the Investment Company Act. 

(v)      The Borrower is not engaged, principally or as one of its important activities, in the
business of extending credit for the purpose of “purchasing” or “carrying” any “margin stock” (as each of the quoted terms is defined or used in Regulation T, U or X promulgated pursuant to the securities Exchange Act
of 1934, as amended). No part of the proceeds of any Receivable has been used for so purchasing or carrying margin stock or for any purpose which violates, or which would be inconsistent with, the provisions of Regulation T, U or X. 

(w)      The Borrower and the Collection Agent each has the right (whether by license,
sublicense or assignment) to use all of the computer software used by the Transferor, the Collection Agent and/or any Originator to account for the Collateral to the extent necessary to administer the Collateral, and, in the case of the Borrower and
the Collection Agent, to assign (by way of sale or collateral pledge) or sublicense such rights to use all of such software to the Administrative Agent. 

(x)      The Borrower has filed or caused to be filed all federal and other material tax
returns which are required to be filed by it, and has paid or caused to be paid all taxes shown to be due and payable on such returns or on any assessments received by it, other than any taxes or assessments, the validity of which are being
contested in good faith by appropriate proceedings and with respect to which the Borrower has set aside or has caused to be set aside adequate reserves on its books (consolidated or otherwise) in accordance with GAAP. 

  
 64 

 (y)      Except as could not reasonably be
expected to result in material liability to the Borrower, each of the Borrower and its ERISA Affiliates is in compliance in all material respects with the applicable provisions of ERISA and the Code and the regulations and published interpretations
thereunder. No ERISA Event has occurred or is reasonably expected to occur that, when taken together with all other such ERISA Events, could reasonably be expected to result in material liability of the Borrower or any of its ERISA Affiliates. The
present value of all benefit liabilities under each Plan (based on the assumptions used for funding purposes) did not, as of the last annual valuation date applicable thereto, exceed the fair market value of the assets of such Plan in such amount
that would reasonably be expected to result in a funding obligation that could reasonably be expected to result in a Material Adverse Effect, and the present value of all benefit liabilities of all underfunded Plans (based on the assumptions used
for funding purposes) did not, as of the last annual valuation dates applicable thereto, exceed the fair market value of the assets of all such underfunded Plans in such amount that could reasonably be expected to result in a Material Adverse
Effect. 
 (z)      The Borrower has timely paid or caused to be paid all sales, excise or
personal property taxes payable in connection with the Receivables, other than any taxes or assessments, the validity of which are being contested in good faith by appropriate proceedings and with respect to which the Borrower has set aside or has
caused to be set aside adequate reserves on its books (consolidated or otherwise) in accordance with GAAP (provided, that, notwithstanding such contest, Receivables subject to such tax claims shall not constitute Eligible Receivables
hereunder). 
 (aa)    The Borrower has not intentionally (i) misstated any calculation of Eligible
Receivables or Net Receivables Balance hereunder (other than in an immaterial amount and based on good faith estimates utilized in the calculation thereof), or (ii) misrepresented any Receivable as qualifying as an Eligible Receivable or
intentionally included such misrepresented Receivable in the Net Receivables Balance at the time so included. 

(bb)    Each remittance of Collections by or on behalf of the Borrower to the Administrative Agent, for
itself, or any Managing Agent or any related Lender, will have been (i) in payment of a debt incurred by the Borrower in the ordinary course of business or financial affairs of the Borrower, and (ii) made in the ordinary course of business
or financial affairs of the Borrower. 
 (cc)    All required Notices have been prepared and delivered
to each of its Obligors (or, in the case of a Governmental Entity, its fiscal intermediary), and all invoices issued after the Closing Date bear only the appropriate remittance instructions for payment direction to a Lock-Box or a Collection
Accounts, as the case may be. No direction is in effect directing Obligors to remit payments on Receivables other than to a Lock-Box or a Collection Account. 

  
 65 

 (dd)    Each of the Collection Accounts has been established
in the name of an Originator by a Collection Account Bank, and a Concentration Account has been established in the name of the Borrower by each Concentration Account Bank. Neither the Collection Agent nor the Borrower has established any
lock-box, lock-box account or other deposit account for the receipt of Collections other than the Lock-Boxes and Collection Accounts. Each Lock-Box is linked to a Collection Account. Each Collection Account has been set up to so that all
available funds automatically sweep to the applicable Concentration Account at the end of each Business Day. The Borrower has taken, or has caused to be taken, all actions necessary or advisable to assure that all Collections are received in
the Lock-Boxes and Collection Accounts. The Borrower will not (i) close any Lock-Box, any Collection Account or any Concentration Account or open any new lock-box or account to function as a Lock-Box, a Collection Account or a
Concentration Account, (ii) make any change to the instructions to the Obligors that all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iii) make any change to the instructions to a Collection Account Bank
as set forth in the applicable Deposit Account Notification Agreement (Government Healthcare Receivables) requiring the automatic sweep of all available funds in each Collection Account to the applicable Concentration Account at the end of each
Business Day, in each case, without the prior written consent of the Administrative Agent and each Managing Agent; provided, if provisions under clauses (i), (ii) or (iii) above have been violated with respect to any Lock-Box or Collection
Account relating to an individual Originator without the prior knowledge or consent of the Borrower, the Collection Agent or CHS, the Borrower (itself or through the Collection Agent or CHS) shall have the opportunity to cure the violation of this
clause (dd) within 15 days of obtaining knowledge of such breach by the Originator and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or
warranty by the Borrower under any Facility Document directly related to or directly arising from such violation without any further action. 

(ee)      Neither the Parent nor the Borrower is (i) a country, territory, organization, person
or entity named on an Office of Foreign Asset Control (OFAC) list, (ii) a Person that resides or has a place of business in a country or territory named on such lists or which is designated as a “Non-Cooperative Jurisdiction” by the
Financial Action Task Force on Money Laundering, or whose subscription funds are transferred from or through such a jurisdiction; (iii) a “Foreign Shell Bank” within the meaning of the USA PATRIOT Act, i.e., a foreign bank that does not
have a physical presence in any country and that is not affiliated with a bank that has a physical presence and an acceptable level of regulation and supervision; or (iv) a person or entity that resides in or is organized under the laws of a
jurisdiction designated by the United States Secretary of the Treasury under Sections 311 or 312 of the USA PATRIOT Act as warranting special measures due to money laundering concerns. 

(ff)      Notice of termination of each of the agreements and other documents relating to the
sale, purchase or transfer of AccessOne Program Receivables from an Originator to any Person other than the Buyer was provided to such Person prior to the Closing Date. 

(gg)      The Borrower (i) is not a “covered fund” as defined in the final
regulations issued December 10, 2013, implementing the Volcker Rule and (ii) is not, and after giving effect to the transactions contemplated hereby, will not be, required to register as an “investment company” within the meaning of the
Investment Company Act. In determining that the Borrower is not a “covered fund”, the Borrower is entitled to rely on the exemption from the definition of “investment company” set forth in Section 3(c)(5) of the Investment
Company Act, and may be able to rely on other exemptions or exclusions. 

  
 66 

 (hh)    Policies and procedures have been implemented and
maintained by or on behalf of the Borrower that are designed to achieve compliance by the Borrower and its directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, giving due regard to the nature of such
Person’s business and activities, and the Borrower and its officers and employees and, to the knowledge of the Borrower and its officers, employees, directors and agents acting in any capacity in connection with or directly benefitting from the
loan facility established hereby, are in compliance with Anti-Corruption Laws and applicable Sanctions, in each case in all material respects. Neither the Borrower nor, to the knowledge of the Borrower, its directors, officers, employees, or
agents that will act in any capacity in connection with or directly benefit from the loan facility established hereby, is a Sanctioned Person, and the Borrower is not organized or resident in a Sanctioned Country. No Advance or use of proceeds
thereof by the Borrower in any manner will violate Anti-Corruption Laws or applicable Sanctions.

(ii)      The Borrower is not an EEA Financial Institution. 

SECTION 4.02.      Representations and Warranties of the Collection Agent. The
Collection Agent represents and warrants to and, where applicable, agrees with each of the Secured Parties, that: 

(a)      The Collection Agent is a limited liability company duly formed, validly existing and
in good standing under the jurisdiction named at the beginning hereof and is duly qualified to do business, and is in good standing, in every jurisdiction in which the nature of its business requires it to be so qualified and the failure to do so
could reasonably be expected to have a Material Adverse Effect. 
 (b)      The execution,
delivery and performance by the Collection Agent of this Agreement and any other documents to be delivered by it hereunder (i) are within the Collection Agent’s limited liability company powers, (ii) have been duly authorized by all
necessary limited liability company action, (iii) do not contravene (1) the Collection Agent’s certificate of formation or limited liability company agreement, (2) any law, rule or regulation applicable to the Collection Agent,
(3) any contractual restriction binding on or affecting the Collection Agent or its property (other than in an immaterial manner), or (4) any order, writ, judgment, award, injunction or decree binding on or affecting the Collection Agent
or its property, and (iv) do not result in or require the creation of any Lien upon or with respect to any of its properties. This Agreement has been duly executed and delivered by the Collection Agent. 

(c)      No authorization or approval or other action by, and no notice to or filing with, any
governmental authority or regulatory body is required for the due execution, delivery and performance by the Collection Agent of this Agreement or any other document to be delivered by it hereunder except such as (i) have been made or obtained and
are in full force and effect and (ii) where the failure to make or obtain could not reasonably be expected to adversely affect the Collection Agent’s ability to perform its material obligations hereunder or the ability of the Borrower to assign
or collect the Receivables hereunder (other than in an immaterial manner). 

  
 67 

 (d)      This Agreement constitutes the legal,
valid and binding obligation of the Collection Agent enforceable against the Collection Agent in accordance with its terms subject to bankruptcy and similar laws affecting creditors generally and general principles of equity (regardless of whether
enforcement is sought in a proceeding in equity or at law). 
 (e)      There is no pending
or, to the Collection Agent’s knowledge, threatened action, investigation or proceeding affecting the Collection Agent or any of its Subsidiaries before any court, governmental agency or arbitrator which may materially adversely affect the
financial condition or operations of the Collection Agent or any of its Subsidiaries or the ability of the Collection Agent to perform its obligations under this Agreement, or which purports to affect the legality, validity or enforceability of this
Agreement, except any such action, investigation or proceeding that the Collection Agent certifies to the Administrative Agent that, in the best judgment of the Collection Agent, if determined adversely, will not have a material impact on the
ability of the Collection Agent to fulfill its duties hereunder, or result in a Lien on the Collateral. 

(f)      The Collection Agent has not intentionally (i) misstated any calculation of Eligible
Receivables or Net Receivables Balance hereunder (other than in an immaterial amount and based on good faith estimates utilized in the calculation thereof), or (ii) misrepresented any Receivable as qualifying as an Eligible Receivable or
intentionally included such misrepresented Receivable in the Net Receivables Balance at the time so included. 

(g)      Each Monthly Report (if prepared by the Collection Agent or one of its Affiliates, or
to the extent that information contained therein is supplied by the Collection Agent or an Affiliate), information, exhibit, financial statement, document, book, record or report furnished or to be furnished at any time by the Collection Agent to
the Administrative Agent, the Managing Agents or the Lenders in connection with this Agreement is or will be accurate in all material respects as of its date or (except as otherwise disclosed to the Administrative Agent, the Managing Agents or the
Lenders, as the case may be, at such time) as of the date so furnished, and no such document contains or will contain any untrue statement of a material fact or omits or will omit to state a material fact necessary in order to make the statements
contained therein, in the light of the circumstances under which they were made, not misleading; provided that to the extent any such information, report, financial statement, exhibit or schedule was based upon or constitutes a forecast or
projection, the Collection Agent represents only that it acted in good faith and utilized assumptions that the Collection Agent believed to be reasonable at the time made. 

(h)      The Collection Agent has (i) timely filed all federal tax returns required to be
filed, (ii) timely filed all other material state and local tax returns and (iii) paid or made adequate provision for the payment of all taxes, assessments and other governmental charges (other than any tax, assessment or governmental
charge which is being contested in good faith and by proper proceedings, and with respect to which the obligation to pay such amount is adequately reserved against in accordance with generally accepted accounting principles), in each case, other
than as to which a failure to do so could reasonably be expected to result in a Material Adverse Effect. 

  
 68 

 (i)      All required Notices have been prepared
and delivered to each of its Obligors (or, in the case of a Governmental Entity, its fiscal intermediary), and all invoices issued after the Closing Date bear only the appropriate remittance instructions for payment direction to a Lock-Box or a
Collection Accounts, as the case may be. No direction is in effect directing Obligors to remit payments on Receivables other than to a Lock-Box or a Collection Account. 

(j)      Each of the Collection Accounts has been established in the name an Originator by a
Collection Account Bank, and each Concentration Account has been established in the name of the Borrower by a Concentration Account Bank. Neither the Collection Agent nor the Borrower has established any lock-box, lock-box account or other
deposit account for the receipt of Collections other than the Lock-Boxes and Collection Accounts. Each Lock-Box is linked to a Collection Account. Each Collection Account has been set up to so that all available funds automatically sweep
to the applicable Concentration Account at the end of each Business Day. The Collection Agent has taken, or has caused to be taken, all actions necessary or advisable to assure that all Collections are received in the Lock-Boxes and Collection
Accounts. The Collection Agent will not, and will not permit the Borrower to, (i) close any Lock-Box, any Collection Account or any Concentration Account or open any new lock-box or account to function as a Lock-Box, a Collection Account or a
Concentration Account, (ii) make any change to the instructions to the Obligors that all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iii) make any change to the instructions to any Collection Account Bank
as set forth in the applicable Deposit Account Notification Agreement (Government Healthcare Receivables) requiring the automatic sweep of all available funds in a Collection Account to the applicable Concentration Account at the end of each
Business Day, in each case, without the prior written consent of the Administrative Agent and each Managing Agent; provided, if provisions under clauses (i), (ii) or (iii) above have been violated with respect to any Lock-Box or Collection
Account relating to an individual Originator without the prior knowledge or consent of the Borrower, the Collection Agent or CHS, the Collection Agent (itself or through CHS) shall have the opportunity to cure the violation of this clause (j) within
15 days of obtaining knowledge of such breach by the Originator and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or warranty by the Collection
Agent under any Facility Document directly related to or directly arising from such violation without any further action.

(k)      Notice of termination of each of the agreements and other documents relating to the
sale, purchase or transfer of AccessOne Program Receivables from an Originator to any Person other than the Buyer was delivered to such Person prior to the Closing Date. 

(l)      Policies and procedures have been implemented and maintained by or on behalf of the
Collection Agent that are designed to achieve compliance by the Collection Agent and its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, giving due regard to the nature
of such Person’s business and activities, and the Collection Agent and its Subsidiaries and, to the knowledge of the Collection Agent, their respective officers, employees, directors and agents acting in any

  
 69 

 
capacity in connection with or directly benefitting from the loan facility established hereby, are in compliance with Anti-Corruption Laws and applicable Sanctions, in each case in all material
respects. Neither the Collection Agent nor any of its Subsidiaries nor, to the knowledge of the Collection Agent, any of their respective directors, officers, employees, or agents that will act in any capacity in connection with or directly
benefit from the loan facility established hereby, is a Sanctioned Person, and the Collection Agent and the Borrower are not organized or resident in a Sanctioned Country. No Advance or use of proceeds thereof by the Borrower or the Collection
Agent in any manner will violate Anti-Corruption Laws or applicable Sanctions. 

(m)      Neither the Collection Agent, nor CHS, nor any Originator, nor any other CHS Party is
an EEA Financial Institution. 
 SECTION 4.03.      Article 9 Representations and
Warranties. The Borrower represents and warrants to and, where applicable, agrees with each of the Secured Parties, that: 

(a)      This Agreement creates a valid and continuing security interest (as defined in the
applicable UCC) in the Receivables in favor of the Administrative Agent, which security interest is prior to all other Liens, and is enforceable as such against creditors of and purchasers from the Borrower. 

(b)      The Receivables constitute “accounts” (including health-care-insurance
receivables) or general intangibles within the meaning of the applicable UCC. 

(c)      Immediately prior to the initial Advance hereunder, the Borrower owns and has good and
marketable title to the Receivables free and clear of any Lien of any Person. 
 (d)      The
Borrower has caused or will have caused, within 10 days after the date hereof, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect the security
interest in the Receivables granted to the Administrative Agent hereunder. 
 (e)      Other
than the security interest granted to the Administrative Agent pursuant to this Agreement, the Borrower has not pledged, assigned, sold, granted a security interest in, or otherwise conveyed any of the Receivables. The Borrower has not
authorized the filing of and is not aware of any financing statements against the Borrower other than any financing statement relating to the security interest granted to the Administrative Agent hereunder. The Borrower is not aware of any
judgment or tax lien filings against the Borrower. 
 ARTICLE V 

GENERAL COVENANTS 

SECTION 5.01.      Covenants of the Borrower. 

(a)      Compliance with Laws; Preservation of Existence. The Borrower shall comply
in all material respects with all Applicable Law (including all applicable Healthcare Laws), orders and Facility Documents and preserve and maintain its limited liability company existence, rights, franchises, qualifications and privileges, except
in each case, where the failure to comply could not reasonably be expected to materially adversely affect the Borrower’s ability to perform its obligations hereunder or the ability to assign or collect the Receivables hereunder. 

  
 70 

 (b)      Sales, Liens, Etc. Except as
otherwise specifically provided in the Facility Documents, the Borrower shall not (i) sell, assign (by operation of law or otherwise) or otherwise dispose of, or create or suffer to exist any Lien (other than Permitted Liens) upon or with
respect to, any Receivable or the related Contract, Collections or Related Security, or upon or with respect to any Collection Account or any Concentration Account or assign any right to receive income in respect thereof or (ii) create or
suffer to exist any Lien (other than Permitted Liens) upon or with respect to any of the Borrower’s other assets (which, for the avoidance of doubt, shall not include any Self Pay Obligations or proceeds thereof); provided that the
Borrower (acting directly or through the Collection Agent) shall have up to 10 days following actual knowledge thereof to remove any immaterial Lien that was improvidently filed without the consent of the Borrower or the Collection Agent;
provided further that the Borrower (acting through the Collection Agent) shall have the time period specified in Section 5.02(k) to remove and terminate the Kay County Lien. 

(c)      No Agreements. The Borrower shall not enter into any agreement, document
or instrument other than the Facility Documents and any agreements in furtherance of the covenants set forth in Section 10.1 of the Borrower’s limited liability company agreement. 

(d)      Merger, Etc. The Borrower will not merge or consolidate with, or convey,
transfer, lease, assign or otherwise dispose of (whether in one transaction or in a series of transactions), all or substantially all of its assets (whether now owned or hereafter acquired), or acquire all or substantially all of the assets or
capital stock or other ownership interest of any Person, other than, with respect to asset dispositions, in connection herewith. 

(e)      Treatment of Borrower Acquisitions. The Borrower will, and will direct the
Transferor to, account for and treat (whether in financial statements, records or otherwise) the transactions contemplated by the Contribution Agreement as capital contributions and sales of the “Transferred Assets” (as defined therein) by
the Transferor to the Borrower. 
 (f)      Nature of Business. The Borrower will
not engage in business other than the acquisition of Receivables and Related Security from the Transferor, the borrowing of Advances hereunder, the grant of a security interest in such Receivables, Related Security, Collections and proceeds thereof
to the Administrative Agent and the other transactions permitted or contemplated by the Facility Documents. 

(g)      The Receivables. With respect to each Receivable acquired by the Borrower
from the Transferor, the Borrower will (i) acquire such Receivable pursuant to and in accordance with the terms of the Contribution Agreement, (ii) take all action necessary to perfect, protect and more fully evidence the Borrower’s
ownership of such Receivable, including (A) filing and maintaining effective financing statements (Form UCC-1) against the Transferor and the applicable Originator in all necessary or appropriate filing offices, and filing continuation statements,
amendments or assignments with respect thereto in such filing offices and (B) executing or causing to be executed such other instruments or notices as may be necessary or appropriate and (iii) take all additional action that the Administrative
Agent may reasonably request to perfect, protect and more fully evidence the respective interests of the parties to this Agreement in the Receivables and other Collateral related thereto. 

  
 71 

 (h)      Maintenance of Separate
Existence. The Borrower will do all things necessary to maintain its limited liability company existence separate and apart from the Transferor and each Originator and all other Affiliates of the Borrower, including: 

(i)      practicing and adhering to limited liability company formalities, such
as maintaining appropriate limited liability company books and records; 

(ii)     maintaining at all times at least one independent director (an
“Independent Director”) (and paying reasonable compensation to such Independent Director for services rendered) who (v) is not currently and has not been during the five years preceding the date of this Agreement an officer,
director, employee or supplier of the Borrower, the Transferor or any of the Originators or any of their Subsidiaries (except the Borrower) (provided, however, that a member of the board of directors who satisfies the requirements of this
clause (ii) shall not be disqualified from serving as an Independent Director if he or she is also an independent director of an Affiliate of the Transferor, the Borrower or any of the Originators or any of their Subsidiaries which is a special
purpose bankruptcy-remote entity), (w) is not a current or former officer or employee of the Borrower, (x) is not an equity holder of any of the Transferor, the Originators or any of their respective Subsidiaries; (y) is an employee of a nationally
recognized provider of corporate or structured finance services, and (z) may not be removed by the Borrower’s equity holders or board of directors except (A) for cause, (B) in the event the Independent Director ceases to be employed
by the service provider which is his or her employer on the date the Independent Director first becomes an Independent Director or (C) with the consent of the Administrative Agent and the Managing Agents in their sole reasonable discretion, which
consent shall not be unreasonably withheld or delayed; provided, that any such removal pursuant to clause (A) or (B) shall not be effective until at least 10 Business Days after written notice to the Independent Director, the Administrative
Agent and the Managing Agents of such removal and the grounds therefor; 

(iii)     refraining from (A) guaranteeing or otherwise becoming liable for any
obligations of any of its Affiliates, (B) having obligations guaranteed by its Affiliates other than as expressly contemplated by the Facility Documents and (C) holding itself out as responsible for debts of any of its Affiliates or for decisions or
actions with respect to the affairs of any of its Affiliates; 

(iv)      maintaining all of its deposit and other bank accounts and all of its
assets separate or readily identifiable from those of any other Person; 

(v)       maintaining all of its financial records separate and apart from
those of any other Person and ensuring that any of the Parent’s and Originator’s consolidated financial statements contain appropriate disclosures to the extent shown to third parties, concerning the Borrower’s separate existence,
provided that the Borrower’s financial statements may be consolidated with the financial statement of the Parent to the extent required by GAAP; 

  
 72 

 (vi)      to the extent
applicable, compensating all its employees, officers, consultants and agents for services provided to it by such Persons, or reimbursing any of its Affiliates in respect of services provided to it by employees, officers, consultants and agents of
such Affiliate, out of its own funds; 
 (vii)     if it requires the use of a
telephone, maintaining a separate telephone number which will be answered only in its name; 

(viii)    accounting for and managing all of its liabilities separately from those of any
of its Affiliates; 
 (ix)      allocating, on an arm’s-length basis,
all shared operating services, leases and expenses, including those associated with the services of shared consultants and agents and shared computer equipment and software; 

(x)       refraining from paying dividends or making distributions, loans
or other advances to any of its Affiliates except, in each case, as contemplated or permitted by the Facility Documents and as duly authorized by its board of directors and in accordance with applicable limited liability company law; 

(xi)     refraining from filing or otherwise initiating or supporting the filing of
a motion in any Insolvency Proceeding involving the Borrower, the Transferor, any Originator or any other Affiliate of the Borrower to substantively consolidate assets and liabilities of the Borrower with the assets and liabilities of any such
Person or any other Affiliate of the Borrower; 
 (xii)    maintaining adequate
capitalization in light of its business and purpose; 
 (xiii)  conducting all of its business
(whether written or oral) solely in its own name; and 
 (xiv)    require that its
employees, if any, when conducting its business identify themselves to non-Affiliates as such and not as employees of any other Affiliate of the Borrower (including by means of providing appropriate employees with business or identification cards
identifying such employees as the Borrower’s employees); and 
 (xv)    comply
with (and cause to be true and correct) each of the facts and assumptions regarding the Borrower contained “Section I - Assumptions of Fact” of the opinion of Kirkland & Ellis LLP delivered pursuant to Section 3.01. 

(i)       Transactions with Affiliates.    The Borrower will
not enter into, or be a party to, any transaction with any of its Affiliates, except (i) the transactions permitted or contemplated by this Agreement, the Contribution Agreement, the Sale Agreement and the other Facility Documents, and
(ii) other transactions (including the lease of office space or computer 

  
 73 

 
equipment or licensing of software by the Borrower to or from an Affiliate) (A) in the ordinary course of business, (B) pursuant to the reasonable requirements of the Borrower’s business, or
(C) upon fair and reasonable terms that are substantially similar to the terms that could be obtained in a comparable arm’s-length transaction with a Person not an Affiliate of the Borrower. It is understood that any compensation
arrangement for officers shall be permitted under clause (ii)(A), (B) and (C) above if such arrangement has been expressly approved by the board of directors of the Borrower. 

(j)      Debt; Investments. The Borrower will not incur any Debt other than Debt
arising hereunder. The Borrower will not make any Investments (including the creation of, and the making of capital contributions to, a subsidiary) other than Permitted Investments. 

(k)      Change in Agreements, Etc. Without the prior written consent of each
Managing Agent, the Borrower will not (a) amend, modify, waive or terminate any terms or conditions of the Contribution Agreement, the Sale Agreement the Performance Undertaking or any other Facility Document (other than this Agreement) to
which it is a party or assignee, or (b) exercise any discretionary rights granted to the Borrower under the Contribution Agreement pursuant to provisions thereof providing for certain actions to be taken “with the consent of the
Company”, “acceptable to the Company” as “specified by the Company”, “in the reasonable judgment of the Company” or similar provisions, or (c) exercise any discretionary rights granted to the Borrower, as
assignee under the Sale Agreement pursuant to provisions thereof providing for certain actions to be taken “with the consent of the Buyer”, “acceptable to the Buyer” as “specified by the Buyer”, “in the reasonable
judgment of the Buyer” or similar provisions. 
 (l)      Amendment to Organizational
Documents. The Borrower will not amend, modify or otherwise make any change to its Certificate of Formation or other organizational documents, except (i) in accordance with the terms and provisions thereof but not in any way that would
be adverse to any Lender, and (ii) with the written consent of the Administrative Agent. 

(m)      Audits. From time to time, but at least once per calendar year, upon
reasonable prior written notice to the Borrower during regular business hours the Borrower will permit the Administrative Agent and the Managing Agents, or their respective agents or representatives, to (i) examine and make copies of and
abstracts from all Records, and (ii) visit the offices and properties of the Borrower for the purpose of examining such Records and to discuss matters relating to the Receivables or the Borrower’s performance hereunder with any of the
officers or employees of the Borrower having knowledge of such matters; provided that the Administrative Agent and the Managing Agents (and their respective agents or representatives) shall not request and the Borrower and the Collection
Agent shall not provide to the Administrative Agent and the Managing Agents (or their respective agents or representatives), any information or access to information that would constitute “Protected Health Information” as that term is
defined in regulations implementing HIPAA, where such examination or access is prohibited by Applicable Law without a Patient Consent Form that lists the Administrative Agent, the Managing Agents and their specific agents or representatives who will
access “Protected Health Information”. Unless an Event of Default or a Trigger Event has occurred and is continuing, only one such examination and visit per calendar year shall be at the expense of the Borrower. 

  
 74 

 (n)      Keeping of Records and Books of
Account. The Borrower will maintain (or cause to be maintained) and implement administrative and operating procedures (including an ability to recreate records evidencing the Receivables in the event of the destruction of the originals
thereof) and keep and maintain, all documents, books, records and other information reasonably necessary or advisable for the collection of all Receivables (including records adequate to permit the daily identification of all collections of and
adjustments of each Receivable). The Borrower will indicate in its books and records that the Receivables have been transferred by CHS to the Borrower and pledged by the Borrower to the Administrative Agent for the benefit of the Lenders. 

(o)      Jurisdiction of Organization; Location of Records; Structure. The Borrower
will keep its jurisdiction of organization, principal place of business and chief executive office, and the offices where it keeps its Records, in the jurisdictions and at the addresses set forth on Schedule V, or, in any
such case, upon 30 days’ prior written notice to the Administrative Agent, at such other jurisdiction or locations within the United States where all action required by Section 6.08 shall have been taken and completed,
and will not change its structure or identity other than upon 30 days’ prior written notice to the Administrative Agent and subject to the further requirement that all action required by Section 6.08 shall have been
taken and completed. 
 (p)      Credit and Collection Policy. The Borrower will,
and will direct the Collection Agent to, comply in all material respects with the Credit and Collection Policy in regard to each Receivable and the related Contract. The Borrower shall not make or agree to make or permit any material change in
the Credit and Collection Policy other than in accordance with Section 6.02(c). 

(q)      Change in Payment Instructions to Obligors. The Borrower will not
(i) add or terminate any bank as a Collection Account Bank or a Concentration Account Bank, (ii) close any Lock-Box, any Collection Account or any Concentration Account or open any new lock-box or account to function as a Lock-Box, Collection
Account or Concentration Account, (iii) make any change to the instructions to the Obligors that all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iv) make any change to the instructions to a Collection
Account Bank requiring all available funds in each Collection Account to automatically sweep to the applicable Concentration Account at the end of each Business Day, in each case, without the prior written consent of the Administrative Agent and
each Managing Agent in their sole discretion, which consent shall not be unreasonably withheld or delayed; provided, if provisions under clauses (i) through (iv) above have been violated with respect to any Lock-Box or Collection Account
relating to an individual Originator without the prior knowledge or consent of the Borrower, the Collection Agent or CHS, the Borrower (itself or through the Collection Agent or CHS) shall have the opportunity to cure the violation of this clause
(q) within 15 days of obtaining knowledge of such breach by the Originator and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or warranty by the
Borrower under any Facility Document directly related to or directly arising from such violation without any further action. 

  
 75 

 (r)      Change in Name. The Borrower
will not make any change to its legal name unless it shall have, prior to the effectiveness of such name change: (i) given the Administrative Agent prompt written notice thereof, and (ii) delivered to the Administrative Agent (in a
manner that will provide reasonable opportunity to allow the Administrative Agent to make the filing thereof prior to or simultaneously with the effectiveness of such name change) all financing statements, instruments and other documents the
Administrative Agent determines are necessary or appropriate to file under the UCC or that are otherwise necessary or appropriate for the Administrative Agent to continue at all times following such change to have a valid, legal and perfected
security interest in the assets of the Borrower. 
 (s)      Taxes. The Borrower
will file or cause to be filed all federal and other material tax returns which are required to be filed by it. The Borrower shall pay or cause to be paid all taxes shown to be due and payable on such returns or on any assessments received by
it, other than any taxes or assessments, the validity of which are being contested in good faith by appropriate proceedings and with respect to which the Borrower shall have set aside or has caused to be set aside adequate reserves on its books
(consolidated or otherwise) in accordance with GAAP. 
 (t)      Facility
Documents. The Borrower will comply in all material respects with the terms of this Agreement and employ the procedures outlined herein. The Borrower will comply in all material respects with the terms of and employ the procedures
outlined in and enforce the obligations of the Transferor under the Contribution Agreement and (as assignee) the Originators under the Sale Agreement, enforce all of the other rights of the Borrower under each of the other Facility Documents to
which it is a party or to which it is an assignee, take all such action to such end as may be from time to time reasonably requested by the Administrative Agent, and maintain all such Facility Documents in full force and effect and make to each
Originator such reasonable demands and requests for information and reports or for action as the Borrower is entitled to make thereunder and as may be from time to time reasonably requested by the Administrative Agent. 

(u)      Segregation of Collections. The Borrower will require the deposit of all
Collections received in the Collection Accounts solely into the applicable Concentration Account, will prevent the deposit into any Concentration Account of any funds other than Collections and proceeds of Self Pay Obligations and, with respect to
proceeds of Self Pay Obligations, the Borrower will hold all such proceeds in trust for the applicable Originator and promptly (and in any event within three Business Days) identify such funds to the Collection Agent for segregation and remittance
to the owner thereof; provided, that the Borrower and the Collection Agent will use reasonable efforts to avoid deposit of the proceeds of Self Pay Obligations into any Collection Account or Concentration Account if such parties determine in
their reasonable business judgment that it is practical to do so, except to the extent requiring unreasonable additional effort or expense; provided further that the parties acknowledge that the Borrower and the Collection Agent have
determined that such identification and segregation is impractical as of the Second Omnibus Amendment Effective Date. With respect to any funds other than Collections and proceeds of Self Pay Obligations that are nevertheless deposited into
such Concentration Account, the Borrower will promptly identify any such funds to the Collection Agent for segregation and remittance to the owner thereof. 

  
 76 

 (v)      Modifications to
Contracts. Except as provided in Section 6.02, the Borrower will not, and will not suffer or permit the Collection Agent, the Transferor or any Originator to, extend, amend or otherwise modify the terms of any
Eligible Receivable or any Contract related thereto. 
 (w)      Sales Taxes. The
Borrower shall timely pay or cause to be paid when due all sales, excise or personal property taxes payable in connection with the Receivables, other than any taxes or assessments, the validity of which are being contested in good faith by
appropriate proceedings and with respect to which the Borrower has set aside or has caused to be set aside adequate reserves on its books (consolidated or otherwise) in accordance with GAAP (provided, that, notwithstanding such contest,
Receivables subject to such tax claims shall not constitute Eligible Receivables hereunder). 

(x)      Deviation from Patient Consent Form. At any time following September 30,
2012, without the prior written consent of the Administrative Agent, the Borrower will not, and will not suffer or permit the Collection Agent or any Originator to, substitute, alter, modify, or change in any way any of the Patient Consent Forms
except in an Immaterial Respect. 
 (y)      AccessOne Program Receivables. After
May 31, 2012, no Receivables will be sold pursuant to any agreement other than the Facility Documents, and prior to May 31, 2012, the aggregate Expected Net Value of the AccessOne Program Receivables shall not exceed $500,000. 

(z)      Anti-Corruption Laws and Sanctions – Policies and
Procedures. Policies and procedures will be maintained and enforced by or on behalf of the Borrower that are designed in good faith and in a commercially reasonable manner to promote and achieve compliance, in the reasonable judgment of the
Borrower, by the Borrower and its directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, in each case giving due regard to the nature of such Person’s business and activities. 

(aa)    Anti-Corruption Laws and Sanctions – Requests for Advances and Uses of
Proceeds. The Borrower will not request any Advance, and shall procure that its Affiliates and its or their respective directors, officers, employees and agents shall not use, the proceeds of any Advance (A) in furtherance of an offer,
payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (B) for the purpose of funding or financing any activities, business or transaction
of or with any Sanctioned Person, or in any Sanctioned Country, in each case to the extent doing so would violate any Sanctions, or (C) in any other manner that would result in liability to any party hereto under any applicable Sanctions or the
violation of any Sanctions by any such Person. 
 SECTION 5.02.      Covenants of the
Collection Agent. 
 (a)      Sales, Liens, Etc. Except as otherwise
specifically provided herein, the Collection Agent shall not, and shall not suffer or permit the Borrower to, (i) sell, assign (by operation of law or otherwise) or otherwise dispose of, or create or suffer to exist any Lien (other than
Permitted Liens) upon or with respect to, any Receivable or the related Contract, Collections or Related Security, or upon or with respect to any Collection Account, any Concentration Account or any other account to which any Collections of any
Receivable are sent, or assign any right to receive income in respect thereof or (ii) create or suffer to exist any 

  
 77 

 
Lien (other than Permitted Liens) upon or with respect to any of the Borrower’s other assets; provided that the Borrower (acting directly or through the Collection Agent) shall have
up to 10 days following actual knowledge thereof to remove any immaterial Lien that was improvidently filed without the consent of the Borrower or the Collection Agent. provided further that the Collection Agent shall have the time
period specified in Section 5.02(k) to remove and terminate the Kay County Lien. 

(b)      General Reporting Requirements.   The Collection Agent will
provide to the Administrative Agent and each Managing Agent the following: 

(i)      within 90 days after the end of each fiscal year of the Parent, a copy
of the consolidated balance sheet of the Parent and its consolidated subsidiaries (including each Originator) and the related statements of income, stockholders’ equity and cash flows for such year, each prepared in accordance with GAAP
consistently applied and reported on by nationally recognized independent public accountants; 

(ii)      within 50 days after the end of each of the first three quarters of
each fiscal year of the Parent, the consolidated balance sheet of the Parent and its consolidated subsidiaries (including each Originator) and the related statements of income, stockholders’ equity and cash flows each for the period commencing
at the end of the previous fiscal year and ending with the end of such quarter, prepared in accordance with GAAP and certified by a senior financial officer of the Parent; 

(iii)      within 50 days after the end of each of the first three quarters and
within 90 days after the end of each fiscal year of the Borrower, the unaudited balance sheet of the Borrower and the related statements of income, stockholders’ equity and cash flows for such year, each prepared in accordance with GAAP
consistently applied and certified by a senior financial officer of the Borrower; 

(iv)      promptly after the same becomes publicly available, copies of all
reports and registration statements which the Parent files with the Securities and Exchange Commission or any national securities exchange other than registration statements relating to employee benefit plans and to registrations of securities for
selling securityholders; 
 (v)      as soon as possible and in any event
within the greater of five days, or three Business Days after the Borrower or the Collection Agent has knowledge of the occurrence of each Default or Event of Default, a statement of a Responsible Officer of such Person setting forth details of such
Default or Event of Default and the action which such Person has taken and proposes to take with respect thereto; 

(vi)      to the extent not already provided, promptly following receipt
thereof, copies of all financial statements, settlement statements, portfolio and other reports, notices, disclosures, certificates, budgets and other written material delivered to the Borrower or the Collection Agent by the Transferor under the
Contribution Agreement or any Originator pursuant to the terms of the Sale Agreement; 

  
 78 

 (vii)     promptly following the
Administrative Agent’s request therefor, such other information, approvals or opinions respecting the Receivables or the conditions or operations, financial or otherwise, of the Borrower or any of its Affiliates as the Administrative Agent may
from time to time reasonably request in order to protect the interests of the Administrative Agent, the Managing Agents or any Lender in connection with this Agreement; 

(viii)    at least 10 Business Days prior to the effectiveness of any removal of any
Independent Director of the Borrower, and within five Business Days after a Responsible Officer of the Borrower has actual knowledge of the death, incapacity or resignation of any Independent Director of the Borrower, notice of such event and
the date of occurrence thereof, together with the name and background of the replacement Independent Director; 

(ix)     at the time of the delivery of the financial statements for the fiscal year
of the Borrower provided for in clause (iii) of this paragraph, the name of the Independent Director of the Borrower as of such date; 

(x)      promptly after the request by the Administrative Agent or any Managing
Agent, copies of (i) any documents described in Section 101(k)(1) of ERISA that the Borrower or any of its ERISA Affiliates may request with respect to any Multiemployer Plan and (ii) any notices described in Section 101(l)(1) of ERISA that the
Borrower or any of its ERISA Affiliates may request with respect to any Multiemployer Plan; provided that if the Borrower or any of its ERISA Affiliates has not requested such documents or notices from the administrator or sponsor of the
applicable Multiemployer Plan, the Borrower or the applicable ERISA Affiliate shall promptly make a request for such documents or notices from such administrator or sponsor and shall provide copies of such documents and notices promptly after
receipt thereof; 
 (xi)      as soon as possible after, and in any event
within 10 days after any Responsible Officer of the Parent, the Borrower or any ERISA Affiliate knows or has reason to know that, any ERISA Event has occurred that, alone or together with any other ERISA Event could reasonably be expected to result
in liability of the Borrower or any ERISA Affiliate in an aggregate amount exceeding $10,000,000, a statement of a Responsible Officer of the Parent or the Borrower setting forth details as to such ERISA Event and the action, if any, that the Parent
or the Borrower proposes to take with respect thereto; and 
 (xii)     such other
information (including nonfinancial information) as the Administrative Agent or any Managing Agent may from time to time reasonably request, including any information available to the Borrower, the Collection Agent or any Originator as any Lender
may reasonably request in order to assist such Lender (or its related Liquidity Provider or other program support provider) in complying with the requirements of Article 122a(4) and (5) of the Banking Consolidation Directive (Directive 2006/48/EC
(as amended)) as may be applicable to such Lender (or Liquidity Provider or other program support provider). 

  
 79 

 Documents required to be delivered pursuant to Section 5.02(b)(i), (ii) or (iv) (to
the extent any such documents are included in materials otherwise filed with the Securities and Exchange Commission) shall be deemed to have been delivered on the date on which such documents are available on the Securities and Exchange
Commission’s electronic database (EDGAR); provided that upon the request of the Administrative Agent or any Managing Agent, the Collection Agent shall deliver paper copies of such documents to such Person until a written request to cease
delivering paper copies is given by such Person. 
 (c)      Treatment of Borrower
Acquisitions. The Collection Agent will, and will direct the Borrower and the Transferor to, account for and treat (whether in financial statements, records or otherwise) the transactions contemplated by the Contribution Agreement as
capital contributions and sales of the “Transferred Assets” (as defined therein) by the Transferor to the Borrower. 

(d)      The Receivables. With respect to each Receivable acquired by the Borrower
from the Transferor, the Collection Agent will, and will direct the Borrower to, (i) acquire such Receivable pursuant to and in accordance with the terms of the Contribution Agreement, (ii) take all action necessary to perfect, protect and
more fully evidence the Borrower’s ownership of such Receivable, including (A) filing and maintaining effective financing statements (Form UCC-1) against the Transferor and the applicable Originator in all necessary or appropriate filing
offices, and filing continuation statements, amendments or assignments with respect thereto in such filing offices and (B) executing or causing to be executed such other instruments or notices as may be necessary or appropriate and (iii) take
all additional action that the Administrative Agent may reasonably request to perfect, protect and more fully evidence the respective interests of the parties to this Agreement in the Receivables and other Collateral related thereto. 

(e)      Maintenance of Separate Existence. The Collection Agent will, and will
direct the Borrower to, do all things necessary to maintain the Borrower’s limited liability company existence separate and apart from the Transferor and all other Affiliates of the Borrower (including any Originator), including doing or
directing the Borrower to do, as specified, the following: 

(i)      practicing and adhering to corporate formalities, such as maintaining
appropriate corporate books and records, and directing the Borrower to practice and adhere to limited liability company formalities, such as maintaining appropriate limited liability company books and records; 

(ii)     directing the Borrower to maintain at all times at least one Independent
Director who (v) is not currently and has not been during the five years preceding the date of this Agreement an officer, director, employee or supplier of an Affiliate of the Borrower, the Transferor or any of the Originators or any of their
Subsidiaries (except the Borrower) (provided, however, that a member of the board of directors who satisfies the requirements of this clause (ii) shall not be disqualified from serving as an Independent Director if he or she is also an
independent director of an Affiliate of the Borrower or any of the Originators or any of their Subsidiaries which is a special purpose bankruptcy-remote entity), (w) is not a current or former officer or

  
 80 

 
employee of the Borrower, (x) is not an equity holder of the Transferor, any of the Originators or any of their respective Subsidiaries or Affiliates, (y) is an employee of a nationally
recognized provider of corporate or structured finance services, and (z) may not be removed by the Borrower’s equity holders or board of directors except (A) for cause, (B) in the event the Independent Director ceases to be employed
by the service provider which is his or her employer on the date the Independent Director first becomes an Independent Director or (C) with the consent of the Administrative Agent and the Managing Agents; provided, that any such removal
pursuant to clause (A) or (B) shall not be effective until at least 10 Business Days after written notice to the Independent Director, the Administrative Agent and the Managing Agents of such removal and the grounds therefor; 

(iii)      directing the Borrower to own or lease pursuant to written leases
all office furniture and equipment necessary to operate its business; 

(iv)      directing the Borrower to refrain from (A) guaranteeing or otherwise
becoming liable for any obligations of any of its Affiliates, (B) having obligations guaranteed by its Affiliates and (C) holding itself out as responsible for debts of any of its Affiliates or for decisions or actions with respect to the affairs of
any of its Affiliates; 
 (v)      directing the Borrower to hold all of the
Borrower’s deposit and other bank accounts and all of the Borrower’s assets separate from those of any other Person; 

(vi)     maintaining all of its financial records separate and apart from those of
any other Person and ensuring that any of the Parent’s and Originator’s consolidated financial statements contain appropriate disclosures concerning the Borrower’s separate existence, except, in each case, as may be required by GAAP;

 (vii)    directing the Borrower, to the extent applicable, to compensate all its
employees, officers, consultants and agents for services provided to it by such Persons, or reimbursing any of its Affiliates in respect of services provided to it by employees, officers, consultants and agents of such Affiliate, out of its own
funds; 
 (viii)   if the Borrower leases or occupies any office space, directing the
Borrower to maintain office space that is physically segregated from that of any of its Affiliates (even if such office space is subleased from or is on or near premises occupied by any of its Affiliates) and, if it requires the use of a telephone,
directing the Borrower to maintain a separate telephone number which will be answered only in the Borrower’s name; 

(ix)     accounting for and managing, and directing the Borrower to account for and
manage, all of the Borrower’s liabilities separately from those of any of its Affiliates; 

(x)     allocating, and directing the Borrower to allocate, on an arm’s-length
basis, all operating services, leases and expenses shared by the Borrower and any of its Affiliates, including those associated with the services of shared consultants and agents and shared computer equipment and software; 

  
 81 

 (xi)      directing the Borrower
to refrain from paying dividends or making distributions, loans or other advances to any of its Affiliates except, in each case, as contemplated or permitted by the Facility Documents and as duly authorized by the Borrower’s board of directors
and in accordance with applicable limited liability company law; 

(xii)     refraining from filing or otherwise initiating or supporting the filing of
a motion in any Insolvency Proceeding involving the Transferor, the Borrower, any Originator or any other Affiliate of the Borrower to substantively consolidate assets and liabilities of the Borrower with the assets and liabilities of any such
Person or any other Affiliate of the Borrower; 
 (xiii)    maintaining adequate
capitalization in light of its business and purpose; 
 (xiv)    directing the Borrower
to conduct all of the Borrower’s business (whether written or oral) solely in its own name; and 

(xv)     directing the Borrower to require that the Borrower’s employees, if
any, when conducting the Borrower’s business identify themselves as such and not as employees of any other Affiliate of the Borrower (including by means of providing appropriate employees with business or identification cards identifying such
employees as the Borrower’s employees); and 
 (xvi)   complying with (and causing to be
true and correct), and directing the Borrower to comply with (and cause to be true and correct) each of the facts and assumptions regarding the Borrower contained “Section I - Assumptions of Fact” of the opinion of Kirkland & Ellis LLP
pursuant to Section 3.01. 
 (f)      Change in Agreements,
Etc. Without the prior written consent of each Managing Agent, the Collection Agent will not, and will not suffer or permit the Borrower to, (a) amend, modify, waive or terminate any terms or conditions of the Contribution Agreement,
the Sale Agreement the Performance Undertaking or any other Facility Document (other than this Agreement) to which it is a party or assignee, or (b) exercise any discretionary rights granted to the Borrower under the Contribution Agreement
pursuant to provisions thereof providing for certain actions to be taken “with the consent of the Company”, “acceptable to the Company” as “specified by the Company”, “in the reasonable judgment of the
Company” or similar provisions, or (c) exercise any discretionary rights granted to the Borrower, as assignee under the Sale Agreement pursuant to provisions thereof providing for certain actions to be taken “with the consent of the
Buyer”, “acceptable to the Buyer” as “specified by the Buyer”, “in the reasonable judgment of the Buyer” or similar provisions. 

  
 82 

 (g)      Keeping of Records and Books of
Account. The Collection Agent will, and will direct the Borrower to, maintain and implement administrative and operating procedures (including, without limitation, an ability to recreate records evidencing the Receivables in the event of
the destruction of the originals thereof) and keep and maintain, all documents, books, records and other information reasonably necessary or advisable for the collection of all Receivables (including records adequate to permit the daily
identification of all collections of and adjustments of each Receivable). The Collection Agent will, and will direct the Borrower to, indicate in the Borrower’s books and records that the Receivables have been transferred by CHS to the
Borrower and pledged by the Borrower to the Administrative Agent for the benefit of the Lenders. 

(h)      Credit and Collection Policy. The Collection Agent will, and will direct
the Borrower to, comply in all material respects with the Credit and Collection Policy in regard to each Receivable and the related Contract. The Collection Agent shall not make or agree to make or permit any material change in the Credit and
Collection Policy other than in accordance with Section 6.02(c). 
 (i)      Change
in Payment Instructions to Obligors. The Collection Agent will not, and will not suffer or permit the Borrower to, (i) add or terminate any bank as a Collection Account Bank or a Concentration Account Bank, (ii) close any Lock-Box, any
Collection Account or any Concentration Account or open any new lock-box or account to function as a Lock-Box, Collection Account or Concentration Account, (iii) make any change to the instructions to the Obligors that all payments with respect to
the Receivables be made to a Lock-Box or Collection Account or (iv) make any change to the instructions to a Collection Account Bank requiring all available funds in each Collection Account to automatically sweep to the applicable Concentration
Account at the end of each Business Day, in each case, without the prior written consent of the Administrative Agent and each Managing Agent in their sole discretion, which consent shall not be unreasonably withheld or delayed; provided, if
provisions under clauses (i) through (iv) above have been violated with respect to any Lock-Box or Collection Account relating to an individual Originator without the prior knowledge or consent of the Collection Agent, the Collection Agent (itself
or through CHS) shall have the opportunity to cure the violation of this clause (i) within 15 days of obtaining knowledge of such breach by the Originator and, if such violation is cured within such 15 day period, the cure of such violation shall be
effective to cure any breach of any covenant, representation or warranty by the Collection Agent under any Facility Document directly related to or directly arising from such violation without any further action. 

(j)      AccessOne Program Receivables. After May 31, 2012, no Receivables will be
sold pursuant to any agreement other than the Facility Documents, and prior to May 31, 2012, the aggregate Expected Net Value of the AccessOne Program Receivables shall not exceed $500,000. 

(k)      Kay County Lien. The Collection Agent will remove and terminate the Kay
County Lien within six months of the Second Omnibus Amendment Effective Date and will utilize its best efforts to remove and terminate such Kay County Lien as promptly as practicable, and the existence of the Kay County Lien shall not constitute a
breach of this covenant or any other representation or covenant hereunder during the continuance of such time period. 

  
 83 

 (l)      Banc of America Leasing & Capital,
LLC Leases. The Collection Agent will utilize its best efforts to cause each of the existing lease agreements and the form for all future lease agreements between an Originator and Banc of America Leasing & Capital, LLC or any of its
affiliates to be amended to remove all references to “accounts” from the defined term “Collateral” identified thereunder as promptly as practicable and in any event within 90 days of the Third Omnibus Amendment Effective Date;
provided, that, to the extent any existing lease agreement or the form for any future lease agreement is not so amended within such 90 day period or any new lease agreement does not reflect such amendment, the Administrative Agent shall have
the right to deduct from the Borrowing Base amounts not exceeding the aggregate amount of all amounts payable under such lease agreements. 

(m)      Anti-Corruption Laws and Sanctions – Policies and
Procedures. The Collection Agent will ensure that policies and procedures will be maintained and enforced by or on behalf of the Borrower and the Collection Agent that are designed in good faith and in a commercially reasonable manner to
promote and achieve compliance, in the reasonable judgment of the Collection Agent, by the Borrower, the Collection Agent and each of the Collection Agent’s Subsidiaries and their respective directors, officers, employees and agents with
Anti-Corruption Laws and applicable Sanctions, in each case giving due regard to the nature of such Person’s business and activities. 

(n)      Anti-Corruption Laws and Sanctions – Requests for Advances and Uses of
Proceeds. The Collection Agent shall procure that the Borrower will not request any Advance, and shall procure that the Borrower, the Collection Agent, each of their Affiliates and their respective directors, officers, employees and agents shall
not use, the proceeds of any Advance (A) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (B) for
the purpose of funding or financing any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country, in each case to the extent doing so would violate any Sanctions, or (C) in any other manner that would
result in liability to any party hereto under any applicable Sanctions or the violation of any Sanctions by any such Person. 
 ARTICLE VI

 ADMINISTRATION, COLLECTION AND MONITORING OF ASSETS 

SECTION 6.01.      Appointment and Designation of the Collection Agent. The
Borrower may, from time to time, with the consent of the Administrative Agent, appoint one or more Persons as the Collection Agent of the Borrower to service, administer and collect the Receivables and otherwise to enforce its rights and interests
in, to and under the Collateral, including the Receivables, the Related Security and the Contracts. Any such consent by the Administrative Agent shall be subject to the approval of the Managing Agents pursuant to this
Section 6.01. The Collection Agent’s authorization under this Agreement shall terminate on the Collection Date. Until the Administrative Agent gives notice to the Borrower of a designation of a new Collection
Agent after the occurrence and during the continuance of a Servicer Termination Event, or consents to the appointment by the Borrower of a new “Collection Agent” under and pursuant to the Sale Agreement, the Contribution Agreement and this
Agreement, Professional Services is hereby designated as, and hereby agrees to perform the duties and obligations of, the Collection Agent pursuant to the terms hereof. The Borrower and the Collection Agent may from time to time agree in any
collection agency or services agreement among them on the allocation of servicing duties to be performed by the Collection Agent.

  
 84 

 
Notwithstanding the foregoing, the Administrative Agent may (with the approval of the Managing Agents), after the occurrence and during the continuance of a Servicer Termination Event, designate
as Collection Agent any Person to succeed Professional Services or any successor Collection Agent, on the condition in each case that any such Person so designated shall agree to perform the duties and obligations of the collection agent pursuant to
the terms hereof and in accordance with applicable Healthcare Laws. The Borrower hereby grants to the Collection Agent and any successor Collection Agent, and the Collection Agent hereby grants to any successor Collection Agent, an irrevocable
power of attorney, with full power of substitution, coupled with an interest, to take any and all steps in the Borrower’s or the Collection Agent’s name, as applicable, and on behalf of the Borrower or the Administrative Agent, as may be
necessary or desirable, in the determination of the Collection Agent or successor Collection Agent, as the case may be, to collect all amounts due under any and all Receivables, including endorsing the Borrower’s name on checks and other
instruments representing Collections and enforcing such Receivables and the related Contracts. The Collection Agent may subcontract the performance of its duties and obligations to a third Person with the prior consent of each Managing Agent,
including with respect to Collection Agency Receivables. Any such subcontract shall not affect the Collection Agent’s liability for performance of its duties and obligations pursuant to the terms hereof, and any such subcontract shall
automatically terminate upon designation of a successor Collection Agent. Notwithstanding anything to the contrary contained in this Agreement, the Collection Agent, if not the Borrower or an Affiliate thereof, shall have no obligation to
collect, enforce or take any other action described in this Article VI with respect to any Receivable that is not a Pledged Receivable other than to deliver to the Borrower or at its direction, the Collections and documents
with respect to any such Receivable that is not a Pledged Receivable as described in Sections 6.03 and 6.07. 

SECTION 6.02.      Collection of Receivables by the Collection Agent; Extensions and
Amendments of Receivables. 
 (a)      The Collection Agent shall take or cause to be
taken all such reasonable actions as may be necessary or advisable to collect each Receivable from time to time, all in accordance with Applicable Law, with reasonable care and diligence, and in accordance with the Credit and Collection Policy;
provided, however, that, if a Servicer Termination Event shall have occurred and be continuing, (i) the Administrative Agent shall have the right to direct the Collection Agent (whether the Collection Agent is the Transferor, an
Originator or an Affiliate thereof or otherwise) to commence or settle any legal action, to enforce collection of any Receivable or to foreclose upon or repossess any Related Security and (ii) the Collection Agent shall not make the
Administrative Agent, any Managing Agent or any Lender a party to any litigation without the express written consent of the Administrative Agent, such Managing Agent or such Lender, as the case may be, such consent not to be unreasonably withheld or
delayed. If the Termination Date applicable to all Lender Groups then party hereto shall not have occurred, Professional Services, while such Person is the Collection Agent, may, with respect to the Receivables and, with respect to any Eligible
Receivable, in accordance with the Credit and Collection Policy, (i) extend the maturity or adjust the Expected Net Value of any Defaulted Receivable as Professional Services may determine to be appropriate to maximize Collections thereof and
(ii) adjust the Expected Net Value of any Receivable to reflect the reductions or cancellations described in the first sentence of Section 2.09, in each such case (except with

  
 85 

 
respect to Receivables which are not Eligible Receivables) (x) in accordance with the requirements of the Credit and Collection Policy and (y) provided that such extension or adjustment shall not
alter the status of such Receivable as a Defaulted Receivable or limit the rights of the Administrative Agent, any Managing Agent or any Lender under this Agreement. Except as otherwise permitted pursuant to the immediately preceding sentence,
neither the Collection Agent nor the Borrower will extend, amend, cancel or otherwise modify the terms of any Receivable without the prior written approval of the Administrative Agent, or amend, modify, cancel or waive any term or condition of any
Contract related to a Receivable, except to the extent consistent with the Credit and Collection Policy or otherwise with the prior written approval of the Administrative Agent. 

(b)      Notwithstanding anything else contained herein, neither the Collection Agent nor any
subcontractor or delegatee thereof is the agent of the Administrative Agent, any Managing Agent or any Lender, and they are not permitted to (nor do they have any authority to) (i) establish an office or other fixed place of business of the
Administrative Agent, any Managing Agent or any Lender, or (ii) contract for, or conclude a contract in the name of, the Administrative Agent, any Managing Agent or any Lender. 

(c)      The Borrower, the Collection Agent, the Transferor and any applicable Originator may
amend the Credit and Collection Policy from time to time provided that (i) no change shall be made in the Credit and Collection Policy that would be adverse to any of the Lenders, including by impairing the collectibility of any Receivable or the
ability of the Borrower or the Collection Agent to perform its obligations under this Agreement and (ii) in the event that any change is made to the Credit and Collection Policy, promptly following such change and, in any event within 30 days
thereof, the Collection Agent shall provide the Administrative Agent and each of the Managing Agents with an updated Credit and Collection Policy and a summary of all material changes. 

SECTION 6.03.      Distribution and Application of Collections. The Collection
Agent shall set aside the Collections of Receivables in accordance with Sections 2.07. The Collection Agent shall as soon as practicable (and in any event within two Business Days) following receipt turn over to the
Borrower or other Person entitled thereto the Collections of any Receivable which is not a Pledged Receivable less, in the event neither Professional Services nor an Affiliate thereof is the Collection Agent, all reasonable and appropriate
out-of-pocket costs and expenses of the Collection Agent of servicing, collecting and administering the Receivables to the extent not covered by the Servicing Fee received by it. 

SECTION 6.04.      Other Rights of the Administrative Agent.

(a)      At any time following the occurrence and during the continuance of a Servicer
Termination Event or the designation pursuant to Section 6.01 of a Collection Agent other than Professional Services, the Borrower or any Affiliate of either thereof, subject to Applicable Law: 

(i)      The Administrative Agent may or, at the request of the Administrative
Agent, the Borrower shall (in either case, at the Borrower’s expense) direct any or all of the Obligors, to pay all amounts payable under any Receivable directly to the Administrative Agent or its designee; 

  
 86 

 (ii)      The Administrative Agent
may or, at the request of the Administrative Agent, the Borrower shall (in either case, at the Borrower’s expense) give each of the Obligors notice of the Administrative Agent’s interests in the Receivables; 

(iii)     The Administrative Agent may have a representative present during any or
all business hours at each office of the Borrower, the Transferor, the Collection Agent and the Originators involved in the administration, servicing and collections of the Receivables; 

(iv)      The Administrative Agent, or its representatives, may, during regular
business hours, (i) review any or all Records, computer programs and files related to the administration, servicing and collection of the Receivables and (ii) visit the offices of the Borrower for the purpose of such review, and, at the
Administrative Agent’s request and at the Borrower’s expense, the Borrower shall (i) assemble all Records and make the same available to the Administrative Agent or its designee at a place selected by the Administrative Agent or its
designee, and (ii) segregate all cash, checks and other instruments received by it from time to time constituting Collections of Receivables in the manner provided herein or such other manner acceptable to the Managing Agents and, promptly
following receipt, remit all such cash, checks and instruments, duly endorsed or with duly executed instruments of transfer, to the Administrative Agent or its designee; 

(v)      The Administrative Agent is authorized to date and deliver to each
Concentration Account Bank, a notice in substantially the form attached to the Control Agreement to transfer exclusive control of such Concentration Account to the Administrative Agent; and 

(vi)     The Administrative Agent shall have all other rights and remedies provided
under the UCC and other Applicable Law, which rights and remedies shall be cumulative. 

(b)      At any time following the occurrence and during the continuance of an
ENV Event, the Administrative Agent may, and shall at the direction of the Managing Agents, itself or through any agent designated by it, determine the Contractual Allowances. The Administrative Agent shall notify the Collection Agent of its
determination of the Contractual Allowances at least 10 days prior to the Monthly Report Due Date for the Collection Period immediately prior to such Collection Period, and such Contractual Allowances shall thereafter be approved by each Managing
Agent in accordance with Section 6.06. 
 (c)      At all times
following the delivery by the Administrative Agent of the notice referred to in Section 6.04(a)(v) to any Concentration Account Bank, the parties agree that the provisions of Section 2.08(c) shall apply with respect to any
proceeds of Self Pay Obligations on deposit in the Concentration Accounts. 

  
 87 

 SECTION 6.05.      Records. The
Collection Agent, whether or not the Borrower or an Affiliate thereof, shall hold all Records in trust for the Borrower and the Administrative Agent, for the benefit of the Secured Parties, in accordance with their respective interests. Subject
to the receipt of contrary instructions from the Administrative Agent that are delivered following the occurrence and continuance of a Servicer Termination Event, the Borrower will deliver all Records to the Collection Agent; provided,
however, that the Collection Agent, if other than the Borrower or any Affiliate thereof, shall as soon as practicable upon demand deliver to the Borrower copies of Records in its possession relating to Receivables. 

SECTION 6.06.      Receivable Reporting.

(a)      On each Monthly Report Due Date, the Collection Agent shall deliver to the
Administrative Agent and each Managing Agent a Monthly Report for the preceding Collection Period, which delivery may be in electronic form. In addition, simultaneously with each delivery of an updated Monthly Report required under the
Contribution Agreement and Sale Agreement, the Collection Agent shall deliver a copy of such updated Monthly Report to the Administrative Agent and each Managing Agent. 

(b)      The Contractual Allowances for the immediately succeeding Collection Period as set
forth in a Monthly Report will be deemed approved by the Administrative Agent and the Managing Agents unless the Administrative Agent or a Managing Agent has notified the Collection Agent, in writing before the later of (i) the last Business Day of
the month in which such Monthly Report is received and (ii) 10 days after receipt by such Person of such Monthly Report, that the Contractual Allowances as set forth therein is not approved. In the event the Contractual Allowances as set forth
in a Monthly Report is not approved, then the most recently approved Contractual Allowances shall remain in effect until the approval under this Section 6.06 of the Contractual Allowances set forth in a subsequent Monthly Report or as
otherwise agreed by the Collection Agent, Administrative Agent and the Managing Agents. 
 SECTION
6.07.      Collections and Lock-Boxes. 
 (a)      The
Borrower and the Collection Agent will instruct all Obligors to cause all Collections to be either (i) remitted to a Lock-Box to be retrieved therefrom by the applicable Collection Account Bank for prompt deposit to the applicable Collection Account
or (ii) remitted directly to a Collection Account. If the Borrower, the Transferor, the Collection Agent or any Originator receives any Collections, the Borrower or the Collection Agent will, and shall instruct such Originator to,
immediately remit such Collections to the applicable Collection Account within two Business Days of receipt thereof, and the Collection Agent, the Transferor or the Borrower shall promptly take, or direct the applicable Originator to take, all such
actions as are reasonably necessary in the Collection Agent’s or the Borrower’s discretion or reasonably requested by the Administrative Agent to ensure that future payments from any Obligor be made to a Collection Account or
Lock-Box. If the Borrower or the Collection Agent does not, or does not cause the applicable Originator to, promptly (and in any event within two Business Days from the Administrative Agent’s request) take such actions as the
Administrative Agent may reasonably request, then the Administrative Agent, its assigns or designees, may, to the maximum extent permitted by law take such actions as the Administrative Agent, its assigns or designees may, on its direction, deem
appropriate. 

  
 88 

 (b)      In accordance with the terms of the
applicable Control Agreement, the Collection Agent shall instruct each Concentration Account Bank to allocate and remit Collections in accordance with Sections 2.07 and 2.08; provided, however, that the
Administrative Agent may, at any time following a Trigger Event and shall, at the direction of any Managing Agent, revoke the Collection Agent’s authority with respect to each Concentration Account, direct each Concentration Account Bank to
cease taking instructions from the Collection Agent or the Borrower and to thereafter take direction solely from the Administrative Agent in each case by delivery of a notice substantially in the form attached to the Control Agreement for such
purpose. Neither the Borrower nor the Collection Agent will (i) add or terminate any bank as a Collection Account Bank or a Concentration Account Bank, (ii) close any Lock-Box, any Collection Account or any Concentration Account or open
any new lock-box or account to function as a Lock-Box, Collection Account or Concentration Account, (iii) make any change to the instructions to the Obligors that all payments with respect to the Receivables be made to a Lock-Box or Collection
Account or (iv) make any change to the instructions to a Collection Account Bank as set forth in the applicable Deposit Account Notification Agreement (Government Healthcare Receivables) requiring all available funds in each Collection Account to
automatically sweep to the applicable Concentration Account at the end of each Business Day, in each case, without the prior written consent of the Administrative Agent and each Managing Agent. The Borrower and the Collection Agent each hereby
agrees to take, or cause to be taken, any and all actions reasonably requested by the Administrative Agent to protect and perfect the interest of the Administrative Agent, for the benefit of the Secured Parties, in the event any such change is
permitted. 
 (c)      At all times following the revocation by the Administrative Agent of
the Collection Agent’s authority with respect to any Concentration Account referred to in Section 6.07(b), the parties agree that the provisions of Section 2.08(c) shall apply with respect to any proceeds of Self Pay Obligations
on deposit in such Concentration Accounts.
 SECTION 6.08.      UCC Matters; Protection
and Perfection of Collateral. The Collection Agent will direct the Borrower to, keep its jurisdiction of organization, principal place of business and chief executive office, and the offices where it keeps its Records, in the jurisdictions
and at the addresses set forth on Schedule V, or, in any such case, upon 30 days’ prior written notice to the Administrative Agent, at such other jurisdiction or locations within the United States where all actions
reasonably requested by the Administrative Agent to protect and perfect the interest of the Administrative Agent, for the benefit of the Secured Parties, in the Collateral have been taken and completed. Each of the Borrower and the Collection
Agent agrees that from time to time, at the Borrower’s expense, it will promptly execute and deliver all further instruments and documents, and take all further action that the Administrative Agent may reasonably request in order to perfect,
protect or more fully evidence the interest in the Collateral acquired by the Administrative Agent hereunder, or to enable the Administrative Agent to exercise or enforce any of its rights hereunder. Without limiting the generality of the
foregoing, each of the Borrower and the Collection Agent agrees that it will upon the request of the Administrative Agent, execute and file such financing or continuation statements, or amendments thereto or assignments thereof, and such other
instruments or notices, as may be necessary or appropriate. The Borrower hereby authorizes the Administrative Agent to file one or more financing or continuation statements, and amendments thereto and assignments thereof, relative to all or any
of the Collateral now existing or hereafter arising without the signature of 

  
 89 

 
the Borrower where permitted by law. If the Borrower or the Collection Agent fails to perform any of its agreements or obligations under this Section 6.08, the
Administrative Agent may (but shall not be required to) itself perform, or cause performance of, such agreement or obligation, and the reasonable expenses of the Administrative Agent incurred in connection therewith shall be payable by the Borrower
upon the Administrative Agent’s demand therefor. For purposes of enabling the Administrative Agent to exercise its rights described in the preceding sentence and elsewhere in this Article VI, the Borrower and the
Collection Agent each hereby authorizes the Administrative Agent following the occurrence and during the continuance of a Trigger Event to take any and all steps in the Borrower’s or the Collection Agent’s, as applicable, name and on
behalf of the Borrower or the Collection Agent, as the case may be, necessary or desirable, in the determination of the Administrative Agent, to collect all amounts due under any and all Receivables, including endorsing the Borrower’s or the
Collection Agent’s name on checks and other instruments representing Collections and enforcing such Receivables and the related Contracts, subject to Applicable Law. 

SECTION 6.09.      Obligations With Respect to Receivables. Each of the Borrower
and the Collection Agent will (a) at the Borrower’s expense, regardless of any exercise by the Administrative Agent, any Managing Agent or any Lender of its rights hereunder, timely and fully perform and comply or cause each of the
Originators to perform or comply with all material provisions, covenants and other promises required to be observed by it under the Contracts related to the Receivables to the same extent as if the Receivables had not been pledged and assigned
hereunder and (b) pay or direct the applicable Originator to pay, when due any taxes, including sales, excise or personal property taxes, payable in connection with the Receivables. In no event shall the Administrative Agent, any Managing
Agent or any Lender have any obligation or liability with respect to any Receivables or related Contracts, nor shall any of them be obligated to perform any of the obligations of the Borrower, the Collection Agent or any Originator or any of their
respective Affiliates thereunder. Each of the Borrower and the Collection Agent agrees it will timely and fully comply in all material respects with the Credit and Collection Policy in regard to each Receivable and the related Contract. 

SECTION 6.10.      Applications of Collections. Any payment by an Obligor in
respect of any indebtedness owed by it to the Borrower or any Originator shall, except as otherwise specified by such Obligor or otherwise required by contract or Applicable Law and unless otherwise instructed by the Administrative Agent, be applied
as a Collection of any Receivable of such Obligor, in the order of the age of such Receivables, starting with the oldest such Receivable, to the extent of any amounts then due and payable thereunder, before being applied to any other indebtedness,
account, general intangible or obligation of such Obligor. 
 SECTION 6.11.      Annual
Servicing Report of Independent Audit Firm. On an annual basis on or before the date which is 90 days after the end of each fiscal year (or such other date as may be approved by the Administrative Agent in its sole discretion), beginning
with the fiscal year ending December 31, 2012, the Collection Agent shall engage and cause FTI Consulting, Inc. or another firm acceptable to each Managing Agent and the Borrower to provide the Collection Agent, each Managing Agent and the
Administrative Agent with a report setting forth the results of such firm’s review of the Receivables in form and in scope satisfactory to the Administrative Agent, the Managing Agents and the Collection Agent; provided that in no event
shall such report include “Protected Health Information”, as such term is defined in regulations 

  
 90 

 
implementing HIPAA; provided further that such independent audit firm shall be required to enter into a Business Associate Agreement with the Collection Agent; provided further
that, solely with respect to the annual servicing report commenced in 2015, the Collection Agent shall engage FTI Consulting, Inc. or another firm acceptable to each Managing Agent and the Borrower within 30 days after the Fifth Omnibus Amendment
Effective Date to provide such report. The Borrower hereby authorizes such firm to discuss such affairs, finances and performance with representatives of the Administrative Agent and each of the Managing Agents. 

SECTION 6.12.      Indemnities by the Collection Agent. (a) Without limiting
any other rights which any Indemnified Party may have hereunder or under Applicable Law, and in consideration of its appointment as Collection Agent, the Collection Agent hereby agrees to indemnify each Indemnified Party from and against any and all
Indemnified Amounts awarded against or actually incurred by any of them arising out of or resulting from any actions it has taken or the failure to perform its duties under this Agreement or the other Facility Documents or with respect to the use of
proceeds of Advances or remittances or the security interests in the Collateral or in respect of any Receivable, Related Security or Contract. Without limiting or being limited by the foregoing, the Collection Agent shall pay on demand to each
Indemnified Party any and all amounts necessary to indemnify such Indemnified Party from and against any and all Indemnified Amounts relating to or resulting from any of the following: 

(i)      reliance on any representation made or deemed made by the Collection
Agent or any of its officers under or in connection with this Agreement or any other Facility Document which shall have been false, incorrect or misleading in any material respect when made or deemed made or delivered; 

(ii)     the failure by the Collection Agent to comply with any term, provision or
covenant contained in this Agreement, any of the other Facility Documents, or any Contract, or with any Applicable Law with respect to any Receivable, the related Contract or the Related Security; 

(iii)    the failure to file, or any delay in filing, financing statements or other
similar instruments or documents under the UCC of any applicable jurisdiction or other Applicable Law with respect to any Receivables, whether at the Closing Date or at any subsequent time; 

(iv)     any failure of the Collection Agent to perform its duties or obligations in
accordance with the provisions of this Agreement or the other Facility Documents; 

(v)     the commingling of Collections of Receivables at any time with other funds;

 (vi)    any action or omission by the Collection Agent that reduces or impairs the
rights of the Administrative Agent, any Managing Agent or any of the Lenders with respect to any Receivable or the value of any Receivable; 

  
 91 

 (vii)      any Servicing Fees or
other costs and expenses payable to any replacement Collection Agent, to the extent in excess of the Servicing Fees payable to the Collection Agent hereunder; or 

(viii)    any claim brought by any Person other than an Indemnified Party arising from
any activity by the Collection Agent or its Affiliates in servicing, administering or collecting any Receivable. 

(b)      Any amounts subject to the indemnification provisions of this Section 6.12
shall be paid by the Collection Agent to the Administrative Agent within 10 Business Days following the Administrative Agent’s demand therefor. Notwithstanding any other provision of this Agreement to the contrary, the Collection Agent
shall not indemnify any Indemnified Party for or with respect to any Indemnified Amounts (i) that would constitute recourse for uncollectible Receivables due to the bankruptcy or insolvency of the related Obligor or (ii) which arise solely from such
Indemnified Party’s gross negligence, bad faith or willful misconduct as determined in a final non-appealable judgment of a court of competent jurisdiction. 

ARTICLE VII 
 EVENTS OF DEFAULT

 SECTION 7.01.      Events of Default. If any of the following events (any such
event, an “Event of Default”) shall occur: 
 (a)      The Collection Agent
or the Borrower shall fail to make any payment or deposit to be made by it hereunder when due, and, if such failure to make any payment or deposit arises in connection with the payment of Interest or Fees hereunder, such failure shall remain
unremedied for five Business Days; or 
 (b)      A Borrowing Base Deficiency shall exist and
such Borrowing Base Deficiency shall remain unremedied for three Business Days; or 

(c)      Any representation or warranty made or deemed to be made by the Borrower or the
Collection Agent (or any of their respective officers or agents) under or in connection with any Facility Document, including any Monthly Report or Funding Request other than with respect to the status of a Receivable as an Eligible Receivable, or
any other information, report or officer’s certificate delivered pursuant hereto, shall prove to have been false, incorrect or misleading in any material respect when made or deemed made, unless and solely to the extent (i) such representation
or warranty does not contain a grace period within such provision, and (ii) such misrepresentation is capable of being cured within 10 days, the Borrower and the Collection Agent deliver a written certificate to the Administrative Agent certifying
that such false, incorrect or misleading statement, and all ramifications thereof under this Agreement or any Facility Document has been cured in full (together with such data demonstrating such cure) by earlier to occur of (x) the date on which
written notice shall have been given to the Collection Agent by the Administrative Agent or the Borrower and (y) the date on which a Responsible Officer of the Collection Agent acquires knowledge thereof; or 

  
 92 

 (d)      The Borrower or the Collection Agent
shall fail to perform or observe, beyond the applicable grace or cure period therein, any term, covenant or agreement (other than any term covenant, or agreement described in another clause of this Section 7.01) contained
in any Facility Document on its part to be performed or observed and any such failure (other than a failure with respect to any of Section 5.01(b), (c), (d), (f), (i), (j), (k), (l), (p) (second sentence), (q), (r), (v) and (x) and
Section 5.02(a), (f), (h) (second sentence) and (i), in each case, as to which no grace period shall apply) shall remain unremedied for 10 days after written notice thereof shall have been given by the Administrative Agent to the
Borrower; or 
 (e)      This Agreement or any other Facility Document shall cease to be
effective or be a legally valid, binding and enforceable obligation of the Borrower or the Collection Agent, as the case may be or any Affiliate thereof shall contest in any manner the effectiveness, validity, binding nature or enforceability of
this Agreement or any other Facility Document; or 
 (f)      (i) The Collection Agent shall
fail to pay any principal, interest or other amount due in respect of any Material Indebtedness, in each case, when and as the same shall become due and payable (after giving effect to any grace period) or (ii) any other event or condition occurs
that results in any Material Indebtedness of the Collection Agent becoming due prior to its scheduled maturity or that enables or permits (after giving effect to any grace period) the holder or holders of any Material Indebtedness of the Collection
Agent or any trustee or agent on its or their behalf to cause any such Debt to become due; provided that this clause (ii) shall not apply to secured Debt that becomes due as a result of the voluntary sale or transfer of the property or assets
securing such Debt; or 
 (g)      (i)      The Borrower, any
Material Originator, the Parent, CHS or the Collection Agent shall (A) become insolvent, generally not pay its debts as such debts become due, or shall admit in writing its inability to pay its debts generally or shall make a general assignment for
the benefit of creditors, (B) any Insolvency Proceeding or any other proceeding seeking the entry of an order for relief or the appointment of a receiver, receiver/manager, custodian, trustee, or other similar official for it or for any substantial
part of its property shall be instituted by the Borrower, any Material Originator, the Parent, CHS or the Collection Agent or (C) any Insolvency Proceeding or any other proceeding seeking the entry of an order for relief or the appointment of a
receiver, receiver/manager, custodian, trustee, or other similar official for it or for any substantial part of its property shall be instituted against the Borrower, any Material Originator, the Parent, CHS or the Collection Agent, and in the case
of any Material Originator, the Parent, CHS or the Collection Agent such other proceeding shall remain unstayed for a period of 60 days, or the requested adjudication, relief or other action sought thereby shall have been made, granted or taken, or
(ii) the Borrower, any Material Originator, the Parent, CHS or the Collection Agent shall take any corporate or entity-level action that authorizes any of the actions set forth above in this Section 7.01(g); or 

(h)      Except during the Temporary Trigger Relief Period, as of the last day of any
Collection Period, (i) the Payment Denial Rate shall exceed 1.25%, (ii) the average of the Default Ratio for each of such Collection Period and the two prior Collection Periods shall exceed 3.50%, or (iii) the average of the Delinquency Ratio for
each of such Collection Period and the two prior Collection Periods shall exceed 5.00%; or 

  
 93 

 (i)      The DSO reported on any Monthly Report
shall exceed, (x) if with respect to a Collection Period occurring during the Temporary Trigger Relief Period, 80 days, or (y) if with respect to a Collection Period occurring at any other time, (a) if the Medicare/Medicaid Expected Net Value for
such Collection Period exceeds 30% of the aggregate Expected Net Value of all Eligible Receivables for such Collection Period, 70 days, or (b) at any other time, 65 days; or 

(j)      (i)      There shall have occurred and be continuing an
“Event of Termination” under the Sale Agreement without regard to waivers, supplements or amendments not approved in writing by the Administrative Agent and the Managing Agents, or (ii) the Sale Agreement shall have ceased to be
valid, binding and enforceable as against any of the parties thereto without any amendment, modification, waiver or termination of any terms or conditions thereof, other than as agreed to in writing by the Administrative Agent; or 

(k)      (i)      There shall have occurred and be continuing an
“Event of Termination” under the Contribution Agreement without regard to waivers, supplements or amendments not approved in writing by the Administrative Agent and the Managing Agents, or (ii) the Contribution Agreement shall have
ceased to be valid, binding and enforceable as against any of the parties thereto without any amendment, modification, waiver or termination of any terms or conditions thereof, other than as agreed to in writing by the Administrative Agent; or 

(l)      The grant of security hereunder shall, for any reason, except to the extent permitted
by the terms hereof, ceases to create a valid and perfected first priority security interest in each Receivable and the Related Security and Collections with respect thereto, or the other Collateral granted hereunder; or 

(m)      (i) Any Originator shall have ceased for any reason to sell all of its
“Receivables” under and as defined in the Sale Agreement to the Borrower pursuant to the Sale Agreement, except with (x) the prior consent of the Administrative Agent, which consent will be at its sole discretion and may be accompanied by
an adjustment of concentration limits or purchase limits as determined by the Administrative Agent and the Managing Agents and (y) delivery of a Monthly Report calculated to reflect such change and related adjustments, or (ii) the
assignment to the Administrative Agent of all of the Borrower’s right and title to and interest in the Sale Agreement shall have ceased, for any reason, to be fully effective and enforceable by the Administrative Agent as against any of the
parties to the Sale Agreement; or 
 (n)      (i) The Transferor shall have ceased for
any reason to contribute all of its “Receivables” under and as defined in the Contribution Agreement to the Borrower pursuant to the Contribution Agreement, or (ii) the assignment to the Administrative Agent of all of the
Borrower’s right and title to and interest in the Contribution Agreement or the Sale Agreement shall have ceased, for any reason, to be fully effective and enforceable by the Administrative Agent as against any of the parties to the
Contribution Agreement or Sale Agreement, as applicable; or 
 (o)      There shall have
occurred a Change in Control; or 
 (p)      There shall have occurred any material adverse
change in the business or financial condition of CHS or the Originators taken as a whole since December 31, 2011, which could reasonably be expected to affect the value or collectability of the Receivables or the ability of the Borrower, the
Collection Agent or any Originator to collect the Receivables or otherwise perform its respective obligations under this Agreement or any other Facility Document; or 

  
 94 

 (q)      A Servicer Termination Event shall have
occurred and be continuing; or 
 (r)      CHS or any subsidiary thereof shall fail to
perform or observe any term, covenant or agreement contained in Section 6.12 or Section 6.13 of the Parent Credit Agreement either as in effect on the Third Omnibus Amendment Effective Date or as in effect from time to time without regard to any
waiver or modification to any of those provisions or any of the defined terms used therein and such failure shall continue for a period of 10 Business Days after the date on which financial statements are required to be delivered with respect to the
applicable fiscal quarter hereunder (the “Financial Covenant Cure Period”); or 

(s)      The Borrower shall have become subject to registration as an “investment
company” within the meaning of the Investment Company Act; or 
 (t)      CHS shall fail
to perform or observe any term, covenant or agreement required to be performed by it under the Performance Undertaking beyond the grace period contained therein, or the Performance Undertaking shall cease to be effective or to be the legally valid,
binding and enforceable obligation of CHS, or CHS shall directly or indirectly contest in any manner the effectiveness, validity, binding nature or enforceability of the Performance Undertaking; or 

(u)      One or more judgments shall be rendered against the Borrower, the Collection Agent or
CHS (not paid or fully covered by insurance) shall remain undischarged for a period of 30 consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to levy upon assets or
properties of the Borrower, the Collection Agent or CHS to enforce any such judgment and such judgment is for the payment of money in an aggregate amount in excess (x) of $50,000, with respect to the Borrower, or (y) $50,000,000, with respect to the
Collection Agent and CHS, collectively; or 
 (v)      either (A) a Governmental Authority
with the authority to determine the permissibility of the Lenders’ making Advances hereunder or the appropriateness of the accounting or regulatory capital treatment thereof asserts that (i) the Borrower is (or may be deemed to be) a
“covered fund” under the Volcker Rule, and (ii) the terms of this Agreement create (or may be deemed to create) an “ownership interest” (as defined in the Volcker Rule) in the Borrower or (B) the Administrative Agent has
reasonably determined that an event of the type described in the foregoing subclause (A) of this clause (v) is likely, with notice or lapse of time, to occur; 

then, and in any such event, the Administrative Agent may, and shall, at the direction of any Managing Agent, (i) with respect any Specified
Event, deliver a Specified Notice to the Borrower, and (ii) with respect to all other Events of Default, by notice to the Borrower (a “Termination Declaration Notice”) declare the Termination Date to have occurred, except
that, in the case of any event described in clause (i)(B) or clause (i)(C) of Section 7.01(g) above, the Termination Date shall be deemed to have occurred automatically
without notice upon the occurrence of such event. Upon any such declaration or automatic occurrence, the 

  
 95 

 
Administrative Agent shall have, in addition to all other rights and remedies under this Agreement or otherwise, all other rights and remedies provided under the UCC and other Applicable Law,
which rights and remedies shall be cumulative; provided that the Administrative Agent shall continue to comply with Section 10.14(d) in connection with the exercise of such rights and remedies. 

For the purposes of this Section 7.01, a Specified Notice shall be deemed for all purposes to constitute a Termination
Declaration Notice automatically and without further notice or action of any kind or nature, effective on the earlier to occur of (i) the fifth day (or the immediately following Business Day) following the delivery of such Specified Notice, unless
on or before such date, the Borrower has made payment to the Administrative Agent that reduces the outstanding amount of the Obligations to zero, and (ii) the 30th day following the delivery
of such Specified Notice to the extent that any Specified Event is then continuing; provided that, in all events, the Administrative Agent may, and shall, at the direction of any Managing Agent deliver a new Termination Declaration Notice
between the 25th and 30th day following the delivery of such Specified Notice, which new Termination Declaration Notice shall become effective
on the fifth day following the delivery thereof. 
 Notwithstanding anything to the contrary contained in this Article VII,
during the Financial Covenant Cure Period and in addition to the Borrower’s rights under Section 2.04(d), the Parent may issue Qualified Capital Stock (as defined in the Parent Credit Agreement) and elect to treat all or any portion of the net
cash proceeds thereof as having increased Consolidated EBITDA (as defined in the Parent Credit Agreement) with respect to such applicable quarter solely for the purpose of determining actual and pro forma compliance with Section 6.12 or Section 6.13
of the Parent Credit Agreement for purposes of Section 7.01(r) at the end of such applicable quarter and applicable subsequent periods, provided that (a) such proceeds (i) are actually received by the Parent and contributed to CHS
no later than ten days after the date on which financial statements are required to be delivered with respect to such fiscal quarter hereunder and (ii) do not exceed the aggregate amount necessary to cause Parent to be in compliance with the
covenants under Section 6.12 or Section 6.13 of the Parent Credit Agreement for purposes of Section 7.01(r) for any applicable period and (b) in each period of four fiscal quarters, there shall be at least two fiscal quarters in which no such
right to cure permitted by this paragraph is utilized. 
 Within 30 days prior to the end of the Temporary Trigger Relief
Period Termination Date, the Borrower, the Collection Agent, the Administrative Agent and the Majority Lenders (or their respective Managing Agents) agree to negotiate in good faith amendments to the Events of Default listed in clauses (h) and (i)
of Section 7.01, based on historical data and financial projections. Immediately following the Temporary Trigger Relief Period Termination Date, unless otherwise agreed pursuant to the immediately preceding sentence, (i) if the
Administrative Agent and the Majority Lenders (or their respective Managing Agents) agree in their sole and absolute discretion, (1) the Events of Default listed in clauses (h) and (i) of Section 7.01 shall be reinstated and shall be deemed
in full force and effect for all purposes under this Agreement or (2) the Temporary Trigger Relief Period shall be extended for a period determined by the Administrative Agent and the Majority Lenders (or their respective Managing Agents), or (ii)
an Event of Default shall occur. 

  
 96 

 SECTION 7.02.      Volcker Extension. 

(a)      If a Volcker Event shall have occurred, then the Administrative Agent may declare the
Termination Date to have occurred pursuant to Section 7.01 (which declaration shall be effective) and, if and for so long as: 

(i)        no Event of Default, other than the Volcker Event and any
Event of Default arising solely as a result of the representation in Section 4.01(gg) being false, incorrect or misleading in any material respect, shall have occurred; 

(ii)       the Borrower and its Affiliates shall be actively engaged in
soliciting or making arrangements to cause the repayment in full of the Obligations (whether by refinancing or otherwise); and 

(iii)      on or prior to the fifth Business Day following the date on which the
Administrative Agent shall have delivered the Termination Declaration Notice relating to the Volcker Event, Professional Services shall have delivered a certificate of a Responsible Officer of Professional Services certifying that the conditions set
forth in the foregoing clauses (i) and (ii) have been satisfied; 
 then (other than the termination of the Revolving
Period and the cessation by the Borrower of additional acquisitions of Receivables under the Contribution Agreement by virtue of the occurrence of the Termination Date (other than a Termination Date that exists solely as a result of the occurrence
of a Scheduled Termination Date under clause (a) of such defined term)) the Administrative Agent, the Managing Agents and the Lenders agree that the Administrative Agent shall not exercise additional remedies available under Section 7.01 for
a period of 30 days from the date of the Termination Declaration Notice relating to a Volcker Event (the “Volcker Extension Period”). 

ARTICLE VIII 
 INDEMNIFICATION 

SECTION 8.01.      Indemnities by the Borrower. (a) Without limiting any other
rights which the Administrative Agent, the Managing Agents, the Lenders, the Liquidity Providers or any of their respective Affiliates may have hereunder or under Applicable Law, the Borrower hereby agrees to indemnify the Administrative Agent, each
Managing Agent, each Lender, each Liquidity Provider, each of their respective Affiliates, and each of their respective directors, officers, employees, agents and attorneys (all of the foregoing being individually referred to as an
“Indemnified Party” and being collectively referred to as “Indemnified Parties”) from and against any and all damages, losses, claims, liabilities and related costs and expenses, including reasonable attorneys’
fees and disbursements (excluding Taxes for which provision is made in Section 2.12) (all of the foregoing being collectively referred to as “Indemnified Amounts”) awarded against or actually incurred by any of them arising
out of or resulting from this Agreement or the other Facility Documents or the use of proceeds of Advances or remittances or the security interests in the Collateral or in respect of any Receivable, Related Security or Contract. Without
limiting or being limited by the foregoing, the Borrower shall pay on demand to each Indemnified Party any and all amounts necessary to indemnify such Indemnified Party from and against any and all Indemnified Amounts relating to or resulting from
any of the following: 

  
 97 

 (i)        reliance on
any representation or warranty made or deemed made by the Borrower or any of its officers under or in connection with this Agreement or any other Facility Document, which shall have been false, incorrect or misleading in any material respect when
made or deemed made or delivered; 
 (ii)       the failure by the
Borrower to comply with any term, provision or covenant contained in this Agreement, any of the other Facility Documents, or any Contract, or with any Applicable Law with respect to any Receivable, the related Contract or the Related Security, or
the nonconformity of any Receivable, the related Contract or the Related Security with any such Applicable Law; 

(iii)      the failure to grant to the Administrative Agent, for the benefit of
itself and the Secured Parties, a valid and perfected first priority security interest under Article 9 of the UCC, in and to the Receivables which are, or are purported to be, Collateral, together with all Collections and Related Security, in
each case free and clear of any Lien whether existing at the time of the pledge of any such Receivable or at any time thereafter; 

(iv)      the failure to file, or any delay in filing, financing statements or
other similar instruments or documents under the UCC of any applicable jurisdiction or other Applicable Law with respect to any Receivables, whether at the Closing Date or at any subsequent time; 

(v)       any failure of the Borrower to perform its duties or obligations
in accordance with the provisions of this Agreement or the other Facility Documents or to perform its duties under the Contracts; 

(vi)      any products liability claim or personal injury or property damage
suit or other similar or related claim or action of whatever sort arising out of or in connection with merchandise or services which are the subject of any Receivable or Contract; 

(vii)     any set-off by any Collection Account Bank or any Concentration Account
Bank against Collections; 
 (viii)    the failure to pay when due any taxes which are
the Borrower’s responsibility, including sales, excise or personal property taxes payable in connection with the Receivables or the contribution or purchase thereof; 

(ix)      any repayment by the Administrative Agent or any other Indemnified
Party of any amount previously distributed in reduction of Revolving Principal Balance or payment of Interest or any other amount due hereunder, in each case which amount the Administrative Agent or such Indemnified Party believes in good faith is
required to be repaid; 

  
 98 

 (x)        the
commingling of Collections of Receivables at any time with other funds; 

(xi)      any investigation, litigation or proceeding related to this Agreement
or the Borrower’s use of proceeds of Advances or the pledge of an interest in the Collateral generally or in respect of any Receivable, Related Security or Contract (including in connection with the preparation of a defense or appearing as a
third party witness in connection therewith and regardless of whether such investigation, litigation or proceeding is brought by the Borrower, an Indemnified Party or any other Person or an Indemnified Party is otherwise a party thereto); 

(xii)      any failure by the Borrower to give reasonably equivalent value to
the Transferor in consideration for the transfer by the Transferor to the Borrower of any Receivables or Related Security, or any attempt by any Person to void or otherwise avoid any such transfer under any statutory provision or common law or
equitable action, including any provision of the Bankruptcy Law; 
 (xiii)     any
failure by the Buyer to give reasonably equivalent value to any Originator in consideration for the transfer by such Originator to the Buyer of any Receivables or Related Security, or any attempt by any Person to void or otherwise avoid any such
transfer under any statutory provision or common law or equitable action, including any provision of the Bankruptcy Law; or 

(xiv)     the inclusion as an Eligible Receivable of any Receivable any portion of
the Expected Net Value of which represents sales taxes. 
 (b)      Any amounts subject to
the indemnification provisions of this Section 8.01 shall be paid by the Borrower to the Administrative Agent within 10 Business Days following the Administrative Agent’s demand therefor. Notwithstanding any other
provision of this Agreement to the contrary, the Borrower shall not indemnify any Indemnified Party for or with respect to any Indemnified Amounts (i) that would constitute recourse for uncollectible Receivables due to the bankruptcy or insolvency
of the related Obligor or (ii) that arise solely from such Indemnified Party’s gross negligence, bad faith or willful misconduct as determined in a final non-appealable judgment of a court of competent jurisdiction. 

ARTICLE IX 
 THE ADMINISTRATIVE
AGENT; MANAGING AGENTS 
 SECTION 9.01.      Authorization and Action. The
Lenders and each Managing Agent hereby appoint and authorize the Administrative Agent to take such action as agent on their behalf and to exercise such powers under this Agreement as are delegated to the Administrative Agent by the terms hereof,
together with such powers as are reasonably incidental thereto, including the power and authority to hold and to perfect any ownership interest or security interest created pursuant hereto or in connection herewith on behalf of the Secured
Parties. The Administrative Agent shall not be required to take any action that exposes it to personal liability or that is contrary to this Agreement, the other Facility Documents or Applicable Law. 

  
 99 

 SECTION 9.02.      Agent’s Reliance,
Etc. Neither the Administrative Agent, nor any of its directors, officers, agents or employees shall be liable for any action taken or omitted to be taken by it or them as Administrative Agent under or in connection with this Agreement
(including any action taken or omitted to be taken by it or them if the Administrative Agent is designated as Collection Agent pursuant to Section 6.01) or any other agreement executed pursuant hereto, except for its or
their own gross negligence or willful misconduct as determined in a final non-appealable judgment of a court of competent jurisdiction. Without limiting the foregoing, the Administrative Agent: (i) may consult with legal counsel
(including counsel for the Borrower, the Originators and CHS), independent public accountants and other experts selected by it and shall not be liable for any action taken or omitted to be taken in good faith by it in accordance with the advice of
such counsel, accountants or experts, (ii) shall not be subject to any fiduciary or other implied duties, regardless of whether an Event of Default has occurred and is continuing, (iii) shall not have any duty to take any discretionary
action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Facility Documents, (iv) except as expressly set forth herein and in the other Facility Documents, shall not have
any duty to disclose, and shall not be liable for the failure to disclose, any information relating to the Borrower or any of its Affiliates that is communicated to or obtained by the bank serving as Administrative Agent or any of its Affiliates in
any capacity, (v) shall not be responsible to any Managing Agent, any Lender or any other Person for the due execution, legality, validity, enforceability, genuineness or sufficiency of value of this Agreement or any other agreement, instrument
or document furnished pursuant hereto, and (vi) shall incur no liability under or in respect of this Agreement or any other agreement executed pursuant hereto, by acting upon any notice (including notice by telephone with respect to notices
under Section 2.01), consent, certificate or other instrument or writing (which may be by telex or facsimile) believed by it to be genuine and signed or sent by the proper party or parties. The Administrative Agent
shall not be liable for any action taken or not taken by it with the consent or at the request of the Lenders or the Managing Agents, or in the absence of its own gross negligence or willful misconduct. Each Managing Agent shall indemnify upon
demand, ratably in accordance with the aggregate Commitments of the related Committed Lenders, the Administrative Agent from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, charges,
expenses and disbursements (including reasonable legal fees and disbursements) with respect to the execution, delivery, enforcement, performance and administration of this Agreement or any Facility Document contemplated by or referred to herein or
therein or the transactions contemplated hereby or thereby; provided, however, that no Managing Agent shall be liable for the payment to the Administrative Agent of any portion of such liabilities resulting from such the Administrative
Agent’s gross negligence or willful misconduct; provided, further however, that no actions taken in accordance with directions of the Managing Agents shall be deemed to constitute gross negligence or willful misconduct for purposes of
this Section 9.02. The Administrative Agent shall not be deemed to have knowledge of any Event of Default unless and until written notice thereof is given to the Administrative Agent by the Borrower, the Collection
Agent, a Managing Agent or a Lender, and the Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other
Facility Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other
terms or 

  
 100 

 
conditions set forth herein or therein, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Facility Document or any other agreement, instrument or
document, or (v) the satisfaction of any condition set forth in Article III or elsewhere herein or therein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent. 

SECTION 9.03.      Administrative Agent and Affiliates. The Administrative Agent
shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not the Administrative Agent. CA-CIB and its Affiliates may generally
engage in any kind of business with the Borrower, the Transferor, any Originator or any Obligor, any of their respective Affiliates and any Person who may do business with or own securities of the Borrower, the Transferor, any Originator or any
Obligor or any of their respective Affiliates, all as if CA-CIB were not the Administrative Agent and without any duty to account therefor to any Managing Agent or any Lender. 

SECTION 9.04.      Resignation of the Administrative Agent. The Administrative
Agent may resign as Administrative Agent hereunder at any time by giving not less than five Business Days’ prior written notice to the Managing Agents, the Borrower and the Collection Agent and shall resign at the request of a Managing Agent at
any time that the Administrative Agent is a Defaulting Lender; such resignation to become effective only upon the later to occur of the earlier of (x) the appointment and acceptance of a successor Administrative Agent as provided below and
(y) the 30th day following delivery of such notice. Upon any such resignation, the Managing Agents and the Committed Lenders that are not Defaulting Lenders shall appoint a financial institution of their choosing (with, if such appointment
is to a financial institution which is not affiliated with the current Administrative Agent or a Managing Agent the prior written consent of the Borrower, such consent not to be unreasonably delayed or withheld) as Administrative
Agent. Following the appointment of a successor Administrative Agent and such successor’s acceptance thereof, such successor Administrative Agent shall succeed to and become vested with all the rights, powers, privileges and duties of the
resigning Administrative Agent as Administrative Agent hereunder, and the resigning Administrative Agent shall be discharged from its duties and obligations as Administrative Agent hereunder. After the Administrative Agent’s resignation,
the provisions of this Article IX shall continue in effect for its benefit in respect of any actions taken or omitted to be taken by it while it was acting as the Administrative Agent. 

SECTION 9.05.      Payments. If in the opinion of the Administrative Agent the
distribution of any amount received or assets held by it in such capacity hereunder or under any of the other Facility Documents might involve it in liability, it may refrain from making distribution until its right to make distribution shall have
been adjudicated by a court of competent jurisdiction. If a court of competent jurisdiction shall adjudge that any amount or asset received and distributed by the Administrative Agent is to be repaid or remitted, each Person to whom any such
distribution shall have been made shall either repay to the Administrative Agent its proportionate share of the amount so adjudged to be repaid or shall pay over or return the same in such manner and to such Persons as shall be determined by such
court. 

  
 101 

 SECTION 9.06.      Managing Agents. 

(a)      Each Lender hereby designates and appoints the Managing Agent for such Lender’s
Lender Group as its Managing Agent hereunder, and authorizes such Managing Agent to take such actions as agent on its behalf and to exercise such powers as are delegated to the Managing Agents by the terms of this Agreement together with such powers
as are reasonably incidental thereto. No Managing Agent shall have any duties or responsibilities, except those expressly set forth herein, or any fiduciary relationship with any Lender, and no implied covenants, functions, responsibilities,
duties, obligations or liabilities on the part of the applicable Managing Agent shall be read into this Agreement or otherwise exist for the applicable Managing Agent. In performing its functions and duties hereunder, each Managing Agent shall
act solely as agent for the Lenders in the related Lender Group and does not assume nor shall be deemed to have assumed any obligation or relationship of trust or agency with or for the Borrower or any of its successors or assigns. No Managing
Agent shall be required to take any action that exposes it to personal liability or that is contrary to this Agreement, the other Facility Documents or Applicable Law. The appointment and authority of each Managing Agent hereunder shall
terminate at the payment in full of the Obligations owing to its related Lender Group and the termination of the Commitments made by its related Lender Group hereunder. 

(b)      Each Person serving as a Managing Agent hereunder shall have the same rights and
powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not a Managing Agent, and such Person and its Affiliates may accept deposits from, lend money to and generally engage in any kind of business with the
Borrower or any subsidiary or other Affiliate thereof as if it were not a Managing Agent hereunder. 

(c)      No Managing Agent shall have any duties or obligations except those expressly set
forth herein and in the other Facility Documents. Without limiting the generality of the foregoing, (i) a Managing Agent shall not be subject to any fiduciary or other implied duties, regardless of whether an Event of Default has occurred
and is continuing, (ii) a Managing Agent shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Facility Documents, and
(iii) except as expressly set forth herein and in the other Facility Documents, a Managing Agent shall not have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to the Borrower or any of its
Affiliates that is communicated to or obtained by the bank serving as Managing Agent or any of its Affiliates in any capacity. A Managing Agent shall not be liable for any action taken or not taken by it with the consent or at the request of
the Lenders members of its Lender Group, or in the absence of its own gross negligence or willful misconduct. A Managing Agent shall be deemed not to have knowledge of any Event of Default unless and until written notice thereof is given to a
Managing Agent by the Borrower Representative, the Administrative Agent or a Lender, and a Managing Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in
connection with this Agreement or any other Facility Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of
any of the covenants, agreements or other terms or conditions set forth herein or therein, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Facility Document or any other agreement, instrument or
document, or (v) the satisfaction of any condition set forth in Article III or elsewhere herein or therein, other than to confirm receipt of items expressly required to be delivered to a Managing Agent. 

  
 102 

 (d)      A Managing Agent may resign as Managing
Agent hereunder at any time by giving not less than five Business Days’ prior written notice to the applicable Lenders, the Administrative Agent and the Borrower, such resignation to become effective only upon the later to occur of the earlier
of (x) the appointment and acceptance of a successor Managing Agent as provided below and (y) the 30th day following delivery of such notice. Upon any such resignation, the related Lenders shall appoint a financial institution of
their choosing as Managing Agent. Following the appointment of a successor Managing Agent and such successor Managing Agent’s acceptance thereof, such successor Managing Agent shall succeed to and become vested with all the rights, powers,
privileges and duties of the resigning Managing Agent as Managing Agent hereunder, and the resigning Managing Agent shall be discharged from its duties and obligations as Managing Agent hereunder. After the Administrative Agent’s
resignation, the provisions of this Article IX shall continue in effect for its benefit in respect of any actions taken or omitted to be taken by it while it was acting as the Managing Agent.

ARTICLE X 
 MISCELLANEOUS 

SECTION 10.01.      Amendments and Waivers. 

(a)      Except as provided in Section 10.01(b), no amendment or
modification of any provision of this Agreement or any Facility Document shall be effective without the written agreement of the Borrower, the Collection Agent, the Administrative Agent and the Majority Lenders (or their respective Managing Agents),
and no termination or waiver of any provision of this Agreement or any Facility Document or consent to any departure therefrom shall be effective without the written concurrence of the Borrower, the Administrative Agent and the Majority Lenders (or
their respective Managing Agents). Any waiver or consent shall be effective only in the specific instance and for the specific purpose for which given. 

(b)      Notwithstanding the provisions of Section 10.01(a), the
written consent of each Lender shall be required for any amendment, modification or waiver (A) reducing any Revolving Principal Balance, or the Interest thereon, for any Fixed Period, or any fee payable to all Lenders, (B) postponing any date for
any payment of any Revolving Principal Balance or the Interest thereon, for any Fixed Period, or for any payment of fees payable under the terms of the Fee Letter in effect at such time, (C) extending the Scheduled Termination Date with respect to
the Obligations, (D) increasing the Facility Limit or the Commitment of any Lender, (E) modifying the calculation of the Borrowing Base, (F) releasing all or substantially all of the Collateral, or (G) modifying the provisions of this
Section 10.01. 
 (c)      Any time that the Commercial Paper of
any Conduit Lender is being rated by one or more nationally recognized statistical ratings organizations (as applicable) (each, a “Rating Agency”), at the request of such Conduit Lender, no material amendment or modification of any
material provisions hereof or of the Sale Agreement or the Contribution Agreement shall be effective absent confirmation, in form satisfactory to such Conduit Lender, by each such Rating Agency that such amendment or modification will not result in
a withdrawal or downgrading of the then-current rating of the Commercial Paper by such Rating Agency. 

  
 103 

 (d)      Notwithstanding any other provision of
this Section 10.01, the Administrative Agent shall not (x) agree to the “Addition” (as defined in the Sale Agreement) of any proposed Originator pursuant to Section 9.14(a)(i), or (y) waive compliance
of Section 9.14(b)(iii) of the Sale Agreement with respect to the “Removal” (as defined in the Sale Agreement) of a Material Originator, in each case, without the prior approval of the Required Lenders. 

(e)      Notwithstanding any other provision of this Section 10.01, the provisions of
Sections 4.03 hereof, Section 4.02 of the Sale Agreement and Section 4.02 of the Contribution Agreement may not be amended or waived without confirmation from S&P that the rating of any Conduit Lender’s Commercial Paper by
S&P will not be reduced or withdrawn as a result thereof. 
 (f)      The Administrative
Agent shall provide notice to S&P of any amendment or modification of any provision of this Agreement or the Contribution Agreement. 

(g)      Notwithstanding any other provision of this Section 10.01, for so long as the
Collection Agent is an Affiliate of CHS and the Performance Undertaking is in effect, no amendment, waiver or consent shall, without the prior written consent of CHS, affect the rights or duties of CHS under this Agreement (such consent not to be
unreasonably withheld or delayed). 
 SECTION 10.02.      Notices. 

(a)      Addresses. All notices, demands, requests and other communications
required or expressly authorized to be made by this Agreement shall be given in writing, unless otherwise expressly specified herein and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by
Electronic Transmission, and addressed to the address set forth on the applicable signature page hereto or, as applicable, the relevant Assignment and Acceptance or to such other address as shall be notified in writing to the Borrower, the
Administrative Agent and each Managing Agent. 
 (b)      Effectiveness. 

(i)      All communications described in clause (a)
above and all other notices, demands, requests and other communications made in connection with this Agreement shall be effective and be deemed to have been received (x) if delivered by hand or overnight courier service or sent by Electronic
Transmission, on the date of receipt, or (y) if delivered by certified or registered mail, five Business Days after dispatch, in each case under clauses (x) and (y), delivered, sent, transmitted or mailed (properly addressed) to such party
as provided in this Section 10.02 or in accordance with the latest unrevoked direction from such party given in accordance with this Section 10.02. Notwithstanding the foregoing, no notice, demand, request or other communication
to the Administrative Agent pursuant to Article II shall be effective until received by the Administrative Agent. 

  
 104 

 (ii)      The submission by the
Borrower or the Collection Agent of any communication pursuant to an Electronic Transmission shall constitute a representation and warranty by such Person that any representation, warranty, certification or other similar statement required by the
Facility Documents to be provided, given or made by such Person in connection with any such communication is true, correct and complete except as expressly noted in such communication. 

(c)      Each Lender shall notify the Administrative Agent in writing of any changes in the
address to which notices to such Lender should be directed, of addresses of its lending office, of payment instructions in respect of all payments to be made to it hereunder and of such other administrative information as the Administrative Agent
shall reasonably request. 
 SECTION 10.03.      Electronic
Transmissions. Subject to the provisions of Subsection 10.02(a), each of the Administrative Agent, each Managing Agent, each Lender, the Borrower, the Collection Agent and each of their respective officer, directors, employees and
agents, is authorized (but not required) to transmit, post or otherwise make or communicate, in its sole discretion, Electronic Transmissions in connection with any Facility Document and the transactions contemplated therein. The Borrower, the
Collection Agent and each Secured Party acknowledges and agrees that the use of Electronic Transmissions is not necessarily secure and that there are risks associated with such use, including risks of interception, disclosure and abuse and each
indicates it assumes and accepts such risks by hereby authorizing the transmission of Electronic Transmissions. 
 SECTION
10.04.      Right of Setoff. Without in any way limiting the provisions of Section 2.14, the Administrative Agent, each Managing Agent and each Lender is hereby authorized (in addition to any other
rights it may have) to set-off, appropriate and apply (without presentment, demand, protest or other notice which are hereby expressly waived) any deposits and any other indebtedness held or owing by the Administrative Agent, such Managing Agent or
such Lender to, or for the account of, the Borrower, the Collection Agent, the Transferor or any Originator against any amount owing by the Borrower, the Collection Agent, the Transferor or any Originator, as the case may be, to such Person or to
the Administrative Agent or Managing Agent on behalf of such Person (even if contingent or unmatured); provided, that in the event that any Defaulting Lender shall exercise any such right of setoff, (a) all amounts so set off shall be paid
over immediately to the Administrative Agent for further application in accordance with the provisions of Section 2.15 and, pending such payment, shall be segregated by such Defaulting Lender from its other funds and deemed
held in trust for the benefit of the other Secured Parties, and (y) the Defaulting Lender shall provide promptly to the Administrative Agent a statement describing in reasonable detail the Obligations owing to such Defaulting Lender as to which it
exercised such right of setoff. For avoidance of doubt, the right of setoff set forth in this Section 10.04 does not permit setoff of deposits and indebtedness held or owing by one Person to or for the account of a second Person against
amounts owing by any Person other than such second Person. 
 SECTION 10.05.      No
Waiver; Remedies. No failure on the part of the Administrative Agent, any Managing Agent or any Lender to exercise, and no delay in exercising, any right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise
of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. The remedies herein provided are cumulative and not exclusive of any remedies provided by law. 

  
 105 

 SECTION 10.06.      Binding Effect;
Assignability. 
 (a)      This Agreement shall be binding upon and inure to the benefit
of the Borrower, the Lenders, the Managing Agents, the Administrative Agent, the Collection Agent, and their respective successors and permitted assigns. 

(b)      The Borrower may not assign any of its rights or delegate any of its duties hereunder
or under the other Facility Documents without the prior written consent of the Administrative Agent and each Managing Agent. A Lender may assign any of its rights and delegate any of its duties hereunder and under the other Facility Documents
(i) without the consent of the Borrower, to any Lender (other than a Defaulting Lender), any Affiliate of any Lender or to any Liquidity Provider and (ii) with the prior written consent of the Borrower (which consent shall not be
unreasonably withheld or delayed), to any other Person; provided that no such consent shall be required during the continuance of an Event of Default. 

(c)      Notwithstanding any other provision of this Agreement, any Lender may at any time in
its sole and absolute discretion assign, participate, grant a security interest in, transfer or pledge all or a portion of its rights (including its rights to payment of the principal and Interest on its Advances) under this Agreement or under its
Liquidity Agreement to secure its obligations to (x) a Federal Reserve Bank or any similar entity or federal program or (y) a trustee or collateral agent, without notice to or consent of the Borrower (and without the execution of any document in
connection therewith); provided that no such assignment under this clause (c) shall release a Lender from any of its obligations hereunder or substitute any such assignee for such Lender as a party hereto, and the Administrative Agent,
the Managing Agents, the other Lenders, the Collection Agent and the Borrower shall have the right to continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement. 

(d)      The parties to each assignment made pursuant to this Section 10.06 shall
execute and deliver to the Administrative Agent for its acceptance and recording in its books and records, an Assignment and Acceptance or other transfer instrument reasonably satisfactory in form and substance to the Administrative Agent, the
related Managing Agent and the Borrower. Each such assignment shall be effective as of the date specified in the applicable Assignment and Acceptance or other instrument only after the execution, delivery, acceptance and recording as described
in the preceding sentence. The Administrative Agent shall notify the Borrower of any assignment made pursuant to this Section 10.06. The Administrative Agent, acting solely for this purpose as an agent of the
Borrower, shall maintain at one of its offices a copy of each Assignment and Acceptance delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest)
of the obligations under this Agreement (the “Register”). The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent and the Lenders shall treat each Person whose name is
recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement. The Register shall be available for inspection by the Borrower and any Lender, at any reasonable time and from time to time upon
reasonable prior notice. This Section 10.06(d) shall be construed so that the obligations under this Agreement are at all times maintained in “registered form” within the meaning of Sections 163(f), 871(h)(2) and 881(c)(2) of
the Code. 

  
 106 

 (e)      Each Lender may sell participations, to
one or more banks or other entities in or to all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment); provided, however, that 

(i)      such Lender’s obligations under this Agreement (including its
Commitment to the Borrower hereunder) shall remain unchanged, 
 (ii)     such
Lender shall remain solely responsible to the other parties to this Agreement for the performance of such obligations, 

(iii)    the Administrative Agent, the Managing Agents, the other Lenders, the Collection
Agent and the Borrower shall have the right to continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement, and 

(iv)    such Lender that sells a participation shall, acting solely for this purpose as
an agent of the Borrower, maintain a register on which it enters the name and address of each participant and the principal amounts (and stated interest) of each Participant’s interest in the obligations under the this Agreement (the
“Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a
Participant’s interest in any commitments, loans, letters of credit or its other obligations under this Agreement) to any person except to the extent that such disclosure is necessary to establish that such commitment, loan, letter of credit or
other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is
recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative
Agent) shall have no responsibility for maintaining a Participant Register. This Section 10.06(e)(iv) shall be construed so that the obligations under this Agreement are at all times maintained in “registered form” within the
meaning of Sections 163(f), 871(h)(2) and 881(c)(2) of the Code. 
 (v)     such
Lender obtains a representation from any proposed assignee of such participation that either (i) the assignee is not acquiring and will not hold the participation with “plan assets” of any “benefit plan investor” within the
meaning of Section 3(42) of ERISA or (ii) the acquisition and holding by the assignee of the participation will not constitute or result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code. 

  
 107 

 (f)      The Lenders may, in connection with any
assignment or participation by any of them or any proposed assignment or participation pursuant to this Section 10.06, disclose to the assignee or participant or proposed assignee or participant any information relating to
the Borrower, the Collection Agent and the Collateral furnished to such Lender by or on behalf of the Borrower or the Collection Agent; provided that prior to any such disclosure of information designated by the Borrower as confidential, each
such assignee or participant or proposed assignee or participant shall executed an agreement whereby such assignee or participant shall agree (subject to customary exceptions) to preserve the confidentiality of such confidential information on terms
no less restrictive than those applicable to the Lenders pursuant to Section 10.14. 
 SECTION
10.07.      Term of this Agreement. This Agreement, including the Borrower’s obligation to observe its covenants set forth in Article V, and the Collection Agent’s obligation to observe its
covenants set forth in Articles V and VI, shall remain in full force and effect until the Collection Date; provided, however, that the rights and remedies with respect to any breach of any representation and warranty made
or deemed made by the Borrower or the Collection Agent pursuant to Articles III and IV, the indemnification and payment provisions of Section 6.12, Article VIII and Article IX
and the provisions of Section 2.11, 2.12, 10.10, 10.11 and Section 10.12 shall be continuing and shall survive any termination of this Agreement. 

SECTION 10.08.      GOVERNING LAW; CONSENT TO JURISDICTION; WAIVER OF
OBJECTION TO VENUE; SERVICE OF PROCESS.
 (a)      THIS AGREEMENT SHALL, IN ACCORDANCE
WITH § 5-1401 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK, BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH LENDER, EACH MANAGING AGENT, THE ADMINISTRATIVE AGENT, THE BORROWER AND
THE COLLECTION AGENT EACH HEREBY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS OF THE UNITED STATES AND THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN NEW YORK COUNTY, NEW YORK IN ANY ACTION OR
PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER FACILITY DOCUMENT, ANY OTHER DOCUMENT DELIVERED PURSUANT HERETO OR THERETO, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH OF THE PARTIES HERETO HEREBY WAIVES ANY
OBJECTION BASED ON FORUM NON CONVENIENS THE MAINTENANCE OF ANY SUCH ACTION OR PROCEEDING AND CONSENTS TO THE GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED APPROPRIATE BY SUCH COURT. 

(b)      Each party hereto agrees that service of process may be effected by mailing a copy
thereof by registered or certified mail, postage prepaid, to it at its address specified in Section 10.02. Nothing in this Section 10.08 shall affect the right of any party to serve legal process in any other manner permitted by
law. 

  
 108 

 SECTION 10.09.      WAIVER OF JURY
TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW, EACH LENDER, EACH MANAGING AGENT, THE ADMINISTRATIVE AGENT, THE BORROWER AND THE COLLECTION AGENT EACH WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING
IN CONTRACT, TORT, OR OTHERWISE BETWEEN THE PARTIES HERETO ARISING OUT OF, CONNECTED WITH, RELATED TO, OR INCIDENTAL TO THE RELATIONSHIP BETWEEN ANY OF THEM IN CONNECTION WITH THIS AGREEMENT, ANY OTHER FACILITY DOCUMENT, ANY OTHER DOCUMENT DELIVERED
PURSUANT HERETO OR THERETO, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY INSTEAD, ANY SUCH DISPUTE RESOLVED IN COURT WILL BE RESOLVED IN A BENCH TRIAL WITHOUT A JURY. 

SECTION 10.10.      Costs, Expenses and Taxes. 

(a)      In addition to the rights of indemnification granted to the Administrative Agent, the
Managing Agents, the Lenders and the other Indemnified Parties under Article VIII hereof, the Borrower agrees to pay on demand all reasonable out-of-pocket costs and expenses of the Managing Agents, the Lenders and the
Administrative Agent incurred in connection with the preparation, execution, delivery, administration (including periodic auditing permitted hereunder), amendment or modification of, or any waiver or consent issued in connection with, this Agreement
and the other documents to be delivered hereunder or in connection herewith, including rating agency fees, auditor fees, the annual servicing report referred to in Section 6.11 and out-of-pocket expenses and the reasonable fees and
out-of-pocket expenses of one external counsel for the Administrative Agent, any Managing Agent and any Lender with respect thereto, collectively, with respect to advising the Administrative Agent, any Managing Agent and any Lender as to their
respective rights and remedies under this Agreement and the other documents to be delivered hereunder or in connection herewith, and all costs and expenses, if any (including counsel fees and expenses), incurred by the Administrative Agent, any
Managing Agent and any Lender in connection with the enforcement of this Agreement and the other documents to be delivered hereunder or in connection herewith. 

(b)      The Borrower shall pay on demand any and all commissions of placement agents and
dealers in respect of commercial paper notes (to the extent not otherwise received by the applicable Conduit Lender as a portion of Interest) issued to fund or maintain the Advances and any and all stamp, documentary, sales, excise, property and
other taxes, charges, levies and fees payable or determined to be payable in connection with the execution, delivery, filing and recording of this Agreement, the other documents to be delivered hereunder or the funding or maintenance of Advances
hereunder (“Other Taxes”). 
 SECTION 10.11.      Waiver of Consequential
Damages. (a) Each of the Collection Agent, the Transferor and the Borrower agrees that no Indemnified Party shall have any liability to them or any of their equity holders or creditors in connection with this Agreement, the other
Facility Documents or the transactions contemplated thereby on any theory of liability for any special, indirect, consequential or punitive damages (including any loss of profits, business or anticipated savings), and hereby waives any such claim.

 (b)      The Administrative Agent, each Managing Agent and each Lender agrees that none of
the Transferor, the Originators, the Collection Agent, the Borrower or their respective Affiliates shall have any liability to them or any of their equity holders or creditors in connection with this Agreement, the other Facility Documents or the
transactions contemplated thereby on any theory of liability for any special, indirect, consequential or punitive damages (including any loss of profits, business or anticipated savings), and hereby waives any such claim. 

  
 109 

 (c)      The provisions of this Section
10.11 shall survive the termination of this Agreement. 
 SECTION 10.12.      Recourse
Against Certain Parties; No Proceedings. (a) No recourse under or with respect to any obligation, covenant or agreement (including the payment of any fees or any other obligations) of any Conduit Lender as contained in this Agreement
or any other agreement, instrument or document entered into by it pursuant hereto or in connection herewith shall be had against any administrator of such Conduit Lender or any incorporator, affiliate, member, officer, employee or director of such
Conduit Lender or of any such administrator, as such, by the enforcement of any assessment or by any legal or equitable proceeding, by virtue of any statute or otherwise, it being expressly agreed and
understood that the agreements of each Conduit Lender contained in this Agreement and all of the other agreements, instruments and documents entered into by it pursuant hereto or in connection herewith are, in each case, solely the limited
liability company obligations of such Conduit Lender; provided that any such liabilities shall be paid by such Conduit Lender only after the repayment in full of all such Conduit Lender’s Commercial Paper and all other liabilities
contemplated in the Facility Documents with respect to such Conduit Lender and that no personal liability whatsoever shall attach to or be incurred by any administrator of such Conduit Lender or any incorporator, member, affiliate, officer, employee
or director of such Conduit Lender or of any such administrator, as such, or any other of them, under or by reason of any of the obligations, covenants or agreements of such Conduit Lender contained in this Agreement or in any other such
instruments, documents or agreements, or which are implied therefrom, and that any and all personal liability of every such administrator of such Conduit Lender and each incorporator, member, affiliate, officer, employee or director of such Conduit
Lender or of any such administrator, or any of them, for breaches by such Conduit Lender of any such obligations, covenants or agreements, which liability may arise either at common law or at equity, by statute or constitution, or otherwise, is
hereby expressly waived as a condition of and in consideration for the execution of this Agreement. The provisions of this Section 10.12 shall survive the termination of this Agreement. 

(b)      Each of the Borrower, the Collection Agent, the Administrative Agent, the Managing
Agents and each other Lender hereby agrees that it will not institute against, or join any other Person in instituting against, any Conduit Lender any proceedings of the type referred to in clause (i)(C) of
Section 7.01(g) so long as any commercial paper issued by such Conduit Lender shall be outstanding or there shall not have elapsed one year and one day since the last day on which any such commercial paper shall have been
outstanding. 
 (c)      The Administrative Agent, the Managing Agents and each other Lender
hereby agrees that it will not, and the Collection Agent agrees that it will not, and will not suffer or permit any Affiliate of the Collection Agent to, institute against, or join any other Person in instituting against, the Borrower any
proceedings of the type referred to in clause (i)(C) of Section 7.01(g) so long as there shall not have elapsed one year and one day since the last day on which any Obligations hereunder shall have
been outstanding. 

  
 110 

 (d)      The provisions of this
Section 10.12 shall survive the termination of this Agreement. 
 SECTION
10.13.      Execution in Counterparts; Severability; Integration. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so
executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement. In case any provision in or obligation under this Agreement shall be invalid, illegal or unenforceable in any
jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. This Agreement and the other
Facility Documents contain the final and complete integration of all prior expressions by the parties hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject
matter hereof, superseding all prior oral or written understandings other than the fee letters described in Section 2.06. 

SECTION 10.14.      Confidentiality. 

(a)      Except to the extent otherwise required by Applicable Law, unless the provider thereof
shall otherwise consent in writing each of the Borrower and the Collection Agent agrees that it shall maintain the confidentiality of information received from any Secured Party related to such Secured Party or its business other than any such
information that was available to the Borrower or the Collection Agent on a non-confidential basis prior to its disclosure by such Secured Party (“Secured Party Information”); provided, however, that the Borrower and the
Collection Agent may disclose any Secured Party Information (w) to its and its Affiliates’ officers, directors, employees and agents, including accountants, legal counsel, administration and service providers, and other advisors (it being
understood that the persons to whom such disclosure is made will be informed of the confidential nature of such Secured Party Information and instructed to keep such Secured Party Information confidential), (x) to the extent such disclosure may
be required by Applicable Law, or by any court or administrative agency having jurisdiction over any party or as may be requested by any regulatory body, (y) to the extent the relevant Secured Party consents in writing to the release of the
Secured Party Information, (z) subject to a written confidentiality agreement having terms substantially similar to this Section 10.14, to the Transferor, any Originator or any Affiliate thereof or to any financial
institution or other party that extends or is considering the extension of debt or equity financing or swap or derivative arrangement to the Transferor, any Originator or any Affiliate thereof, or (aa) as may be required or appropriate in response
to a court order or in connection with any litigation; provided further, however, that the Borrower and the Collection Agent shall have no obligation of confidentiality whatsoever in respect of any Secured Party Information or other
information which (i) may be generally available to the public other than as a result of a breach of this Section 10.14(a), (ii) is in the possession of Borrower or the Collection Agent prior to the date hereof and receipt
thereof from a Secured Party, and is not subject to a confidentiality agreement or legal or regulatory restriction on disclosure or (iii) is independently developed by the Borrower or the Collection Agent or one or more of their respective
representatives without violating the terms of this Section 10.14(a). 

  
 111 

 (b)      Except to the extent otherwise required
by Applicable Law, unless the provider thereof shall otherwise consent in writing each of the Administrative Agent, each Managing Agent and each Lender agrees that it shall maintain the confidentiality of (i) the Credit and Collection Policy, and
(ii) all other information received from the Borrower, the Collection Agent or any of their Affiliates (each a “CHS Party” and, collectively, the “CHS Parties”) related to such CHS Party or its business, other than
any such information that was available to such Person on a non-confidential basis prior to its disclosure by such CHS Party (“CHS Party Information”); provided, however, that each of the Administrative Agent, any Managing
Agent and any Lender may disclose any CHS Party Information (w) to its and its Affiliates’ officers, directors, employees and agents, including accountants, legal counsel, administration and service providers, and other advisors (it being
understood that the persons to whom such disclosure is made will be informed of the confidential nature of such CHS Party Information and instructed to keep such CHS Party Information confidential), (x) to the extent such disclosure may be
required by Applicable Law, or by any court or administrative agency having jurisdiction over any party or as may be requested by any regulatory body, (y) to the extent the relevant CHS Party consents in writing to the release of the CHS Party
Information, (z) subject to a written confidentiality agreement having terms substantially similar to this Section 10.14, to any actual or prospective assignee of or participant in any of its rights or obligations
under this Agreement and the other Facility Documents, (aa) as may be required or appropriate in response to a court order or in connection with any litigation, (bb) to any Rating Agency in connection with the rating of any Commercial Paper of any
Conduit Lender and (cc) as contemplated by Rule 17g-5 under the Securities Exchange Act of 1934 (and various agreements between the Administrative Agent, any Managing Agent or any Conduit Lender and any nationally recognized statistical rating
organization), to any nationally recognized statistical rating organization which is not then rating such Conduit Lender’s Commercial Paper, and which accesses such CHS Party Information on a website maintained by a Conduit Lender in compliance
with such Rule 17g-5 or (dd) to credit enhancers and dealers and investors in respect of promissory notes of each Conduit Lender in accordance with customary practices of such Conduit Lender for disclosures to credit enhancers, dealers or investors,
as the case may be; provided further, however, that each of the Administrative Agent, each Managing Agent and each Lender shall have no obligation of confidentiality whatsoever in respect of any CHS Party Information or other information
which (i) becomes known or which may be generally available to the public other than as a result of a breach of this Section 10.14(b), (ii) is in the possession of the Administrative Agent, any Managing Agent or and any
Lender prior to receipt thereof from a CHS Party and is not subject to a confidentiality agreement or legal or regulatory restriction on disclosure, or (iii) is independently developed by the Administrative Agent, any Managing Agent or any Lender,
or one or more of their respective representatives without violating the terms of this Section 10.14(b). 

(c)      Notwithstanding any other provision herein or in any other Facility Document, each
Managing Agent, each Lender and the Administrative Agent hereby confirms that the Borrower, the Transferor, each Originator and the Collection Agent (and each employee, representative or other agent of each such party) may disclose to any and all
Persons, without limitation of any kind, the U.S. tax treatment and U.S. tax structure of the transaction contemplated by this Agreement and the other Facility Documents. 

  
 112 

 (d)      The Administrative Agent hereby agrees to
comply with the terms and conditions of the Business Associate Agreement. Each member of the Lender Group hereby agrees to, and shall take reasonable steps to cause each other member of the Lender Group to, comply with all applicable Healthcare
Laws (including the provisions set forth in the Business Associate Agreement, if applicable) regarding confidential patient information, if any, it receives in connection with the transactions described in this Agreement. 

SECTION 10.15.      Acknowledgment and Consent to Bail-In of EEA Financial Institutions.
Notwithstanding anything to the contrary in any Facility Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA Financial Institution arising under any
Facility Document, to the extent such liability is unsecured, may be subject to the write-down and conversion powers of an EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by: 

(a)      the application of any of any Write-Down and Conversion Powers by an EEA Resolution
Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an EEA Financial Institution; and 

(b)      the effects of any Bail-In Action on any such liability, including, if applicable:

 (i)     a reduction in full or in part or cancellation of any such liability;

 (ii)    a conversion of all, or a portion of, such liability into shares or other
instruments of ownership in such EEA Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu
of any rights with respect to any such liability under this Agreement or any other Facility Documents; or 

(iii)    the variation of the terms of such liability in connection with the exercise of
the write-down and conversion powers of any EEA Resolution Authority. 
 [THE REST OF THIS PAGE IS INTENTIONALLY LEFT BLANK] 

  
 113 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by
their respective officers thereunto duly authorized, as of the date first above written. 
  

											
	BORROWER:	 		 		 	  CHS RECEIVABLES FUNDING, LLC	 	
						
		 		 		 	  By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
					
		 		 		 	 CHS Receivables Funding, LLC

4000 Meridian Boulevard
 Franklin,
Tennessee 37067
 Attention: Rachel A. Seifert

Telephone No: (615) 465-7000

Facsimile No: (615) 373-9704

Email: rachel_seifert@chs.net
	 	

  
 Signature Page to

 Receivables Loan Agreement 

											
	THE COLLECTION AGENT:	 		 	  CHSPC, LLC	 	
						
		 		 		 	  By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
					
		 		 		 	CHSPC, LLC	 	
		 		 		 	4000 Meridian Boulevard	 	
		 		 		 	Franklin, Tennessee 37067	 	
		 		 		 	Attention: Rachel A. Seifert	 	
		 		 		 	Telephone No: (615) 465-7000	 	
		 		 		 	Facsimile No: (615) 373-9704	 	
		 		 		 	Email: rachel_seifert@chs.net	 	

  
 Signature Page to

 Receivables Loan Agreement 

											
		 		 		 	CRÉDIT AGRICOLE CORPORATE AND INVESTMENT BANK, as Administrative Agent, a Managing Agent and a Committed Lender
						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
					
		 		 		 	Crédit Agricole CIB	 	
		 		 		 	1301 Avenue of the Americas, 17th Floor	 	
		 		 		 	New York, NY 10019	 	
		 		 		 	Attention: Sunny Gulrajani	 	
		 		 		 	Telephone No: (212) 261-7845	 	
		 		 		 	Facsimile No: (917) 849-5584	 	
		 		 		 	Email: sunny.gulrajani@ca-cib.com	 	

  
 Signature Page to

 Receivables Loan Agreement 

											
		 		 		 	 ATLANTIC ASSET SECURITIZATION LLC, as a Conduit Lender
  

by CRÉDIT AGRICOLE CORPORATE AND INVESTMENT BANK, as attorney-in-fact

						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
					
		 		 		 	 Atlantic Asset Securitization
 c/o
Crédit Agricole CIB
	 	
		 		 		 	1301 Avenue of the Americas, 17th Floor	 	
		 		 		 	New York, NY 10019	 	
		 		 		 	Attention: Sunny Gulrajani	 	
		 		 		 	Telephone No: (212) 261-7845	 	
		 		 		 	Facsimile No: (917) 849-5584	 	
		 		 		 	Email:  sunny.gulrajani@ca-cib.com	 	

  
 Signature Page to

 Receivables Loan Agreement 

											
		 		 		 	THE BANK OF NOVA SCOTIA, as a Managing
		 		 		 	Agent and a Committed Lender
						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
					
		 		 		 	 The Bank of Nova Scotia
 250 Vesey
Street, 23rd Floor
 New York, NY 10281
 Attention: Peter
Gartland
 Telephone No.: 212-225-5115
 Facsimile
No.: 646-436-1940
 Email: peter.gartland@scotiabank.com
	 	

  
 Signature Page to

 Receivables Loan Agreement 

											
		 		 		 	LIBERTY STREET FUNDING LLC, as a Conduit
		 		 		 	Lender
						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
					
		 		 		 	 Liberty Street Funding LLC
 c/o The
Bank of Nova Scotia
	 	
		 		 		 	Global Securitization Services, LLC	 	
		 		 		 	114 West 47th Street, Suite 2310	 	
		 		 		 	New York, NY 10036	 	
		 		 		 	Attention: Jill Russo	 	
		 		 		 	Telephone No.: 212-295-2742	 	
		 		 		 	Facsimile No.: 212-302-8767	 	
		 		 		 	Email:  jrusso@gssnyc.com 	 	
					
		 		 		 	with a copy to:	 	
					
		 		 		 	 The Bank of Nova Scotia
 250 Vesey
Street, 23rd Floor
 New York, NY 10281
 Attention: Peter
Gartland
 Telephone No.: 212-225-5115
 Facsimile
No.: 646-436-1940
 Email: peter.gartland@scotiabank.com
	 	

  
 Signature Page to

 Receivables Loan Agreement 

													
		 		 		 	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
		 		 		 		 	as a Managing Agent
						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 		 	
		 		 		 		 	Title:	 		 	
				
		 		 		 	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
		 		 		 	NEW YORK BRANCH
		 		 		 	1221 Avenue of the Americas	 	
		 		 		 	New York, New York 10020	 	
		 		 		 	Attention:    Securitization Group	 	
		 		 		 	Telephone No.: (212) 782-6959	 	
		 		 		 	Telecopier No.: (212) 782-6448	 	
		 		 		 	Email:	 	 securitization_reporting@us.mufg.jp

lmills@us.mufg.jp

				
		 		 		 	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
		 		 		 		 	as a Committed Lender	 	
						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 		 	
		 		 		 		 	Title:	 		 	
				
		 		 		 	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,
		 		 		 	NEW YORK BRANCH
		 		 		 	1221 Avenue of the Americas
		 		 		 	New York, New York 10020
		 		 		 	Attention:    Securitization Group
		 		 		 	Telephone No.: (212) 782-6957
		 		 		 	Telecopier No.: (212) 782-6448
		 		 		 	Email:	 	securitization_reporting@us.mufg.jp	 	

  
 Signature Page to

 Receivables Loan Agreement 

											
		 		 		 	VICTORY RECEIVABLES CORPORATION, as a
		 		 		 		 	Conduit Lender	 	
						
		 		 		 	By: 	 	  
	 	
		 		 		 		 	Name:	 	
		 		 		 		 	Title:	 	
					
		 		 		 	 VICTORY RECEIVABLES CORPORATION

c/o Global Securitization Services, LLC

68 South Service Road, Suite 120

Melville, NY 11747

Telephone:      (631) 930-7216

Facsimile:       (212) 302-8767

Attention:       David V. DeAngelis

Email:        
ddeangelis@gssnyc.com
	 	
					
		 		 		 	 With a copy to:
	 	
					
		 		 		 	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD.,	 	
		 		 		 	                NEW YORK BRANCH	 	
		 		 		 	1221 Avenue of the Americas	 	
		 		 		 	New York, New York 10020	 	
		 		 		 	Attention:    Securitization Group	 	
		 		 		 	Telephone No.: (212) 782-6957	 	
		 		 		 	Telecopier No.: (212) 782-6448	 	
		 		 		 	Email:	 	         securitization_reporting@us.mufg.jp

areddy@us.mufg.jp

  
 Signature Page to

 Receivables Loan Agreement 

 SCHEDULE I 

LENDERS 
 Commitments and
Lender Groups 
  

							
	Managing Agent	 	
Conduit Lender,
 if
any
	 	Committed Lender	 	Committed Lender
Commitment
	 Credit Agricole

Corporate and
 Investment Bank
	 	Atlantic Asset Securitization LLC	 	 Credit Agricole

Corporate and
 Investment Bank
	 	$270,000,000
	The Bank of Nova Scotia	 	Liberty Street Funding LLC	 	The Bank of Nova Scotia	 	$180,000,000
	The Bank of Tokyo-Mitsubishi UFJ, Ltd.	 	Victory Receivables Corporation	 	The Bank of Tokyo-Mitsubishi UFJ, Ltd.	 	$250,000,000

  
 Schedule I 

 SCHEDULE II 

CONDITION PRECEDENT DOCUMENTS (CLOSING LIST) 

  
 Schedule II 

 SCHEDULE III 

[INTENTIONALLY OMITTED] 

  
 Schedule III 

 SCHEDULE IV 

NON-GOVERNMENTAL ENTITY OBLIGOR CONCENTRATION PERCENTAGES 
  

									
	  

Short-Term Rating

(S&P/Moody’s)
  
	 	  	 	 Long-Term Rating

(S&P/Moody’s)
  
	 	  	 	
Obligor Concentration

Percentage
  

	  

A-1 and above/P-1 and
 above

 
	 	 	 	  

AAA to A/Aaa to A2
	 	 	 	  

20.0%

	  

A-2/P-2
  
	 	 	 	  

A- to BBB+/A3 to Baa1
	 	 	 	  

10.00%

	  

A-3/P-3
  
	 	 	 	  

BBB to BBB-/Baa2 to Baa3
	 	 	 	  

6.66%

	  

Non Rated or below
 Investment
Grade
  
	 	 	 	  

BB+ and under/Ba1 and under/or

unrated
	 	 	 	  

4.00%

 For purposes of this provision, an Obligor’s “Short-Term Rating” and “Long-Term
Rating” will be the lower of the Obligor’s short-term debt rating or long-term debt rating, as applicable, from either Moody’s or S&P and the lower of the Short-Term Rating and the Long-Term Rating; provided that if
only one short-term debt rating or only one long-term debt rating is available from the Rating Agencies, such rating shall be such Obligor’s Short-Term Rating or Long-Term Rating, as applicable; provided, however, the Aggregate Excess
Concentration for any Obligor shall be calculated as if such Obligor and all of such Obligor’s Affiliates were one single Obligor, except in the case of Blue Cross/Blue Shield which shall be considered under each individual subdivision (i.e.,
Blue Cross/Blue Shield of Alabama, Blue Cross/Blue Shield of Arizona, etc.). The Collection Agent shall specify on each Monthly Report (as applicable under Section 6.06 herein) the amount of the Aggregate Excess
Concentration for each Obligor. 

  
 Schedule IV 

 SCHEDULE V 

JURISDICTION OF ORGANIZATION, PRINCIPAL PLACE OF BUSINESS 

AND CHIEF EXECUTIVE OFFICE, AND LOCATION OF RECORDS 

The Borrower is organized in Delaware. 

The principal place of business of the Borrower is 4000 Meridian Blvd., Franklin, TN 37067. 

The chief executive office of the Borrower is 4000 Meridian Blvd., Franklin, TN 37067. 

The Borrower keeps its Records at its principal place of business. 

  
 Schedule V 

 SCHEDULE VI 

SPECIFIED ORIGINATORS 
  

							
	  	  	Originator	  	CHS %	 
	1.	  	ARMC, L.P.	  	 	87.577	  
	2.	  	Crestview Hospital Corporation	  	 	97.6393	  
	3.	  	Deaconess Health System, LLC	  	 	98.13	  
	4.	  	Durant H.M.A., LLC	  	 	92.249	  
	5.	  	East Georgia Regional Medical Center, LLC	  	 	89.25	  
	6.	  	Greenbrier VMC, LLC	  	 	96.0	  
	7.	  	Haines City HMA, LLC	  	 	97.894	  
	8.	  	Hernando HMA, LLC	  	 	98.85	  
	9.	  	IOM Health System, L.P.	  	 	86.30	  
	10.	  	Jackson, Tennessee Hospital Company, LLC	  	 	96.94	  
	11.	  	Kirksville Missouri Hospital Co., LLC	  	 	88.10	  
	12.	  	Lake Wales Hospital Corporation	  	 	96.8178	  
	13.	  	Lancaster HMA, LLC	  	 	98.73	  
	14.	  	Lutheran Musculoskeletal Center, LLC	  	 	60.00	  
	15.	  	Midwest Regional Medical Center, LLC	  	 	98.6	  
	16.	  	Petersburg Hospital Company, LLC	  	 	99.3	  
	17.	  	Piney Woods Healthcare System, L.P.	  	 	96.4985	  
	18.	  	Porter Hospital, LLC	  	 	91.17	  
	19.	  	Rehab Hospital of Fort Wayne General Partnership	  	 	86.30	  
	20.	  	Rose City HMA, LLC	  	 	89.9	  
	21.	  	San Angelo Hospital, L.P.	  	 	94.318	  
	22.	  	St. Joseph Health System LLC	  	 	86.30	  
	23.    	  	Warsaw Health System LLC	  	 	99.08	  

  
 Schedule VII 

 EXHIBIT A 

FORM OF MONTHLY REPORT 

Separately provided. 

  
 Exhibit A 

 EXHIBIT B 

FORM OF PERFORMANCE UNDERTAKING 

Attached. 

  
 Exhibit B 

 EXHIBIT C-1 

FORM OF FUNDING REQUEST 
 Dated as
of ____________, 20__ 
 The undersigned, hereby certifies, with respect to the Advance to be made on the date indicated
below pursuant to that certain Receivables Loan Agreement dated as of March 21, 2012 (as the same may be amended, supplemented or otherwise modified, renewed, restated or replaced from time to time, the “Loan Agreement”; capitalized
terms used but not otherwise defined herein shall have the meanings given to such terms in the Loan Agreement), among CHS Receivables Funding, LLC, as borrower (the “Borrower”), Atlantic Asset Securitization LLC, as a conduit lender
(“Atlantic”), Victory Receivables Corporation, as a conduit lender (“Victory”), Liberty Street Funding LLC, as a conduit lender (“Liberty Street” and together with Atlantic and Victory, the
“Conduit Lenders”), The Bank of Nova Scotia, as a committed lender (“Scotia”), The Bank of Tokyo-Mitsubishi UFJ, Ltd., as a committed lender (“BTMU”), Credit Agricole Corporate and Investment Bank
(“Credit Agricole”), as a committed lender (together with Scotia and BTMU, the “Committed Lenders” and together with the Conduit Lenders, the “Lenders”), as administrative agent (in such capacity,
the “Administrative Agent”), and Community Health Systems Professional Services Corporation, as collection agent (the “Collection Agent”), that: 

(a)    the Borrower requests the following Advance on the terms and conditions stated in the Loan
Agreement: 
 (i)    the requested Business Day for the Advance is [__________], 20[__] (the
“Funding Date”);1 and 

(ii)    the aggregate amount of the requested Advance is $[__________],2 of which: 
     1. [___]% or
$[__________] is requested from the Atlantic Lender Group; 
     2. [___]% or
$[__________] is requested from the Liberty Street Lender Group; and 
     3. [___]%
or $[__________] is requested from the Victory Lender Group; 
  

 
  

	1 	 The requested date shall be no sooner than one Business Day from the execution and delivery of the Funding
Request. 

  

	2 	 The aggregate amount of the requested Advance shall be in an amount equal to at least $1,000,000, with
increments of $50,000 thereafter. 

  
 Exhibit C-1 

 (b)      the outstanding amount of Advances under
the Loan Agreement as of the Funding Date before giving effect to the Advance will be $[__________], and after giving effect to the Advance will be $[__________]; 

(c)      the information for the account to which the Advance should be funded is set forth
below: 
  

			
	 [insert name of the beneficiary bank]

[insert address of the beneficiary bank]
 [insert name of the
beneficiary]

	Account No.:	  	[                ]
	ABA No.:	  	[                ]
	Reference:	  	[                ]

 (d)      the Collection Agent has delivered, or will deliver on
or before the Funding Date (as defined below), to the Administrative Agent (i) a Monthly Report in form and substance satisfactory to the Administrative Agent dated no more than one month before the Funding Date, and (ii) such additional
information as the Administrative Agent has reasonably requested; 
 (e)      the
representations and warranties contained in Section 4.01 of the Loan Agreement will be correct on and as of the Funding Date as though made on and as of such date, except for those that refer to specific dates, which will
be correct as of the dates indicated therein; 
 (f)      no event has occurred and is
continuing, or would result from the Advance requested hereunder, which constitutes an Event of Default, or would, with the passage of time or the giving of notice, constitute and Event of Default; 

(g)      on and as of the Funding Date, after giving effect to the Advance requested hereunder,
a Borrowing Base Deficiency will not exist; 
 (h)      no law or regulation will prohibit,
and no order, judgment or decree of any federal, state or local court or governmental body, agency or instrumentality will prohibit or enjoin, the making of such Advance by the Lenders in accordance with the provisions of the Loan Agreement; 

(i)      on the Funding Date, the requested Advance will not exceed the Availability on the
Funding Date. 
 [Signature Page Follows] 

  
 Exhibit C-1-2 

 IN WITNESS WHEREOF, the undersigned has caused this certificate to be duly
executed by its duly authorized officer as of the date first set forth above. 
  

			
	CHS RECEIVABLES FUNDING, LLC
		
	By:	 	  

		 	Name:
		 	Title:

  
 Exhibit C-1-3 

 EXHIBIT C-2 

FORM OF BORROWER NOTICE 
 Dated as
of ____________, 20__ 
 The undersigned, hereby certifies, with respect to the optional prepayment to be made on the date
indicated below pursuant to that certain Receivables Loan Agreement dated as of March 21, 2012 (as the same may be amended, supplemented or otherwise modified, renewed, restated or replaced from time to time, the “Loan Agreement”;
capitalized terms used but not otherwise defined herein shall have the meanings given to such terms in the Loan Agreement), among CHS Receivables Funding, LLC, as borrower (the “Borrower”), Atlantic Asset Securitization LLC, as a
conduit lender (“Atlantic”), Victory Receivables Corporation, as a conduit lender (“Victory”), Liberty Street Funding LLC, as a conduit lender (“Liberty Street” and together with Atlantic and
Victory, the “Conduit Lenders”), The Bank of Nova Scotia, as a committed lender (“Scotia”), The Bank of Tokyo-Mitsubishi UFJ, Ltd., as a committed lender (“BTMU”), Credit Agricole Corporate and
Investment Bank (“Credit Agricole”), as a committed lender (together with Scotia and BTMU, the “Committed Lenders” and together with the Conduit Lenders, the “Lenders”), as administrative agent (in
such capacity, the “Administrative Agent”), and Community Health Systems Professional Services Corporation, as collection agent (the “Collection Agent”), that: 

 

	 	(a)	the Borrower hereby delivers written notice of the following optional prepayment of a portion of the Advances made under the Loan Agreement on the terms and conditions stated in the Loan Agreement: 

 

	 	(i)	the requested Business Day for the optional prepayment is [_______________________] (the “Paydown Date”); 

  

	 	(ii)	the aggregate amount of the optional prepayment is $[_____________]; and 

  

	 	(iii)	the optional prepayment will be made pro-rata, such that: 

	 	a.	$[_______________] will be paid to Credit Agricole Corporate and Investment Bank, for its benefit and the benefit of each related Lender, as applicable; 

	 	b.	$[_______________] will be paid to The Bank of Nova Scotia, for its benefit and the benefit of each related Lender, as applicable; and 

	 	c.	$[_______________] will be paid to The Bank of Tokyo-Mitsubishi UFJ, Ltd., for its benefit and the benefit of each related Lender, as applicable. 

  
 Exhibit C-2 

 (b) after giving effect to such optional prepayment, the outstanding amount of Advances under the
Loan Agreement as of the Paydown Date will be $[_______________]; and 
 (c) the information for the accounts to which such optional
prepayment will be funded is as set forth below: 
 To Credit Agricole Corporate and Investment Bank: 

 

			
	[NAME OF BANK]
	ABA No.:	  	[                ]
	Account:	  	[NAME]
	Account No.:	  	[                ]
	Reference:	  	[                ]

 To The Bank of Nova Scotia: 

 

			
	[NAME OF BANK]
	ABA No.:	  	[                ]
	Account:	  	[NAME]
	Account No.:	  	[                ]
	Reference:	  	[                ]

 To The Bank of Tokyo-Mitsubishi UFJ, Ltd.: 

 

			
	[NAME OF BANK]
	ABA No.:	  	[                ]
	Account:	  	[NAME]
	Account No.:	  	[                ]
	Reference:	  	[                ]

 [Remainder of page intentionally left blank.] 

  
 Exhibit C-2-2 

 IN WITNESS WHEREOF, the undersigned has caused this Borrower Notice to be duly
executed by its duly authorized officer as of the date first set forth above. 
  

			
	CHS RECEIVABLES FUNDING, LLC
		
	By:	 	  

		 	Name:
		 	Title:

  
 Exhibit C-2-3 

 EXHIBIT D 

FORM OF BUSINESS ASSOCIATE AGREEMENT 

Attached. 

  
 Exhibit D 

 EXHIBIT E 

FORM OF ASSIGNMENT OF AGREEMENTS 

Attached. 

  
 Exhibit E 

 EXHIBIT F-1 

FORM OF U.S. TAX COMPLIANCE CERTIFICATE (FOR FOREIGN LENDERS THAT 

ARE NOT PARTNERSHIPS FOR U.S. FEDERAL INCOME TAX PURPOSES) 

Attached. 

  
 Exhibit F-1 

 EXHIBIT F-2 

FORM OF U.S. TAX COMPLIANCE CERTIFICATE (FOR FOREIGN PARTICIPANTS 

THAT ARE NOT PARTNERSHIPS FOR U.S. FEDERAL INCOME TAX PURPOSES) 

Attached. 

  
 Exhibit F-2 

 EXHIBIT F-3 

FORM OF U.S. TAX COMPLIANCE CERTIFICATE (FOR FOREIGN PARTICIPANTS 

THAT ARE PARTNERSHIPS FOR U.S. FEDERAL INCOME TAX PURPOSES) 

Attached. 

  
 Exhibit F-3 

 EXHIBIT F-4 

FORM OF U.S. TAX COMPLIANCE CERTIFICATE (FOR FOREIGN PARTICIPANTS 

THAT ARE PARTNERSHIPS FOR U.S. FEDERAL INCOME TAX PURPOSES) 

Attached. 

  
 Exhibit F-4 

 ANNEX B 

RECEIVABLES PURCHASE AND CONTRIBUTION AGREEMENT 

Dated as of March 21, 2012 (as amended through November 18, 2016), 

Among 
 CHS/COMMUNITY HEALTH
SYSTEMS, INC. 
 as the Transferor, 

and 
 CHSPSC, LLC 

(as successor-by-conversion to Community Health Systems Professional Services Corporation), 

as the Collection Agent 
 and 

CHS RECEIVABLES FUNDING, LLC, 
 as
the Company 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
		
	 ARTICLE I DEFINITIONS
	  	 	1	  
	 SECTION 1.01.
	 	Certain Defined Terms	  	 	1	  
	 SECTION 1.02.
	 	Other Terms	  	 	23	  
	 SECTION 1.03.
	 	Accounting Terms and Principles	  	 	23	  
	 SECTION 1.04.
	 	Computation of Time Periods	  	 	24	  
		
	 ARTICLE II AMOUNTS AND TERMS OF THE TRANSFERS
	  	 	24	  
	 SECTION 2.01.
	 	Agreement to Transfer	  	 	24	  
	 SECTION 2.02.
	 	Consideration for the Transferred Receivables	  	 	26	  
	 SECTION 2.03.
	 	Settlement Procedures	  	 	26	  
	 SECTION 2.04.
	 	Payments and Computations, Etc	  	 	27	  
	 SECTION 2.05.
	 	Transfer of Records to the Company	  	 	28	  
		
	 ARTICLE III CONDITIONS OF TRANSFERS
	  	 	28	  
	 SECTION 3.01.
	 	Conditions Precedent to Initial Transfer	  	 	28	  
	 SECTION 3.02.
	 	Conditions Precedent to All Transfers	  	 	28	  
	 SECTION 3.03.
	 	Transfer Effective on the Transfer Date	  	 	29	  
		
	 ARTICLE IV REPRESENTATIONS AND WARRANTIES
	  	 	29	  
	 SECTION 4.01.
	 	Representations and Warranties of the Transferor	  	 	29	  
	 SECTION 4.02.
	 	Article 9 Representations and Warranties	  	 	36	  
		
	 ARTICLE V GENERAL COVENANTS
	  	 	37	  
	 SECTION 5.01.
	 	General Covenants	  	 	37	  
		
	 ARTICLE VI ADMINISTRATION, COLLECTION AND MONITORING OF ASSETS
	  	 	41	  
	 SECTION 6.01.
	 	Appointment and Designation of the Collection Agent	  	 	41	  
	 SECTION 6.02.
	 	 Collection of Receivables by the Collection Agent; Extensions and Amendments of
Receivables
	  	 	42	  
	 SECTION 6.03.
	 	Distribution and Application of Collections	  	 	43	  
	 SECTION 6.04.
	 	Other Rights of the Company	  	 	43	  
	 SECTION 6.05.
	 	Records	  	 	44	  
	 SECTION 6.06.
	 	Receivable Reporting	  	 	44	  
	 SECTION 6.07.
	 	Collections and Lock-Boxes	  	 	44	  
	 SECTION 6.08.
	 	UCC Matters; Protection and Perfection of Transferred Property	  	 	45	  
	 SECTION 6.09.
	 	Obligations With Respect to Receivables	  	 	46	  
	 SECTION 6.10.
	 	Applications of Collections	  	 	46	  
	 SECTION 6.11.
	 	Annual Servicing Report of Independent Audit Firm	  	 	46	  
		
	 ARTICLE VII EVENTS OF TERMINATION
	  	 	47	  
	 SECTION 7.01.
	 	Events of Termination	  	 	47	  
		
	 ARTICLE VIII INDEMNIFICATION
	  	 	49	  
	 SECTION 8.01.
	 	Indemnities by the Transferor	  	 	49	  

  
 i 

							
	 	 	 	  	Page	 
		
	 ARTICLE IX MISCELLANEOUS
	  	 	51	  
	 SECTION 9.01.
	 	Amendments and Waivers	  	 	51	  
	 SECTION 9.02.
	 	Notices, Etc.	  	 	51	  
	 SECTION 9.03.
	 	Setoff and Counterclaim	  	 	52	  
	 SECTION 9.04.
	 	No Waiver; Remedies	  	 	52	  
	 SECTION 9.05.
	 	Binding Effect; Assignability; Third Party Beneficiary	  	 	52	  
	 SECTION 9.06.
	 	Term of this Agreement	  	 	53	  
	 SECTION 9.07.
	 	 GOVERNING LAW; CONSENT TO JURISDICTION; WAIVER OF OBJECTION TO VENUE; SERVICE OF
PROCESS
	  	 	53	  
	 SECTION 9.08.
	 	WAIVER OF JURY TRIAL	  	 	53	  
	 SECTION 9.09.
	 	Costs, Expenses and Taxes	  	 	54	  
	 SECTION 9.10.
	 	No Proceedings	  	 	54	  
	 SECTION 9.11.
	 	Execution in Counterparts; Severability; Integration	  	 	54	  
	 SECTION 9.12.
	 	Waiver of Consequential Damages	  	 	54	  

  
 ii 

 LIST OF SCHEDULES AND EXHIBITS 

 

			
	 SCHEDULES
	  	 
		
	SCHEDULE I	  	Condition Precedent Documents (Closing List)
	SCHEDULE II        	  	Legal Name, Jurisdiction of Organization, Organizational ID Number, Principal Place of Business, Chief Executive Office, Location of Records and Registered Names
		
	 EXHIBITS
	  	 
		
	EXHIBIT A	  	Form of Assignment of Agreements
	EXHIBIT B	  	Form of Business Associate Agreement
	EXHIBIT C	  	Form of Monthly Report

  
 iii 

 THIS RECEIVABLES PURCHASE AND CONTRIBUTION AGREEMENT, dated as of March 21,
2012 (as amended through November 18, 2016), among: 
  

	 	(1)	 CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (the “Transferor”);

  

	 	(2)	 CHSPSC, LLC (as successor-by-conversion to Community Health Systems Professional Services Corporation), a
Delaware limited liability company (“Professional Services”), in its capacity as the initial Collection Agent hereunder (in such capacity, the “Collection Agent”); and 

 

	 	(3)	 CHS RECEIVABLES FUNDING, LLC, a Delaware limited liability company (the “Company”).

 PRELIMINARY STATEMENTS. 

WHEREAS, pursuant to the Sale Agreement, each Originator is selling and transferring to the Transferor all of such
Originator’s right, title and interest in the accounts receivable originated by such Originator on the terms and conditions provided therein; 

WHEREAS, the Transferor desires to sell or contribute, and the Company desires to purchase or accept as a contribution, all
of the Transferor’s right, title and interest in the accounts receivable originated by the Originators and purchased by the Transferor under the Sale Agreement on the terms and conditions provided herein; 

WHEREAS, the Collection Agent may from time to time, in accordance with the Documents and subject to the restrictions
thereunder, perform servicing duties with respect to the Transferred Property; 
 IT IS AGREED as follows: 

ARTICLE I 
 DEFINITIONS 

SECTION 1.01.  Certain Defined Terms. 

(a)      Certain capitalized terms used throughout this Agreement are defined above or in this
Section 1.01. 
 (b)      As used in this Agreement and its
exhibits, the following terms shall have the following meanings (such meanings to be equally applicable to both the singular and plural forms of the terms defined). 

“AccessOne Program Receivables” means any Receivable that is subject to, and has not been repurchased
pursuant to the terms of, (i) that certain Amended and Restated Receivables Purchase Agreement, dated October 19, 2004, between QHG of South Carolina, Inc. and HRA Financial Services, Inc., (ii) that certain Amended and Restated Receivables Purchase
Agreement, dated October 15, 2004, between Mary Black Health System LLC and HRA 

 
Financial Services, Inc., as amended, restated, supplemented or modified from time to time, (iii) that certain Amended and Restated Receivables Purchase Agreement, dated October 12, 2004,
between QHG of Enterprise, Inc. and AccessOne Medcard, Inc., as amended, restated, supplemented or modified from time to time, (iv) that certain Amended and Restated Receivables Purchase Agreement, dated October 12, 2004, between Carlsbad Medical
Center, LLC and HRA Financial Services, Inc., as amended, restated, supplemented or modified from time to time, (v) that certain Amended and Restated Receivables Purchase Agreement, dated October 13, 2004, between Lea Regional Hospital, LLC and HRA
Financial Services, Inc., as amended, restated, supplemented or modified from time to time, or (vi) that certain Amended and Restated Receivables Purchase Agreement, dated October 15, 2004, between Las Cruces Medical Center, LLC and HRA Financial
Services, Inc., as amended, restated, supplemented or modified from time to time. 
 “Administrative
Agent” means, Credit Agricole Corporate and Investment Bank, as administrative agent under the Loan Agreement. 

“Affiliate” when used with respect to a Person means any other Person controlling, controlled by or under
common control with such Person. 
 “Aggregate Transfer Value” means, as of any Settlement Date, the
aggregate Transfer Value with respect to all Receivables Transferred from Transferor to the Company during the related Collection Period. 

“Agreement” means this Receivables Purchase and Contribution Agreement, as the same may be amended,
restated, supplemented or otherwise modified from time to time. 
 “Anti-Corruption Laws” means all laws,
rules, and regulations of any jurisdiction applicable to the CHS Parties or their respective Subsidiaries from time to time concerning or relating to bribery or corruption, including, without limitation, the Foreign Corrupt Practices Act of 1977, as
amended, and any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions. 

“Applicable Law” means, as to any Person, all statutes, laws, ordinances, rules, and regulations of any
Governmental Entity, in each case applicable to or binding upon the Person or any of its property or to which the Person or any of its property is subject. 

“Assignment of Agreements” means that certain Assignment of Agreements, dated as of the Closing Date, among
the Transferor, the Company and the Administrative Agent in the form attached hereto as Exhibit A, as such agreement may be amended, restated, supplemented or otherwise modified from time to time in accordance with its terms and the terms
hereof. 
 “Bad Debt Reserve” means the allocable portion of the bad debt reserve on the books and records
of the Originators as established and allocated from time to time by the Originators and the Collection Agent in their sole discretion with respect to the Receivables included in a Transfer. 

  
 2 

 “Bankruptcy Law” means the United States Bankruptcy Reform Act
of 1978 (11 U.S.C. §§ 101, et seq.) as amended from time to time, or any successor statute, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership,
insolvency, reorganization, or similar debtor relief laws of the United States or other applicable U.S. jurisdictions from time to time in effect and affecting the rights of creditors generally. 

“Base Rate” means, on any day, a fluctuating rate of interest per annum equal to the higher of
(i) the per annum rate of interest equal to the PRBKCHMN Index as published by Bloomberg (or other commercially available source designated by the Administrative Agent) and (ii) 0.50% per annum above the Federal Funds Rate.

 “Business Associate Agreement” means an agreement in substantially the form of Exhibit B, as
such agreement may be amended, restated, supplemented or otherwise modified from time to time. 
 “Business
Day” means a day of the year other than a Saturday or a Sunday on which banks are required to be open in New York City. 

“Buyer” means CHS/Community Health Systems, Inc. in its capacity as the buyer under the Sale Agreement. 

A “Change in Control” shall be deemed to have occurred if (a) any “person” or “group”
(within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934 as in effect on the Closing Date), shall own, directly or indirectly, beneficially or of record, shares representing more than 40% of the aggregate ordinary voting power
represented by the issued and outstanding capital stock of the Parent, (b) a majority of the seats (other than vacant seats) on the board of directors of the Parent or the Transferor shall at any time be occupied by persons who were neither
(i) nominated by the board of directors of the Parent or the Transferor, nor (ii) appointed by directors so nominated, (c) any change in control (or similar event, however denominated) with respect to the Parent, the Transferor or the
Collection Agent (if it is an Affiliate of the Transferor, any Originator or the Parent) shall occur under and as defined in any indenture or agreement in respect of Material Indebtedness to which such Person is a party (other than, under any
indenture or agreement in respect of Material Indebtedness assumed in connection with a permitted acquisition or any change in control triggered by the permitted acquisition pursuant to which such Material Indebtedness was assumed), or (d) the
Parent shall cease to own, directly or indirectly, beneficially and of record (i) 100% of the issued and outstanding equity interests of the Transferor, any Originator (other than the Specified Originators) or the Collection Agent (if it is an
Affiliate of the Transferor, any Originator or the Parent), or (ii) the percentage of the issued and outstanding equity interests of any Specified Originator specified on Schedule V to the Sale Agreement or such other percentage that is not less
than 5% below such percentage listed on such Schedule V. 
 “Closing Date” means March 21,
2012. 
 “CMS” means the Centers for Medicare and Medicaid Services of the United States Department of
Health and Human Services. 

  
 3 

 “Code” means the Internal Revenue Code of 1986, as amended from
time to time, and any successor and the regulations promulgated and rulings issued thereunder. 
 “Collection
Account” means an account that is (i) maintained at a bank or other financial institution in the name of an Originator for the purpose of receiving Collections and (ii) subject to a Deposit Account Notification Agreement (Government
Healthcare Receivables). 
 “Collection Account Bank” means a bank or other financial institution holding
one or more Collection Accounts, which on the Closing Date shall be Bank of America, N.A., and on the Second Omnibus Amendment Effective Date and thereafter shall be Bank of America, N.A., or Fifth Third Bank, as context requires. 

“Collection Agency Receivable” means a Receivable that has been referred to a third party secondary
collection agency by the Collection Agent. 
 “Collection Agent” means, at any time, the Person or Persons
then authorized pursuant to Article VI to service, administer and collect Receivables, initially Professional Services, in such capacity. 

“Collection Date” means the date following the Termination Date on which the aggregate Outstanding Balance
of all Transferred Receivables (other than Transferred Receivables which have not been paid as a result of an Insolvency Proceeding with respect to an Obligor) has been reduced to zero and the Company has received all other amounts due to it in
connection with this Agreement or any other agreement executed pursuant hereto or in connection herewith. 

“Collection Period” means a calendar month. 

“Collections” means, with respect to any Receivable, all cash collections and other cash proceeds of such
Receivable, including insurance payments under any insurance policy and all cash proceeds of the Related Security with respect to such Receivable. 

“Company” has the meaning set forth in the Preamble. 

“Concentration Account” means an account, subject to a Control Agreement and maintained in the name of the
Company at a Concentration Account Bank for the purpose of receiving transfers from the applicable Collection Accounts and for transacting all banking activities in accordance with the Facility Documents. 

“Concentration Account Bank” means Bank of America, N.A., Fifth Third Bank or, with the prior written
consent of the Administrative Agent, another bank or financial institution. 
 “Contract” means an
insurance policy, contract or other instrument obligating an Obligor to make payment with respect to a Receivable. 

“Contractual Allowances” means, with respect to any Receivable, an amount set forth in the Monthly Report
and approved by the Administrative Agent by which such 

  
 4 

 
Receivable, consistent with the applicable Originator’s historical collection experience, is expected to be reduced prior to payment thereof by the Obligor, as such amount may be adjusted,
upwards or downwards, in the manner set forth in the Loan Agreement. 
 “Contributed Property” means, with
respect to a Collection Period, an undivided percentage interest equal to the Contribution Percentage in (i) all Receivables that are Contributed or intended to be Contributed to the Company under this Agreement during such Collection Period, (ii)
all Related Security relating to such Receivables and (iii) all Collections with respect to, and other proceeds of such Receivables. 

“Contribution” means a contribution of Contributed Property to the Company from the Transferor pursuant to
Section 2.01. “Contributing” and “Contributed” have meanings correlative thereto. 

“Contribution Percentage” means, with respect to any Collection Period, the amount (expressed as a
percentage) equal to 1 minus the Purchase Percentage. 
 “Contribution Value” means, with respect
to any Contribution as of a Settlement Date, the Contribution Percentage of the Aggregate Transfer Value with respect to the related Collection Period. 

“Control Agreement” means (a) that certain Deposit Account Control Agreement, dated as of the Closing Date,
among the Company, the Administrative Agent and Bank of America, N.A., as the Concentration Account Bank, (b) that certain Deposit Account Control Agreement, dated as of the Second Omnibus Amendment Effective Date, among the Company, the
Administrative Agent and Fifth Third Bank, as the Concentration Account Bank, and (c) each other Deposit Account Control Agreement entered into among the Company, the Administrative Agent and a Concentration Account Bank, in each case in form and
substance satisfactory to the Administrative Agent, as each such agreement may be amended, modified, supplemented or restated in accordance with its terms and the terms hereof. 

“Credit and Collection Policy” means the credit, contracting and collection policies and practices relating
to Contracts and Receivables of the Originators previously provided to each Managing Agent, as modified in compliance with Section 6.02(c) of this Agreement and provided to or accessible to each Managing Agent in electronic format. 

“Critical Accounting Policy” means the “Critical Accounting Policy” (as such term is defined in
the annual report on Form 10-K of the Parent). 
 “Debt” of any Person means (a) indebtedness of such
Person for borrowed money, (b) obligations of such Person evidenced by bonds, debentures, notes or other similar instruments, (c) obligations of such Person to pay the deferred purchase price of property or services beyond ordinary course of
business payment terms for trade payables, (d) obligations secured by a valid Lien upon property or assets owned by such Person, even though such Person has not assumed or become liable for the payment of such obligations and (e) obligations of such
Person under direct or indirect guaranties in respect of, and obligations (contingent or otherwise) to purchase or otherwise acquire, or otherwise to assure a creditor against loss in respect of, indebtedness or obligations of others of the kinds
referred to in clauses (a) through (d) above. 

  
 5 

 “Defaulted Receivable” means a Receivable: 

(a)      as to which, as of the date that is 150 days after the Last Service Date, the amount
paid thereon is less than the Expected Net Value of such Receivable (other than as a result of a miscalculation by the Collection Agent of Contractual Allowances), 

(b)      as to which the Obligor thereof is currently the subject of an Insolvency Proceeding,
or 
 (c)      which, consistent with the Credit and Collection Policy, has been or should be
written off the Company’s or an Originator’s books as uncollectible. 
 “Delinquent Receivable”
means a Receivable, other than a Defaulted Receivable, as to which, as of the date that is 120 days after the Last Service Date, the amount paid thereon is less than the Expected Net Value of such Receivable (other than as a result of a
miscalculation by the Collection Agent of Contractual Allowances). 
 “Deposit Account Notification Agreement
(Government Healthcare Receivables)” means (a) that certain Deposit Account Notification Agreement (Government Healthcare Receivables), dated as of the Closing Date, among the Originators party thereto, the Administrative Agent, Bank of
America, N.A., as the Collection Account Bank, and, solely for purposes of Section 11 thereof, the Transferor, (b) that certain Deposit Account Instructions and Service Agreement, dated as of the Second Omnibus Amendment Effective Date, among the
Originators party thereto, the Administrative Agent and Fifth Third Bank, as the Collection Account Bank, and (c) each other agreement entered into by one or more Originators, the Administrative Agent and a Collection Account Bank providing for,
among other things, standing revocable instructions by such Originators to transfer Collection Account funds to a Concentration Account and notification to the Administrative Agent of any change in such instructions, in each case in form and
substance satisfactory to the Administrative Agent, in each case as such agreement may be amended, modified, supplemented or restated in accordance with its terms and the terms hereof. 

“Discount” means, in respect of each Transfer hereunder, a percentage of the aggregate Expected Net Value of
the Receivables that are the subject of such Transfer. The initial Discount shall be 0.20%. The Transferor and the Company may agree in writing from time to time to change the Discount based on changes in one or more of the items affecting the
calculation thereof; provided, however, that any change to the Discount shall take effect as of the commencement of a Collection Period, shall apply only prospectively and shall not affect the Purchase Price payment or Contribution Value in
respect of Transfers which occurred during any Collection Period ending prior to the Collection Period in respect of which the Transferor and the Company agree to make such change. 

“Distributed Funds” has the meaning assigned to that term in Section 2.03(a). 

“Documents” means this Agreement, the Sale Agreement, the Loan Agreement, the Transferor Documents, the
Facility Documents, and all other certificates, instruments, UCC financing statements, reports, notices, agreements and documents executed or delivered under or in connection with this Agreement, in each case as the same may be amended, supplemented
or otherwise modified from time to time in accordance with this Agreement. 

  
 6 

 “Eligible Obligor” means, at any time, an Obligor which is:

 (a)      not an Affiliate of the Company, the Transferor or any Originator;

 (b)      a resident of the United States; 

(c)      not the Obligor of Defaulted Receivables having an Expected Net Value
in an aggregate amount of 25% or more of the aggregate Expected Net Value of all Receivables of such Obligor; 

(d)      not the subject of any Insolvency Proceeding; and 

(e)      an Insurer or a Governmental Entity. 

For the avoidance of doubt, an Obligor that is ineligible pursuant to two or more clauses above shall be counted as ineligible under this
Agreement once, without duplication. 
 “Eligible Receivable” means, at any time, a Receivable: 

(a)      the Obligor of which is an Eligible Obligor; 

(b)      which is not a Delinquent Receivable, a Defaulted Receivable or a
Collection Agency Receivable; 
 (c)      which (i) is an
“account”, including a health-care-insurance receivable, or a general intangible within the meaning of the UCC and is not evidenced by any instrument or chattel paper, (ii) unless it is an Unbilled Receivable, has been invoiced by the
applicable Originator and as to which all performance and other action required to be taken in connection therewith by the applicable Originator (and, if applicable, the Company) for the Obligor has been so performed or taken, (iii) is denominated
and payable only in U.S. Dollars, (iv) that has not been compromised in any manner that would reduce the amount payable with respect thereto in any manner not reflected in the Total Reserves or the Contractual Allowances with respect thereto
(including by extension of time of payment) and, in any event, is payable in an amount approximating its Expected Net Value by the Obligor or Obligors identified by the applicable Originator in its records as being obligated to do so, (v) is net of
any deductible limitations, commissions, fees, or other discounts, (vi) is based on an actual and bona fide rendition of services or sale of goods to the patient by the applicable Originator in the ordinary course of business, (vii) to the extent
required under Applicable Law, is subject to a Patient Consent Form executed by the applicable patient, and (viii) satisfies all applicable requirements of, and, in the case of Receivables owed by Governmental Entities or Insurers, was originated
and processed in accordance with, the Credit and Collection Policy or the Critical Accounting Policy, as applicable, and the billing requirements of the applicable Obligor except in any Immaterial Respect; 

  
 7 

 (d)      which is payable in an
amount at least equal to its Expected Net Value by the Obligor or Obligors identified by the applicable Originator in its records as being obligated to do so; 

(e)      (i) neither the applicable Originator nor the Transferor of which was
at the time of transfer or currently is the subject of any Insolvency Proceeding, and (ii) the applicable Originator of which has not been the subject of a Removal; 

(f)       which is not the subject of any action, suit, proceeding or
dispute (pending or threatened), setoff, counterclaim, defense, abatement, suspension, deferment, deductible, reduction or termination by the Obligor thereof (except for statutory rights of Governmental Entities that are not pending or threatened)
unless, in the case of a Receivable from a Governmental Entity, Medicare/Medicaid Cost Report Liability Reserves have been established with respect thereto in an amount in compliance with the Critical Accounting Policy and otherwise reasonably
satisfactory to the Administrative Agent; 
 (g)      which is not based on
any cost report settlement or expected settlement due from any Governmental Entity; 

(h)      the invoice for the goods and services constituting the basis for
which, has been prepared, delivered and is in a form such that, after application of all relevant Contractual Allowances adjustments have been applied to such Receivable and the invoiced balance thereunder, the expected payments for the invoiced
goods and services will be in an amount approximating the Expected Net Value of such Receivable; 

(i)       the transactions contemplated hereunder are made in good faith
and without actual intent to hinder, delay or defraud present or future creditors of the Transferor or any Originator; 

(j)       the assignment of which (including the grant of a perfected
security interest therein and the assignment of any Related Security) does not contravene or conflict in any material respect with any Applicable Law or any contractual or other restriction, limitation or restriction with regard to confidentiality;

 (k)      the Obligor with respect to which has been directed to make
payments on such Receivable to a Lock-Box or Collection Account; 

(l)       the Contract with respect to which, (i) together with such
Receivable, does not contravene in any material respect any Applicable Law (including laws, rules and regulations relating to truth in lending, fair credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices and
privacy) and with respect to which no party to the Contract related thereto is in violation of any such Applicable Law in any material respect, (ii) does not contain any provision prohibiting the grant of a Lien in such payment obligation from the
patient to the Originator, from the Originator to the Transferor, from the Transferor to the Company or from the Company to the Administrative Agent, (iii) has been duly authorized and, together with such Receivable, constitutes the legal, valid and
binding obligation of the Obligor, and (iv) was in full force and effect and applicable to the customer or patient at the time the goods or services constituting the basis for such Receivable were sold or performed; 

  
 8 

 (m)      with respect to which no consents by any third party to the grant of a security interest therein are required other than
consents previously obtained in writing by the applicable Originator or the Transferor, as the case may be; 

(n)      as to which the Administrative Agent has not notified the Company and
the Collection Agent that the Administrative Agent has determined, in its reasonable business judgment exercised in good faith, that the inclusion of such Receivable (or class of Receivables (other than Medicare or Medicaid)) would have a material
adverse effect on the program; 
 (o)      (i) which, prior to the grant of an
interest therein pursuant to this Agreement, is owned by the Transferor free and clear of any Lien (other than Permitted Liens), and (ii) with respect to which, from and after the grant of an interest therein pursuant to this Agreement, the
Company has a properly perfected first priority security interest therein, free and clear of any Lien (other than Permitted Liens) which has been assigned to the Administrative Agent, who has a properly perfected first priority security interest
therein, free and clear of any Lien (other than Permitted Liens) (which, for clarity, will exclude Receivables originated by Kay County Oklahoma Hospital Company, LLC as “Eligible Receivables” until such time as the Kay County Lien is
released and terminated in full); 
 (p)      which is not an Ineligible
Receivable; 
 (q)      which, if it is an Unbilled Receivable, is not within
10 days of the statutory limit for billing and collection applicable to the Obligor thereof and is not aged more than 30 days from its Last Service Date; 

(r)       except
for an Unbilled Receivable, all information set forth in the bill and supporting claim documents with respect to which is true, complete and correct except in any Immaterial Respect, and, in all cases, if additional information is requested by the
Obligor, the Collection Agent (or related Originator) has or will promptly provide (or cause to be provided) the same, and if any error has been made with respect to such information, the Collection Agent (or related Originator) will promptly
correct the same and, if necessary, rebill such Receivable; 

(s)       with respect to which the Originator’s Medicare or Medicaid cost reports have been examined and audited or “final settled” or for which a Notice of Program Reimbursement
(“NPR”) has been issued by (i) as to Medicaid, the applicable state agency or other CMS designated agent or agents of such state agency, charged with such responsibility, or (ii) as to Medicare, the Medicare intermediary or other
CMS designated agents charged with such responsibility, and there is no basis for any Governmental Entity to assert an offset with respect to such Receivable, including as the result of any unpaid amounts, with respect to any audit, financial
settlement or NPR, except to the extent covered by Medicare/Medicaid Cost Report Liability Reserves; 

  
 9 

 (t)       which is not an
AccessOne Program Receivable; and 
 (u)      which is not an Illinois
Medicaid Receivable. 
 For the avoidance of doubt, (i) a Receivable or portion of a Receivable that is ineligible pursuant
to two or more clauses above shall be counted as ineligible under this Agreement once, without duplication, and (ii) so long as no Termination or Event of Termination is continuing, an Eligible Receivable that becomes ineligible under any clause
hereunder may be resubmitted as an Eligible Receivable at a future date if and to the extent all qualifications under this definition are satisfied as of the date of resubmission (including curing the basis for the initial determination of
ineligibility hereunder). 
 “ERISA” means the Employee Retirement Income Security Act of 1974, as the
same may be amended from time to time. 
 “ERISA Affiliate” means any trade or business (whether or not
incorporated) that, together with the Parent, is treated as a single employer under Section 414(b) or (c) of the Code, or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under Section 414 of
the Code. 
 “ERISA Event” means (a) any “reportable event”, as defined in Section 4043 of ERISA
or the regulations issued thereunder, with respect to a Plan (other than an event for which the 30-day notice period is waived), (b) a failure by any Plan to meet the minimum funding standards (within the meaning of Sections 412 or 430 of the Code
or Section 302 of ERISA) applicable to such Plan, in each case whether or not waived, (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA, of an application for a waiver of the minimum funding standard with respect to
any Plan, (d) a determination that any Plan is, or is expected to be, in “at-risk” status (as defined in Section 303(i)(4) of ERISA or Section 430(i)(4) of the Code), (e) the incurrence by the Parent or any of its ERISA Affiliates of any
liability under Title IV of ERISA with respect to the termination of any Plan or the withdrawal or partial withdrawal of the Parent or any of its ERISA Affiliates from any Plan or Multiemployer Plan, (f) the receipt by the Parent or any of its ERISA
Affiliates from the PBGC or a plan administrator of any notice relating to the intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan, (g) the receipt by the Parent or any of its ERISA Affiliates of any notice, or
the receipt by any Multiemployer Plan from the Parent or any of its ERISA Affiliates of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent or in
reorganization, within the meaning of Title IV of ERISA or in endangered or critical status, within the meaning of Section 432 of the Code or Section 305 of ERISA, (h) the occurrence of a “prohibited transaction” with respect to which the
Parent or any of the subsidiaries is a “disqualified person” (within the meaning of Section 4975 of the Code) or with respect to which the Parent or any such subsidiary could otherwise be liable or (i) any other event or condition with
respect to a Plan or Multiemployer Plan that could result in liability of the Parent or any subsidiary. 
 “Event
of Termination” has the meaning assigned to that term in Section 7.01. 

  
 10 

 “Expected Net Value” means, with respect to any Receivable, the
sum of (a) the gross unpaid amount of such Receivable on the date of creation thereof minus (b) all Contractual Allowances with respect to such Receivable. 

“Facility Documents” has the meaning set forth in the Loan Agreement. 

“Federal Funds Rate” means, for any day, a fluctuating interest rate per annum equal to the weighted
average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers, as published for such day (or, if such day is not a Business Day, for the next preceding Business Day) by the
Federal Reserve Bank of New York, or, if such rate is not so published for any day which is a Business Day, the average of the quotations for such day for such transactions received by the Administrative Agent from three Federal funds brokers of
recognized standing selected by it. 
 “Fifth Amendment to Loan Agreement” means that certain Fifth
Amendment to Receivables Loan Agreement, made as of February 28, 2015, among the Borrower, as Borrower, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole
Corporate and Investment Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under the Loan Agreement, and such other parties as are named therein, and acknowledged and agreed by
certain other CHS Parties party to the Facility Documents. 
 “Fifth Omnibus Amendment” means that certain
Fifth Omnibus Amendment, made as of the Fifth Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a
Committed Lender, CA-CIB, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Loan Agreement, and the Sale Agreement, and as Authorized Representative
(as defined in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), the Originators party thereto and such other parties as are named therein. 

“Fifth Omnibus Amendment Effective Date” means November 13, 2015. 

“First Omnibus Amendment” means that certain First Omnibus Amendment, made as of July 30, 2012, among the
Borrower, as Borrower and as the Company, Scotia, as a Managing Agent, CA-CIB, as a Managing Agent and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the
Contribution Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as Transferor and as Buyer, and each of the Initial Originators, as Originators. 

“Fourth Amendment to Loan Agreement” means that certain Fourth Amendment to Receivables Loan Agreement, made
as of August 29, 2014, among the Borrower, as Borrower, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole Corporate and Investment Bank, as a Managing
Agent, as a Committed Lender and as Administrative Agent, 

  
 11 

 
the Collection Agent, as Collection Agent under the Loan Agreement, and such other parties as are named therein, and acknowledged and agreed by certain other CHS Parties party to the Facility
Documents. 
 “Fourth Omnibus Amendment” means that certain Fourth Omnibus Amendment, made as of the
Fourth Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, CA-CIB, as a Managing Agent,
as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Loan Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as
Transferor, as Buyer and individually (as a performance undertaking party), the Originators party thereto and such other parties as are named therein. 

“Fourth Omnibus Amendment Effective Date” means March 31, 2015. 

“GAAP” means the generally accepted accounting principles in the United States in effect from time to time
including, at any time after the adoption thereof in the United States, the generally accepted accounting standards from time to time developed and approved by the International Accounting Standards Board. 

“Governmental Entity” means the United States of America, any state thereof, any political subdivision of a
state thereof and any agency or instrumentality of the United States of America or any state or political subdivision thereof and any entity exercising executive, legislative, judicial, regulatory, or administrative functions of or pertaining to
government. Payments from Governmental Entities will be deemed to include payments governed under the Social Security Act (42 U.S.C. §§ 1395 et seq.), including payments under Medicare, Medicaid and TRICARE/CHAMPUS, and payments
administered or regulated by CMS; provided that for purposes of the definition of “Eligible Obligor”, Governmental Entities with respect to Medicaid-related and Medicare-related Receivables shall be treated as separate entities in
the manner identified in the Monthly Report. 
 “Healthcare Laws” means all applicable statutes, laws,
ordinances, rules, and regulations of any Governmental Entity with respect to regulatory matters primarily relating to patient healthcare, healthcare providers, and healthcare services (including Section 1128B(b) of the Social Security Act, as
amended, 42 U.S.C. § 1320a 7(b) (Criminal Penalties Involving Medicare or State Health Care Programs), commonly referred to as the “Federal Anti-Kickback Statute,” HIPAA and the Social Security Act, as amended, Section 1877, 42 U.S.C.
§ 1395nn (Prohibition Against Certain Referrals), commonly referred to as “Stark Statute”). 

“HIPAA” means the Health Insurance Portability and Accountability Act of 1996, Pub. L. No.
104-191, the Privacy Standards, the Security Standards, and the Privacy provisions (Subtitle D) of the Health Information Technology for Economic Clinical Health Act, Division A, Title XIII of Pub. L. 111-5, and its implementing
regulations. 

  
 12 

 “Illinois Medicaid Receivable” means any Receivable with
respect to which the Obligor is the State of Illinois or any agency or instrumentality thereof acting through Illinois’ Medicaid agency that arises out of charges reimbursable under Medicaid. 

“Illinois Receivable” means a Receivable payable by a Governmental Entity to an Originator that is organized
under the laws of the State of Illinois. 
 “Immaterial Respect” means, with respect to (1) any
eligibility criteria relating to the Transfer of a Receivable, any non-compliance with such eligibility criteria that does not result in (i) the diminution in any amount whatsoever (x) in the timely payment or, (y) in the amount of Transfer Value of
such Receivable, or (ii) the impairment exclusion, elimination or limitation of any material rights, remedies or benefit that otherwise would be available to obtain Collections on such Receivable, or (2) any representation or warranty hereunder, any
breach of a representation or warranty that does not result in (i) the diminution in any amount whatsoever (x) in the timely payment or, (y) in the amount of Transfer Value of the Transferred Receivables, or (ii) the impairment exclusion,
elimination or limitation of any material rights, remedies or benefit that otherwise would be available to obtain Collections on the Transferred Receivables. 

“Indemnified Amounts” has the meaning assigned to that term in Section 8.01. 

“Initial Originators” means each of the Persons affiliated with the Parent and party to the Sale Agreement
as of the Closing Date as an originator collectively, and “Initial Originator” means any of them individually. 

“Indemnified Parties” has the meaning assigned to that term in Section 8.01. 

“Ineligible Receivable” means a Receivable on the books and records of an Originator in one of the following
financial classes from the list of all financial classes categorized by the Originators set forth on the schedule of financial classes provided to the Administrative Agent on the Closing Date: (i) Early-Out Blue Cross, (ii) Early-Out HMO/PPO, (iii)
Early-Out Other Insurance, (iv) Champus, (v) Workers Comp., (vi) Other Governmental, (vii) Schip Standards, (viii) Schip Nonstandard, (ix) Industrial, (x) Auto Insurance Liability, or (xi) Other Non-Government. 

“Initial Transfer” means the initial Transfer made by the Transferor hereunder. 

“Initial Transfer Date” means March 26, 2012 or the first date thereafter on which all of the conditions
precedent specified in Sections 3.01 and 3.02 have been satisfied. 
 “Insolvency
Proceeding” means, with respect to any Person, any of the following events: (a) any proceeding shall be instituted by such Person seeking to adjudicate it as bankrupt or insolvent, or seeking liquidation, winding up, reorganization,
dissolution, stay of proceedings, arrangement, adjustment, protection, relief, or composition of it or its debts under any Bankruptcy Law or (b) any proceeding shall be instituted against such Person seeking to adjudicate it a bankrupt or insolvent,
or seeking liquidation, dissolution, stay of proceedings, winding up, reorganization, arrangement, adjustment, protection, relief, or composition of it or its debts under any Bankruptcy Law, and such proceeding shall remain unstayed for a period of
60 days, or the requested adjudication, relief or other action sought thereby shall have been made, granted or taken. 

  
 13 

 “Insurer” means any Person (other than a Governmental Entity)
which in the ordinary course of its business or activities agrees to pay for healthcare goods and services received by individuals, including commercial insurance companies, nonprofit insurance companies (such as the Blue Cross, Blue Shield
entities), employers or unions which self insure for employee or member health insurance, prepaid health care organizations, preferred provider organizations, health maintenance organizations or any other similar Person. “Insurer” includes
insurance companies issuing health, personal injury, workers’ compensation or other types of insurance but does not include any individual guarantor. 

“Investment Company Act” means the Investment Company Act of 1940, as amended. 

“Kay County Lien” means (a) the tax lien evidenced by (i) the Notice of Federal Tax Lien filed against Kay
County Oklahoma Hospital Company, LLC, for a total amount of $9,594,943.55, prepared and signed at Nashville, Tennessee, on October 2, 2012, filed at the Kay County Clerk in the State of Oklahoma and recorded in Book F17, Page 95 on October 9, 2012,
and (ii) the Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital Company, LLC, for a total amount of $9,594,943.55, prepared and signed at Nashville, Tennessee, on October 2, 2012, filed at the Oklahoma County Clerk, in the state
of Oklahoma under filing no. 20121009030027290 on October 9, 2012; and (b) the tax lien evidenced by (i) the Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital Company, LLC, for a total amount of $1,191,207.26, prepared and signed
at Nashville, Tennessee, on November 15, 2012, filed at the Kay County Clerk in the State of Oklahoma and recorded in Book F17, Page 104 on November 26, 2012, and (ii) the Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital
Company, LLC, for a total amount of $1,191,207.26, prepared and signed at Nashville, Tennessee, on November 15, 2012, filed at the Oklahoma County Clerk in the State of Oklahoma under filing no. 20121126030032200 on November 26, 2012. 

“Last Service Date” means, with respect to any Receivable, the date on which the related patient was
discharged from the care of the applicable Originator. 
 “Lenders” has the meaning set forth in the Loan
Agreement. 
 “Lien” means a lien, assignment, mortgage, pledge, hypothecation, privilege, title
retention, security interest, charge, hypothec, encumbrance or other right or claim of any Person. 
 “Loan
Agreement” means that certain Receivables Loan Agreement, dated as of the Closing Date, among the Company, Professional Services, in its capacity as Collection Agent, the Lenders party thereto from time to time, the Managing Agents party
thereto from time to time and Credit Agricole Corporate and Investment Bank, as Administrative Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment, the Third Omnibus Amendment, the Fourth Amendment to Loan Agreement, the
Fifth Amendment to Loan Agreement, the Fourth Omnibus Amendment, the Fifth Omnibus Amendment, and the Sixth Omnibus Amendment, and as such agreement may be further amended, restated, supplemented or otherwise modified from time to time in accordance
with its terms. 

  
 14 

 “Lock-Box” means a post office box to which Collections are
remitted for retrieval by a Collection Account Bank and deposited by such Collection Account Bank into a Collection Account. 

“Majority Lenders” has the meaning set forth in the Loan Agreement. 

“Managing Agent” has the meaning set forth in the Loan Agreement. 

“Material Adverse Effect” means a material adverse change since December 31, 2011 in, or a material adverse
effect upon, (a) the operations, business, properties or financial condition of (i) the Originators taken as a whole, or the Collection Agent or (ii) the Parent and its subsidiaries, taken as a whole, (b) the ability of the Collection
Agent, the Parent, CHS or any Material Originator to perform in any material respects their respective obligations under this Agreement or any other Document to which it is a party, or (c) (i) the legality, validity, binding effect or enforceability
of any Document, or (ii) the perfection or priority of any ownership interest granted under any of the Documents (other than with respect to an immaterial amount of Transferred Property and which the applicable Originator, Collection Agent or CHS is
diligently disputing by appropriate proceedings). 
 “Material Indebtedness” means any Debt (other than
any Debt incurred under the Documents) of any one or more of the Parent, the Transferor, the Collection Agent or any Originator in an aggregate principal amount exceeding $50,000,000. 

“Material Originator” has the meaning set forth in the Sale Agreement. 

“Medicaid” means the medical assistance program established by Title XIX of the Social Security Act (42
U.S.C. § 1396 et seq.) and any statutes succeeding thereto. 
 “Medicare” means the health insurance
program for the aged and disabled established by Title XVIII of the Social Security Act (42 U.S.C. § 1395 et seq.) and any statutes succeeding thereto. 

“Medicare/Medicaid Cost Report Liability Reserve” has the meaning set forth in the Loan Agreement. 

“Monthly Distributed Funds” has the meaning assigned to that term in
Section 2.03(a). 
 “Monthly Report” means a report, in substantially the form
of Exhibit C, executed by a Responsible Officer of the Collection Agent and furnished to the Administrative Agent and each Managing Agent pursuant to Section 2.03. 

“Monthly Report Due Date” means, with respect to any Collection Period, the 20th day of the calendar month
following such Collection Period, or, if such day is not a Business Day, the next succeeding Business Day. 

  
 15 

 “Multiemployer Plan” means a multiemployer plan as defined in
Section 4001(a)(3) of ERISA that is contributed to by the Transferor or with respect to which the Transferor has any liability (including on behalf of any ERISA Affiliate). 

“Net Receivables Balance” has the meaning set forth in the Loan Agreement. 

“Noncomplying Receivable” means any Receivable with respect to which the Company has received notice from
the Transferor or the Collection Agent (or following a Termination or Event of Termination, the replacement Collection Agent) that such Receivable was included in calculations contained in the most recently delivered Monthly Report as an Eligible
Receivable that was not an Eligible Receivable as of the date Transferred hereunder or that the Transferor otherwise breached any representation, warranty or covenant made with respect to such Receivable hereunder when Transferred. 

“Noncomplying Receivable Portion” means, with respect to any Noncomplying Receivable, the portion of such
Receivable that has caused such Receivable to be classified as a Noncomplying Receivable (whether due to a dispute, discount, deduction, claim, offset, defense or counterclaim of any kind relating to such Receivable or any other performance related
or contractual dilution affecting such Receivable, including, without limitation, product quality, warranties, setoffs, deductions, discounts, rebates, incentive programs and adjustments) such that, if such amount is paid to the Company pursuant to
Section 2.03(b), the remaining Outstanding Balance of such Receivable shall constitute an Eligible Receivable in all respects; provided ̧ if the Noncomplying Receivable Portion exceeds 50% of the Outstanding Balance for any
Receivable, then the Noncomplying Receivable Portion shall be deemed to equal 100% of the Outstanding Balance of such Receivable.

By way of example, if the Company purchased or accepted for a contribution a Receivable hereunder with an Expected Net Value
of $1,100,000 and, by virtue of clerical error, the Expected Net Value was overstated by $100,000 (i.e., the Expected Net Value as of the Transfer Date was in fact $1,000,000), the Noncomplying Receivable Portion of such Receivable is equal to
$100,000. 
 “Noncomplying Receivables Adjustment” means, with respect to any Collection Period, an amount
equal to the aggregate of, with respect to each Receivable which the Collection Agent or the Company (or its assigns) has identified to the Authorized Representative as a Noncomplying Receivable during such Collection Period, either (i) as of any
date prior to the Termination Date that no Termination or Event of Termination is outstanding, the Noncomplying Receivable Portion of each such Receivable, and (ii) in all other circumstances, the Outstanding Balance of each such Receivable. 

“Notice” has the meaning set forth in the Sale Agreement. 

“NPR” has the meaning assigned to that term in clause (s) of the defined term “Eligible
Receivable”. 
 “Obligor” means an Insurer or Governmental Entity, as applicable who is responsible
for the payment of all or any portion of a Receivable. For the avoidance of doubt, the term “Obligor” shall not include any Person that is currently classified in a “self-pay” financial class by the Collection Agent. 

  
 16 

 “Originator” or “Originators” has the meaning
set forth in the Sale Agreement. 
 “Originator Notes” has the meaning set forth in the Sale Agreement.

 “Outstanding Balance” of any Receivable at any time means (x) the Expected Net Value of such
Receivable, minus (y) the aggregate amount of (i) all Collections received in the applicable Concentration Account with respect to such Receivable, and (ii) all Noncomplying Receivables Adjustment with respect to such Receivable that have
been applied or paid in accordance with Section 2.03. 
 “Parent” means Community Health Systems,
Inc., a Delaware corporation. 
 “Parent Credit Agreement” means that certain Credit Agreement, dated as
of July 25, 2007, as amended and restated as of November 5, 2010, February 2, 2012 and January 27, 2014, and as further amended as of March 9, 2015, among CHS, as borrower, the Parent, the lenders party thereto, and Credit Suisse AG, as
administrative agent and as collateral agent for the lenders, as such agreement may be further amended, modified, supplemented or restated from time to time in accordance with its terms. 

“Patient Consent Form” has the meaning set forth in the Sale Agreement. 

“PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor
entity performing similar functions. 
 “Performance Undertaking” has the meaning set forth in the Loan
Agreement. 
 “Permitted Liens” means (a) liens for taxes, fees, assessments and other governmental
charges that are not delinquent and in respect of which adequate reserves have been established, (b) any Lien created by or in connection with any Facility Document, (c) Liens created by or in connection with the Parent Credit Agreement which, by
their terms, do not attach to Transferred Receivables or any rights, title or interest in or to any of the Documents, except that the Originator Notes may be pledged to the extent required by the Parent Credit Agreement, and (d) Liens
(i) which do not interfere in any material respect with the business of any Originator, or (ii) arising from precautionary UCC financing statements or similar filings made in respect of operating leases entered into by an Originator, in each
case under this clause (d), which do not secure any Debt. 
 “Person” means an individual, partnership,
corporation (including a business trust), limited liability company, joint stock company, trust, unincorporated association, joint venture, government (or any agency or political subdivision thereof) or other entity. 

“Plan” shall mean any employee pension benefit plan (other than a Multiemployer Plan) subject to the
provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, sponsored, maintained or contributed to by the Parent or an Originator, with respect to an Originator or Parent has any liability (including on behalf of any ERISA
Affiliate). 

  
 17 

 “Professional Services” has the meaning assigned to that term
in the Recitals. 
 “Purchase” means a purchase of Purchased Property by the Company from the Transferor
pursuant to Section 2.01. “Purchasing” and “Purchased” have meanings correlative thereto. 

“Purchase Percentage” means, with respect to a Collection Period, the lesser of (x) 100% and (y) the
percentage equivalent of a fraction, the numerator of which is the Monthly Distributed Funds and the denominator of which is the Aggregate Transfer Value, in each case for such Collection Period. 

“Purchase Price” means, with respect to any Purchase as of a Settlement Date, the Purchase Percentage of the
Aggregate Transfer Value with respect to the related Collection Period. 
 “Purchased Property” means,
with respect to a Collection Period, an undivided percentage interest equal to the Purchase Percentage in (i) all Receivables that are sold or intended to be sold to the Company under this Agreement during such Collection Period, (ii) all Related
Security relating to such Receivables and (iii) all Collections with respect to, and other proceeds of such Receivables. 

“Receivables” means all accounts (including health-care-insurance receivables), instruments and general
intangibles, whether now existing or hereafter arising, and all proceeds of any of the foregoing, in each case, consisting of rights of payment arising out of the rendition of medical, surgical, diagnostic or other professional medical services or
the sale of medical products by an Originator in the ordinary course of its business, including all third-party reimbursable portions or third-party directly payable portions of health-care-insurance receivables or general intangibles owing (or in
the case of Unbilled Receivables, to be owing) by an Obligor, including all rights to reimbursement from Obligors under any agreements with Obligors or other Persons and payments from Obligors, together with all books, records, ledger cards, rights
to access and use data processing records, rights to use computer software, and other property at any time used or useful in connection with, evidencing, embodying, referring to, or relating to any of the foregoing, in all cases, to the extent
acquired by Transferor from the Originators from time to time under the Sale Agreement. For the avoidance of doubt, this definition shall not include any Self Pay Obligation. 

“Records” means all Contracts and other documents, books, records and other information (including computer
programs, tapes, disks, punch cards, rights to access and use data processing software and related property and rights) maintained with respect to Receivables and the related Obligors. 

“Related Security” means with respect to any Receivable: 

(a)      all of the applicable Originator’s interest in the merchandise
(including returned, repossessed or foreclosed merchandise), if any, relating to the sale which gave rise to such Receivable; 

  
 18 

 (b)      all other Liens and
property subject thereto from time to time purporting to secure payment of such Receivable, whether pursuant to the Contract related to such Receivable or otherwise; 

(c)      the assignment to the Company of all UCC financing statements or
similar documents covering any collateral securing payment of such Receivable; 

(d)      all guarantees, indemnities, warranties, letters of credit, insurance
policies and proceeds and premium refunds thereof and other agreements or arrangements of whatever character from time to time supporting or securing payment of such Receivable whether pursuant to the Contract related to such Receivable or
otherwise; 
 (e)      all Records; and 

(f)      all present and future claims, demands, causes and choses in action in
respect of any or all of the foregoing and all payments on or under and all proceeds of every kind and nature whatsoever in respect of any or all of the foregoing, including all proceeds of the conversion, voluntary or involuntary, into cash or
other liquid property, all cash proceeds, accounts, accounts receivable, notes, drafts, acceptances, chattel paper, checks, deposit accounts, securities accounts, insurance proceeds, condemnation awards, rights to payment of any and every kind and
other forms of obligations and receivables, instruments and other property which at any time constitute all or part of or are included in the proceeds of any of the foregoing. 

“Responsible Officer” means, with respect to any Person, its president, company controller, vice president,
treasurer or chief financial officer designated by resolution of such Person as being authorized to deliver notices, reports and certificates under this Agreement. 

“Revolving Principal Balance” has the meaning set forth in the Loan Agreement. 

“Sale Agreement” means that certain Receivables Sale Agreement dated as of the Closing Date, among the
Originators, the Buyer and the Collection Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment, the Third Omnibus Amendment, the Fourth Omnibus Amendment, the Fifth Omnibus Amendment, and the Sixth Omnibus Amendment, and as
the same may be further amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof, together with all instruments, documents and agreements executed by any of the Originators in connection therewith,
in each case, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof. 

“Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from
time to time by the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of Treasury, the U.S. State Department, the U.S. Department of Commerce or the U.S. Department of the Treasury. 

  
 19 

 “Sanctioned Country” means, at any time, a country or territory
that is itself the subject or target of any Sanctions (at the date of this Agreement, Cuba, Iran, North Korea, Sudan and Syria). 

“Sanctioned Person” means (a) any person listed in any Sanctions-related list of specially designated
foreign nationals or other persons maintained by the Office of Foreign Assets Control of the U.S. Department of Treasury, the U.S. State Department, the U.S. Department of Commerce or the U.S. Department of the Treasury or (b) any person controlled
by any such person. 
 “Second Omnibus Amendment” means that certain Second Omnibus Amendment, made as of
the Second Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole
Corporate and Investment Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Sale Agreement, and the Loan Agreement, and as Authorized
Representative (as defined in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), and each of the Originators party to the Sale Agreement as of the Second Omnibus Amendment Effective Date, as
Originators. 
 “Second Omnibus Amendment Effective Date” means March 7, 2013. 

“Self Pay Obligations” means, as of any date, all accounts, instruments and general intangibles, whether now
existing or hereafter arising, that are payable by a Person other than an Obligor and classified in a “self pay” financial class by the Collection Agent as of such date and all proceeds of any of the foregoing, in each case, consisting of
rights of payment arising out of the rendition of medical, surgical, diagnostic or other professional medical services or the sale of medical products by an Originator in the ordinary course of its business. 

“Servicer Termination Event” means the occurrence of any of the following: 

(a)      any Event of Termination; 

(b)      any withdrawal by the Collection Agent from a Collection Account or a
Concentration Account in contravention of or otherwise not in accordance with the terms of this Agreement or any other Facility Document; 

(c)      any failure on the part of the Collection Agent duly to comply in any
material respect with any of its duties, covenants or obligations hereunder, as “Collection Agent” under this Agreement, the Sale Agreement, the Loan Agreement or under any Document, any Contract, any Applicable Law with respect to any
Receivable, or under the standards, duties and obligations set forth in the Credit and Collection Policy, in each case, as determined by the Company (or its assigns) in the exercise of its reasonable commercial judgment, which failure shall continue
uncured or unwaived for a period of 10 days (if such failure can be remedied) after the earlier to occur of (x) the date on which written notice of such failure shall have been given to the Collection Agent by the Company or its assigns, and (y) the
date on which a Responsible Officer of the Collection Agent acquires knowledge thereof; 

  
 20 

 (d)      the Collection Agent
agrees to or otherwise permits to occur any material change in the Credit and Collection Policy that is not in compliance with Section 6.02(c); 

(e)      Professional Services (if then acting as Collection Agent) assigns its
rights or obligations as “Collection Agent” hereunder to any Person without the consent of the Administrative Agent and the approval of each Managing Agent (as required by Section 6.01); 

(f)      any financial or other information reasonably requested by the
Administrative Agent or any Managing Agent is not provided as requested within a reasonable amount of time following such request; or 

(g)      any representation or warranty made or deemed made by the Collection
Agent or any of its officers under or in connection with this Agreement or any other Facility Document shall have been false, incorrect or misleading in any material respect when made or deemed made. 

“Servicing Fee” has the meaning set forth in the Sale Agreement. 

“Settlement Date” means, with respect to each Transfer, the Monthly Report Due Date covering the monthly
period in which the related Transfer Date occurred. 
 “Specified Originators” has the meaning set forth
in the Sale Agreement. 
 “Sixth Omnibus Amendment” means that certain Sixth Omnibus Amendment, made as of
the Sixth Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, CA-CIB, as a Managing
Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Loan Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS,
as Transferor, as Buyer and individually (as a performance undertaking party), the Originators party thereto and such other parties as are named therein. 

“Sixth Omnibus Amendment Effective Date” means November 18, 2016. 

“Termination” means any event or circumstance that but for notice or lapse of time or both would constitute
an Event of Termination. 
 “Termination Date” means the date on which the Transferor’s obligation to
sell and contribute and the Company’s obligation to purchase and accept as a contribution Receivables hereunder terminates, which date shall occur on the earliest to occur of (i) the delivery of a Termination Declaration Notice, (ii) the
occurrence of any event described in clause (i)(B) or clause (i)(C) of Section 7.01(f), (iii) the occurrence of any event described in Section 7.01(d) and (iv) the date on which all amounts payable
under the Documents have been paid in full and all commitments under the Documents have been terminated. 

  
 21 

 “Termination Declaration Notice” has the meaning assigned to
that term in Section 7.01. 
 “Third Omnibus Amendment” means that certain Third
Omnibus Amendment, made as of the Third Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed
Lender, CA-CIB, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Loan Agreement, and the Sale Agreement, and as Authorized Representative (as defined
in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), each of the Originators party to the Sale Agreement as of the Third Omnibus Amendment Effective Date, as Originators, and such other parties
as are named therein. 
 “Third Omnibus Amendment Effective Date” means March 31, 2014. 

“Transfer” means a Contribution or a Purchase. “Transferring” and
“Transferred” have meanings correlative thereto. 
 “Transfer Date” has the meaning
assigned to that term in Section 2.01(a). 
 “Transfer Value” means, with respect to any Transfer,
the aggregate Expected Net Value of the Receivables included in such Transfer minus the Discount for such Transfer, minus the Bad Debt Reserve, which the parties agree is the best estimation of the fair market value of such
Receivables. 
 “Transferor” has the meaning set forth in the Preamble. 

“Transferor Documents” means this Agreement, the Control Agreement, the Deposit Account Notification
Agreement (Government Healthcare Receivables) and all other certificates, instruments, UCC financing statements, reports, notices, agreements and documents executed or delivered under or in connection with this Agreement, in each case as the same
may be amended, supplemented or otherwise modified from time to time in accordance with this Agreement. 

“Transferor’s Account” means the account of the Transferor for the benefit of the Transferor at Bank of
America, N.A., identified in writing by the Collection Agent to the Administrative Agent, which account shall be utilized by the Company for all payments and distributions to the Transferor hereunder, or such other bank account identified in writing
by the Transferor to the Company from time to time. 
 “Transferred Property” means Contributed Property
or Purchased Property. 
 “Transferred Receivable” means any Receivable included in the Contributed
Property or in the Purchased Property. 

  
 22 

 “TRICARE/CHAMPUS” means the Civilian Health and Medical Program
of the Uniformed Service, a program of medical benefits covering former and active members of the uniformed services and certain of their dependents, financed and administered by the United States Departments of Defense, Health and Human Services
and Transportation and established pursuant to 10 USC §§ 1071-1106, and all regulations promulgated thereunder including (1) all federal statutes (whether set forth in 10 USC §§ 1071-1106 or elsewhere) affecting TRICARE/CHAMPUS,
and (2) all rules, regulations (including 32 CFR 199), manuals, orders and administrative, reimbursement, and other guidelines of all Governmental Entities (including the Department of Health and Human Services, the Department of Defense, the
Department of Transportation, the Assistant Secretary of Defense (Health Affairs), and the Office of TRICARE/CHAMPUS, or any Person or entity succeeding to the functions of any of the foregoing) promulgated pursuant to or in connection with any of
the foregoing (whether or not having the force of law) in each case as may be amended, supplemented or otherwise modified from time to time. 

“Trigger Event” has the meaning set forth in the Loan Agreement. 

“UCC” means the Uniform Commercial Code as from time to time in effect in the specified jurisdiction. 

“Unbilled Receivable” means a Receivable in respect of which the goods have been shipped, or the services
rendered, to the relevant customer or patient, rights to payment thereon have accrued, but the invoice has not been rendered to the applicable Obligor. 

“United States” or “U.S.” means the United States of America. 

“U.S. Dollars” or “US $” means the lawful currency of the United States. 

“Withdrawal Liability” shall mean liability to a Multiemployer Plan as a result of a complete or partial
withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA. 
 SECTION
1.02. Other Terms.    All terms used in Article 9 of the UCC in the State of New York, and not specifically defined herein are used herein as defined in such Article 9. The words “herein,”
“hereof,” and “hereunder” and other words of similar import refer to this Agreement as a whole, including the exhibits and schedules hereto, as the same may from time to time be amended or supplemented and not to any particular
section, subsection, or clause contained in this Agreement, and all references to Sections, Exhibits and Schedules shall mean, unless the context clearly indicates otherwise, the Sections hereof and the Exhibits and Schedules attached hereto, the
terms of which Exhibits and Schedules are hereby incorporated into this Agreement. Whenever appropriate, in the context, terms used herein in the singular also include the plural, and vice versa. The words “including”, “included”
and words of similar impact are not limiting. 
 SECTION 1.03. Accounting Terms and
Principles.    All accounting terms not specifically defined herein shall be construed in accordance with GAAP, and all accounting determinations required to be made pursuant hereto and all financial statements prepared
hereunder shall, unless expressly otherwise provided herein, be made in accordance with GAAP. 

  
 23 

 
If there occurs after the date hereof any change in GAAP that affects in any respect the calculation of any financial ratio or covenant, the Transferor and the Company and its assigns shall
negotiate in good faith any amendment required in this Agreement with the intent of having the respective positions of the Transferor and the Company after such change conform as nearly as possible to their respective positions as of the date of
this Agreement and, until any such amendments have been agreed upon, all calculations shall be made as if no change in GAAP has occurred. 

SECTION 1.04. Computation of Time Periods.    Unless otherwise stated in this Agreement, in
the computation of a period of time from a specified date to a later specified date, the word “from” means “from and including” and the words “to” and “until” each mean “to but excluding.” 

ARTICLE II 
 AMOUNTS AND TERMS OF
THE TRANSFERS 
 SECTION 2.01. Agreement to Transfer. 

(a)      On the Initial Transfer Date and on each Business Day after the Initial Transfer until
the Termination Date (each, a “Transfer Date”), on the terms and conditions hereinafter set forth, and without recourse to the Transferor (except to the extent specifically provided herein) the Transferor hereby offers to sell or
contribute to the capital of the Company and, upon satisfaction of the applicable conditions set forth in Article III, the Transferor does hereby sell or contribute and the Company does hereby purchase or accept as a capital contribution from
the Transferor on such Transfer Date all Receivables owned by the Transferor as of the close of business on the immediately preceding Business Day (other than any AccessOne Program Receivables originated prior to the date that is 30 days after the
Closing Date) which have not been previously Transferred to the Company hereunder, together with all of the Related Security relating to such Receivables and all Collections with respect to and other proceeds of such Receivables; provided
that notwithstanding anything to contrary, each Transfer of an Illinois Receivable hereunder shall be effectuated through a Contribution and not a Purchase. 

(b)      The Company shall convey to the Transferor the Transfer Value in respect of each
Transfer, which shall be conveyed in the manner provided in Sections 2.02 and 2.03. 

(c)      Effective on each Transfer Date hereunder, the Company shall own the Transferred
Property that was Transferred by the Transferor to the Company on such Transfer Date, and the Transferor shall not take any action inconsistent with such ownership and shall not claim any ownership interest in such Transferred Property. 

(d)      It is the intention of the parties hereto that each Purchase of Receivables to be made
hereunder shall constitute a “sale of accounts,” as such term is used in Article 9 of the UCC of the State of New York, and not a loan secured by such accounts. Each sale of Receivables by Transferor to the Company is made without
recourse; provided, however, that (i) the Transferor shall be liable to the Company for all representations, warranties and covenants made by the Transferor pursuant to the terms of this Agreement, and (ii) such sale does not

  
 24 

 
constitute and is not intended to result in an assumption by the Company or any assignee thereof of any obligation of the Originator or any other Person arising in connection with the Purchased
Property, or any other obligations of any Originator or the Transferor. In view of the expressed intention of the parties hereto that the Purchases of Receivables to be made hereunder shall constitute a sale of such Receivables to the Company, the
Transferor and the Company each agrees to note on its financial statements that the Receivables have been sold to the Company to the extent other treatment in the financial statements is not required by GAAP. If at any time contrary to the mutual
intent of the Transferor and the Company a court characterizes the transactions hereunder as loans by the Company to the Transferor, then the Transferor shall, effective as of the Closing Date, be deemed to have granted (and the Transferor hereby
does grant) to the Company a first priority security interest in all of its right and title to and interest in all Purchased Property and the proceeds thereof as security for such loans advanced to the Transferor hereunder with accrued interest
thereon, and this Agreement shall be deemed to be a security agreement. 
 (e)      It is the
intention of the parties hereto that each Contribution of Receivables to be made hereunder shall constitute a “true contribution” and not a loan secured by the Receivables. Each contribution of Receivables by the Transferor to the Company
is made without recourse; provided, however, that (i) the Transferor shall be liable to the Company for all representations, warranties and covenants made by the Transferor pursuant to the terms of this Agreement, and (ii) such
Contribution does not constitute and is not intended to result in an assumption by the Company or any assignee thereof of any obligation of the Originator or any other Person arising in connection with the Contributed Property, or any other
obligations of any Originator or the Transferor. In view of the expressed intention of the parties hereto that the Contributions of Receivables to be made hereunder shall constitute a capital contribution of such Receivables to the Company, the
Transferor and the Company each agrees to note on its financial statements that the Receivables have been Contributed to the capital of the Company to the extent other treatment in the financial statements is not required by GAAP. If at any time
contrary to the mutual intent of the Transferor and the Company a court characterizes the transactions hereunder as loans by the Company to the Transferor, then the Transferor shall, effective as of the Closing Date, be deemed to have granted (and
the Transferor has granted) to the Company a first priority security interest in all of its right and title to and interest in all Contributed Property and the proceeds thereof as security for such loans advanced to the Transferor hereunder with
accrued interest thereon, and this Agreement shall be deemed to be a security agreement. 

(f)      In no event does the Transferor pledge, sell or offer to sell, nor does the Company
obtain a security interest, purchase or offer to purchase from the Transferor, (A) any Self Pay Obligation or any collections thereon or proceeds thereof or (B) any account, general intangible, instrument, license, property right, permit or any
other contract or agreement to which the Transferor is a party or any of its rights or interests thereunder if and for so long as the grant of such security interest or such sale shall constitute or result in (x) the abandonment, invalidation or
unenforceability of any right, title or interest of the Transferor therein, or (y) a violation of a valid and enforceable restriction in respect of such account, general intangible, instrument, license, property right, permit or any other contract
or agreement or other such rights (1) in favor of a third party or (2) under any Applicable Law; provided, however, that such security interest shall attach, or such sale shall be consummated, immediately at such time as the

  
 25 

 
condition causing such abandonment, invalidation or unenforceability, as the case may be, shall be remedied and, to the extent severable, shall attach or be consummated, as applicable,
immediately to any portion of such account, general intangible, instrument, license, property right, permit or any other contract or agreement that does not result in any of the consequences specified in the immediately preceding clause (x) or
clause (y) including any proceeds of such account, general intangible, instrument, license, property rights, permit or any other contract or agreement. 

SECTION 2.02. Consideration for the Transferred Receivables. 

(a)      With respect to each Purchase, the Company shall pay the Transferor an amount equal to
the Purchase Price for such Purchased Property. 
 (b)      With respect to each
Contribution, the Company shall increase the amount of the capital account of the Company held by the Transferor in an amount equal to the Contribution Value of such Contributed Property. 

(c)      Settlement of the amounts specified in the foregoing clauses (a) and (b) shall be
effected as provided in Section 2.03. 
 (d)      The Transferor hereunder shall be
deemed to have certified, with respect to the Transferred Property to be Transferred by the Company on any Transfer Date, that its representations and warranties contained in Sections 4.01 and 4.02 are true and
correct on and as of such day, with the same effect as though made on and as of such day (other than any representation or warranty that is made as of a specific date), that no Termination or Event of Termination has occurred and is continuing or
would result therefrom. 
 SECTION 2.03. Settlement Procedures. 

(a)      On each Business Day during the term of this Agreement, the Company (or the Collection
Agent on behalf of the Company) shall remit to the Transferor all funds that are available to the Company on such Business Day, whether constituting (i) amounts on deposit in a Concentration Account that may be withdrawn by the Collection Agent as
provided in Section 2.07(c) of the Loan Agreement, (ii) Advances (as defined in the Loan Agreement) deposited to the Company’s account as provided in Section 2.01(g) of the Loan Agreement or (iii) other funds available to the
Company, in each case other than (x) funds required to be maintained by the Company to comply with Applicable Law and the requirements of the Loan Agreement and (y) to the extent the Company determines to retain any or all of such available funds
for its own purposes. The funds transferred to the Transferor on a Business Day pursuant to the preceding sentence constitute the “Distributed Funds” for such Business Day, and all Distributed Funds transferred to the Transferor during a
Collection Period constitute the “Monthly Distributed Funds” for such Collection Period. 

(b)      The Monthly Report with respect to each Collection Period shall specify, among other
things, the Aggregate Transfer Value, the aggregate Monthly Distributed Funds, the Purchase Percentage, the Contribution Percentage and the Noncomplying Receivables Adjustment, in each case in respect of such Collection Period. 

  
 26 

 (c)      On each Settlement Date, based on
calculations set forth in the Monthly Report: 

  (i)        (A) an amount of the Monthly Distributed Funds
equal to the Purchase Percentage of the Aggregate Transfer Value shall constitute and shall be deemed for all purposes as payment of the Purchase Price to the Transferor, and (B) the Purchased Property for such Collection Period shall be the
Purchase Percentage of the Receivables, Related Security and Collections Transferred to the Company during such Collection Period; 

  (ii)       (A) an amount equal to the Contribution Percentage
of the Aggregate Transfer Value shall constitute and shall be deemed for all purposes as a contribution by the Transferor to its capital account in the Company, and (B) the Contributed Property for such Collection Period shall be the Contribution
Percentage of the Receivables, Related Security and Collections Transferred to the Company during such Collection Period; and 

  (iii)      if the Monthly Distributed Funds exceeds the Aggregate
Transfer Value for the related Collection Period, then (A) the amount of such excess, to the extent permitted by Applicable Law, shall be treated as a distribution by the Company to the Transferor of that amount of capital, and (B) the
Transferor’s capital account in the Company shall be reduced by the amount of such excess and any amount of such excess that cannot be treated as a distribution under Applicable Law may be treated as part of the Monthly Distributed Funds for
the following Collection Period. 
 (d)      If the Company notifies the Collection Agent of
any exceptions to its calculations in the Monthly Report, the Transferor and the Company shall promptly endeavor to resolve and reconcile the matters set forth in such notice. 

(e)      The Transferor shall make a payment to the Company, within two Business Days of notice
thereof and in immediately available funds in an amount equal to the Noncomplying Receivables Adjustment with respect to any Noncomplying Receivables identified by the Collection Agent or the Company (or its assigns) from time to
time. Notwithstanding such payment obligation, on any Settlement Date prior to the occurrence of a Termination or Event of Termination, the Company in its sole discretion may elect to setoff or subtract all or any portion of such
Noncomplying Receivables Adjustment for the related Collection Period from the Aggregate Transfer Value which would otherwise be paid to the Transferor or credited to the capital account of the Transferor on such day, which setoff will reduce such
payment or credit obligation on a dollar for dollar basis. 
 SECTION 2.04. Payments and Computations,
Etc. The payment or deposit of all amounts to be paid by the Transferor or the Collection Agent to the Company hereunder shall be initiated in accordance with the terms hereof no later than 12:00 P.M. (New York City time) on the day when
due in immediately available funds to such account as the Company may from time to time specify in writing. In the event that any payment becomes due on a day which is not a Business Day, then such payment shall be made on the next succeeding
Business Day. The Transferor shall, to the extent permitted by law, pay to the Company, on demand, interest on all 

  
 27 

 
amounts not paid when due hereunder (whether owing by the Transferor or by a Collection Agent) at 2.0% per annum above the Base Rate, payable on demand; provided, however, that such
interest rate shall not at any time exceed the maximum rate permitted by applicable law. All computations of interest payable hereunder shall be made on the basis of a year of 360 days for the actual number of days (including the first but
excluding the last day) elapsed. 
 SECTION 2.05. Transfer of Records to the Company. 

(a)      Each Transfer of Transferred Receivables hereunder shall include the transfer to the
Company of all the Originators’ and Transferor’s right and title to and interest in the Records relating to such Receivables and rights to the use of the Originators’ and the Transferor’s computer software to access and create
the Records, and the Transferor hereby agrees that such transfer shall be effected automatically with each such Transfer, without any action on the part of the parties hereto or any further documentation. 

(b)      The Transferor shall take such action requested by the Company, from time to time
hereafter, that may be necessary or appropriate to ensure that the Company and its assignees have (i) an enforceable ownership interest in the Records relating to the Receivables Transferred hereunder and (ii) an enforceable right (whether by
license or sublicense or otherwise) to use all of the computer software used to account for the Receivables and/or to recreate such Records. 

ARTICLE III 
 CONDITIONS OF
TRANSFERS 
 SECTION 3.01. Conditions Precedent to Initial Transfer.    The Initial
Transfer hereunder is subject to the conditions precedent that the Company shall have received on or before the Initial Transfer Date each of the items listed in Schedule I, each (unless otherwise indicated) dated such
date, in form and substance satisfactory to the Company. 
 SECTION 3.02. Conditions Precedent to All
Transfers.  Each Transfer (including the Initial Transfer) shall be subject to the further conditions precedent that: 

(a)      with respect to any such Transfer, on or prior to the Transfer Date relating thereto,
the Collection Agent shall have delivered to the Company, in each case in form and substance satisfactory to the Company, a completed Monthly Report dated on or before the most recent Monthly Report Due Date; provided, that so long as
Professional Services is acting as Collection Agent, a Monthly Report delivered in a timely fashion under the Loan Agreement shall constitute delivery of a Monthly Report under this Section 3.02(a), 

(b)      the Transferor shall have marked its master data processing records and all other
relevant records evidencing the Receivables which are the subject of such Transfer with a legend, acceptable to the Company, stating that such Receivables, the Related Security and Collections with respect thereto, have been Transferred in
accordance with this Agreement, 
 (c)      on the date of such Transfer, the following
statements shall be true: 
   (i)        The
representations and warranties contained in Article IV are correct on and as of such day as though made on and as of such date, except for those that refer to specific dates, which shall be correct as of the dates indicated therein, 

  
 28 

   (ii)       No
event has occurred and is continuing, or would result from such Transfer, which constitutes a Termination or an Event of Termination, and 

  (iii)      No law or regulation shall prohibit, and no order,
judgment or decree of any federal, state or local court or governmental body, agency or instrumentality shall prohibit or enjoin, the making of such Transfer by the Transferor in accordance with the provisions hereof. 

SECTION 3.03. Transfer Effective on the Transfer Date. On each Transfer Date, the Transferor, upon accepting
the Company’s unconditional commitment to pay the Purchase Price or increase the capital account of the Transferor on the related Settlement Date for such Transfer as provided in Section 2.03, shall be deemed to have certified to the
Company the satisfaction of the conditions precedent described in the immediately preceding Section 3.02. On the Transfer Date, title to the Transferred Property included in such Transfer shall vest irrevocably in the
Company, whether or not the conditions precedent to such Transfer were in fact satisfied; provided, that the obligation of the Company to pay the Purchase Price or increase the capital account of the Transferor on the related Settlement Date
is unconditional and irrevocable; and provided, further, however, that the Company shall not be deemed to have waived thereby any claim for indemnification it may have under this Agreement for the failure by the Transferor in fact to have
satisfied any such condition precedent. If any of the foregoing conditions precedent is not satisfied, the Company shall have available to it (and shall not be deemed to have waived by reason of completing such Transfer) all applicable rights and
remedies under this Agreement and otherwise. 
 ARTICLE IV 

REPRESENTATIONS AND WARRANTIES 

SECTION 4.01. Representations and Warranties of the Transferor.    The Transferor represents
and warrants as follows: 
 (a)      It is a corporation, duly incorporated, validly existing
and in good standing under the laws of the State of Delaware and is duly qualified to do business, and is in good standing, in every jurisdiction in which the nature of its business requires it to be so qualified and the failure to do so could
reasonably be expected to have a Material Adverse Effect. 
 (b)      The execution, delivery
and performance by the Transferor of this Agreement and all other Transferor Documents to be entered into by it, including the Transferor’s sale or contribution of Receivables, and, in the case of a Purchase, its use of the proceeds of
Purchases, are within the Transferor’s corporate powers, have been duly authorized by all necessary corporate action, do not contravene (i) its charter or by-laws, (ii) any Applicable Law except where such contravention could not reasonably be
expected to result in a Material Adverse Effect, (iii) any material contractual restriction binding on or affecting it or its property 

  
 29 

 
other than such restrictions that could not reasonably be expected to adversely affect the Transferor’s ability to perform its material obligations hereunder or, with respect to the transfer
of the Receivables and Collections thereon, in any Immaterial Respect, or (iv) any material order, writ, judgment, award, injunction or decree binding on or affecting it or its property, and do not result in or require the creation of any Lien upon
or with respect to any of its properties (other than in favor of the Company with respect to the Transferred Property), and no transaction contemplated hereby requires compliance with any bulk sales act or similar law. This Agreement and each
other Transferor Document to be entered into by the Transferor have been duly executed and delivered by it. 

(c)      No authorization or approval or other action by, and no notice to or filing with, any
governmental authority or regulatory body is required for its due execution, delivery and performance of this Agreement or any other Transferor Document to be entered into by it, except (i) for the filing of UCC financing statements, all of which
financing statements have been duly filed and, to its knowledge, are in full force and effect, (ii) such as have been made or obtained and are in full force and effect and (iii) where the failure to make or obtain could not reasonably be expected to
adversely affect the Company’s ability to perform its material obligations hereunder or the ability to assign or collect the Receivables hereunder. 

(d)      This Agreement and each other Transferor Document to be entered into by the Transferor
constitute its legal, valid and binding obligation enforceable against the Transferor in accordance with their respective terms subject to bankruptcy and similar laws affecting creditors generally and general principles of equity (regardless of
whether enforcement is sought in a proceeding in equity or at law). 
 (e)      (i) The
Transferor has furnished to the Company and the Administrative Agent copies of the Parent’s audited consolidated balance sheet as at December 31, 2011, and the related audited consolidated statements of income and cash flow for the fiscal year
of the Parent then ended reported on by Deloitte & Touche LLP which financial statements present fairly in all material respects in accordance with GAAP the financial position of the Parent and its consolidated subsidiaries as at December 31,
2011, and the results of operations of the Parent and its consolidated subsidiaries for the fiscal year of the Parent then ended, which financial statements present fairly in all material respects in accordance with GAAP the financial position of
the Parent and its consolidated subsidiaries as at such date, and the results of operations of the Parent and its consolidated subsidiaries for the fiscal year then ended; and 

(ii)     Since December 31, 2011, (A) no material adverse change has occurred in
the business, assets, liabilities, financial condition or results of operations of the Parent and its subsidiaries taken as a whole, and (B) no event has occurred or failed to occur which has had or could reasonably be expected to result in, singly
or in the aggregate, a Material Adverse Effect. 
 (f)      Except as disclosed in the
periodic and other reports, proxy statements and other materials filed with or publicly furnished to the U.S. Securities Exchange Commission by the Parent and its subsidiaries prior to the date hereof, there is no material pending legal proceeding
(i) other than ordinary routine litigation incidental to the business, to which the Parent or any of its subsidiaries is a party or of which any of their property is the subject, or 

  
 30 

 
(ii) that could reasonably be expected to impair any material rights, remedies or benefit that otherwise would be available to the Company, the Collection Agent or the Administrative Agent
to obtain Collections on the Receivables. None of the Parent, CHS, any Originator or the Collection Agent is in default with respect to any order of any court, arbitrator or governmental body except for defaults with respect to orders of
governmental agencies which defaults are not material to the business or operations of the Parent and its subsidiaries taken as a whole. 

(g)      No proceeds of any Purchase will be used by it to acquire any security of a class
which is registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended or in any transaction which is subject to Section 13 or 14 of the Securities Exchange Act of 1934, as amended. 

(h)      Immediately prior to each Transfer hereunder, each Receivable to be Transferred
hereunder, together with the Contract related thereto and the other Transferred Property relating thereto, is owned by the Transferor free and clear of any Lien (other than Permitted Liens), and the Company shall acquire all of the Transferor’s
right, title and interest in such Transferred Property and a valid and perfected first priority ownership interest in each such Transferred Receivable then existing or thereafter arising and in the Related Security and Collections with respect
thereto, free and clear of any Lien (other than Permitted Liens referred to in clauses (b) and (d) of the definition thereof) except as created hereby, by the Buyer under the Sale Agreement (to the extent assigned to the Company, to the extent
further assigned to the Administrative Agent), and by the Administrative Agent under the Loan Agreement; provided that the Transferor (acting directly or through the Collection Agent) shall have up to 10 days following actual knowledge
thereof to remove any immaterial Lien that was improvidently filed without the consent of the Transferor or the Collection Agent; provided further that the Transferor (acting through the Collection Agent) shall have the time period specified
in Section 5.01(p) to remove and terminate the Kay County Lien. No effective financing statement or other instrument similar in effect covering any Transferred Property shall at any time be on file in any recording office except such as
may be filed in favor of the Company relating to this Agreement or in favor of the Buyer under the Sale Agreement (to the extent assigned to the Company, to the extent further assigned to the Administrative Agent), and by the Administrative Agent
under the Loan Agreement; provided that the Transferor (acting directly or through the Collection Agent) shall have up to 10 days following actual knowledge thereof to remove any immaterial Lien that was improvidently filed without the
consent of the Transferor or the Collection Agent; provided further that the Transferor (acting through the Collection Agent) shall have the time period specified in Section 5.01(p) to remove and terminate the Kay County Lien. The
Transfers of the Transferred Property by the Transferor to the Company constitute valid and true Transfers for consideration (and not merely a pledge of such Transferred Property for security purposes), enforceable against creditors of the Company
and no Transferred Property shall constitute property of the Transferor. 
 (i)      No
Monthly Report (if prepared by the Collection Agent, the Transferor or any of their respective Affiliates, or to the extent that information contained therein is supplied by the Collection Agent, the Transferor or any such Affiliates), information,
exhibit, financial statement, document, book, record or report furnished or to be furnished by the Transferor to the Company (or its assigns) in connection with this Agreement is or will be inaccurate in any material respect as of the date it is or
shall be dated or (except as otherwise disclosed to the 

  
 31 

 
Company, as the case may be, at such time) as of the date so furnished or dated, and no such document contains or will contain any material misstatement of fact or omits or shall omit to state a
material fact or any fact necessary to make the statements contained therein not misleading; provided that to the extent any such information, report, financial statement, exhibit or schedule was based upon or constitutes a forecast or
projection, the Transferor represents only that it acted in good faith and utilized assumptions that the Transferor believed to be reasonable at the time made.

(j)      The Transferor’s correct legal name, jurisdiction of incorporation or formation,
organizational identification number, principal place of business and chief executive office and the office where the Transferor keeps all of its Records are set forth on Schedule II hereto. As of the Sixth Omnibus Amendment Effective
Date, the Transferor does not have any currently registered trade names, fictitious names, assumed names or “doing business as” names or other names under which it is doing business, except as set forth on Schedule II. 

(k)      No event or circumstance has occurred and is continuing, or would result from any
Transfer hereunder or from the application of the proceeds therefrom, which constitutes an Event of Termination. 

(l)       This Agreement is the only agreement pursuant to which the Transferor transfers
Receivables. 
 (m)     The Transfer Value constitutes reasonably equivalent value in
consideration for the transfer to the Company of the Transferred Property from the Transferor, no such transfer shall have been made for or on account of an antecedent debt owed by the Transferor to the Company, and no such transfer is or may be
voidable or subject to avoidance under any section of the Bankruptcy Law. 
 (n)      The
Transferor is not an insolvent person, in insolvent circumstances or on the eve of insolvency, as applicable (within the meaning of such term in the Bankruptcy Law) and at the time of (and immediately after) each Transfer hereunder, the Transferor
shall not have been an insolvent person, in insolvent circumstances or on the eve of insolvency, as applicable, within the meaning of the Bankruptcy Law. The Transferor will not become an insolvent person or be put in insolvent circumstances
within the meaning of the Bankruptcy Law by entering into, or immediately after completion of the transactions contemplated by, this Agreement. The transfers of Transferred Property by the Transferor to the Company pursuant to this Agreement,
and all other transactions between the Transferor and the Company, have been and will be made in good faith and not for the purpose of defeating, hindering, delaying, defrauding or oppressing the rights and claims of creditors or others against the
Transferor. 
 (o)      The Transferor accounts for and otherwise treats (i) each Purchase of
Purchased Property hereunder in its books, records and financial statements as a legal sale of such Purchased Property, and (ii) each Contribution of Contributed Property hereunder in its books, records and financial statements as a legal
contribution of such Contributed Property, in each case to the extent other treatment is not required by GAAP. 

  
 32 

 (p)      The Transferor has not (i) guaranteed or
otherwise become liable for any obligation of the Company, allowed any of its other Affiliates to guarantee any obligations of the Company, and neither the Transferor nor any of its other Affiliates has held itself out as responsible for debts of
the Company or actions with respect to the business and affairs of the Company (other than as set forth in the Performance Undertaking), or (ii) permitted the commingling or pooling of its funds or other assets with those of the Company and has not
otherwise permitted any other of its Affiliates to commingle or pool any of its funds or other assets with those of the Company in a manner that would not allow such funds or other assets to be readily identifiable from those of any other
Person. The Transferor and the Company allocate between themselves shared corporate operating services and expenses which are not reflected in the Servicing Fee (including the services of shared employees, consultants and agents and reasonable
legal and auditing expenses) on the basis of the reasonably projected use or the projected value of services rendered, and otherwise on a basis reasonably related to actual use or the value of services rendered. The Transferor acknowledges that
the Company, the Lenders, the Managing Agents and the Administrative Agent are entering into the transactions contemplated by this Agreement and the Loan Agreement in reliance upon the Company’s identity as a separate legal entity from each of
the Parent, the Transferor and each of their other respective Affiliates. 
 (q)      The
Transferor is not an “investment company” or a company controlled by an “investment company” registered or required to be registered under the Investment Company Act. 

(r)       The Transferor is not engaged, principally or as one of its important
activities, in the business of extending credit for the purpose of “purchasing” or “carrying” any “margin stock” (as each of the quoted terms is defined or used in Regulation T, U or X promulgated pursuant to the
Securities Exchange Act of 1934, as amended). No part of the proceeds of any Transferred Property has been used for so purchasing or carrying margin stock or for any purpose which violates, or which would be inconsistent with, the provisions of
Regulation T, U or X. 
 (s)       The Transferor and the Collection Agent each has the
right (whether by license, sublicense or assignment) to use all of the computer software used by the Collection Agent and/or the Transferor to account for the Transferred Property to the extent necessary to administer the Transferred Property, and,
in the case of the Transferor and the Collection Agent, to assign (by way of Transfer) or sublicense such rights to use all of such software to the Company. 

(t)       The Transferor has filed or caused to be filed all federal and other material
tax returns which are required to be filed by it, and has paid or caused to be paid all taxes shown to be due and payable on such returns or on any assessments received by it, other than any taxes or assessments, (i) the validity of which are being
contested in good faith by appropriate proceedings and with respect to which the Transferor has set aside or has caused to be set aside adequate reserves on its books (consolidated or otherwise) in accordance with GAAP or (ii) which the failure
to pay could not reasonably be expected to have a Material Adverse Effect. 

  
 33 

 (u)      Except as could not reasonably be
expected to result in material liability to the Transferor, the Transferor and its ERISA Affiliates is in compliance in all material respects with the applicable provisions of ERISA and the Code and the regulations and published interpretations
thereunder. No ERISA Event has occurred or is reasonably expected to occur that, when taken together with all other such ERISA Events, could reasonably be expected to result in material liability of the Transferor or any of its ERISA
Affiliates. The present value of all benefit liabilities under each Plan (based on the assumptions used for funding purposes) did not, as of the last annual valuation date applicable thereto, exceed the fair market value of the assets of such
Plan in such amount that would reasonably be expected to result in a funding obligation that could reasonably be expected to result in a Material Adverse Effect, and the present value of all benefit liabilities of all underfunded Plans (based on the
assumptions used for funding purposes) did not, as of the last annual valuation dates applicable thereto, exceed the fair market value of the assets of all such underfunded Plans in such amount that could reasonably be expected to result in a
Material Adverse Effect. 
 (v)      The Transferor has not intentionally (i) misstated any
calculation of Eligible Receivables or Net Receivables Balance hereunder (other than in an immaterial amount and based on good faith estimates utilized in the calculation thereof), or (ii) misrepresented any Receivable as qualifying as an
Eligible Receivable or intentionally included such misrepresented Receivable in the Net Receivables Balance at the time so included. 

(w)      All required Notices have been prepared and delivered to each of its Obligors (or, in
the case of a Governmental Entity, its fiscal intermediary), and all invoices issued after the Closing Date bear only the appropriate remittance instructions for payment direction to a Lock-Box or a Collection Accounts, as the case may be. No
direction is in effect directing Obligors to remit payments on Receivables other than to a Lock-Box or a Collection Account. 

(x)      Each of the Collection Accounts has been established in the name of an Originator by a
Collection Account Bank, and a Concentration Account has been established in the name of the Company by each Concentration Account Bank. Such Originator has not established any lock-box, lock-box account or other deposit account for the receipt
of Collections other than the Lock-Boxes and Collection Accounts. Each Lock-Box is linked to a Collection Account. Each Collection Account has been set up so that all available funds automatically sweep to the applicable Concentration
Account at the end of each Business Day. The Transferor has taken, or has caused to be taken, all actions necessary or advisable to assure that all Collections are received in the Lock-Boxes and Collection Accounts. The Transferor will not
(i) close any Lock-Box, any Collection Account or any Concentration Account or open any new lock-box or account to function as a Lock-Box, a Collection Account or a Concentration Account, (ii) make any change to the instructions to the Obligors that
all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iii) make any change to the instructions to a Collection Account Bank as set forth in the applicable Deposit Account Notification Agreement (Government
Healthcare Receivables) requiring the automatic sweep of all available funds in each Collection Account to the applicable Concentration Account at the end of each Business Day, in each case, without the prior written consent of the Company and the
Administrative Agent and each Managing Agent; provided, if any of the provisions under clauses (i), (ii) or (iii) above have been violated with respect to any Lock-Box or Collection 

  
 34 

 
Account relating to an individual Originator without the prior knowledge or consent of the Transferor or the Collection Agent, the Transferor (itself or through the Collection Agent) shall have
the opportunity to cure the violation of this clause (x) within 15 days of obtaining knowledge of such breach by the Originator and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any
breach of any covenant, representation or warranty by the Transferor under any Facility Document directly related to or directly arising from such violation without any further action. 

(y)        No Lien on the Transferor’s inventory attaches to the proceeds of the
sale or contribution of such inventory to the extent that such sale or contribution would give rise to a Receivable. 

(z)        No Lien on the Transferor’s accounts receivable attaches to
Transferred Receivables, except for Liens granted under the Documents. 
 (aa)      The
Transferor has all power and authority, and has all material permits, licenses, accreditations, certifications, authorizations, approvals, consents and agreements of all Obligors, Governmental Entities, accreditation agencies and other Persons
(including (i) accreditation by the appropriate Governmental Entities and industry accreditation agencies, (ii) accreditation and certifications as a provider of healthcare services eligible to receive payment and compensation and to participate
under Medicare, Medicaid, TRICARE/CHAMPUS, Blue Cross/Blue Shield and other equivalent programs, and (iii) valid provider identification numbers and licenses to generate the Receivables) necessary or required for it, except in any Immaterial
Respect, (A) to own the assets (including Receivables) that it now owns, (B) to carry on its business as now conducted, (C) to execute, deliver and perform this Agreement and the other Transferor Documents to which it is a party, and (D) if
applicable, to receive payments from the Obligors in the manner contemplated in this Agreement and the other Transferor Documents, except in an Immaterial Respect. 

(bb)      The Transferor, except in any Immaterial Respect has (i) maintained all relevant
records required to be maintained by the Joint Commission on Accreditation of Healthcare Organizations, the Food and Drug Administration, the Drug Enforcement Agency, the State Boards of Pharmacy, and the federal and state Medicare and Medicaid
programs as required by Healthcare Laws, and that, to the best knowledge of the Transferor, there are no presently existing circumstances which likely would result in material violations of any Healthcare Laws and (ii) complied in all material
respects with all other Applicable Law to which it may be subject and no Receivable or other Transferred Property contravenes in any material respect any Applicable Law, except in any Immaterial Respect. 

(cc)      Commencing September 30, 2012, Patient Consent Forms are being obtained from each
patient and customer receiving services or products. 
 (dd)      Without limiting or being
limited by any other provision of any Transferor Document, the Transferor has timely filed or caused to be filed all material cost and other reports of every kind required by law, agreement or otherwise. There are no material claims, actions or
appeals pending before any commission, board or agency or other Governmental Entity, including any intermediary or carrier, the Provider Reimbursement Review Board, or the 

  
 35 

 
administrator of CMS, with respect to any material state or federal Medicare or Medicaid cost reports or material claims filed by the Transferor, or any disallowance by any commission, board or
agency or other Governmental Entity in connection with any audit of such cost reports, except in any Immaterial Respect or which would affect the ability of the Buyer to fulfill its material obligations under any Facility Document. No
validation review or program integrity review related to the Transferor, the consummation of the transactions contemplated by this Agreement, or the Transferred Property have been conducted by any commission, board, or agency or other Governmental
Entity in connection with the Medicare or Medicaid programs, and, to the knowledge of the Transferor, no such reviews are scheduled, pending, or threatened against or affecting the Transferor, any of the Transferred Property or the consummation of
the transactions contemplated by this Agreement except in any Immaterial Respect or which would affect the ability of the Company to fulfill its material obligations under any Facility Document. 

(ee)      The Transferor has not been notified by any Governmental Entity, accreditation agency
or any other Person, during the immediately preceding 24-month period, that such Person has rescinded or not renewed, or is reasonably likely to rescind or not renew, any material permit, license, accreditation, certification, authorization,
approval, consent or agreement granted to the Transferor or to which it is a party and no other condition exists or event has occurred which, in itself or with the giving of notice or lapse of time or both, would result in the suspension,
revocation, impairment, forfeiture or non renewal of any material permit, license, authorization, approval, entitlement or accreditation, and to the best of the Transferor’s knowledge, there is no claim that any thereof is not in full force and
effect. 
 (ff)       Notice of termination of each of the agreements and other
documents relating to the sale, purchase or transfer of AccessOne Program Receivables from an Originator to any Person other than the Buyer has been delivered to such Person prior to the Closing Date. 

(gg)      The Transferor is not an EEA Financial Institution (as defined in the Loan
Agreement). 
 SECTION 4.02.  Article 9 Representations and
Warranties.      The Transferor represents and warrants as follows: 

(a)        This Agreement creates a valid and continuing security interest (as
defined in the applicable UCC) in the Receivables in favor of the Company, which security interest is prior to all other Liens, and is enforceable as such against creditors of and purchasers from the Transferor. 

(b)        The Receivables constitute “accounts” (including
health-care-insurance receivables) or general intangibles within the meaning of the applicable UCC. 

(c)        Immediately prior to each Transfer hereunder, the Transferor owns and has
good and marketable title to the Receivables and the other Transferred Property free and clear of any Lien of any Person. 

(d)        The Transferor has caused or will have caused, within ten days after the
date hereof, the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect the security interest in the Receivables Transferred to the Company hereunder. 

  
 36 

 (e)      Other than the ownership interest
conveyed to the Company pursuant to this Agreement, the Transferor has not pledged, assigned, sold, granted a security interest in, or otherwise conveyed any of the Receivables. The Transferor has not authorized the filing of and is not aware
of any financing statements against the Transferor relating to the Receivables or to all assets of the Transferor other than any financing statement relating to (i) the Transfers to the Company hereunder and (ii) the security interest granted to the
collateral agent under the Parent Credit Agreement. The Transferor is not aware of any judgment or tax lien filings against it. 

(f)      Policies and procedures have been implemented and maintained by or on behalf of the
Transferor that are designed to achieve compliance by the Transferor and its directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, giving due regard to the nature of such Person’s business and activities,
and the Transferor and its officers and employees and, to the knowledge of the Transferor and its officers, employees, directors and agents acting in any capacity in connection with or directly benefitting from the loan facility established hereby,
are in compliance with Anti-Corruption Laws and applicable Sanctions, in each case in all material respects. Neither the Transferor nor, to the knowledge of the Transferor, its directors, officers, employees, or agents that will act in any
capacity in connection with or directly benefit from the loan facility established hereby, is a Sanctioned Person, and the Transferor is not organized or resident in a Sanctioned Country. No Advance or use of proceeds thereof by the Transferor
in any manner will violate Anti-Corruption Laws or applicable Sanctions. 
 ARTICLE V 

GENERAL COVENANTS 

SECTION 5.01.  General Covenants. 

(a)      Compliance with Laws; Preservation of Existence.   The
Transferor shall comply in all material respects with all Applicable Law (including all applicable Healthcare Laws), orders and the Transferor Documents and preserve and maintain its corporate, limited liability company or limited partnership
existence, rights, franchises, qualifications and privileges, except where the failure to comply could not reasonably be expected to materially adversely affect the Transferor’s ability to perform its obligations hereunder or the ability to
sell or collect the Transferred Property hereunder. 
 (b)      Sales, Liens,
Etc.   Except as otherwise specifically provided herein, the Transferor shall not (i) sell, assign (by operation of law or otherwise) or otherwise dispose of, or create or suffer to exist any Lien (other than Permitted Liens
referred to in clauses (b), (c) and (d) of the definition thereof) upon or with respect to, any of its Receivables, Related Security, Collections, any Collection Account or any Concentration Account, or assign any right to receive income in respect
thereof or (ii) create or suffer to exist any Lien (other than Permitted Liens referred to in clauses (c) and (d) of the definition thereof) upon or with respect to the proceeds of the sale of any of the Transferor’s inventory, to the extent
such sale would give rise to a Receivable; provided ̧ that the Transferor shall have up to 10 days following actual knowledge 

  
 37 

 
thereof to remove any immaterial Lien that was improvidently filed without the consent of the Transferor; provided further that the Transferor (acting through the Collection Agent) shall
have the time period specified in Section 5.01(p) to remove and terminate the Kay County Lien. 

(c)      Treatment of Purchases and Contributions.   The Transferor will
account for and treat (whether in financial statements, records or otherwise) the transactions contemplated hereby as (i) a legal sale of the Purchased Property by the Transferor to the Company, in the case of a Purchase, and (ii) a capital
contribution of the Contributed Property by the Transferor to the Company, in the case of a Contribution. 

(d)      Change in Company Name.  The Transferor will not make any change to
its legal name unless it shall have, prior to the effectiveness of such name change: (i) given the Company prompt written notice thereof and (ii) delivered to the Company (in a manner that will provide reasonable opportunity to allow
the Company to make the filing thereof prior to or simultaneously with the effectiveness of such name change) all financing statements, instruments and other documents the Company determines are necessary or appropriate to file under the UCC or that
are otherwise necessary or appropriate for the Company to continue at all times following such change to have a valid, legal and perfected security interest in the Transferred Property of the Transferor. 

(e)      Audits.   From time to time, but at least once per calendar
year, upon reasonable prior written notice from the Company during regular business hours, the Transferor will permit the Company, or its agents or representatives, to (i) examine and make copies of and abstracts from all Records, (ii) visit the
offices and properties of the Transferor for the purpose of examining such Records, and to discuss matters relating to the Receivables or the Transferor’s performance hereunder with any of the officers or employees of the Transferor having
knowledge of such matters and (iii) have access to its software for the purposes of examining such Records; provided that in no event shall Transferor be required to allow examination of or access to “Protected Health Information”, as such
term is defined in regulations implementing HIPAA, where such examination or access is prohibited by Applicable Law without a Patient Consent Form that lists the Company and its specific agents or representatives who will access “Protected
Health Information”. Unless an Event of Termination or an “Event of Default” or a “Trigger Event” under the Loan Agreement has occurred and is continuing, only one such examination and visit per calendar year shall be
at the expense of the Transferor. 
 (f)      Keeping of Records and Books of
Account.  The Transferor will maintain (or cause to be maintained) and implement administrative and operating procedures (including an ability to recreate records evidencing the Receivables in the event of the destruction of the
originals thereof) and keep and maintain, all documents, books, records and other information reasonably necessary or advisable for the collection of all Transferred Property (including records adequate to permit the daily identification of each new
Receivable and all collections of and adjustments of each Receivable). The Transferor will indicate in its books and records that the Receivables have been transferred to the Transferor by the Originators and Transferred by the Transferor to
the Company. 
 (g)      Jurisdiction of Organization; Location of Records;
Structure.      The Transferor will keep its jurisdiction of incorporation or organization, principal place of business 

  
 38 

 
and chief executive office and the offices where it keeps its Records, in the jurisdictions and at the addresses set forth on Schedule II, or, in any such case, upon prompt prior written
notice to the Company in the manner provided in Section 6.08, at such other jurisdiction or locations within the United States where all action required by Section 6.08 shall have been taken and completed, and will
not change its structure or identity other than upon prior written notice to the Company and subject to the further requirement that all action required by Section 6.08 shall have been taken and completed. 

(h)      Credit and Collection Policy.   The Transferor will, and will
cause the Collection Agent to, comply in all material respects with the Credit and Collection Policy in regard to each Receivable and the related Contract. The Transferor shall not, without the written consent of the Company and the
Administrative Agent, (i) make any material change in the character of its business such that its principal business ceases to be a provider of healthcare services, or (ii) make or agree to make or permit any material change in the Credit and
Collection Policy other than in accordance with Section 6.02(c). 

(i)       Change in Payment Instructions to Obligors.   The
Transferor will not (i) add or terminate any bank as a Collection Account Bank or a Concentration Account Bank, (ii) close any Lock-Box, any Collection Account or any Concentration Account or open any new lock-box or account to function as a
Lock-Box, Collection Account or Concentration Account, (iii) make any change to the instructions to the Obligors that all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iv) make any change to the
instructions to a Collection Account Bank as set forth in the applicable Deposit Account Notification Agreement (Government Healthcare Receivables) requiring all available funds in each Collection Account to automatically sweep to the applicable
Concentration Account at the end of each Business Day, in each case, without the prior written consent of the Company, Administrative Agent and each of the Managing Agents in their sole discretion, which consent shall not be unreasonably withheld or
delayed; provided, if any of the provisions under clauses (i) through (iv) above have been violated with respect to any Lock-Box or Collection Account relating to an individual Originator without the prior knowledge or consent of the
Transferor or the Collection Agent, the Transferor (itself or through the Collection Agent) shall have the opportunity to cure the violation of this clause (i) within 15 days of obtaining knowledge of such breach by the Originator and, if such
violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or warranty by the Transferor under any Facility Document directly related to or directly arising from
such violation without any further action. 

(j)       Taxes.   The Transferor will file or cause to be filed all
federal and other material returns which are required to be filed by it. The Transferor shall pay or cause to be paid all taxes shown to be due and payable on such returns or on any assessments received by it, other than any taxes or
assessments, the validity of which are being contested in good faith by appropriate proceedings and with respect to which the Transferor shall have set aside or has caused to be set aside adequate reserves on its books (consolidated or otherwise) in
accordance with GAAP. 
 (k)      Transferor Documents.    The
Transferor will comply in all material respects with the terms of this Agreement and employ the procedures outlined herein, enforce all 

  
 39 

 
of its other rights under each of the Transferor Documents to which it is a party, take all such action to such end as may be from time to time reasonably requested by the Company, and maintain
all such Transferor Documents and the UCC financing statements filed in connection with this Agreement in full force and effect. 

(l)       Segregation of Collections.  The Transferor will require the
deposit of all Collections into a Collection Account and the deposit of all Collections received in the Collection Accounts solely into the applicable Concentration Account, will prevent the deposit into any Concentration Account of any funds other
than Collections and proceeds of Self Pay Obligations and, with respect to proceeds of Self Pay Obligations, the Transferor will hold all such proceeds in trust for the applicable Originator and promptly (and in any event within three Business Days)
identify such funds to the Collection Agent for segregation and remittance to the owner thereof; provided, that the Transferor and the Collection Agent will use reasonable efforts to avoid deposit of the proceeds of Self Pay Obligations into
any Collection Account or Concentration Account if such parties determine in their reasonable business judgment that it is practical to do so, except to the extent requiring unreasonable additional effort or expense; provided further that the
parties acknowledge that the Transferor and the Collection Agent have determined that such identification and segregation is impractical as of the Second Omnibus Amendment Effective Date. With respect to any funds other than Collections and
proceeds of Self Pay Obligations that are nevertheless deposited into such Concentration Account, the Transferor will promptly identify any such funds to the Collection Agent for segregation and remittance to the owner thereof. 

(m)      Payment to Lenders.    The Transferor will pay to the
Company (and forward to the Administrative Agent) all amounts owing by the Company to the Lenders under Article VIII of the Loan Agreement. 

(n)       Sales Taxes.   The Transferor shall timely pay or cause to
be paid when due all sales, excise or personal property taxes payable in connection with the Receivables, other than any taxes or assessments, the validity of which are being contested in good faith by appropriate proceedings and with respect to
which the Transferor has set aside or has caused to be set aside adequate reserves on its books (consolidated or otherwise) in accordance with GAAP. 

(o)      AccessOne Program Receivables.   After May 31, 2012, no
Receivables will be sold pursuant to any agreement other than the Documents, and prior to May 31, 2012, the aggregate Expected Net Value of the AccessOne Program Receivables shall not exceed $500,000. 

(p)      Kay County Lien.   The Transferor will cause the Collection
Agent to remove and terminate the Kay County Lien within six months of the Second Omnibus Amendment Effective Date and will utilize its best efforts to remove and terminate such Kay County Lien as promptly as practicable, and the existence of the
Kay County Lien shall not constitute a breach of this covenant or any other representation or covenant hereunder during the continuance of such time period. 

  
 40 

 (a)      Anti-Corruption Laws and Sanctions
– Policies and Procedures.  Policies and procedures will be maintained and enforced by or on behalf of the Transferor that are designed in good faith and in a commercially reasonable manner to promote and achieve compliance, in
the reasonable judgment of the Transferor, by the Transferor and its directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, in each case giving due regard to the nature of such Person’s business and
activities. 
 (b)      Anti-Corruption Laws and Sanctions – Requests for Advances
and Uses of Proceeds.     The Transferor and its Affiliates and its or their respective directors, officers, employees and agents shall not use, the proceeds of any Purchase (A) in furtherance of an offer, payment,
promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (B) for the purpose of funding or financing any activities, business or transaction of or
with any Sanctioned Person, or in any Sanctioned Country, in each case to the extent doing so would violate any Sanctions, or (C) in any other manner that would result in liability to any party hereto under any applicable Sanctions or the
violation of any Sanctions by any such Person. 
 ARTICLE VI 

ADMINISTRATION, COLLECTION AND MONITORING OF ASSETS 

SECTION 6.01.  Appointment and Designation of the Collection Agent.    The Transferor
and the Company may, from time to time, appoint one or more Persons, as the Collection Agent of the Company to service, administer and collect the Receivables and otherwise to enforce its rights and interests in, to and under the Receivables, the
Related Security and the Contracts. The Collection Agent’s authorization under this Agreement shall terminate on the Collection Date. Until the Company, with the consent of the Administrative Agent as its assignee, gives notice to the
Transferor of a designation of a new Collection Agent after the occurrence and during the continuance of a Servicer Termination Event, Professional Services is hereby designated as, and hereby agrees to perform the duties and obligations of, the
Collection Agent pursuant to the terms hereof. The Transferor, the Company and the Collection Agent may from time to time agree in any collection agency or services agreement among them on the allocation of servicing duties to be performed by
the Collection Agent. Notwithstanding the foregoing, the Company may (with the approval of the Administrative Agent, as its assignee, and the Managing Agents), after the occurrence and during the continuance of a Servicer Termination Event,
designate as Collection Agent any Person to succeed Professional Services or any successor Collection Agent, on the condition in each case that any such Person so designated shall agree to perform the duties and obligations of the Collection Agent
pursuant to the terms hereof and of the Sale Agreement and the Loan Agreement and in accordance with applicable Healthcare Laws. The Transferor hereby grants to the Collection Agent and any successor Collection Agent, and the Collection Agent
hereby grants to any successor Collection Agent, an irrevocable power of attorney, with full power of substitution, coupled with an interest, to take any and all steps in the Transferor’s or the Collection Agent’s name, as applicable, and
on behalf of the Company, as may be necessary or desirable, in the determination of the Collection Agent or the successor Collection Agent, as the case may be, to collect all amounts due under any and all Receivables, including endorsing the
Transferor’s name on checks and other instruments representing Collections and enforcing such Receivables and the related Contracts. The Collection Agent may subcontract the performance of its duties and obligations to a third

  
 41 

 
Person with the prior consent of the Company, including with respect to Collection Agency Receivables. Any such subcontract shall not affect the Collection Agent’s liability for
performance of its duties and obligations pursuant to the terms hereof, and any such subcontract shall automatically terminate upon designation of a successor Collection Agent. Notwithstanding anything to the contrary contained in this
Agreement, the Collection Agent, if not the Transferor or an Affiliate thereof, shall have no obligation to collect, enforce or take any other action described in this Article VI with respect to any Receivable that is not a
Transferred Receivable other than to deliver to the Transferor or at its direction, the Collections and documents with respect to any such Receivable that is not a Transferred Property as described in Sections 6.03 and
6.07. 
 SECTION 6.02.  Collection of Receivables by the Collection Agent; Extensions and Amendments of
Receivables. 
 (a)      The Collection Agent shall take or cause to be taken all such
reasonable actions as may be necessary or advisable to collect each Receivable from time to time, all in accordance with Applicable Law, with reasonable care and diligence, and in accordance with the Credit and Collection Policy; provided,
however, that, if a Servicer Termination Event shall have occurred and be continuing, (i) the Company shall have the right to direct the Collection Agent (whether the Collection Agent is the Transferor or an Affiliate thereof or otherwise) to
commence or settle any legal action, to enforce collection of any Transferred Property or to foreclose upon or repossess any Related Security, and (ii) the Collection Agent shall not make the Company a party to any litigation without the express
written consent of the Company, such consent not to be unreasonably withheld or delayed. If the Termination Date shall not have occurred, Professional Services, while such Person is the Collection Agent, may, with respect to the Receivables
and, with respect to any Eligible Receivable, in accordance with the Credit and Collection Policy, (i) extend the maturity or adjust the Expected Net Value of any Defaulted Receivable as Professional Services may determine to be appropriate to
maximize Collections thereof and (ii) adjust the Expected Net Value of any Receivable to reflect (x) any reduction or adjustment as a result of any defective, rejected, returned, repossessed or foreclosed merchandise, any defective or rejected
services, any failure to provide services, any discount, rebate or any other adjustment made or performed by the Company or any other Person or (y) any reduction or cancelation as a result of a setoff in respect of any claim by the Obligor
thereof against the Transferor or an Affiliate of the Transferor, in each such case (except with respect to Receivables which are not Eligible Receivables) (x) in accordance with the requirements of the Credit and Collection Policy and (y) provided
that such extension or adjustment shall not alter the status of such Receivable as a Defaulted Receivable or limit the rights of the Company under this Agreement. Except as otherwise permitted pursuant to the immediately preceding sentence,
neither the Collection Agent nor the Transferor will extend, amend, cancel or otherwise modify the terms of any Receivable without the prior written approval of the Company, or amend, modify, cancel or waive any term or condition of any Contract
related to a Receivable, except to the extent consistent with the Credit and Collection Policy or otherwise with the prior written approval of the Company. 

(b)      Notwithstanding anything else contained herein, neither the Collection Agent nor any
subcontractor or delegatee thereof is the agent of the Company, and they are not permitted to (nor do they have any authority to) (i) establish an office or other fixed place of business of the Company, or (ii) contract for, or conclude a contract
in the name of, the Company. 

  
 42 

 (c)      The Credit and Collection Policy may be
amended from time to time provided that (i) no change shall be made in the Credit and Collection Policy that would be adverse to any of the Company or its assignees, including by impairing the collectibility of any Receivable or the ability of the
Company or the Collection Agent to perform its obligations under this Agreement, the Sale Agreement or the Loan Agreement and (ii) in the event that any change is made to the Credit and Collection Policy, promptly following such change and, in any
event within 30 days thereof, the Collection Agent shall provide the Company with an updated Credit and Collection Policy and a summary of all material changed. 

SECTION 6.03.  Distribution and Application of Collections.    The Collection Agent
shall set aside and segregate funds to the extent required in this Agreement and the Loan Agreement and shall set aside and segregate all Collections of Receivables from the other funds belonging to the Collection Agent. The Collection Agent
shall as soon as practicable (and in any event within two Business Days) following receipt turn over to the Transferor or other Person entitled thereto the collections of any account receivable which is not a Transferred Property less, in the event
neither Professional Services nor an Affiliate thereof is the Collection Agent, all reasonable and appropriate out-of-pocket costs and expenses of the Collection Agent of servicing, collecting and administering the Receivables to the extent not
covered by the Servicing Fee received by it. 
 SECTION 6.04.  Other Rights of the
Company.    At any time following the occurrence and during the continuance of a Servicer Termination Event or the designation pursuant to Section 6.01 of a Collection Agent other than Professional
Services, the Company or any Affiliate of either thereof, subject to Applicable Law: 

(a)      The Company may or, at the request of the Company, the Transferor shall (in either
case, at the Transferor’s expense) direct any or all of the Obligors to pay all amounts payable under any Receivable directly to the Company or its designee; 

(b)      The Company may or, at the request of the Company, the Transferor shall (in either
case, at the Transferor’s expense) give each of the Obligors notice of the Company’s interests in the Transferred Property; 

(c)      The Company may have a representative present during any or all business hours at each
office of the Collection Agent and the Transferor involved in the administration, servicing and collections of the Receivables; 

(d)      The Company, or its representatives, may, during regular business hours,
(i) review any or all Records, computer programs and files related to the administration, servicing and collection of the Receivables and (ii) visit the offices of the Transferor for the purpose of such review, and, at the Company’s
request and at the Transferor’s expense, the Company shall (i) assemble all Records and make the same available to the Company or its designee at a place selected by the Company or its designee, and (ii) segregate all cash, checks and
other instruments received by it from time to time constituting Collections of Receivables in 

  
 43 

 
the manner provided herein or such other manner acceptable to the Company and, promptly following receipt, remit all such cash, checks and instruments, duly endorsed or with duly executed
instruments of transfer, to the Company or its designee; and 
 (e)      The Company shall
have all other rights and remedies provided under the UCC and other Applicable Law, which rights and remedies shall be cumulative. 

SECTION 6.05.  Records. 

(a)      The Transferor will maintain and implement administrative and operating procedures
(including an ability to recreate records evidencing the Receivables in the event of the destruction of the originals thereof), and keep and maintain all documents, books, records and other information reasonably necessary or advisable for the
timely and full collection of all Receivables (including records adequate to permit the daily identification of each new Transferred Property and all Collections of and adjustments to each existing Transferred Property). The Transferor will
indicate in its books and records that the Receivables have been transferred to the Transferor by the Originators and Transferred by the Transferor to the Company. The Collection Agent will maintain access and copies of all such documents,
books, records and other information of the Transferor necessary to comply with clause (b) below. 

(b)      The Transferor and the Collection Agent, whether or not the Company or an Affiliate
thereof, shall hold all Records in trust for the Company and its assigns. Subject to the receipt of contrary instructions from the Company that are delivered following the occurrence and continuance of a Servicer Termination Event, the
Collection Agent and the Transferor will deliver all Records to any new Collection Agent hereunder; provided, however, that such new Collection Agent, if other than an Affiliate of the Company, shall as soon as practicable upon demand deliver
to the Transferor copies of Records in its possession relating to Transferred Property. 
 SECTION
6.06.  Receivable Reporting.   On each Monthly Report Due Date, the Collection Agent shall deliver to the Company a Monthly Report for the preceding Collection Period, which delivery may be in electronic form;
provided, that so long as Professional Services is acting as Collection Agent, a Monthly Report delivered in a timely fashion under the Loan Agreement shall constitute delivery of a Monthly Report under this Section 6.06. 

SECTION 6.07.  Collections and Lock-Boxes.

(a)      The Transferor and the Collection Agent will instruct all Obligors to cause all
Collections to be either (i) remitted to a Lock-Box to be retrieved therefrom by the applicable Collection Account Bank for prompt deposit to the applicable Collection Account or (ii) remitted directly to a Collection Account. If the Collection
Agent or the Transferor receives any Collections, the Transferor or the Collection Agent shall immediately remit such Collections to the applicable Collection Account within two Business Days of receipt thereof and the Collection Agent or the
Transferor will take all such actions as are reasonably necessary in the Collection Agent or Transferor’s discretion or as reasonably requested by the Company to ensure that future payments from any Obligor be made to a Collection Account or
Lock-Box. If the Transferor or the Collection Agent does not promptly (and in any event within two Business 

  
 44 

 
Days from the Company’s request) take such actions as the Company may reasonably request, then the Company, its assigns or designees, may, to the maximum extent permitted by law take such
actions as the Company, its assigns or designees may, on its direction, deem appropriate. 

(b)      In accordance with the terms of the Control Agreement, the Collection Agent shall
instruct each Concentration Account Bank to allocate and remit Collections in accordance with the Loan Agreement; provided, however, that the Company may, at any time following a Trigger Event and shall, at the direction of the Administrative
Agent, as its assignee, revoke the Collection Agent’s authority with respect to each Concentration Account, direct each Concentration Account Bank to cease taking instructions from the Collection Agent or the Company and to thereafter take
direction solely from the Administrative Agent, in each case by delivery of a notice substantially in the form attached to such Control Agreement for such purpose. None of the Transferor, the Company or the Collection Agent will (i) add or
terminate any bank as a Collection Account Bank or a Concentration Account Bank, (ii) close any Lock-Box, any Collection Account or any Concentration Account or open any new lock-box or account to function as a Lock-Box, Collection Account or
Concentration Account, (iii) make any change to the instructions to the Obligors that all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iv) make any change to the instructions to a Collection
Account Bank as set forth in the applicable Deposit Account Notification Agreement (Government Healthcare Receivables) requiring all available funds in each Collection Account to automatically sweep to the applicable Concentration Account at the end
of each Business Day, in each case, without the prior written consent of the Company and the Administrative Agent and each Managing Agent; provided, if any of the provisions under clauses (i) through (iv) above have been violated with respect
to any Lock-Box or Collection Account relating to an individual Originator without the prior knowledge or consent of the Transferor or the Collection Agent, the Transferor or the Collection Agent shall have the opportunity to cure the violation of
this clause (b) within 15 days of obtaining knowledge of such breach by the Originator and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or
warranty by the Transferor under any Facility Document directly related to or directly arising from such violation without any further action. The Transferor and the Collection Agent each hereby agrees to take, or cause to be taken, any and all
actions reasonably requested by the Company to protect and perfect the interest of the Company in the event any such change is permitted. 

SECTION 6.08.  UCC Matters; Protection and Perfection of Transferred Property.  The Transferor
will keep its jurisdiction of incorporation or organization, principal place of business and chief executive office, and the offices where it keeps its Records, in the jurisdictions and at the addresses set forth on Schedule II, or, in any
such case, upon 30 days’ prior written notice to the Company, at such other jurisdictions or locations within the United States where all actions reasonably requested by the Company to protect and perfect the interest of the Company in the
Transferred Property have been taken and completed. Each of the Transferor and the Collection Agent agrees that from time to time, at the Transferor’s expense, it will promptly execute and deliver all further instruments and documents, and
take all further action that the Company may reasonably request in order to perfect, protect or more fully evidence the Transferred Property acquired by the Company hereunder, or to enable the Company to exercise or enforce any of its rights
hereunder. Without limiting the generality of the foregoing, each of the Transferor and the Collection Agent agrees that it will, upon the 

  
 45 

 
request of the Company, execute and file such financing or continuation statements, or amendments thereto or assignments thereof, and such other instruments or notices, as may be necessary or
appropriate. The Transferor hereby authorizes the Company to file one or more financing or continuation statements, and amendments thereto and assignments thereof, relative to all or any of the Transferred Property now existing or hereafter
arising without the signature of the Transferor where permitted by law. If the Transferor or the Collection Agent fails to perform any of its agreements or obligations under this Section 6.08, the Company, or its
assignee, may (but shall not be required to) itself perform, or cause performance of, such agreement or obligation, and the reasonable expenses of the Company incurred in connection therewith shall be payable by the Transferor upon the
Company’s demand therefor. For purposes of enabling the Company to exercise its rights described in the preceding sentence and elsewhere in this Article VI, each of the Transferor and the Collection Agent hereby
authorizes the Company to take any and all steps following an Event of Termination in the Transferor’s or the Collection Agent’s, as applicable, name and on behalf of the Transferor necessary or desirable, in the determination of the
Company, to collect all amounts due under any and all Receivables, including endorsing the Transferor’s or the Collection Agent’s name on checks and other instruments representing Collections and enforcing such Receivables and the related
Contracts. 
 SECTION 6.09.  Obligations With Respect to Receivables.     Each of
the Transferor and the Collection Agent will (a) at the Transferor’s expense, regardless of any exercise by the Company of its rights hereunder, timely and fully perform and comply with all material provisions, covenants and other promises
required to be observed by it under the Contracts related to the Transferred Property to the same extent as if Transferred Property therein had not been Transferred hereunder and (b) pay when due any taxes, including sales, excise or personal
property taxes, payable in connection with the Transferred Property. In no event shall the Company have any obligation or liability with respect to any Transferred Property or related Contracts, nor shall it be obligated to perform any of the
obligations of the Collection Agent or the Transferor or any of their respective Affiliates thereunder. Each of the Transferor and the Collection Agent agrees it will timely and fully comply in all material respects with the Credit and
Collection Policy in regard to each Receivable and the related Contract. 
 SECTION 6.10.  Applications of
Collections.   Any payment by an Obligor in respect of any indebtedness owed by it to the Transferor shall, except as otherwise specified by such Obligor or otherwise required by contract or Applicable Law and unless otherwise
instructed by the Company, be applied as a Collection of any Receivables constituting Transferred Property of such Obligor, in the order of the age of such Receivables, starting with the oldest such Receivable, to the extent of any amounts then due
and payable thereunder, before being applied to any other indebtedness, account, general intangible or obligation of such Obligor. 

SECTION 6.11.  Annual Servicing Report of Independent Audit Firm.   On an annual basis on or
before the date which is 90 days after the end of each fiscal year, beginning with the fiscal year ending December 31, 2012, the Collection Agent shall engage and cause FTI Consulting, Inc. or another firm acceptable to the Company and its assigns,
to provide the Collection Agent and the Company with a report setting forth the results of such firm’s review of the Receivables, in form and in scope satisfactory to the Company and the Collection Agent; provided that in no event shall
such report include “Protected Health Information”, as such term 

  
 46 

 
is defined in regulations implementing HIPAA; provided further that such independent audit firm shall be required to enter into a Business Associate Agreement with the Collection
Agent. The Transferor hereby authorizes such firm to discuss such affairs, finances and performance with representatives of the Company and its designees. 

ARTICLE VII 
 EVENTS OF TERMINATION

 SECTION 7.01.  Events of Termination.  If any of the following events (any such event, an
“Event of Termination”) shall occur: 
 (a)      The Collection Agent or the
Transferor shall fail to make any payment or deposit to be made by it hereunder when due and such failure shall remain unremedied for five Business Days; or 

(b)      Any representation or warranty made or deemed to be made by the Transferor or the
Collection Agent (or any of their respective officers or agents) under or in connection with any Document, including any Monthly Report other than with respect to the status of a Receivable as an Eligible Receivable or any other information, report
or officer’s certificate delivered pursuant hereto, shall prove to have been false, incorrect or misleading in any material respect when made or deemed made, unless and solely to the extent (i) such representation or warranty does not contain a
grace period within such provision, and (ii) such misrepresentation is capable of being cured within 10 days, the Collection Agent or the Transferor delivers a written certificate to the Company certifying that such false, incorrect or
misleading statement, and all ramifications thereof under this Agreement or any Document has been cured in full (together with such data demonstrating such cure) by earlier to occur of (x) the date on which written notice shall have been given to
the Transferor and (y) the date on which a Responsible Officer of the Collection Agent or the Transferor acquires knowledge thereof; or 

(c)      The Transferor or the Collection Agent shall fail to perform or observe, beyond the
applicable grace or cure period therein, any term, covenant or agreement (other than any term, covenant or agreement described in another clause of this Section 7.01) contained in any Document on its part to be performed or
observed and any such failure (other than a failure with respect to any of Section 5.01(d) and (i), in each case, as to which no grace period shall apply) shall remain unremedied for 10 days after written notice thereof shall have been
given by the Company to the Transferor, or this Agreement or any other Document shall cease to be effective or be a legally valid, binding and enforceable obligation of the Company, the Transferor or the Collection Agent, as the case may be or any
of their respective Affiliates shall contest in any manner the effectiveness, validity, binding nature or enforceability of this Agreement or any other Document; or 

(d)      (i) The Transferor, the Parent or the Collection Agent shall fail to pay any
principal, interest or other amount due in respect of any Material Indebtedness, when and as the same shall become due and payable (after giving effect to any grace period) or (ii) any other event or condition occurs that results in any Material
Indebtedness becoming due prior to its scheduled maturity or that enables or permits (after giving effect to any grace period) the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any

  
 47 

 
Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity or that results in the termination or permits any
counterparty to terminate any interest rate protection agreement, foreign currency exchange agreement, commodity price protection agreement or other interest or currency exchange rate or commodity price hedging arrangement, the obligations under
which constitute Material Indebtedness; provided that this clause (ii) shall not apply to secured Debt that becomes due as a result of the voluntary sale or transfer of the property or assets securing such Debt; or 

(e)      Either (i) any Transfer shall, for any reason, except to the extent permitted by the
terms hereof, cease to create with the Company a valid and perfected first priority ownership interest in the Transferred Property with respect thereto free and clear of any Lien (other than Permitted Liens referred to in clause (b) of the
definition thereof and, during the continuance of the time period specified in Section 5.01(p), the Kay County Lien), which shall remain unremedied for five Business Days after the earlier of delivery of notice thereof by the Company or discovery
thereof by the Collection Agent or the Transferor or (ii) this Agreement shall for any reason cease to evidence the transfer to the Company of legal and equitable title to, and ownership of, the Transferred Property; or 

(f)       (i) The Transferor, the Parent or the Collection Agent shall (A) become
insolvent, generally not pay its debts as such debts become due, or shall admit in writing its inability to pay its debts generally or shall make a general assignment for the benefit of creditors; (B) any Insolvency Proceeding or any other
proceeding seeking the entry of an order for relief or the appointment of a receiver, receiver/manager, custodian, trustee, or other similar official for it or for any substantial part of its property shall be instituted by the Transferor, the
Parent or the Collection Agent or (C) any Insolvency Proceeding or any other proceeding seeking the entry of an order for relief or the appointment of a receiver, receiver/manager, custodian, trustee, or other similar official for it or for any
substantial part of its property shall be instituted against any the Transferor, the Parent or the Collection Agent, and such other proceeding shall remain unstayed for a period of 60 days, or the requested adjudication, relief or other action
sought thereby shall have been made, granted or taken, or (ii) the Transferor, the Parent or the Collection Agent shall take any corporate or entity-level action that authorizes any of the actions set forth above in this
Section 7.01(f); or 
 (g)      There shall have occurred and be
continuing an “Event of Default” under the Loan Agreement; or 
 (h)      There
shall have occurred and be continuing an “Event of Termination” under the Sale Agreement; or 

(i)       There shall have occurred a Change in Control; or 

(j)       There shall have occurred any material adverse change in the business or
financial condition of the Transferor since December 31, 2011, which could reasonably be expected to affect the value or collectability of the Receivables or the ability of the Company, the Collection Agent or the Transferor to collect the
Receivables or otherwise perform its respective obligations under this Agreement or any other Document; or 

  
 48 

 (k)      A Servicer Termination Event shall have
occurred and be continuing; or 
 (l)       The Transferor or the Company shall have
become subject to registration as an “investment company” within the meaning of the Investment Company Act; or 

(m)     One or more judgments shall be rendered against the Transferor, the Collection Agent, the
Company or the Parent or any combination thereof (to the extent not paid or fully covered by insurance) and the same shall remain undischarged for a period of 30 consecutive days during which execution shall not be effectively stayed, or any action
shall be legally taken by a judgment creditor to levy upon assets or properties of the Transferor, the Collection Agent, the Company or the Parent to enforce any such judgment and such judgment is for the payment of money in an aggregate amount in
excess of $50,000,000; or 
 (n)      An ERISA Event shall have occurred that, in the opinion
of the Company, when taken together with all other such ERISA Events, could reasonably be expected to result in liability of the Parent and its ERISA Affiliates in an aggregate amount exceeding $50,000,000; 

then, and in any such event, the Company may, by notice to the Transferor (a “Termination Declaration Notice”) declare the
Termination Date to have occurred, except that, in the case of any event described in clause (i)(B) or clause (i)(C) of Section 7.01(f) above or any event described in
Section 7.01(d) above, the Termination Date shall be deemed to have occurred automatically without notice upon the occurrence of such event. 

ARTICLE VIII 
 INDEMNIFICATION 

SECTION 8.01.  Indemnities by the Transferor. 

(a)      Without limiting any other rights which the Company may have hereunder or under
Applicable Law, each of the Collection Agent and the Transferor hereby agrees to indemnify the Company and its transfers and assigns, and each of their respective directors, officers, employees, agents and attorneys (all of the foregoing being
individually referred to as an “Indemnified Party” and being collectively referred to as “Indemnified Parties”) from and against any and all damages, losses, claims, liabilities and related costs and expenses,
including reasonable attorneys’ fees and disbursements (all of the foregoing being collectively referred to as “Indemnified Amounts”) awarded against or actually incurred by any of them arising out of or resulting from this
Agreement, the Sale Agreement, the Loan Agreement or any other Document or the use of proceeds of any Transfer or in respect of any Transferred Property. Without limiting or being limited by the foregoing, the Transferor shall pay on demand to each
Indemnified Party any and all amounts necessary to indemnify such Indemnified Party from and against any and all Indemnified Amounts relating to or resulting from any of the following: 

(i)       Any Receivable represented or deemed represented by the
Transferor to be an Eligible Receivable which was not an Eligible Receivable as of the Transfer Date thereof; 

(ii)      reliance on any representation or warranty made or deemed made by the
Transferor, the Collection Agent or any of their respective officers under or in connection 

  
 49 

 
with this Agreement, the Sale Agreement, the Loan Agreement or any other Document, which shall have been false, incorrect or misleading in any material respect when made or deemed made or
delivered; 
 (iii)      the failure by the Transferor or the Collection Agent
to comply with any term, provision or covenant contained in this Agreement, the Sale Agreement, the Loan Agreement or any other Documents, or any Contract, or with any Applicable Law with respect to any Receivable, the related Contract or the
Related Security, or the nonconformity of any Receivable, the related Contract or the Related Security with any such Applicable Law; 

(iv)      the failure to (A) vest and maintain vested in the Company or to
transfer to the Company, legal and equitable title to and ownership of, the Receivables and the other Transferred Property which are, or are intended to be, Contributed by the Transferor hereunder or (B) grant to the Company a valid and perfected
first priority “security interest” under Article 9 of the UCC in and to the Receivables which are, or are purported to be, Transferred Property, together with all Collections and Related Security, in each case free and clear of any
Lien (other than Permitted Liens referred to in clause (b) of the definition thereof) whether existing at the time of the Transfer of any such Receivable or at any time thereafter; 

(v)       the failure by the Transferor to make any payment required on its
part to be made hereunder; 
 (vi)      the failure to file, or any delay in
filing, financing statements or other similar instruments or documents under the UCC of any applicable jurisdiction or other Applicable Law with respect to any Receivables and other Transferred Property which are, or are intended to be, Transferred
by the Transferor hereunder, whether at the time of any Transfer or at any subsequent time; 

(vii)     any failure of the Transferor or the Collection Agent to perform its duties
or obligations in accordance with the provisions of this Agreement or the other Documents or to perform its duties under the Contracts; 

(viii)    any products liability claim or personal injury or property damage suit or other
similar or related claim or action of whatever sort arising out of or in connection with merchandise or services which are the subject of any Receivable or Contract; 

(ix)      any set-off by any Collection Account Bank or any Concentration
Account Bank against Collections; 
 (x)       the failure to pay when
due any taxes which are the Transferor’s responsibility, including sales, excise or personal property taxes payable in connection with the Transferred Property or the sale or contribution thereof; 

(xi)      the commingling of Collections of Transferred Property at any time
with other funds; 

  
 50 

 (xii)    any investigation, litigation or
proceeding related to this Agreement or the use of proceeds of Transfers or the ownership by the Company of Transferred Property; 

(xiii)   any attempt by any Person to void or otherwise avoid any transfer of any Transferred
Property from the Transferor to the Company under any statutory provision or common law or equitable action, including any provision of the Bankruptcy Law; or 

(xiv)   the inclusion in any Transferred Receivable any portion of the Expected Net Value of
which represents sales taxes.
 (b)      Any amounts subject to the indemnification
provisions of this Section 8.01 shall be paid by the Transferor to the Company within 10 Business Days following the Company’s demand therefor. Notwithstanding any other provision of this Agreement to the contrary, the Transferor shall
not indemnify any Indemnified Party for or with respect to any Indemnified Amounts (i) that would constitute recourse for uncollectible Receivables due to the bankruptcy or insolvency of the related Obligor or (iii) that arise solely from such
Indemnified Party’s gross negligence, bad faith or willful misconduct as determined in a final non-appealable judgment of a court of competent jurisdiction. 

ARTICLE IX 
 MISCELLANEOUS 

SECTION 9.01.  Amendments and Waivers.   No amendment or modification of any provision of
this Agreement or any Document shall be effective without the written agreement of the parties hereto and, to the extent then required in the Loan Agreement, the written consent of the Administrative Agent and the Majority Lenders (or their
respective Managing Agents), and no termination or waiver of any provision of this Agreement or any Document or consent to any departure therefrom shall be effective without the written concurrence of the Company, the Administrative Agent and the
Majority Lenders (or their respective Managing Agents). Any waiver or consent shall be effective only in the specific instance and for the specific purpose for which given. 

SECTION 9.02.  Notices, Etc. 

(a)      All notices, demands, requests and other communications required or expressly
authorized to be made by this Agreement shall be given in writing, unless otherwise expressly specified herein and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by facsimile or electronic
mail, and addressed to (i) if to the Transferor, at 4000 Meridian Boulevard, Franklin, TN 37067, to the attention of Rachel A. Seifert, Facsimile No.: 615-373-9704, Telephone No.: 615-465-7000, Email: Rachel_Seifert@chs.net, (ii) if to the
Collection Agent at 4000 Meridian Boulevard, Franklin, TN 37067, to the attention of Rachel A. Seifert, Facsimile No.: 615-373-9704, Telephone No.: 615-465-7000, Email: Rachel_Seifert@chs.net, and (iii) if to the Company at 4000 Meridian
Boulevard, Franklin, TN 37067, to the attention of Rachel A. Seifert, Facsimile No.: 615-373-9704, Telephone No.: 615-465-7000, Email: Rachel_Seifert@chs.net, or to such other address as shall be notified in writing to the other parties
hereto. 
 (b)      All communications described in clause (a)
above and all other notices, demands, requests and other communications made in connection with this Agreement shall be effective and be deemed to have been received (x) if delivered by hand or overnight courier service or sent by facsimile or
electronic mail, on the date of receipt or (y) if delivered by certified or registered mail, five Business Days after dispatch, in each case under clauses (x) and (y), delivered, sent, transmitted or mailed (properly addressed) to such party as
provided in this Section 9.02 or in accordance with the latest unrevoked direction from such party given in accordance with this Section 9.02. Notwithstanding the foregoing, no notice, demand, request or other communication pursuant to
Article II shall be effective until received. 

  
 51 

 SECTION 9.03.  Setoff and
Counterclaim.     All payments to be made by the Transferor or the Collection Agent under this Agreement shall be made free and clear and each of the Transferor and the Collection Agent hereby irrevocably and
unconditionally waives all rights of any counterclaim, set-off, deduction or other defense, which the Transferor or the Collection Agent may have against the Company, or against each other, whether under contract (including this Agreement),
Applicable Law, in equity or otherwise. The obligation of the Transferor and the Collection Agent to make the payments and deposits contemplated by this Agreement is absolute and unconditional. 

SECTION 9.04.  No Waiver; Remedies.  No failure on the part of the Company to exercise, and no
delay in exercising, any right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. The remedies herein
provided are cumulative and not exclusive of any remedies provided by law. 
 SECTION 9.05.  Binding Effect;
Assignability; Third Party Beneficiary.    This Agreement shall be binding upon and inure to the benefit of the Transferor, the Company, the Collection Agent and their respective successors and permitted assigns. The
Transferor may not assign its rights and obligations or any interest herein or delegate any of its duties hereunder or under the other Transferor Documents, in each case, without the prior written consent of the Company. The Company may assign at
any time all of its rights and obligations hereunder and interests herein without the consent of the Transferor or the Collection Agent. All such assignees, including parties to the Loan Agreement, shall be third party beneficiaries of, and shall be
entitled to enforce the Company’s rights and remedies under, this Agreement to the same extent as if they were parties thereto, except to the extent specifically limited under the terms of their assignment. Without limiting the foregoing, the
Transferor acknowledges (a) the assignment of Company’s rights and interests hereunder to the Administrative Agent (via the assignment by the Company to the Administrative Agent) pursuant to the Assignment of Agreements and agrees that, subject
to the terms set forth in the Assignment of Agreements, the Sale Agreement and the Loan Agreement, the Administrative Agent (and any further assignee of any such assignee) shall have the right, as the assignee of the Company (or the assignee of such
assignee), to enforce the Company’s rights and remedies under this Agreement directly against such party (including the right (i) to appoint a successor Collection Agent and (ii) to give or withhold any and all consents, requests, notices,
directions, approvals, demands, extensions or waivers under or with respect to this Agreement or the obligations in respect of the Transferor hereunder to the same extent as the Company may do), but without any obligation on the part of any such
assignee to perform any of the obligations of the Company hereunder and (b) that the 

  
 52 

 
Administrative Agent, each Managing Agent, each Lender and each other Secured Party (as defined in the Loan Agreement) is an intended third party beneficiary of this Agreement to the same extent
as if they were parties hereto, and that each of them is relying on, among other things, the representation and warranties of the Transferor hereunder in entering into the Loan Agreement. The Transferor and the Collection Agent agrees that it shall
send to the Administrative Agent and each Managing Agent (at the address set forth in the Loan Agreement) a copy of all written notices required to be given by such Person to the Company hereunder. 

SECTION 9.06.  Term of this Agreement.     This Agreement, including the
Transferor’s and the Collection Agent’s obligation to observe its covenants set forth in Articles V and VI, shall remain in full force and effect until the Collection Date; provided, however, that
the rights and remedies with respect to any breach of any representation and warranty made or deemed made by the Transferor pursuant to Article IV, the indemnification and payment provisions of Article VIII and the
provisions of Section 9.12 shall be continuing and shall survive any termination of this Agreement. 
 SECTION
9.07.  GOVERNING LAW; CONSENT TO JURISDICTION; WAIVER OF OBJECTION TO VENUE; SERVICE OF PROCESS.

(a)      THIS AGREEMENT SHALL, IN ACCORDANCE WITH § 5-1401 OF THE GENERAL OBLIGATIONS LAW
OF THE STATE OF NEW YORK, BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. THE COMPANY, THE TRANSFEROR, AND THE COLLECTION AGENT EACH HEREBY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS OF
THE UNITED STATES AND THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN NEW YORK COUNTY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER TRANSFEROR DOCUMENT, ANY OTHER DOCUMENT
DELIVERED PURSUANT HERETO OR THERETO, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH OF THE PARTIES HERETO HEREBY WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS, THE MAINTENANCE OF ANY SUCH ACTION OR PROCEEDING AND CONSENTS TO THE
GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED APPROPRIATE BY SUCH COURT. 

(b)      Each party hereto agrees that service of process may be effected by mailing a copy
thereof by registered or certified mail, postage prepaid, to it at its address specified in Section 9.02. Nothing in this Section 9.07 shall affect the right of any party to serve legal process in any other manner permitted
by law. 
 SECTION 9.08.  WAIVER OF JURY TRIAL.  TO THE EXTENT PERMITTED BY APPLICABLE LAW, THE
COMPANY, THE TRANSFEROR AND THE COLLECTION AGENT EACH WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT, OR OTHERWISE BETWEEN THE PARTIES HERETO ARISING OUT OF, CONNECTED WITH, RELATED TO, OR
INCIDENTAL TO THE RELATIONSHIP BETWEEN ANY OF THEM IN CONNECTION WITH THIS AGREEMENT, ANY OTHER TRANSFEROR DOCUMENT, 

  
 53 

 
ANY OTHER DOCUMENT DELIVERED PURSUANT HERETO OR THERETO, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. INSTEAD, ANY SUCH DISPUTE RESOLVED IN COURT WILL BE RESOLVED IN A BENCH TRIAL WITHOUT
A JURY. 
 SECTION 9.09.  Costs, Expenses and Taxes.    In addition to the rights of
indemnification granted to the Company and the other Indemnified Parties under Article VIII hereof, the Transferor agrees to pay on demand all reasonable out-of-pocket costs and expenses of the Company and its assignee
incurred in connection with the preparation, execution, delivery, administration (including periodic auditing permitted hereunder), amendment or modification of, or any waiver or consent issued in connection with, this Agreement and the other
documents to be delivered hereunder or in connection herewith, including rating agency fees, auditor fees, the annual servicing report referred to in Section 6.11 and out-of-pocket expenses and the reasonable fees and out-of-pocket expenses
of counsel for the Company and its assignee with respect thereto, and with respect to advising the Company and its assignee as to its rights and remedies under this Agreement and the other documents to be delivered hereunder or in connection
herewith, and all costs and expenses, if any (including counsel fees and expenses), incurred by the Company and its assignee in connection with the enforcement of this Agreement and the other documents to be delivered hereunder or in connection
herewith. 
 SECTION 9.10.  No Proceedings.  The Transferor and the Collection Agent each hereby
agrees that it will not institute against, or join any other Person in instituting against, the Company any action, event or proceeding of the type referred to in Section 7.01(f) so long as there shall not have elapsed one year plus one day
since the later of (i) the Collection Date and (ii) the date on which all of the Transferred Receivables are either collected in full or become Defaulted Receivables. 

SECTION 9.11.  Execution in Counterparts; Severability; Integration.     This
Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same
agreement. In case any provision in or obligation under this Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or
obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. This Agreement, the Sale Agreement, the Loan Agreement and the other Documents contain the final and complete integration of all prior expressions by the
parties hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof, superseding all prior oral or written understandings. 

SECTION 9.12.  Waiver of Consequential Damages.  (a)  Each of the Collection Agent and
the Transferor agrees that no Indemnified Party shall have any liability to them or any of their equity holders or creditors in connection with this Agreement, the other Documents or the transactions contemplated thereby on any theory of liability
for any special, indirect, consequential or punitive damages (including any loss of profits, business or anticipated savings), and hereby waives any such claim. 

  
 54 

 (b)      The Company agrees that none of the
Transferor, the Collection Agent or their respective Affiliates shall have any liability to them or any of their equity holders or creditors in connection with this Agreement, the other Documents or the transactions contemplated thereby on any
theory of liability for any special, indirect, consequential or punitive damages (including any loss of profits, business or anticipated savings), and hereby waives any such claim. 

(c)      The provisions of this Section 9.12 shall survive the termination of this
Agreement. 

  
 55 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by
their respective officers thereunto duly authorized, as of the date first above written. 
  
  

									
	COMPANY:	 		 	CHS RECEIVABLES FUNDING, LLC
					
		 		 	By:	 	  
	 	
		 		 		 	Name:	 	
		 		 		 	Title:	 	
			
	TRANSFEROR:	 		 	CHS/COMMUNITY HEALTH SYSTEMS, INC.
					
		 		 	By:	 	  
	 	
		 		 		 	Name:	 	
		 		 		 	Title:	 	

  
 Signature Page to

 Receivables Purchase and Contribution Agreement 

									
	COLLECTION AGENT:	 		 	CHSPSC, LLC	 	
					
		 		 	By:	 	  
	 	
		 		 		 	Name:	 	
		 		 		 	Title:	 	

  
 Signature Page to

 Receivables Purchase and Contribution Agreement 

 SCHEDULE I 

CONDITION PRECEDENT DOCUMENTS 

As required by Section 3.01 of the Agreement, each of the following items must be delivered to the
Company prior to the initial Transfer Date: 

  
 Sch. I-1 

 SCHEDULE II 

LEGAL NAME, JURISDICTION OF ORGANIZATION, 

ORGANIZATIONAL ID NUMBER, PRINCIPAL PLACE OF BUSINESS, 

CHIEF EXECUTIVE OFFICE, LOCATION OF RECORDS AND REGISTERED NAMES 

The Legal Name of the Transferor is CHS/Community Health Systems, Inc. 

The Transferor is organized in Delaware. 
 The Organizational ID
Number of the Transferor is 2057824. 
 The principal place of business of the Transferor is 4000 Meridian Blvd., Franklin, TN 37067. 

The chief executive office of the Transferor is 4000 Meridian Blvd., Franklin, TN 37067. 

The Transferor keeps its Records at its principal place of business. 

The Transferor does not have any currently registered trade names, fictitious names, assumed names or “doing business as” names or other names under
which it is doing business. 

  
 Sch. II-1 

 EXHIBIT A 

FORM OF ASSIGNMENT OF AGREEMENTS 

Attached. 

  
 Ex. A-1 

 EXHIBIT B 

FORM OF BUSINESS ASSOCIATE AGREEMENT 

Attached. 

  
 Ex. B-1 

 EXHIBIT C 

FORM OF MONTHLY REPORT 

Separately provided. 

  
 Ex. C-1 

 ANNEX C 
  

RECEIVABLES SALE AGREEMENT 
 Dated
as of March 21, 2012 (as amended through November 18, 2016), 
 Among 

EACH OF THE PERSONS LISTED ON SCHEDULE I 

AFFILIATED WITH 
 CHS/COMMUNITY
HEALTH SYSTEMS, INC. 
 as the Originators, 

and 
 CHSPSC, LLC 

(as successor-by-conversion to Community Health Systems Professional Services Corporation), 

as the Collection Agent and the Authorized Representative 

and 
 CHS/COMMUNITY HEALTH
SYSTEMS, INC., 
 as the Buyer 

 TABLE OF CONTENTS 

 

									
	 	 	 	 	 	  	Page	 
		
	 ARTICLE I DEFINITIONS
	  	 	1	 
		 	 SECTION 1.01.
	 	 Certain Defined Terms
	  	 	1	 
		 	 SECTION 1.02.
	 	 Other Terms
	  	 	23	 
		 	 SECTION 1.03.
	 	 Accounting Terms and Principles
	  	 	23	 
		 	 SECTION 1.04.
	 	 Computation of Time Periods
	  	 	23	 
		
	 ARTICLE II AMOUNTS AND TERMS OF THE PURCHASES
	  	 	24	 
		 	 SECTION 2.01.
	 	 Agreement to Purchase
	  	 	24	 
		 	 SECTION 2.02.
	 	 Payment for the Purchases
	  	 	25	 
		 	 SECTION 2.03.
	 	 Settlement Procedures
	  	 	25	 
		 	 SECTION 2.04.
	 	 Payments and Computations, Etc.
	  	 	27	 
		 	 SECTION 2.05.
	 	 Transfer of Records to the Buyer
	  	 	27	 
		
	 ARTICLE III CONDITIONS OF PURCHASES
	  	 	28	 
		 	 SECTION 3.01.
	 	 Conditions Precedent to Initial Purchase
	  	 	28	 
		 	 SECTION 3.02.
	 	 Conditions Precedent to All Purchases
	  	 	28	 
		 	 SECTION 3.03.
	 	 Sale Effective on the Purchase Date
	  	 	28	 
		
	 ARTICLE IV REPRESENTATIONS AND WARRANTIES
	  	 	29	 
		 	 SECTION 4.01.
	 	 Representations and Warranties of the Originators
	  	 	29	 
		 	 SECTION 4.02.
	 	 Article 9 Representations and Warranties
	  	 	36	 
		
	 ARTICLE V GENERAL COVENANTS
	  	 	37	 
		 	 SECTION 5.01.
	 	 General Covenants
	  	 	37	 
		
	 ARTICLE VI ADMINISTRATION, COLLECTION AND MONITORING OF ASSETS
	  	 	43	 
		 	 SECTION 6.01.
	 	 Appointment and Designation of the Collection Agent
	  	 	43	 
		 	 SECTION 6.02.
	 	 Collection of Receivables by the Collection Agent; Extensions and Amendments of
Receivables
	  	 	44	 
		 	 SECTION 6.03.
	 	 Distribution and Application of Collections
	  	 	45	 
		 	 SECTION 6.04.
	 	 Other Rights of the Buyer
	  	 	45	 
		 	 SECTION 6.05.
	 	 Records
	  	 	46	 
		 	 SECTION 6.06.
	 	 Receivable Reporting
	  	 	46	 
		 	 SECTION 6.07.
	 	 Collections and Lock-Boxes
	  	 	46	 
		 	 SECTION 6.08.
	 	 UCC Matters; Protection and Perfection of Purchased Property
	  	 	47	 
		 	 SECTION 6.09.
	 	 Obligations With Respect to Receivables
	  	 	48	 
		 	 SECTION 6.10.
	 	 Applications of Collections
	  	 	48	 
		 	 SECTION 6.11.
	 	 Annual Servicing Report of Independent Audit Firm
	  	 	48	 
		
	 ARTICLE VII EVENTS OF TERMINATION
	  	 	49	 
		 	 SECTION 7.01.
	 	 Events of Termination
	  	 	49	 
		
	 ARTICLE VIII INDEMNIFICATION
	  	 	51	 
		 	 SECTION 8.01.
	 	 Indemnities by the Originators
	  	 	51	 

  
 i 

									
	 	 	 	 	 	  	Page	 
		
	 ARTICLE IX MISCELLANEOUS
	  	 	53	 
		 	 SECTION 9.01.
	 	 Amendments and Waivers
	  	 	53	 
		 	 SECTION 9.02.
	 	 Notices, Etc.
	  	 	53	 
		 	 SECTION 9.03.
	 	 Setoff and Counterclaim
	  	 	54	 
		 	 SECTION 9.04.
	 	 No Waiver; Remedies
	  	 	54	 
		 	 SECTION 9.05.
	 	 Binding Effect; Assignability; Third Party Beneficiary
	  	 	54	 
		 	 SECTION 9.06.
	 	 Term of this Agreement
	  	 	55	 
		 	 SECTION 9.07.
	 	 GOVERNING LAW; CONSENT TO JURISDICTION; WAIVER OF OBJECTION TO VENUE; SERVICE OF
PROCESS
	  	 	55	 
		 	 SECTION 9.08.
	 	 WAIVER OF JURY TRIAL
	  	 	56	 
		 	 SECTION 9.09.
	 	 Costs, Expenses and Taxes
	  	 	56	 
		 	 SECTION 9.10.
	 	 No Proceedings
	  	 	56	 
		 	 SECTION 9.11.
	 	 Execution in Counterparts; Severability; Integration
	  	 	56	 
		 	 SECTION 9.12.
	 	 Confidentiality
	  	 	57	 
		 	 SECTION 9.13.
	 	 Joint and Several Liability; Designation and Appointment of Authorized Representative
	  	 	57	 
		 	 SECTION 9.14.
	 	 Addition and Removal of Originators
	  	 	58	 
		 	 SECTION 9.15.
	 	 Waiver of Consequential Damages
	  	 	60	 

  
 ii 

 LIST OF SCHEDULES AND EXHIBITS 

 

			
	 SCHEDULES
	  	 
		
	SCHEDULE I	  	Originators
	SCHEDULE II	  	Condition Precedent Documents (Closing List)
	SCHEDULE III	  	Legal Name, Jurisdiction of Organization, Organizational ID Number, Principal Place of Business, Chief Executive Office, Location of Records and Registered Names
	SCHEDULE IV	  	[Intentionally Omitted]
	SCHEDULE V	  	Specified Originators
	SCHEDULE VI	  	Tax Liens
	SCHEDULE VII	  	Originators to be Removed
		
	 EXHIBITS
	  	 
		
	EXHIBIT A	  	Form of Assignment of Agreements
	EXHIBIT B	  	Form of Originator Note
	EXHIBIT C	  	Form of Business Associate Agreement
	EXHIBIT D	  	Form of Monthly Report

  
 iii 

 THIS RECEIVABLES SALE AGREEMENT, dated as of March 21, 2012 (as amended through
November 18, 2016), among: 
  

	 	(1)	 EACH OF THE PERSONS LISTED ON SCHEDULE I AFFILIATED WITH CHS/COMMUNITY HEALTH SYSTEMS, INC., (each an
“Originator” and, jointly and severally, the “Originators”); 

  

	 	(2)	 CHSPSC, LLC (as successor-by-conversion to Community Health Systems Professional Services Corporation), a
Delaware limited liability company (“Professional Services”), in its capacity as the initial Collection Agent hereunder (in such capacity, the “Collection Agent”) and the initial Authorized Representative hereunder
(the “Authorized Representative”); and 

  

	 	(3)	 CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (the “Buyer”)

 PRELIMINARY STATEMENTS. 

WHEREAS, the Originators desire to sell, and the Buyer desires to purchase, all of each Originator’s right, title and
interest in the accounts receivable originated by such Originator on the terms and conditions provided herein; 
 WHEREAS,
the Collection Agent may from time to time, in accordance with the Documents and subject to the restrictions thereunder, perform servicing duties with respect to the Purchased Property; 

IT IS AGREED as follows: 

ARTICLE I 
 DEFINITIONS 

SECTION 1.01.  Certain Defined Terms. 

(a)      Certain capitalized terms used throughout this Agreement are defined above or in this
Section 1.01. 
 (b)      As used in this Agreement and its
exhibits, the following terms shall have the following meanings (such meanings to be equally applicable to both the singular and plural forms of the terms defined). 

“AccessOne Program Receivables” means any Receivable that is subject to, and has not been repurchased
pursuant to the terms of, (i) that certain Amended and Restated Receivables Purchase Agreement, dated October 19, 2004, between QHG of South Carolina, Inc. and HRA Financial Services, Inc., (ii) that certain Amended and Restated Receivables
Purchase Agreement, dated October 15, 2004, between Mary Black Health System LLC and HRA Financial Services, Inc., as amended, restated, supplemented or modified from time to time, (iii) that certain Amended and Restated Receivables Purchase
Agreement, dated October 12, 2004, between QHG of Enterprise, Inc. and AccessOne Medcard, Inc., as amended, restated, 

 
supplemented or modified from time to time, (iv) that certain Amended and Restated Receivables Purchase Agreement, dated October 12, 2004, between Carlsbad Medical Center, LLC and HRA Financial
Services, Inc., as amended, restated, supplemented or modified from time to time, (v) that certain Amended and Restated Receivables Purchase Agreement, dated October 13, 2004, between Lea Regional Hospital, LLC and HRA Financial Services, Inc., as
amended, restated, supplemented or modified from time to time, or (vi) that certain Amended and Restated Receivables Purchase Agreement, dated October 15, 2004, between Las Cruces Medical Center, LLC and HRA Financial Services, Inc., as amended,
restated, supplemented or modified from time to time. 
 “Addition” has the meaning assigned to that
term in Section 9.14(a). 
 “Administrative Agent” means, Credit Agricole
Corporate and Investment Bank, as administrative agent under the Loan Agreement. 
 “Affiliate” when used
with respect to a Person means any other Person controlling, controlled by or under common control with such Person. 

“Aggregate Purchase Price” means, as of any Settlement Date, the aggregate Purchase Price with respect to
all Receivables Purchased by Buyer from the Originators during the related Collection Period. 

“Agreement” means this Receivables Sale Agreement, as the same may be amended, restated, supplemented or
otherwise modified from time to time. 
 “Allocable Share” means, with respect to each Originator on any
Settlement Date, an amount equal to the Total Amount Owed to such Originator on such Settlement Date divided by the aggregate of the Total Amount Owed to all Originators on such Settlement Date. 

“Anti-Corruption Laws” means all laws, rules, and regulations of any jurisdiction applicable to the CHS
Parties or their respective Subsidiaries from time to time concerning or relating to bribery or corruption, including, without limitation, the Foreign Corrupt Practices Act of 1977, as amended, and any applicable law or regulation implementing the
OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions. 

“Applicable Law” means, as to any Person, all statutes, laws, ordinances, rules, and regulations of any
Governmental Entity, in each case applicable to or binding upon the Person or any of its property or to which the Person or any of its property is subject. 

“Assignment of Agreements” means that certain Assignment of Agreements, dated as of the Closing Date, among
the Buyer, the Company and the Administrative Agent in the form attached hereto as Exhibit A, as such agreement may be amended, restated, supplemented or otherwise modified from time to time in accordance with its terms and the terms hereof.

 “Authorized Representative” has the meaning assigned to that term in
Section 9.13(b). 

  
 2 

 “Bad Debt Reserve” means the allocable portion of the bad debt
reserve on the books and records of the Originators as established and allocated from time to time by the Originators and the Collection Agent in their sole discretion with respect to the Receivables included in a Purchase. 

“Bankruptcy Law” means the United States Bankruptcy Reform Act of 1978 (11 U.S.C. §§ 101, et
seq.) as amended from time to time, or any successor statute, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor
relief laws of the United States or other applicable U.S. jurisdictions from time to time in effect and affecting the rights of creditors generally. 

“Base Rate” means, on any day, a fluctuating rate of interest per annum equal to the higher of
(i) the per annum rate of interest equal to the PRBKCHMN Index as published by Bloomberg (or other commercially available source designated by the Administrative Agent) and (ii) 0.50% per annum above the Federal Funds Rate.

 “Business Associate Agreement” means an agreement in substantially the form of Exhibit C, as
such agreement may be amended, restated, supplemented or otherwise modified from time to time. 
 “Business
Day” means a day of the year other than a Saturday or a Sunday on which banks are required to be open in New York City. 

“Buyer” has the meaning assigned to that term in the Recitals. 

A “Change in Control” shall be deemed to have occurred if (a) any “person” or “group”
(within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934 as in effect on the Closing Date), shall own, directly or indirectly, beneficially or of record, shares representing more than 40% of the aggregate ordinary voting power
represented by the issued and outstanding capital stock of the Parent, (b) a majority of the seats (other than vacant seats) on the board of directors of the Parent shall at any time be occupied by persons who were neither (i) nominated by the
board of directors of the Parent, nor (ii) appointed by directors so nominated, (c) any change in control (or similar event, however denominated) with respect to the Parent, the Buyer or the Collection Agent (if it is an Affiliate of the Buyer, any
Originator or the Parent) shall occur under and as defined in any indenture or agreement in respect of Material Indebtedness to which such Person is a party (other than, under any indenture or agreement in respect of Material Indebtedness assumed in
connection with a permitted acquisition or any change in control triggered by the permitted acquisition pursuant to which such Material Indebtedness was assumed), or (d) the Parent shall cease to own, directly or indirectly, beneficially and of
record, (i) 100% of the issued and outstanding equity interests of the Buyer, any Originator (other than the Specified Originators) or the Collection Agent (if it is an Affiliate of the Buyer, any Originator or the Parent), or (ii) the percentage of
the issued and outstanding equity interests of any Specified Originator listed on Schedule V hereto or such other percentage that is not less than 5% below such percentage listed on Schedule V. 

“CHS” means CHS/Community Health Systems, Inc., a Delaware corporation. 

  
 3 

 “Closing Date” means March 21, 2012. 

“CMS” means the Centers for Medicare and Medicaid Services of the United States Department of Health and
Human Services. 
 “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any
successor and the regulations promulgated and rulings issued thereunder. 
 “Collection Account” means an
account that is (i) maintained at a bank or other financial institution in the name of an Originator for the purpose of receiving Collections and (ii) subject to a Deposit Account Notification Agreement (Government Healthcare Receivables). 

“Collection Account Bank” means a bank or other financial institution holding one or more Collection
Accounts, which on the Closing Date shall be Bank of America, N.A., and on the Second Omnibus Amendment Effective Date and thereafter shall be Bank of America, N.A., or Fifth Third Bank, as context requires. 

“Collection Agency Receivable” means a Receivable that has been referred to a third party secondary
collection agency by the Collection Agent. 
 “Collection Agent” means, at any time, the Person or Persons
then authorized pursuant to Article VI to service, administer and collect Receivables, initially Professional Services, in such capacity. 

“Collection Date” means the date following the Termination Date on which the aggregate Outstanding Balance
of all Purchased Receivables (other than Purchased Receivables which have not been paid as a result of an Insolvency Proceeding with respect to an Obligor) has been reduced to zero and the Buyer has received all other amounts due to it in connection
with this Agreement or any other agreement executed pursuant hereto or in connection herewith. 
 “Collection
Period” means a calendar month. 
 “Collections” means, with respect to any Receivable, all cash
collections and other cash proceeds of such Receivable, including insurance payments under any insurance policy and all cash proceeds of the Related Security with respect to such Receivable. 

“Company” means CHS Receivables Funding, LLC, a Delaware limited liability company. 

“Concentration Account” means an account, subject to a Control Agreement and maintained in the name of the
Company at a Concentration Account Bank for the purpose of receiving transfers from the applicable Collection Accounts and for transacting all banking activities in accordance with the Facility Documents. 

“Concentration Account Bank” means Bank of America, N.A., Fifth Third Bank or, with the prior written
consent of the Administrative Agent, another bank or financial institution. 

  
 4 

 “Contract” means an insurance policy, contract or other
instrument obligating an Obligor to make payment with respect to a Receivable. 
 “Contractual Allowances”
means, with respect to any Receivable, an amount set forth in the Monthly Report and approved by the Administrative Agent by which such Receivable, consistent with the applicable Originator’s historical collection experience, is expected to be
reduced prior to payment thereof by the Obligor, as such amount may be adjusted, upwards or downwards, in the manner set forth in the Loan Agreement. 

“Contribution Agreement” means that certain Receivables Purchase and Contribution Agreement dated as of the
Closing Date, among the Transferor, the Company and the Collection Agent, as amended by the First Omnibus Amendment, the Second Omnibus Amendment, the Third Omnibus Amendment, the Fourth Omnibus Amendment, the Fifth Omnibus Amendment and the Sixth
Omnibus Amendment and as the same may be further amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof, together with all instruments, documents and agreements executed by any of the
CHS Parties party thereto in connection therewith, in each case, as the same may be amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof and hereof. 

“Control Agreement” means (a) that certain Deposit Account Control Agreement, dated as of the Closing Date,
among the Company, the Administrative Agent and Bank of America, N.A., as the Concentration Account Bank, (b) that certain Deposit Account Control Agreement, dated as of the Second Omnibus Amendment Effective Date, among the Company, the
Administrative Agent and Fifth Third Bank, as the Concentration Account Bank, and (c) each other Deposit Account Control Agreement entered into among the Company, the Administrative Agent and a Concentration Account Bank, in each case in form and
substance satisfactory to the Administrative Agent, as each such agreement may be amended, modified, supplemented or restated in accordance with its terms and the terms hereof. 

“Credit and Collection Policy” means the credit, contracting and collection policies and practices relating
to Contracts and Receivables of the Originators previously provided to each Managing Agent, as modified in compliance with Section 6.02(c) of this Agreement and provided to or accessible to each Managing Agent in electronic format. 

“Critical Accounting Policy” means the “Critical Accounting Policy” (as such term is defined in
the annual report on Form 10-K of the Parent). 
 “Debt” of any Person means (a) indebtedness of such
Person for borrowed money, (b) obligations of such Person evidenced by bonds, debentures, notes or other similar instruments, (c) obligations of such Person to pay the deferred purchase price of property or services beyond ordinary course of
business payment terms for trade payables, (d) obligations secured by a valid Lien upon property or assets owned by such Person, even though such Person has not assumed or become liable for the payment of such obligations and (e) obligations of such
Person under direct or indirect guaranties in respect of, and obligations (contingent or otherwise) to purchase or otherwise acquire, or otherwise to assure a creditor against loss in respect of, indebtedness or obligations of others of the kinds
referred to in clauses (a) through (d) above. 

  
 5 

 “Defaulted Receivable” means a Receivable: 

(a)      as to which, as of the date that is 150 days after the Last Service Date, the amount
paid thereon is less than the Expected Net Value of such Receivable (other than as a result of a miscalculation by the Collection Agent of Contractual Allowances), 

(b)      as to which the Obligor thereof is currently the subject of an Insolvency Proceeding,
or 
 (c)      which, consistent with the Credit and Collection Policy, has been or should be
written off the Buyer’s or an Originator’s books as uncollectible. 
 “Delinquent Receivable”
means a Receivable, other than a Defaulted Receivable, as to which, as of the date that is 120 days after the Last Service Date, the amount paid thereon is less than the Expected Net Value of such Receivable (other than as a result of a
miscalculation by the Collection Agent of Contractual Allowances). 
 “Deposit Account Notification Agreement
(Government Healthcare Receivables)” means (a) that certain Deposit Account Notification Agreement (Government Healthcare Receivables), dated as of the Closing Date, among the Originators party thereto, the Administrative Agent, Bank of
America, N.A., as the Collection Account Bank, and, solely for purposes of Section 11 thereof, CHS, (b) that certain Deposit Account Instructions and Service Agreement, dated as of the Second Omnibus Amendment Effective Date, among the Originators
party thereto, the Administrative Agent and Fifth Third Bank, as the Collection Account Bank, and (c) each other agreement entered into by one or more Originators, the Administrative Agent and a Collection Account Bank providing for, among other
things, standing revocable instructions by such Originators to transfer Collection Account funds to a Concentration Account and notification to the Administrative Agent of any change in such instructions, in each case in form and substance
satisfactory to the Administrative Agent, in each case as such agreement may be amended, modified, supplemented or restated in accordance with its terms and the terms hereof. 

“Distributed Funds” has the meaning assigned to that term in Section 2.03(a). 

“Documents” means this Agreement, the, Contribution Agreement, the Loan Agreement, the Originator Documents,
the Facility Documents, and all other certificates, instruments, UCC financing statements, reports, notices, agreements and documents executed or delivered under or in connection with this Agreement, in each case as the same may be amended,
supplemented or otherwise modified from time to time in accordance with this Agreement. 
 “Eligible
Obligor” means, at any time, an Obligor which is: 
 (a)      not an
Affiliate of the Company, CHS or any Originator; 
 (b)      a resident of the
United States; 

  
 6 

 (c)      not the Obligor of
Defaulted Receivables having an Expected Net Value in an aggregate amount of 25% or more of the aggregate Expected Net Value of all Receivables of such Obligor; 

(d)      not the subject of any Insolvency Proceeding; and 

(e)      an Insurer or a Governmental Entity. 

For the avoidance of doubt, an Obligor that is ineligible pursuant to two or more clauses above shall be counted as ineligible under this
Agreement once, without duplication. 
 “Eligible Receivable” means, at any time, a
Receivable: 
 (a)      the Obligor of which is an Eligible Obligor; 

(b)      which is not a Delinquent Receivable, a Defaulted Receivable or a
Collection Agency Receivable; 
 (c)      which (i) is an
“account”, including a health-care-insurance receivable, or a general intangible within the meaning of the UCC and is not evidenced by any instrument or chattel paper, (ii) unless it is an Unbilled Receivable, has been invoiced by the
applicable Originator and as to which all performance and other action required to be taken in connection therewith by the applicable Originator (and, if applicable, the Company) for the Obligor has been so performed or taken, (iii) is
denominated and payable only in U.S. Dollars, (iv) that has not been compromised in any manner that would reduce the amount payable with respect thereto in any manner not reflected in the Total Reserves or the Contractual Allowances with respect
thereto (including by extension of time of payment) and, in any event, is payable in an amount approximating its Expected Net Value by the Obligor or Obligors identified by the applicable Originator in its records as being obligated to do so,
(v) is net of any deductible limitations, commissions, fees, or other discounts, (vi) is based on an actual and bona fide rendition of services or sale of goods to the patient by the applicable Originator in the ordinary course of business,
(vii) to the extent required under Applicable Law, is subject to a Patient Consent Form executed by the applicable patient, and (viii) satisfies all applicable requirements of, and, in the case of Receivables owed by Governmental Entities or
Insurers, was originated and processed in accordance with, the Credit and Collection Policy or the Critical Accounting Policy, as applicable, and the billing requirements of the applicable Obligor except in any Immaterial Respect; 

(d)      which is payable in an amount at least equal to its Expected Net Value
by the Obligor or Obligors identified by the applicable Originator in its records as being obligated to do so; 

(e)      the Originator of which (i) is not the subject of any Insolvency
Proceeding and (ii) has not been the subject of a Removal; 
 (f)      which
is not the subject of any action, suit, proceeding or dispute (pending or threatened), setoff, counterclaim, defense, abatement, suspension, deferment, 

  
 7 

 
deductible, reduction or termination by the Obligor thereof (except for statutory rights of Governmental Entities that are not pending or threatened) unless, in the case of a Receivable from a
Governmental Entity, Medicare/Medicaid Cost Report Liability Reserves have been established with respect thereto in an amount in compliance with the Critical Accounting Policy and otherwise reasonably satisfactory to the Administrative Agent; 

(g)      which is not based on any cost report settlement or expected settlement
due from any Governmental Entity; 
 (h)      the invoice for the goods and
services constituting the basis for which, has been prepared, delivered and is in a form such that, after application of all relevant Contractual Allowances adjustments have been applied to such Receivable and the invoiced balance thereunder, the
expected payments for the invoiced goods and services will be in an amount approximating the Expected Net Value of such Receivable; 

(i)       the financing of which hereunder is made in good faith and
without actual intent to hinder, delay or defraud present or future creditors of the Buyer or any Originator; 

(j)       the assignment of which (including the grant of a perfected
security interest therein and the assignment of any Related Security) does not contravene or conflict in any material respect with any Applicable Law or any contractual or other restriction, limitation or restriction with regard to confidentiality;

 (k)      the Obligor with respect to which has been directed to make
payments on such Receivable to a Lock-Box or Collection Account; 

(l)       the Contract with respect to which, (i) together with such
Receivable, does not contravene in any material respect any Applicable Law (including laws, rules and regulations relating to truth in lending, fair credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices and
privacy) and with respect to which no party to the Contract related thereto is in violation of any such Applicable Law in any material respect, (ii) does not contain any provision prohibiting the grant of a Lien in such payment obligation from the
patient to the Originator, from the Originator to the Buyer, from the Buyer to the Company or from the Company to the Administrative Agent, (iii) has been duly authorized and, together with such Receivable, constitutes the legal, valid and binding
obligation of the Obligor, and (iv) was in full force and effect and applicable to the customer or patient at the time the goods or services constituting the basis for such Receivable were sold or performed; 

(m)     with respect to which no consents by any third party to the grant of a
security interest therein are required other than consents previously obtained in writing by the applicable Originator; 

(n)      as to which the Administrative Agent has not notified the Company and
the Collection Agent that the Administrative Agent has determined, in its reasonable business judgment exercised in good faith, that the inclusion of such Receivable (or class of Receivables (other than Medicare or Medicaid)) would have a material
adverse effect on the program; 

  
 8 

 (o)     (i) which, prior to the grant of
an interest therein pursuant to this Agreement, is owned by the applicable Originator free and clear of any Lien (other than Permitted Liens), and (ii) with respect to which, from and after the grant of an interest therein pursuant to this
Agreement, the Buyer has a properly perfected first priority security interest therein, free and clear of any Lien (other than Permitted Liens) which has been assigned to the Administrative Agent, who has a properly perfected first priority security
interest therein, free and clear of any Lien (other than Permitted Liens) (which, for clarity, will exclude Receivables originated by Kay County Oklahoma Hospital Company, LLC as “Eligible Receivables” until such time as the Kay County
Lien is released and terminated in full); 
 (p)      which is not an
Ineligible Receivable; 
 (q)      which, if it is an Unbilled Receivable, is
not within 10 days of the statutory limit for billing and collection applicable to the Obligor thereof and is not aged more than 30 days from its Last Service Date; 

(r)      except for an Unbilled Receivable, all information set forth in the
bill and supporting claim documents with respect to which is true, complete and correct except in any Immaterial Respect, and, in all cases, if additional information is requested by the Obligor, the Collection Agent (or related Originator) has or
will promptly provide (or cause to be provided) the same, and if any error has been made with respect to such information, the Collection Agent (or related Originator) will promptly correct the same and, if necessary, rebill such Receivable; 

(s)      with respect to which the Originator’s Medicare or Medicaid cost
reports have been examined and audited or “final settled” or for which a Notice of Program Reimbursement (“NPR”) has been issued by (i) as to Medicaid, the applicable state agency or other CMS designated agent or agents of
such state agency, charged with such responsibility, or (ii) as to Medicare, the Medicare intermediary or other CMS designated agents charged with such responsibility, and there is no basis for any Governmental Entity to assert an offset with
respect to such Receivable, including as the result of any unpaid amounts, with respect to any audit, financial settlement or NPR, except to the extent covered by Medicare/Medicaid Cost Report Liability Reserves; 

(t)      which is not an AccessOne Program Receivable; and 

(u)     which is not an Illinois Medicaid Receivable. 

For the avoidance of doubt, (i) a Receivable or portion of a Receivable that is ineligible pursuant to two or more clauses
above shall be counted as ineligible under this Agreement once, without duplication, and (ii) so long as no Termination or Event of Termination is continuing, an Eligible Receivable that becomes ineligible under any clause hereunder may be
resubmitted as an Eligible Receivable at a future date if and to the extent all qualifications under this definition are satisfied as of the date of resubmission (including curing the basis for the initial determination of ineligibility hereunder).

  
 9 

 “ERISA” means the Employee Retirement Income Security Act of
1974, as the same may be amended from time to time. 
 “ERISA Affiliate” means any trade or business
(whether or not incorporated) that, together with the Parent, is treated as a single employer under Section 414(b) or (c) of the Code, or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated as a single employer under
Section 414 of the Code. 
 “ERISA Event” means (a) any “reportable event”, as defined in
Section 4043 of ERISA or the regulations issued thereunder, with respect to a Plan (other than an event for which the 30-day notice period is waived), (b) a failure by any Plan to meet the minimum funding standards (within the meaning of Sections
412 or 430 of the Code or Section 302 of ERISA) applicable to such Plan, in each case whether or not waived, (c) the filing pursuant to Section 412(c) of the Code or Section 302(c) of ERISA, of an application for a waiver of the minimum funding
standard with respect to any Plan, (d) a determination that any Plan is, or is expected to be, in “at-risk” status (as defined in Section 303(i)(4) of ERISA or Section 430(i)(4) of the Code), (e) the incurrence by the Parent or any of its
ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan or the withdrawal or partial withdrawal of the Parent or any of its ERISA Affiliates from any Plan or Multiemployer Plan, (f) the receipt by the
Parent or any of its ERISA Affiliates from the PBGC or a plan administrator of any notice relating to the intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan, (g) the receipt by the Parent or any of its ERISA
Affiliates of any notice, or the receipt by any Multiemployer Plan from the Parent or any of its ERISA Affiliates of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be,
insolvent or in reorganization, within the meaning of Title IV of ERISA or in endangered or critical status, within the meaning of Section 432 of the Code or Section 305 of ERISA, (h) the occurrence of a “prohibited transaction” with
respect to which the Parent or any of the subsidiaries is a “disqualified person” (within the meaning of Section 4975 of the Code) or with respect to which the Parent or any such subsidiary could otherwise be liable or (i) any other event
or condition with respect to a Plan or Multiemployer Plan that could result in liability of the Parent or any subsidiary. 

“Event of Termination” has the meaning assigned to that term in Section 7.01. 

“Expected Net Value” means, with respect to any Receivable, the sum of (a) the gross unpaid amount of such
Receivable on the date of creation thereof minus (b) all Contractual Allowances with respect to such Receivable. 

“Facility Documents” has the meaning set forth in the Loan Agreement. 

“Federal Funds Rate” means, for any day, a fluctuating interest rate per annum equal to the weighted
average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers, as published for such day (or, if such day is not a Business Day, for the next preceding Business Day) by the
Federal Reserve 

  
 10 

 
Bank of New York, or, if such rate is not so published for any day which is a Business Day, the average of the quotations for such day for such transactions received by the Administrative Agent
from three Federal funds brokers of recognized standing selected by it. 
 “Fifth Amendment to Loan
Agreement” means that certain Fifth Amendment to Receivables Loan Agreement, made as of February 28, 2015, among the Borrower, as Borrower, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing
Agent and as a Committed Lender, Credit Agricole Corporate and Investment Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under the Loan Agreement, and such other parties as are
named therein, and acknowledged and agreed by certain other CHS Parties party to the Facility Documents. 
 “Fifth
Omnibus Amendment” means that certain Fifth Omnibus Amendment, made as of the Fifth Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed
Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole Corporate and Investment Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this
Agreement, the Contribution Agreement, and the Loan Agreement, and as Authorized Representative, CHS, as Transferor, as Buyer and individually (as a performance undertaking party), the Originators party thereto, and such other parties as are named
therein. 
 “Fifth Omnibus Amendment Effective Date” means November 13, 2015. 

“First Omnibus Amendment” means that certain First Omnibus Amendment, made as of July 30, 2012, among
the Borrower, as Borrower and as the Company, Scotia, as a Managing Agent, CA-CIB, as a Managing Agent and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the
Contribution Agreement, and the Sale Agreement, and as Authorized Representative (as defined in the Sale Agreement), CHS, as Transferor and as Buyer, and each of the Initial Originators, as Originators. 

“Fourth Amendment to Loan Agreement” means that certain Fourth Amendment to Receivables Loan Agreement, made
as of August 29, 2014, among the Borrower, as Borrower, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole Corporate and Investment Bank, as a Managing
Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under the Loan Agreement, and such other parties as are named therein, and acknowledged and agreed by certain other CHS Parties party to the Facility
Documents. 
 “Fourth Omnibus Amendment” means that certain Fourth Omnibus Amendment, made as of the
Fourth Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole Corporate
and Investment Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution 

  
 11 

 
Agreement, and the Loan Agreement, and as Authorized Representative, CHS, as Transferor, as Buyer and individually (as a performance undertaking party), the Originators party thereto, and such
other parties as are named therein. 
 “Fourth Omnibus Amendment Effective Date” means March 31, 2015.

 “GAAP” means the generally accepted accounting principles in the United States in effect from time to
time including, at any time after the adoption thereof in the United States, the generally accepted accounting standards from time to time developed and approved by the International Accounting Standards Board. 

“Governmental Entity” means the United States of America, any state thereof, any political subdivision of a
state thereof and any agency or instrumentality of the United States of America or any state or political subdivision thereof and any entity exercising executive, legislative, judicial, regulatory, or administrative functions of or pertaining to
government. Payments from Governmental Entities will be deemed to include payments governed under the Social Security Act (42 U.S.C. §§ 1395 et seq.), including payments under Medicare, Medicaid and TRICARE/CHAMPUS, and payments
administered or regulated by CMS; provided that for purposes of the definition of “Eligible Obligor”, Governmental Entities with respect to Medicaid-related and Medicare-related Receivables shall be treated as separate entities in
the manner identified in the Monthly Report. 
 “Healthcare Laws” means all applicable statutes, laws,
ordinances, rules, and regulations of any Governmental Entity with respect to regulatory matters primarily relating to patient healthcare, healthcare providers, and healthcare services (including Section 1128B(b) of the Social Security Act, as
amended, 42 U.S.C. § 1320a 7(b) (Criminal Penalties Involving Medicare or State Health Care Programs), commonly referred to as the “Federal Anti-Kickback Statute,” HIPAA and the Social Security Act, as amended, Section 1877, 42
U.S.C. § 1395nn (Prohibition Against Certain Referrals), commonly referred to as “Stark Statute”). 

“HIPAA” means the Health Insurance Portability and Accountability Act of 1996, Pub. L. No.
104-191, the Privacy Standards, the Security Standards, and the Privacy provisions (Subtitle D) of the Health Information Technology for Economic Clinical Health Act, Division A, Title XIII of Pub. L. 111-5, and its implementing
regulations. 
 “Illinois Medicaid Receivable” means any Receivable with respect to which the Obligor is
the State of Illinois or any agency or instrumentality thereof acting through Illinois’ Medicaid agency that arises out of charges reimbursable under Medicaid. 

“Immaterial Respect” means, with respect to (1) any eligibility criteria relating to the Purchase of a
Receivable, any non-compliance with such eligibility criteria that does not result in (i) the diminution in any amount whatsoever (x) in the timely payment or, (y) in the amount of Purchase Price of such Receivable, or (ii) the impairment exclusion,
elimination or limitation of any material rights, remedies or benefit that otherwise would be available to obtain Collections on such Receivable, or (2) any representation or warranty hereunder, any breach of a representation or warranty that does
not result in (i) the diminution in any amount whatsoever (x) in the timely payment or, (y) in the amount of Purchase Price of the Purchased Receivables, or (ii) the impairment exclusion, elimination or limitation of any material rights, remedies or
benefit that otherwise would be available to obtain Collections on the Purchased Receivables. 

  
 12 

 “Indemnified Amounts” has the meaning assigned to that term in
Section 8.01. 
 “Indemnified Parties” has the meaning assigned to that term in
Section 8.01. 
 “Ineligible Receivable” means a Receivable on the books and
records of an Originator in one of the following financial classes from the list of all financial classes categorized by the Originators set forth on the schedule of financial classes provided to the Buyer on the Closing Date: (i) Early-Out Blue
Cross, (ii) Early-Out HMO/PPO, (iii) Early-Out Other Insurance, (iv) Champus, (v) Workers Comp., (vi) Other Governmental, (vii) Schip Standards, (viii) Schip Nonstandard, (ix) Industrial, (x) Auto Insurance Liability, or (xi) Other Non-Government.

 “Initial Originators” means each of the Persons affiliated with the Parent and party to the Sale
Agreement as of the Closing Date as an originator collectively, and “Initial Originator” means any of them individually. 

“Initial Purchase” means the initial Purchase made by the Buyer hereunder. 

“Initial Purchase Date” means March 26, 2012 or the first date thereafter on which all of the conditions
precedent specified in Sections 3.01 and 3.02 have been satisfied. 
 “Insolvency Proceeding” means, with
respect to any Person, any of the following events: (a) any proceeding shall be instituted by such Person seeking to adjudicate it as bankrupt or insolvent, or seeking liquidation, winding up, reorganization, dissolution, stay of proceedings,
arrangement, adjustment, protection, relief, or composition of it or its debts under any Bankruptcy Law or (b) any proceeding shall be instituted against such Person seeking to adjudicate it a bankrupt or insolvent, or seeking liquidation,
dissolution, stay of proceedings, winding up, reorganization, arrangement, adjustment, protection, relief, or composition of it or its debts under any Bankruptcy Law, and such proceeding shall remain unstayed for a period of 60 days, or the
requested adjudication, relief or other action sought thereby shall have been made, granted or taken. 

“Insurer” means any Person (other than a Governmental Entity) which in the ordinary course of its business
or activities agrees to pay for healthcare goods and services received by individuals, including commercial insurance companies, nonprofit insurance companies (such as the Blue Cross, Blue Shield entities), employers or unions which self insure for
employee or member health insurance, prepaid health care organizations, preferred provider organizations, health maintenance organizations or any other similar Person. “Insurer” includes insurance companies issuing health, personal injury,
workers’ compensation or other types of insurance but does not include any individual guarantor. 

“Investment Company Act” means the Investment Company Act of 1940, as amended. 

  
 13 

 “Kay County Lien” means (a) the tax lien evidenced by (i) the
Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital Company, LLC, for a total amount of $9,594,943.55, prepared and signed at Nashville, Tennessee, on October 2, 2012, filed at the Kay County Clerk in the State of Oklahoma and
recorded in Book F17, Page 95 on October 9, 2012, and (ii) the Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital Company, LLC, for a total amount of $9,594,943.55, prepared and signed at Nashville, Tennessee, on October 2, 2012,
filed at the Oklahoma County Clerk, in the state of Oklahoma under filing no. 20121009030027290 on October 9, 2012; and (b) the tax lien evidenced by (i) the Notice of Federal Tax Lien filed against Kay County Oklahoma Hospital Company, LLC, for a
total amount of $1,191,207.26, prepared and signed at Nashville, Tennessee, on November 15, 2012, filed at the Kay County Clerk in the State of Oklahoma and recorded in Book F17, Page 104 on November 26, 2012, and (ii) the Notice of Federal Tax Lien
filed against Kay County Oklahoma Hospital Company, LLC, for a total amount of $1,191,207.26, prepared and signed at Nashville, Tennessee, on November 15, 2012, filed at the Oklahoma County Clerk in the State of Oklahoma under filing no.
20121126030032200 on November 26, 2012. 
 “Last Service Date” means, with respect to any Receivable, the
date on which the related patient was discharged from the care of the applicable Originator. 
 “Lenders”
has the meaning set forth in the Loan Agreement. 
 “Lien” means a lien, assignment, mortgage, pledge,
hypothecation, privilege, title retention, security interest, charge, hypothec, encumbrance or other right or claim of any Person. 

“Loan Agreement” means that certain Receivables Loan Agreement, dated as of the Closing Date, among the
Buyer, Professional Services, in its capacity as Collection Agent, the Lenders party thereto from time to time, the Managing Agents party thereto from time to time, and Credit Agricole Corporate and Investment Bank, as Administrative Agent, as
amended by the First Omnibus Amendment, the Second Omnibus Amendment, the Third Omnibus Amendment, the Fourth Amendment to Loan Agreement, the Fifth Amendment to Loan Agreement, the Fourth Omnibus Amendment, the Fifth Omnibus Amendment and the Sixth
Omnibus Amendment and as such agreement may be further amended, restated, supplemented or otherwise modified from time to time in accordance with its terms. 

“Lock-Box” means a post office box to which Collections are remitted for retrieval by a Collection Account
Bank and deposited by such Collection Account Bank into a Collection Account. 
 “Majority Lenders” has
the meaning set forth in the Loan Agreement. 
 “Managing Agent” has the meaning set forth in the Loan
Agreement. 
 “Material Adverse Effect” means a material adverse change since December 31, 2011 in, or a
material adverse effect upon, (a) the operations, business, properties or financial condition of (i) the Originators taken as a whole, or the Collection Agent or (ii) the Parent and its subsidiaries, taken as a whole, (b) the ability of
the Collection Agent, the Parent, CHS or any Material Originator to perform in any material respects their respective obligations under this Agreement or any other Document to which it is a party, or (c) (i) the legality, validity, binding

  
 14 

 
effect or enforceability of any Document, or (ii) the perfection or priority of any ownership interest granted under any of the Documents (other than with respect to an immaterial amount of
Purchased Property and which the applicable Originator, Collection Agent or CHS is diligently disputing by appropriate proceedings). 

“Material Indebtedness” means any Debt (other than any Debt incurred under the Documents) of any one or more
of the Parent, CHS, the Collection Agent or any Originator in an aggregate principal amount exceeding $50,000,000. 

“Material Originator” means, as of any date of determination, any Originator or group of Originators,
collectively, the Receivables of which constitute at least 7.5% of the average of the Net Receivables Balances determined as of the last day of each of the three consecutive Collection Periods occurring immediately prior to such date of
determination. 
 “Medicaid” means the medical assistance program established by Title XIX of the Social
Security Act (42 U.S.C. § 1396 et seq.) and any statutes succeeding thereto. 
 “Medicare” means the
health insurance program for the aged and disabled established by Title XVIII of the Social Security Act (42 U.S.C. § 1395 et seq.) and any statutes succeeding thereto. 

“Medicare/Medicaid Cost Report Liability Reserve” has the meaning set forth in the Loan Agreement. 

“Monthly Distributed Funds” has the meaning assigned to that term in
Section 2.03(a). 
 “Monthly Report” means a report, in substantially the form
of Exhibit D, executed by a Responsible Officer of the Collection Agent and furnished to the Administrative Agent and each Managing Agent pursuant to Section 2.03. 

“Monthly Report Due Date” means, with respect to any Collection Period, the 20th day of the calendar month
following such Collection Period, or, if such day is not a Business Day, the next succeeding Business Day. 

“Multiemployer Plan” means a multiemployer plan as defined in Section 4001(a)(3) of ERISA that is
contributed to by the Buyer or with respect to which the Buyer has any liability (including on behalf of any ERISA Affiliate). 

“Net Receivables Balance” has the meaning set forth in the Loan Agreement. 

“Noncomplying Receivable” means any Receivable with respect to which the Authorized Representative has
received notice from the Buyer or the Collection Agent (or following a Termination or Event of Termination, the replacement Collection Agent) that such Receivable was included in calculations contained in the most recently delivered Monthly Report
as an Eligible Receivable that was not an Eligible Receivable as of the date purchased hereunder or that an Originator otherwise breached any representation, warranty or covenant made with respect to such Receivable hereunder when purchased. 

  
 15 

 “Noncomplying Receivable Portion” means, with respect to any
Noncomplying Receivable, the portion of such Receivable that has caused such Receivable to be classified as a Noncomplying Receivable (whether due to a dispute, discount, deduction, claim, offset, defense or counterclaim of any kind relating to such
Receivable or any other performance related or contractual dilution affecting such Receivable, including, without limitation, product quality, warranties, setoffs, deductions, discounts, rebates, incentive programs and adjustments) such that, if
such amount is paid to the Buyer pursuant to Section 2.03(b), the remaining Outstanding Balance of such Receivable shall constitute an Eligible Receivable in all respects.

By way of example, if the Buyer purchased a Receivable hereunder with an Expected Net Value of $1,100,000 and, by virtue of
clerical error, the Expected Net Value was overstated by $100,000 (i.e., the Expected Net Value as of the Purchase Date was in fact $1,000,000), the Noncomplying Receivable Portion of such Receivable is equal to $100,000. 

“Noncomplying Receivables Adjustment” means, with respect to any Collection Period, an amount equal to the
aggregate of, with respect to each Receivable which the Collection Agent or the Buyer (or its assigns) has identified to the Authorized Representative as a Noncomplying Receivable during such Collection Period, either (i) as of any date prior to the
Termination Date that no Termination or Event of Termination is outstanding, the Noncomplying Receivable Portion of each such Receivable, and (ii) in all other circumstances, the Outstanding Balance of each such Receivable. 

“Notice” means such notice letter or form delivered by an Originator to an Obligor directing such Obligor to
make payments on Receivables solely into a Collection Account. 
 “NPR” has the meaning assigned to
that term in clause (s) of the defined term “Eligible Receivable”. 
 “Obligor” means an Insurer
or Governmental Entity, as applicable, who is responsible for the payment of all or any portion of a Receivable. For the avoidance of doubt, the term “Obligor” shall not include any Person that is currently classified in a
“self-pay” financial class by the Collection Agent. 
 “Originator” and
“Originators” has the meaning assigned to that term in the Recitals. 
 “Originator
Documents” means this Agreement, the Control Agreement, the Deposit Account Notification Agreement (Government Healthcare Receivables) and all other certificates, instruments, UCC financing statements, reports, notices, agreements and
documents executed or delivered under or in connection with this Agreement, in each case as the same may be amended, supplemented or otherwise modified from time to time in accordance with this Agreement. 

“Originator Loan” has the meaning assigned to that term in Section 2.03(c)(i).

 “Originator Notes” means the subordinated promissory notes, each of which is (i) payable to the
Authorized Representative as the paying agent for one or more Originators and (ii) 

  
 16 

 
is substantially in the form of Exhibit B attached hereto, as each such note may be amended, restated, supplemented or otherwise modified from time to time in accordance with its terms and the
terms hereof. 
 “Outstanding Balance” of any Receivable at any time means (x) the Expected Net Value of
such Receivable, minus (y) the aggregate amount of (i) all Collections received in the applicable Concentration Account with respect to such Receivable, and (ii) all Noncomplying Receivables Adjustment with respect to such Receivable that
have been applied or paid in accordance with Section 2.03. 
 “Parent” means Community Health
Systems, Inc., a Delaware corporation. 
 “Parent Credit Agreement” means that certain Credit Agreement,
dated as of July 25, 2007, as amended and restated as of November 5, 2010, February 2, 2012 and January 27, 2014, and as further amended as of March 9, 2015, among CHS, as borrower, the Parent, the lenders party thereto, and Credit
Suisse AG, as administrative agent and as collateral agent for the lenders, as such agreement may be further amended, modified, supplemented or restated from time to time in accordance with its terms. 

“Patient Consent Form” means a form signed by each patient for which a Receivable has been or will be
created: (i) with respect to Receivables originated on or prior to September 30, 2012, that is in form and substance consistent in all material respects with those forms used by the applicable Originator in the ordinary course of its business, and
(ii) with respect to Receivables originated after September 30, 2012, that is in form and substance in compliance with Applicable Law to permit an Originator to disclose certain demographic and health information with respect to each patient to the
Originator’s servicing agents and by such servicing agents and to any other Person (including the Administrative Agent and any Collection Agent) in the manner required or otherwise contemplated under the Facility Documents, except that, to the
extent Applicable Law requires the Patient Consent Form to list specific persons or entities who may receive such patient information, such Patient Consent Form need not list the specific servicing agents or any other Person, including the
Administrative Agent or any Collection Agent, in order to satisfy the requirements of this definition. 

“PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor
entity performing similar functions. 
 “Permitted Liens” means (a) liens for taxes, fees, assessments and
other governmental charges that are not delinquent and in respect of which adequate reserves have been established, (b) any Lien created by or in connection with any Facility Document, (c) Liens created by or in connection with the Parent Credit
Agreement which, by their terms, do not attach to Purchased Receivables or any rights, title or interest in or to any of the Documents, except that the Originator Notes may be pledged to the extent required by the Parent Credit Agreement, and (d)
Liens (i) which do not interfere in any material respect with the business of any Originator, or (ii) arising from precautionary UCC financing statements or similar filings made in respect of operating leases entered into by an Originator, in
each case under this clause (d), which do not secure any Debt. 

  
 17 

 “Person” means an individual, partnership, corporation
(including a business trust), limited liability company, joint stock company, trust, unincorporated association, joint venture, government (or any agency or political subdivision thereof) or other entity. 

“Plan” shall mean any employee pension benefit plan (other than a Multiemployer Plan) subject to the
provisions of Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, sponsored, maintained or contributed to by the Parent or an Originator, with respect to an Originator or Parent has any liability (including on behalf of any ERISA
Affiliate). 
 “Professional Services” has the meaning assigned to that term in the Recitals. 

“Purchase” means a purchase of Purchased Property by the Buyer from an Originator pursuant to
Section 2.01. 
 “Purchase Date” has the meaning assigned to that term in
Section 2.01(a). 
 “Purchase Price” means, with respect to any Purchase on any
date, the aggregate Expected Net Value of the Receivables included in such Purchase minus the Bad Debt Reserve. 

“Purchased Property” means (i) all outstanding Receivables sold or intended to be sold under this Agreement,
(ii) all Related Security relating to such Receivables and (iii) all Collections with respect to, and other proceeds of such Receivables. 

“Purchased Receivable” means any Receivable included in the Purchased Property. 

“Receivables” means all accounts (including health-care-insurance receivables), instruments and general
intangibles, whether now existing or hereafter arising, and all proceeds of any of the foregoing, in each case, consisting of rights of payment arising out of the rendition of medical, surgical, diagnostic or other professional medical services or
the sale of medical products by an Originator in the ordinary course of its business, including all third-party reimbursable portions or third-party directly payable portions of health-care-insurance receivables or general intangibles owing (or in
the case of Unbilled Receivables, to be owing) by an Obligor, including all rights to reimbursement from Obligors under any agreements with Obligors or other Persons and payments from Obligors, together with all books, records, ledger cards, rights
to access and use data processing records, rights to use computer software, and other property at any time used or useful in connection with, evidencing, embodying, referring to, or relating to any of the foregoing. For the avoidance of doubt, this
definition shall not include any Self Pay Obligation. 
 “Records” means all Contracts and other
documents, books, records and other information (including computer programs, tapes, disks, punch cards, rights to access and use data processing software and related property and rights) maintained with respect to Receivables and the related
Obligors. 
 “Related Removals” means all proposed Removals of Originators made in connection with one or
more Originators being party to or the subject of a transaction or series of related transactions (such as merger, sale or lease transactions). 

  
 18 

 “Related Security” means with respect to any Receivable: 

(a)       all of the applicable Originator’s interest in the
merchandise (including returned, repossessed or foreclosed merchandise), if any, relating to the sale which gave rise to such Receivable; 
  

	 	(b)	 all other Liens and property subject thereto from time to time purporting to secure payment of such
Receivable, whether pursuant to the Contract related to such Receivable or otherwise; 

  

	 	(c)	 the assignment to the Buyer of all UCC financing statements or similar documents covering any collateral
securing payment of such Receivable; 

  

	 	(d)	 all guarantees, indemnities, warranties, letters of credit, insurance policies and proceeds and premium
refunds thereof and other agreements or arrangements of whatever character from time to time supporting or securing payment of such Receivable whether pursuant to the Contract related to such Receivable or otherwise; 

 

	 	(e)	 all Records; and 

  

	 	(f)	 all present and future claims, demands, causes and choses in action in respect of any or all of the foregoing
and all payments on or under and all proceeds of every kind and nature whatsoever in respect of any or all of the foregoing, including all proceeds of the conversion, voluntary or involuntary, into cash or other liquid property, all cash proceeds,
accounts, accounts receivable, notes, drafts, acceptances, chattel paper, checks, deposit accounts, securities accounts, insurance proceeds, condemnation awards, rights to payment of any and every kind and other forms of obligations and receivables,
instruments and other property which at any time constitute all or part of or are included in the proceeds of any of the foregoing. 

“Removal” has the meaning assigned to that term in Section 9.14(b). 

“Responsible Officer” means, with respect to any Person, its president, company controller, vice president,
treasurer or chief financial officer designated by resolution of such Person as being authorized to deliver notices, reports and certificates under this Agreement. 

“Revolving Principal Balance” has the meaning set forth in the Loan Agreement. 

“Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from
time to time by the U.S. government, including those administered by the Office of Foreign Assets Control of the U.S. Department of Treasury, the U.S. State Department, the U.S. Department of Commerce or the U.S. Department of the Treasury. 

  
 19 

 “Sanctioned Country” means, at any time, a country or territory
that is itself the subject or target of any Sanctions (at the date of this Agreement, Cuba, Iran, North Korea, Sudan and Syria). 

“Sanctioned Person” means (a) any person listed in any Sanctions-related list of specially designated
foreign nationals or other persons maintained by the Office of Foreign Assets Control of the U.S. Department of Treasury, the U.S. State Department, the U.S. Department of Commerce or the U.S. Department of the Treasury or (b) any person controlled
by any such person. 
 “Second Omnibus Amendment” means that certain Second Omnibus Amendment, made as of
the Second Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole
Corporate and Investment Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Contribution Agreement, and the Loan Agreement, and as Authorized
Representative, CHS, as Transferor, as Buyer and individually (as a performance undertaking party), and each of the Originators party to this Agreement as of the Second Omnibus Amendment Effective Date, as Originators. 

“Second Omnibus Amendment Effective Date” means March 7, 2013. 

“Self Pay Obligations” means, as of any date, all accounts, instruments and general intangibles, whether now
existing or hereafter arising, that are payable by a Person other than an Obligor and classified in a “self pay” financial class by the Collection Agent as of such date and all proceeds of any of the foregoing, in each case, consisting of
rights of payment arising out of the rendition of medical, surgical, diagnostic or other professional medical services or the sale of medical products by an Originator in the ordinary course of its business. 

“Servicer Termination Event” means the occurrence of any of the following: 

(a)      any Event of Termination; 

(b)      any withdrawal by the Collection Agent from a Collection Account or a
Concentration Account in contravention of or otherwise not in accordance with the terms of this Agreement or any other Facility Document; 

(c)      any failure on the part of the Collection Agent duly to comply in any
material respect with any of its duties, covenants or obligations hereunder, as “Collection Agent” under this Agreement, the Contribution Agreement, the Loan Agreement or under any Document, any Contract, any Applicable Law with respect to
any Receivable, or under the standards, duties and obligations set forth in the Credit and Collection Policy, in each case, as determined by the Buyer (or its assigns) in the exercise of its reasonable commercial judgment, which failure shall
continue uncured or unwaived for a period of 10 days (if such failure can be remedied) after the earlier to occur of (x) the date on which written notice of such failure shall have been given to the Collection Agent by the Buyer or its assigns, and
(y) the date on which a Responsible Officer of the Collection Agent acquires knowledge thereof; 

  
 20 

 (d)      the Collection Agent
agrees to or otherwise permits to occur any material change in the Credit and Collection Policy that is not in compliance with Section 6.02(c); 

(e)      Professional Services (if then acting as Collection Agent) assigns its
rights or obligations as “Collection Agent” hereunder to any Person without the consent of the Administrative Agent and the approval of each Managing Agent (as required by Section 6.01); 

(f)      any financial or other information reasonably requested by the
Administrative Agent or any Managing Agent is not provided as requested within a reasonable amount of time following such request; or 

(g)      any representation or warranty made or deemed made by the Collection
Agent or any of its officers under or in connection with this Agreement or any other Facility Document shall have been false, incorrect or misleading in any material respect when made or deemed made. 

“Servicing Fee” means a fee payable by the Buyer to the Collection Agent on each Payment Date equal to 1.0%
per annum on the aggregate Purchase Price of the Purchased Receivables outstanding during the immediately preceding calendar month, payable solely from available Collections. 

“Settlement Date” means, with respect to each Purchase, the Monthly Report Due Date covering the monthly
period in which the related Purchase Date occurred. 
 “Sixth Omnibus Amendment” means that certain Sixth
Omnibus Amendment, made as of the Sixth Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender, BTMU, as a Managing Agent and as a Committed
Lender, CA-CIB, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the Loan Agreement, and the Sale Agreement, and as Authorized Representative (as defined
in the Sale Agreement), CHS, as Transferor, as Buyer and individually (as a performance undertaking party), the Originators party thereto and such other parties as are named therein. 

“Sixth Omnibus Amendment Effective Date” means November 18, 2016. 

“Specified Originators” means the Originators listed on Schedule V, which Schedule also sets forth
the percentage ownership of the issued and outstanding equity interests of each such Originator that is held by CHS and its subsidiaries as of the Third Omnibus Amendment Effective Date. 

“Termination” means any event or circumstance that but for notice or lapse of time or both would constitute
an Event of Termination. 

  
 21 

 “Termination Date” means the date on which the
Originators’ obligation to sell and the Buyer’s obligation to purchase Receivables hereunder terminates, which date shall occur on the earliest of (i) the delivery of a Termination Declaration Notice, (ii) the occurrence of any event
described in clause (i)(B) or clause (i)(C) of Section 7.01(f), (iii) the occurrence of any event described in Section 7.01(d) and (iv) the date on which all amounts payable under the Documents have
been paid in full and all commitments under the Documents have been terminated. 
 “Termination Declaration
Notice” has the meaning assigned to that term in Section 7.01. 
 “Third Omnibus
Amendment” means that certain Third Omnibus Amendment, made as of the Third Omnibus Amendment Effective Date, among the Company, as Borrower and as the Company, the Conduit Lenders, Scotia, as a Managing Agent and as a Committed Lender,
BTMU, as a Managing Agent and as a Committed Lender, Credit Agricole Corporate and Investment Bank, as a Managing Agent, as a Committed Lender and as Administrative Agent, the Collection Agent, as Collection Agent under each of this Agreement, the
Contribution Agreement, and the Loan Agreement, and as Authorized Representative, CHS, as Transferor, as Buyer and individually (as a performance undertaking party), each of the Originators party to this Agreement as of the Third Omnibus Amendment
Effective Date, as Originators, and such other parties as are named therein. 
 “Third Omnibus Amendment Effective
Date” means March 31, 2014. 
 “Total Amount Owed” means, with respect to an Originator on any
given Settlement Date, the sum of the principal amount owed to such Originator under the applicable Originator Note on the preceding Settlement Date (after all distributions and payments on such date) and the aggregate Expected Net Value of
Receivables transferred by such Originator to the Buyer during the Collection Period related to the given Settlement Date. 

“Total Reserves” has the meaning set forth in the Loan Agreement. 

“Transferor” means CHS in its capacity as the Transferor under the Contribution Agreement. 

“TRICARE/CHAMPUS” means the Civilian Health and Medical Program of the Uniformed Service, a program of
medical benefits covering former and active members of the uniformed services and certain of their dependents, financed and administered by the United States Departments of Defense, Health and Human Services and Transportation and established
pursuant to 10 USC §§ 1071-1106, and all regulations promulgated thereunder including (1) all federal statutes (whether set forth in 10 USC §§ 1071-1106 or elsewhere) affecting TRICARE/CHAMPUS, and (2) all rules, regulations
(including 32 CFR 199), manuals, orders and administrative, reimbursement, and other guidelines of all Governmental Entities (including the Department of Health and Human Services, the Department of Defense, the Department of Transportation, the
Assistant Secretary of Defense (Health Affairs), and the Office of TRICARE/CHAMPUS, or any Person or entity succeeding to the functions of any of the foregoing) promulgated pursuant to or in connection with any of the foregoing (whether or not
having the force of law) in each case as may be amended, supplemented or otherwise modified from time to time. 

  
 22 

 “Trigger Event” has the meaning set forth in the Loan
Agreement. 
 “UCC” means the Uniform Commercial Code as from time to time in effect in the specified
jurisdiction. 
 “Unbilled Receivable” means a Receivable in respect of which the goods have been shipped,
or the services rendered, to the relevant customer or patient, rights to payment thereon have accrued, but the invoice has not been rendered to the applicable Obligor. 

“United States” or “U.S.” means the United States of America. 

“U.S. Dollars” or “US $” means the lawful currency of the United States. 

“Withdrawal Liability” shall mean liability to a Multiemployer Plan as a result of a complete or partial
withdrawal from such Multiemployer Plan, as such terms are defined in Part I of Subtitle E of Title IV of ERISA. 

SECTION 1.02.  Other Terms.   All terms used in Article 9 of the UCC in the State of New
York, and not specifically defined herein are used herein as defined in such Article 9. The words “herein,” “hereof,” and “hereunder” and other words of similar import refer to this Agreement as a whole, including
the exhibits and schedules hereto, as the same may from time to time be amended or supplemented and not to any particular section, subsection, or clause contained in this Agreement, and all references to Sections, Exhibits and Schedules shall mean,
unless the context clearly indicates otherwise, the Sections hereof and the Exhibits and Schedules attached hereto, the terms of which Exhibits and Schedules are hereby incorporated into this Agreement. Whenever appropriate, in the context, terms
used herein in the singular also include the plural, and vice versa. The words “including”, “included” and words of similar impact are not limiting. 

SECTION 1.03.  Accounting Terms and Principles.   All accounting terms not specifically
defined herein shall be construed in accordance with GAAP, and all accounting determinations required to be made pursuant hereto and all financial statements prepared hereunder shall, unless expressly otherwise provided herein, be made in accordance
with GAAP. If there occurs after the date hereof any change in GAAP that affects in any respect the calculation of any financial ratio or covenant, the Originators and the Buyer and its assigns shall negotiate in good faith any amendment
required in this Agreement with the intent of having the respective positions of the Originators and the Buyer after such change conform as nearly as possible to their respective positions as of the date of this Agreement and, until any such
amendments have been agreed upon, all calculations shall be made as if no change in GAAP has occurred. 
 SECTION
1.04.  Computation of Time Periods.   Unless otherwise stated in this Agreement, in the computation of a period of time from a specified date to a later specified date, the word “from” means “from and
including” and the words “to” and “until” each mean “to but excluding.” 

  
 23 

 ARTICLE II 

AMOUNTS AND TERMS OF THE PURCHASES. 

SECTION 2.01.  Agreement to Purchase. 

(a)      On the Initial Purchase Date and on each Business Day after the Initial Purchase until
the Termination Date (each, a “Purchase Date”), on the terms and conditions hereinafter set forth, and without recourse to the Originators (except to the extent specifically provided herein), each of the Originators hereby offers to
sell to the Buyer and, upon satisfaction of the applicable conditions set forth in Article III, each of the Originators does hereby sell and the Buyer does hereby purchase from each of the Originators on such Purchase Date all Receivables
owned by such Originator as of the close of business on the immediately preceding Business Day (other than any AccessOne Program Receivables originated prior to the date that is 30 days after the Closing Date) which have not been previously sold to
the Buyer hereunder, together with all of the Related Security relating to such Receivables and all Collections with respect to and other proceeds of such Receivables. 

(b)      The Buyer shall convey to the Authorized Representative, for the benefit of the
Originators, the Purchase Price in respect of each Purchase, which shall be conveyed in the manner provided in Sections 2.02 and 2.03. 

(c)      Effective on each Purchase Date hereunder, the Buyer shall own the Purchased Property
that was sold by the Originators to the Buyer on such Purchase Date, and the Originators shall not take any action inconsistent with such ownership and shall not claim any ownership interest in such Purchased Property. 

(d)      It is the intention of the parties hereto that each Purchase of Receivables to be made
hereunder shall constitute a “sale of accounts,” as such term is used in Article 9 of the UCC of the State of New York, and not a loan secured by such accounts. Each sale of Receivables by an Originator to the Buyer is made
without recourse; provided, however, that (i) the Originators shall be jointly and severally liable to the Buyer for all representations, warranties and covenants made by any Originator pursuant to the terms of this Agreement,
(provided, that the liability of the Specified Originators shall be limited to representations, warranties and covenants relating to the Purchased Property of each such Specified Originator), and (ii) such sale does not constitute and is not
intended to result in an assumption by the Buyer or any assignee thereof of any obligation of any Originator or any other Person arising in connection with the Purchased Property, or any other obligations of any Originator. In view of the
expressed intention of the parties hereto that the Purchases of Receivables to be made hereunder shall constitute a sale of such Receivables, each Originator agrees to note on its financial statements that the Receivables have been sold to the Buyer
to the extent other treatment in the financial statements is not required by GAAP. If at any time contrary to the mutual intent of the Originators and the Buyer a court characterizes the transactions hereunder as loans by the Buyer to the
Originators, then each of the Originators shall, effective as of the Closing Date (with respect to Initial Originators) or effective as of the date of such Originator’s Addition (with respect to Originators added as additional Originators
hereunder after the Closing Date), be deemed to have granted (and each Originator hereby does grant) to the Buyer a first priority security interest in all of its right and title to and interest in all Purchased Property and

  
 24 

 
the proceeds thereof as security for such loans and for the repayment of all amounts advanced to the Originators hereunder with accrued interest thereon, and this Agreement shall be deemed to be
a security agreement. 
 (e)      In no event does any Originator pledge, sell or offer to
sell, nor does the Buyer obtain a security interest, purchase or offer to purchase from any Originator, (A) any Self Pay Obligation or any collections thereon or proceeds thereof or (B) any account, general intangible, instrument, license, property
right, permit or any other contract or agreement to which such Originator is a party or any of its rights or interests thereunder if and for so long as the grant of such security interest or such sale shall constitute or result in (x) the
abandonment, invalidation or unenforceability of any right, title or interest of such Originator therein, or (y) a violation of a valid and enforceable restriction in respect of such account, general intangible, instrument, license, property right,
permit or any other contract or agreement or other such rights (1) in favor of a third party or (2) under any Applicable Law; provided, however, that such security interest shall attach, or such sale shall be consummated, immediately at such
time as the condition causing such abandonment, invalidation or unenforceability, as the case may be, shall be remedied and, to the extent severable, shall attach or be consummated, as applicable, immediately to any portion of such account, general
intangible, instrument, license, property right, permit or any other contract or agreement that does not result in any of the consequences specified in the immediately preceding clause (x) or clause (y) including any proceeds of such account,
general intangible, instrument, license, property rights, permit or any other contract or agreement. 
 SECTION
2.02.  Payment for the Purchases. 
 (a)      With respect to each Purchase,
the Buyer shall pay to the Authorized Representative for the benefit of the applicable Originator(s) an amount equal to the Purchase Price for such Purchased Property by means of any one or combination of the following in accordance with the terms
of Section 2.03:    (i) a transfer of funds to the Authorized Representative (for distribution or crediting by the Authorized Representative to such Originators), and (ii) an Originator Loan in accordance with
Section 2.03(c)(ii). 
 (b)      Settlement of the amounts specified in the
foregoing clause (a) shall be effected as provided in Section 2.03. 

(c)      Each of the Originators hereunder shall be deemed to have certified, with respect to
the Purchased Property to be Purchased by the Buyer on any Purchase Date, that its representations and warranties contained in Sections 4.01 and 4.02 are true and correct on and as of such day, with the same effect
as though made on and as of such day (other than any representation or warranty that is made as of a specific date), and that no Termination or Event of Termination has occurred and is continuing or would result therefrom. 

SECTION 2.03.  Settlement Procedures. 

(a)      On each Business Day during the term of this Agreement, the Buyer (or the Collection
Agent on behalf of the Buyer) shall remit to the Authorized Representative for the benefit of the Originators all funds that are received by the Buyer on such Business Day pursuant 

  
 25 

 
to the Contribution Agreement and the Buyer may (but is not required to) remit additional funds to the Authorized Representative for the benefit of the Originators. The funds transferred to the
Authorized Representative for the benefit of the Originators on a Business Day pursuant to the preceding sentence constitute the “Distributed Funds” for such Business Day, and all Distributed Funds transferred to the Authorized
Representative for the benefit of the Originators during a Collection Period constitute the “Monthly Distributed Funds” for such Collection Period. 

(b)       The Monthly Report with respect to each Collection Period shall specify, among
other things, the Aggregate Purchase Price, the aggregate Monthly Distributed Funds and the Noncomplying Receivables Adjustment due to the Buyer from the Originators, in each case in respect of such Collection Period. 

(c)       On each Settlement Date, based on calculations set forth in the Monthly Report:

 (i)         Monthly Distributable Funds for such Collection Period will be
credited to each Originator by the Authorized Representative in proportion to the Allocable Share of each Originator on such Settlement Date, to be applied in the following order: 

(1)      first, so long as (i) no Event of Termination exists, (ii) no Event of Default exists
under the Loan Agreement and (iii) no Event of Termination exists under the Contribution Agreement and otherwise to the extent permitted under the Originator Notes, to accrued and unpaid interest owed to such Originator in respect of the
Originator’s interest in the applicable Originator Note; 
 (2)      next, so long as
(i) no Event of Termination exists, (ii) no Event of Default exists under the Loan Agreement and (iii) no Event of Termination exists under the Contribution Agreement and otherwise to the extent permitted under the Originator Notes, to the extent of
remaining amounts, to unpaid principal owed to such Originator in respect of such Originator’s interest in the applicable Originator Note; 

(3)      then, to the extent of remaining amounts, to pay the unpaid Purchase Price of
Receivables transferred by such Originator to the Buyer; and 
 (4)      any remaining
Monthly Distributed Funds shall be returned to the Buyer, unless the Buyer elects to treat such amounts as Monthly Distributed Funds for the following Collection Period; and 

(ii)      to the extent that the funds available in the preceding clause (c)(i)(3) are
insufficient to pay the full unpaid Purchase Price of Receivables transferred by an Originator to the Buyer during the applicable Collection Period, the remaining amount owing to such Originator shall be treated as a loan from such Originator (an
“Originator Loan”) and shall be added to the principal balance of the applicable Originator Note on such Originator’s account. 

(d)      If the Authorized Representative or the Buyer notifies the Collection Agent of any
exceptions to its calculations in the Monthly Report, the Authorized Representative and the Buyer shall promptly endeavor to resolve and reconcile the matters set forth in such notice. 

(e)      The Authorized Representative on behalf of the relevant Originators shall make a
payment to the Buyer, within two Business Days of notice thereof and in immediately available funds in an amount equal to the Noncomplying Receivables Adjustment with respect to any Noncomplying Receivables identified by the Collection Agent or the
Buyer (or its assigns) from time to time. Notwithstanding such payment obligation, on any Settlement Date prior to the occurrence of a Termination or Event of Termination, the Buyer in its sole discretion may elect to setoff or subtract all or
a portion of such Noncomplying Receivables Adjustment for the related Collection Period from the Aggregate Purchase Price which would otherwise be paid to the Originators on such day, which setoff will reduce such payment obligation on a dollar for
dollar basis. 

  
 26 

 SECTION 2.04.  Payments and Computations, Etc.  The
payment or deposit of all amounts to be paid by the Originators or the Collection Agent to the Buyer hereunder shall be initiated in accordance with the terms hereof no later than 12:00 P.M. (New York City time) on the day when due in immediately
available funds to such account as the Buyer may from time to time specify in writing. In the event that any payment becomes due on a day which is not a Business Day, then such payment shall be made on the next succeeding Business Day. The
Originators shall, to the extent permitted by law, pay to the Buyer, on demand, interest on all amounts not paid when due hereunder (whether owing by an Originator individually, the Originators collectively or by a Collection Agent) at 2.0% per
annum above the Base Rate, payable on demand; provided, however, that such interest rate shall not at any time exceed the maximum rate permitted by applicable law. All computations of interest payable hereunder shall be made on the basis
of a year of 360 days for the actual number of days (including the first but excluding the last day) elapsed. 
 SECTION
2.05.  Transfer of Records to the Buyer. 
 (a)      Each Purchase of
Receivables hereunder shall include the transfer to the Buyer of all the applicable Originator’s right and title to and interest in the Records relating to such Receivables and rights to the use of such Originator’s computer software to
access and create the Records, and each of the Originators hereby agrees that such transfer shall be effected automatically with each such Purchase, without any action on the part of the parties hereto or any further documentation. 

(b)      Each of the Originators shall take such action requested by the Buyer, from time to
time hereafter, that may be necessary or appropriate to ensure that the Buyer and its assignees have (i) an enforceable ownership interest in the Records relating to the Receivables Purchased hereunder and (ii) an enforceable right (whether by
license or sublicense or otherwise) to use all of the computer software used to account for the Receivables and/or to recreate such Records. 

  
 27 

 ARTICLE III 

CONDITIONS OF PURCHASES 

SECTION 3.01.  Conditions Precedent to Initial Purchase.   The Initial Purchase hereunder is
subject to the conditions precedent that the Buyer shall have received on or before the Initial Purchase Date each of the items listed in Schedule II, each (unless otherwise indicated) dated such date, in form and substance
satisfactory to the Buyer. 
 SECTION 3.02.  Conditions Precedent to All
Purchases.     Each Purchase (including the Initial Purchase) shall be subject to the further conditions precedent that: 

(a)      with respect to any such Purchase, on or prior to the Purchase Date relating thereto,
the Collection Agent shall have delivered to the Buyer, in each case in form and substance satisfactory to the Buyer, a completed Monthly Report dated on or before the most recent Monthly Report Due Date; provided, that so long as
Professional Services is acting as Collection Agent, a Monthly Report delivered in a timely fashion under the Loan Agreement shall constitute delivery of a Monthly Report under this Section 3.02(a), 

(b)      each of the Originators shall have marked its master data processing records and all
other relevant records evidencing the Receivables which are the subject of such Purchase with a legend, acceptable to the Buyer, stating that such Receivables, the Related Security and Collections with respect thereto, have been sold in accordance
with this Agreement, 
 (c)      on the date of such Purchase, the following statements shall
be true: 
   (i)      The representations and warranties contained
in Article IV are correct on and as of such day as though made on and as of such date, except for those that refer to specific dates, which shall be correct as of the dates indicated therein, 

  (ii)     No event has occurred and is continuing, or would result from
such Purchase, which constitutes a Termination or an Event of Termination, and 

  (iii)    No law or regulation shall prohibit, and no order, judgment or
decree of any federal, state or local court or governmental body, agency or instrumentality shall prohibit or enjoin, the making of such Purchase by the Buyer in accordance with the provisions hereof. 

SECTION 3.03.  Sale Effective on the Purchase Date.   On each Purchase Date, each of the
Originators, by accepting the unconditional commitment of the Buyer on each Purchase Date to pay the Purchase Price on the related Settlement Date for such Purchase as provided in Section 2.03 shall be deemed to have certified to the
Buyer the satisfaction of the conditions precedent described in the immediately preceding Section 3.02. On the Purchase Date, title to the Purchased Property included in such Purchase shall vest irrevocably in the Buyer,
whether or not the conditions precedent to such Purchase were in fact satisfied; provided, that the obligation of the Buyer to pay the Purchase Price on the related Settlement Date is unconditional and irrevocable; and, provided, further,
however, that the Buyer shall not be deemed to have waived thereby any claim for indemnification it may have under this Agreement 

  
 28 

 
for the failure by any Originator in fact to have satisfied any such condition precedent. If any of the foregoing conditions precedent is not satisfied, the Buyer shall have available to it
(and shall not be deemed to have waived by reason of completing such Purchase) all applicable rights and remedies under this Agreement and otherwise. 

ARTICLE IV 
 REPRESENTATIONS AND
WARRANTIES 
 SECTION 4.01.  Representations and Warranties of the Originators.   Each of
the Originators represents and warrants as to itself as follows: 
 (a)      Such Originator
is either a corporation, a limited liability company or a limited partnership, duly incorporated or organized, validly existing and in good standing under the laws of its jurisdiction of incorporation or organization and is duly qualified to do
business, and is in good standing, in every jurisdiction in which the nature of its business requires it to be so qualified and the failure to do so could reasonably be expected to have a Material Adverse Effect. 

(b)      The execution, delivery and performance by such Originator of this Agreement and all
other Originator Documents to be entered into by it, including such Originator’s sale of Receivables and use of the proceeds of Purchases, are within such Originator’s corporate, limited liability company or partnership powers, have been
duly authorized by all necessary corporate, limited liability company or partnership action, do not contravene (i) such Originator’s charter, by-laws, limited liability company agreement or limited partnership agreement, (ii) any Applicable Law
except where such contravention could not reasonably be expected to result in a Material Adverse Effect, (iii) any material contractual restriction binding on or affecting such Originator or its property other than such restrictions that could
not reasonably be expected to adversely affect the Collection Agent’s ability to perform its material obligations hereunder or, with respect to the transfer of the Receivables and Collections thereon, in any Immaterial Respect, or (iv) any
material order, writ, judgment, award, injunction or decree binding on or affecting such Originator or its property, and do not result in or require the creation of any Lien upon or with respect to any of its properties (other than in favor of the
Buyer with respect to the Purchased Property), and no transaction contemplated hereby requires compliance with any bulk sales act or similar law. This Agreement and each other Originator Document to be entered into by such Originator have each
been duly executed and delivered by such Originator. 
 (c)      No authorization or approval
or other action by, and no notice to or filing with, any governmental authority or regulatory body is required for the due execution, delivery and performance by such Originator of this Agreement or any other Originator Document to be entered into
by it, except (i) for the filing of UCC financing statements, all of which financing statements have been duly filed and, to such Originator’s knowledge, are in full force and effect, (ii) such as have been made or obtained and are in full
force and effect and (iii) where the failure to make or obtain could not reasonably be expected to adversely affect such Originator’s ability to perform its material obligations hereunder or the ability to assign or collect the Receivables
hereunder. 

  
 29 

 (d)      This Agreement and each other Originator
Document to be entered into by such Originator constitute the legal, valid and binding obligation of such Originator enforceable against such Originator in accordance with their respective terms subject to bankruptcy and similar laws affecting
creditors generally and general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law). 

(e)      (i) The Authorized Representative has furnished to the Buyer and the Administrative
Agent copies of the Parent’s audited consolidated balance sheet as at December 31, 2011, and the related audited consolidated statements of income and cash flow for the fiscal year of the Parent then ended reported on by Deloitte & Touche
LLP which financial statements present fairly in all material respects in accordance with GAAP the financial position of the Parent and its consolidated subsidiaries as at December 31, 2011, and the results of operations of the Parent and its
consolidated subsidiaries for the fiscal year of the Parent then ended, which financial statements present fairly in all material respects in accordance with GAAP the financial position of the Parent and its consolidated subsidiaries as at such
date, and the results of operations of the Parent and its consolidated subsidiaries for the fiscal year then ended; and 

(ii)     Since December 31, 2011, (A) no material adverse change has occurred in
the business, assets, liabilities, financial condition or results of operations of the Parent and its subsidiaries taken as a whole, and (B) no event has occurred or failed to occur which has had or could reasonably be expected to result in, singly
or in the aggregate, a Material Adverse Effect. 
 (f)      Except as disclosed in the
periodic and other reports, proxy statements and other materials filed with or publicly furnished to the U.S. Securities Exchange Commission by the Parent and its subsidiaries prior to the date hereof, there is no material pending legal proceeding
(i) other than ordinary routine litigation incidental to the business, to which the Parent or any of its subsidiaries is a party or of which any of their property is the subject, or (ii) that could reasonably be expected to impair any material
rights, remedies or benefit that otherwise would be available to the Buyer, the Collection Agent or the Administrative Agent to obtain Collections on the Receivables. None of the Parent, CHS, any Originator or the Collection Agent is in default
with respect to any order of any court, arbitrator or governmental body except for defaults with respect to orders of governmental agencies which defaults are not material to the business or operations of the Parent and its subsidiaries taken as a
whole. 
 (g)      No proceeds of any Purchase will be used by such Originator to acquire any
security of a class which is registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended or in any transaction which is subject to Section 13 or 14 of the Securities Exchange Act of 1934, as amended. 

(h)      Immediately prior to each Purchase hereunder, each Receivable to be sold hereunder,
together with the Contract related thereto and the other Purchased Property relating thereto, is owned by such Originator free and clear of any Lien (other than Permitted Liens), and the Buyer shall acquire all of such Originator’s right, title
and interest in such Purchased Property and a valid and perfected first priority ownership interest in each such Receivable then existing or thereafter arising and in the Related Security and Collections with respect thereto, free and clear of any
Lien (other than Permitted Liens referred to in clauses (b) and (d) of the 

  
 30 

 
definition thereof) except as created hereby, by the Company under the Contribution Agreement (to the extent assigned to the Administrative Agent), and by the Administrative Agent under the Loan
Agreement; provided that any Originator (acting directly or through the Authorized Representative) shall have up to 10 days following actual knowledge thereof to remove any immaterial Lien that was improvidently filed without the consent of
such Originator or the Authorized Representative; provided further that Kay County Oklahoma Hospital Company, LLC (acting directly or through the Authorized Representative) shall have the time period specified in Section 5.01(u)
to remove and terminate the Kay County Lien. No effective financing statement or other instrument similar in effect covering any Purchased Property shall at any time be on file in any recording office except such as may be filed in favor of the
Buyer relating to this Agreement or in favor of the Company under the Contribution Agreement (to the extent assigned to the Administrative Agent), and by the Administrative Agent under the Loan Agreement; provided that any Originator (acting
directly or through the Authorized Representative) shall have up to 10 days following actual knowledge thereof to remove any immaterial Lien that was improvidently filed without consent of such Originator or the Authorized Representative;
provided further that Kay County Oklahoma Hospital Company, LLC (acting directly or through the Authorized Representative) shall have the time period specified in Section 5.01(u) to remove and terminate the Kay County
Lien. The Purchases of the Purchased Property by the Buyer constitute valid and true sales and transfers for consideration (and not merely a pledge of such Purchased Property for security purposes), enforceable against creditors of the Buyers
and no Purchased Property shall constitute property of such Originator.
 (i)      No Monthly
Report (if prepared by the Collection Agent, such Originator or any of their respective Affiliates, or to the extent that information contained therein is supplied by the Collection Agent, such Originator or any such Affiliates), information,
exhibit, financial statement, document, book, record or report furnished or to be furnished by the Authorized Representative or an Originator to the Buyer (or its assigns) in connection with this Agreement is or will be inaccurate in any material
respect as of the date it is or shall be dated or (except as otherwise disclosed to the Buyer, as the case may be, at such time) as of the date so furnished or dated, and no such document contains or will contain any material misstatement of fact or
omits or shall omit to state a material fact or any fact necessary to make the statements contained therein not misleading; provided that to the extent any such information, report, financial statement, exhibit or schedule was based upon or
constitutes a forecast or projection, such Originator represents only that it acted in good faith and utilized assumptions that such Originator believed to be reasonable at the time made.

(j)      Such Originator’s correct legal name, jurisdiction of incorporation or formation,
organizational identification number, principal place of business and chief executive office and the office where such Originator keeps all of its Records are set forth on Schedule III hereto. As of the Sixth Omnibus Amendment Effective
Date, such Originator does not have any currently registered trade names, fictitious names, assumed names or “doing business as” names or other names under which it is doing business, except as set forth on Schedule III. 

(k)     No event or circumstance has occurred and is continuing, or would result from any Purchase
hereunder or from the application of the proceeds therefrom, which constitutes an Event of Termination. 

  
 31 

 (l)       This Agreement is the only
agreement pursuant to which such Originator sells Receivables (other than, prior to May 31, 2012, AccessOne Receivables). 

(m)     The Purchase Price constitutes reasonably equivalent value in consideration for the transfer
to the Buyer of the Purchased Property from such Originator, no such transfer shall have been made for or on account of an antecedent debt owed by such Originator to the Buyer, and no such transfer is or may be voidable or subject to avoidance under
any section of the Bankruptcy Law. 
 (n)      Such Originator is not an insolvent person, in
insolvent circumstances or on the eve of insolvency, as applicable (within the meaning of such term in the Bankruptcy Law) and at the time of (and immediately after) each Purchase hereunder, such Originator shall not have been an insolvent person,
in insolvent circumstances or on the eve of insolvency, as applicable, within the meaning of the Bankruptcy Law. Such Originator will not become an insolvent person or be put in insolvent circumstances within the meaning of the Bankruptcy Law by
entering into, or immediately after completion of the transactions contemplated by, this Agreement. The transfers of Purchased Property by such Originator to the Buyer pursuant to this Agreement, and all other transactions between such Originator
and the Buyer, have been and will be made in good faith and not for the purpose of defeating, hindering, delaying, defrauding or oppressing the rights and claims of creditors or others against such Originator. 

(o)      Such Originator accounts for and otherwise treats each Purchase of Purchased Property
hereunder in its books, records and financial statements as a legal sale of such Purchased Property, in each case to the extent other treatment is not required by GAAP. 

(p)      Such Originator has not (i) guaranteed or otherwise become liable for any obligation
of the Company, allowed any of its other Affiliates to guarantee any obligations of the Company, and neither such Originator nor any of its other Affiliates has held itself out as responsible for debts of the Company or actions with respect to the
business and affairs of the Company, or (ii) permitted the commingling or pooling of its funds or other assets with those of the Company and has not otherwise permitted any other of its Affiliates to commingle or pool any of its funds or other
assets with those of the Company in a manner that would not allow such funds or other assets to be readily identifiable from those of any other Person. The Originators and the Company allocate between themselves shared corporate operating services
and expenses which are not reflected in the Servicing Fee (including the services of shared employees, consultants and agents and reasonable legal and auditing expenses) on the basis of the reasonably projected use or the projected value of services
rendered, and otherwise on a basis reasonably related to actual use or the value of services rendered. Such Originator acknowledges that the Company, the Lenders, the Managing Agents and the Administrative Agent are entering into the transactions
contemplated by the Contribution Agreement and the Loan Agreement in reliance upon the Company’s identity as a separate legal entity from each of the Parent, CHS, each Originator and each of their other respective Affiliates. 

(q)      Such Originator is not an “investment company” or a company controlled by an
“investment company” registered or required to be registered under the Investment Company Act. 

  
 32 

 (r)      Such Originator is not engaged,
principally or as one of its important activities, in the business of extending credit for the purpose of “purchasing” or “carrying” any “margin stock” (as each of the quoted terms is defined or used in
Regulation T, U or X promulgated pursuant to the Securities Exchange Act of 1934, as amended). No part of the proceeds of any Purchased Property has been used for so purchasing or carrying margin stock or for any purpose which violates, or
which would be inconsistent with, the provisions of Regulation T, U or X. 

(s)      Such Originator and the Collection Agent each has the right (whether by license,
sublicense or assignment) to use all of the computer software used by the Collection Agent and/or such Originator to account for the Purchased Property to the extent necessary to administer the Purchased Property, and, in the case of such Originator
and the Collection Agent, to assign (by way of sale) or sublicense such rights to use all of such software to the Buyer. 

(t)      Such Originator has filed or caused to be filed all federal and other material tax
returns which are required to be filed by it, and has paid or caused to be paid all taxes shown to be due and payable on such returns or on any assessments received by it, other than any taxes or assessments, (i) the validity of which are being
contested in good faith by appropriate proceedings and with respect to which such Originator has set aside or has caused to be set aside adequate reserves on its books (consolidated or otherwise) in accordance with GAAP or (ii) which the
failure to pay could not reasonably be expected to have a Material Adverse Effect. 

(u)      Except as could not reasonably be expected to result in material liability to an
Originator, such Originator and its ERISA Affiliates is in compliance in all material respects with the applicable provisions of ERISA and the Code and the regulations and published interpretations thereunder. No ERISA Event has occurred or is
reasonably expected to occur that, when taken together with all other such ERISA Events, could reasonably be expected to result in material liability of such Originator or any of its ERISA Affiliates. The present value of all benefit
liabilities under each Plan (based on the assumptions used for funding purposes) did not, as of the last annual valuation date applicable thereto, exceed the fair market value of the assets of such Plan in such amount that would reasonably be
expected to result in a funding obligation that could reasonably be expected to result in a Material Adverse Effect, and the present value of all benefit liabilities of all underfunded Plans (based on the assumptions used for funding purposes) did
not, as of the last annual valuation dates applicable thereto, exceed the fair market value of the assets of all such underfunded Plans in such amount that could reasonably be expected to result in a Material Adverse Effect. 

(v)      No Originator has intentionally (i) misstated any calculation of Eligible Receivables
or Net Receivables Balance hereunder (other than in an immaterial amount and based on good faith estimates utilized in the calculation thereof), or (ii) misrepresented any Receivable as qualifying as an Eligible Receivable or intentionally
included such misrepresented Receivable in the Net Receivables Balance at the time so included. 

(w)      All required Notices have been prepared and delivered to each of its Obligors (or, in
the case of a Governmental Entity, its fiscal intermediary), and all invoices issued after the Closing Date bear only the appropriate remittance instructions for payment 

  
 33 

 
direction to a Lock-Box or a Collection Account, as the case may be. No direction is in effect directing Obligors to remit payments on Receivables other than to a Lock-Box or a Collection
Account. 
 (x)      Each of the Collection Accounts has been established in the name of an
Originator by a Collection Account Bank, and a Concentration Account has been established in the name of the Company by each Concentration Account Bank. Such Originator has not established any lock-box, lock-box account or other deposit account
for the receipt of Collections other than the Lock-Boxes and Collection Accounts. Each Lock-Box is linked to a Collection Account. Each Collection Account has been set up so that all available funds automatically sweep to the applicable
Concentration Account at the end of each Business Day. Such Originator has taken, or has caused to be taken, all actions necessary or advisable to assure that all Collections are received in the Lock-Boxes and Collection Accounts. Such
Originator will not (i) close, or cause to be closed, any Lock-Box, any Collection Account or any Concentration Account or open, or cause to be opened, any new lock-box or account to function as a Lock-Box, a Collection Account or a Concentration
Account, (ii) make any change to the instructions to the Obligors that all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iii) make any change to the instructions to a Collection Account Bank as set
forth in the applicable Deposit Account Notification Agreement (Government Healthcare Receivables) requiring the automatic sweep of all available funds in each Collection Account to the applicable Concentration Account at the end of each Business
Day, in each case, without the prior written consent of the Buyer and the Administrative Agent and each Managing Agent; provided, if any Originator violates any of the provisions under clauses (i), (ii) or (iii) above with respect to any
Lock-Box or Collection Account relating to such Originator without the prior knowledge or consent of the Buyer or the Collection Agent, the Originator (itself or through the Collection Agent) shall have the opportunity to cure the violation of this
clause (x) within 15 days of obtaining knowledge of such breach and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or warranty by any Originator
under any Facility Document directly related to or directly arising from such violation without any further action. 

(y)      No Lien on such Originator’s inventory attaches to the proceeds of the sale of
such inventory to the extent that such sale would give rise to a Receivable. 
 (z)      Each
Originator has all power and authority, and has all material permits, licenses, accreditations, certifications, authorizations, approvals, consents and agreements of all Obligors, Governmental Entities, accreditation agencies and other Persons
(including (i) accreditation by the appropriate Governmental Entities and industry accreditation agencies, (ii) accreditation and certifications as a provider of healthcare services eligible to receive payment and compensation and to
participate under Medicare, Medicaid, TRICARE/CHAMPUS, Blue Cross/Blue Shield and other equivalent programs in which such Originator participates, and (iii) valid provider identification numbers and licenses to generate the Receivables) necessary or
required for it, except in any Immaterial Respect, (A) to own the assets (including Receivables) that it now owns, (B) to carry on its business as now conducted, (C) to execute, deliver and perform this Agreement and the other Originator Documents
to which it is a party, and (D) if applicable, to receive payments from the Obligors in the manner contemplated in this Agreement and the other Originator Documents, except in an Immaterial Respect. 

  
 34 

 (aa)    Each Originator, except in any Immaterial Respect
has (i) maintained all relevant records required to be maintained by the Joint Commission on Accreditation of Healthcare Organizations, the Food and Drug Administration, the Drug Enforcement Agency, the State Boards of Pharmacy, and the federal and
state Medicare and Medicaid programs as required by Healthcare Laws, and that, to the best knowledge of each Originator, there are no presently existing circumstances which likely would result in material violations of any Healthcare Laws and (ii)
complied in all material respects with all other Applicable Law to which it may be subject and no Receivable or other Purchased Property contravenes in any material respect any Applicable Law, except in any Immaterial Respect. 

(bb)    Commencing September 30, 2012, Patient Consent Forms are being obtained from each patient and
customer receiving services or products. 
 (cc)    Without limiting or being limited by any other
provision of any Originator Document, each Originator has timely filed or caused to be filed all material cost and other reports of every kind required by law, agreement or otherwise. There are no material claims, actions or appeals pending before
any commission, board or agency or other Governmental Entity, including any intermediary or carrier, the Provider Reimbursement Review Board, or the administrator of CMS, with respect to any material state or federal Medicare or Medicaid cost
reports or material claims filed by any Originator, or any disallowance by any commission, board or agency or other Governmental Entity in connection with any audit of such cost reports, except in any Immaterial Respect or which would affect the
ability of the Buyer to fulfill its material obligations under any Facility Document. No validation review or program integrity review related to any Originator, the consummation of the transactions contemplated by this Agreement, or the Purchased
Property have been conducted by any commission, board, or agency or other Governmental Entity in connection with the Medicare or Medicaid programs, and, to the knowledge of the Originators, no such reviews are scheduled, pending, or threatened
against or affecting any of the Originators, any of the Purchased Property or the consummation of the transactions contemplated by this Agreement except in any Immaterial Respect or which would affect the ability of the Buyer to fulfill its material
obligations under any Facility Document. 
 (dd)    No Originator has been notified by any Governmental
Entity, accreditation agency or any other Person, during the immediately preceding 24-month period, that such Person has rescinded or not renewed, or is reasonably likely to rescind or not renew, any material permit, license, accreditation,
certification, authorization, approval, consent or agreement granted to it or to which it is a party and no other condition exists or event has occurred which, in itself or with the giving of notice or lapse of time or both, would result in the
suspension, revocation, impairment, forfeiture or non renewal of any material permit, license, authorization, approval, entitlement or accreditation, and to the best of each Originator’s knowledge, there is no claim that any thereof is not in
full force and effect. 
 (ee)    No portion of the Originator’s assets include “plan
assets” of any “benefit plan investor” within the meaning of Section 3(42) of ERISA. 

  
 35 

 (ff)     Notice of termination of each of the
agreements and other documents relating to the sale, purchase or transfer of AccessOne Program Receivables from an Originator to any Person other than the Buyer has been provided to such Person prior to the Closing Date. 

(gg)    Kay County Oklahoma Hospital Company, LLC represents and warrants that the Kay County Lien was
filed as a result of a good faith error on the part of Kay County Oklahoma Hospital Company, LLC and that the original amount of all federal tax liabilities owing by it (excluding interest and penalties relating to such good faith error) has been
remitted to the Internal Revenue Service. 
 (hh)    Policies and procedures have been implemented and
maintained by or on behalf of each of the Originators that are designed to achieve compliance by each of the Originators and their respective Subsidiaries, directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions,
giving due regard to the nature of such Person’s business and activities, and each of the Originators and their respective Subsidiaries and, to the knowledge of each of the Originators, any of their respective officers, employees, directors and
agents acting in any capacity in connection with or directly benefitting from the loan facility established by the Facility Documents, are in compliance with Anti-Corruption Laws and applicable Sanctions, in each case in all material respects. None
of (a) the Originators or any of their respective Subsidiaries or, to the knowledge of the Originators, as applicable, any of their respective directors, officers, employees, or agents that will act in any capacity in connection with or directly
benefit from the loan facility established by the Facility Documents, is a Sanctioned Person, and (b) the Originators nor any of their respective Subsidiaries is organized or resident in a Sanctioned Country. No use of proceeds of any Purchase by
any Originator in any manner will violate Anti-Corruption Laws or applicable Sanctions.

(ii)      No Originator is an EEA Financial Institution (as defined in the Loan Agreement).

 SECTION 4.02.  Article 9 Representations and Warranties.     Each of the
Originators represents and warrants as follows: 
 (a)      This Agreement creates a valid
and continuing security interest (as defined in the applicable UCC) in the Receivables in favor of the Buyer, which security interest is prior to all other Liens, and is enforceable as such against creditors of and purchasers from the such
Originator. 
 (b)      The Receivables constitute “accounts” (including
health-care-insurance receivables) or general intangibles within the meaning of the applicable UCC. 

(c)      Immediately prior to each Purchase hereunder, an Originator owns and has good and
marketable title to the Receivables and the other Purchased Property free and clear of any Lien of any Person. 

(d)      Such Originator has caused or will have caused, within ten days after the date hereof,
the filing of all appropriate financing statements in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect the security interest in the Receivables granted to the Buyer hereunder. 

  
 36 

 (e)      Other than the ownership interest granted
to the Buyer pursuant to this Agreement, such Originator has not pledged, assigned, sold, granted a security interest in, or otherwise conveyed any of the Receivables. Such Originator has not authorized the filing of and is not aware of any
financing statements against such Originator relating to the Receivables or to all assets of such Originator other than any financing statement relating to (i) the security interest granted to the Buyer hereunder and (ii) the security interest
granted to the collateral agent under the Parent Credit Agreement. Such Originator is not aware of any judgment or tax lien filings against it, except, in the case of Greenbrier VMC, LLC, West Virginia state tax lien filings against it as set forth
on Schedule VI, which tax liens were resolved within six months of the Closing Date. 
 ARTICLE V 

GENERAL COVENANTS 

SECTION 5.01.  General Covenants. 

(a)      Compliance with Laws; Preservation of Existence.  Each Originator
shall comply in all material respects with all Applicable Law (including all applicable Healthcare Laws), orders and Originator Documents and preserve and maintain its corporate, limited liability company or limited partnership existence, rights,
franchises, qualifications and privileges, except where the failure to comply could not reasonably be expected to materially adversely affect such Originator’s ability to perform its obligations hereunder or the ability to sell or collect the
Purchased Property hereunder. 
 (b)      Sales, Liens, Etc.   Except
as otherwise specifically provided herein, no Originator shall (i) sell, assign (by operation of law or otherwise) or otherwise dispose of, or create or suffer to exist any Lien (other than Permitted Liens referred to in clauses (b), (c) and (d) of
the definition thereof) upon or with respect to, any of its Receivables, Related Security, Collections, any Collection Account or any Concentration Account, or assign any right to receive income in respect thereof or (ii) create or suffer to exist
any Lien (other than Permitted Liens referred to in clauses (c) and (d) of the definition thereof) upon or with respect to the proceeds of the sale of any of such Originator’s inventory, to the extent such sale would give rise to a Receivable;
provided, that the relevant Originator shall have up to 10 days following actual knowledge thereof to remove any immaterial Lien that was improvidently filed without the consent of such Originator; provided further that Kay County
Oklahoma Hospital Company, LLC (acting directly or through the Authorized Representative) shall have the time period specified in Section 5.01(u) to remove and terminate the Kay County Lien. 

(c)      General Reporting Requirements.   The Authorized Representative
will provide to the Buyer the following: 
 (i)      within 90 days after the
end of each fiscal year of the Parent, a copy of the consolidated balance sheet of the Parent and its consolidated subsidiaries (including each Originator) and the related statements of income, stockholders’ equity and cash flows for such year,
each prepared in accordance with GAAP consistently applied and reported on by nationally recognized independent public accountants; 

  
 37 

 (ii)       within 50 days
after the end of each of the first three quarters of each fiscal year of the Parent, the consolidated balance sheet of the Parent and its consolidated subsidiaries (including each Originator) and the related statements of income, stockholders’
equity and cash flows each for the period commencing at the end of the previous fiscal year and ending with the end of such quarter, prepared in accordance with GAAP and certified by a senior financial officer of the Parent; 

(iii)      promptly after the same becomes publicly available, copies of all
reports and registration statements which the Parent files with the Securities and Exchange Commission or any national securities exchange other than registration statements relating to employee benefit plans and to registrations of securities for
selling securityholders; 
 (iv)      as soon as possible and in any event
within the greater of five days or three Business Days after any Originator, the Administrative Agent or the Collection Agent has knowledge of the occurrence of each Termination or Event of Termination, a statement of a Responsible Officer of such
Person setting forth details of such Termination or Event of Termination and the action which such Person and the Originators have taken and propose to take with respect thereto; 

(v)       promptly following the Buyer’s request therefor, such other
information, approvals or opinions respecting the Receivables or the conditions or operations, financial or otherwise, of any Originator or any of its Affiliates as the Buyer may from time to time reasonably request in order to protect the interests
of the Buyer and its assigns in connection with this Agreement; 

(vi)      promptly after the request by the Buyer, copies of (i) any documents
described in Section 101(k)(1) of ERISA that the Parent or any of its ERISA Affiliates may request with respect to any Multiemployer Plan and (ii) any notices described in Section 101(l)(1) of ERISA that the Parent or any of its ERISA Affiliates may
request with respect to any Multiemployer Plan; provided that if the Parent or any of its ERISA Affiliates has not requested such documents or notices from the administrator or sponsor of the applicable Multiemployer Plan, the Parent or the
applicable ERISA Affiliate shall promptly make a request for such documents or notices from such administrator or sponsor and shall provide copies of such documents and notices promptly after receipt thereof; and 

(vii)     as soon as possible after, and in any event within ten days after any
Responsible Officer of the Parent, any Originator or any ERISA Affiliate knows or has reason to know that, any ERISA Event has occurred that, alone or together with any other ERISA Event could reasonably be expected to result in liability of the
Parent or any ERISA Affiliate in an aggregate amount exceeding $10,000,000, a statement of a Responsible Officer of the Parent or the Authorized Representative setting forth details as to such ERISA Event and the action, if any, that the Parent or
the Originators propose to take with respect thereto. 

  
 38 

 Documents required to be delivered pursuant to Section 5.01(c)(i), (ii) or (iii)
(to the extent any such documents are included in materials otherwise filed with the Securities and Exchange Commission) shall be deemed to have been delivered on the date on which such documents are available on the Securities and Exchange
Commission’s electronic database (EDGAR); provided that upon the request of the Buyer or the Authorized Representative shall deliver paper copies of such documents to the Buyer until a written request to cease delivering paper copies is
given by the Buyer. 
 (d)      Merger, Etc.  No Originator shall (i) merge
or consolidate with any other Person unless (A) that Person is an Originator and (B) no Termination or Event of Termination has occurred and is continuing or would result therefrom, or (ii) convey, transfer, lease, assign, or otherwise dispose of
all or substantially all of its assets, except (A) any Originator may purchase and sell inventory in the ordinary course of business and (B) so long as no Termination or Event of Termination has occurred and is continuing or would result therefrom,
(x) dispositions of assets in the ordinary course of its business for fair value that do not materially alter the nature of such Originator’s business or operations or (y) such sale is to another Originator and has no adverse impact on the
rights of the Buyer (including its rights in and to the Receivables and Collections thereon). 

(e)      Treatment of Purchases.   Each Originator will account for and
treat (whether in financial statements, records or otherwise) the transactions contemplated hereby as a legal sale of the Purchased Property by such Originator to the Buyer. 

(f)      Maintenance of Separate Existence.  Each Originator will take all
actions required on its part to help maintain the Company’s status as a separate legal entity, including (i) not misleading third parties as to the Company’s identity as an entity with assets and liabilities distinct from those of such
Originator and its Affiliates, (ii) refraining from (A) guaranteeing or otherwise becoming liable for any obligations of the Company, (B) having obligations guaranteed by the Company and (C) holding itself out as responsible for debts of the Company
or for decisions or actions with respect to the affairs of the Company, (iii) using its best efforts not to commingle its funds or other assets with those of the Company, and not to hold its assets in any manner that would create an appearance that
such assets belong to the Company or that the Company’s assets belong to it, (iv) taking such action as is necessary on its part to ensure that the covenants made in Section 5.01(h) and Section 5.01(e) of the Loan Agreement is not
breached, (v) taking such other actions as are necessary on its part to ensure that the representations made in Section 4.01(p) hereunder and by the Company in Section 4.01(t) of the Loan Agreement are true and correct
at all times, and (vi) taking such actions as are necessary on its part to ensure that the Company’s limited liability company procedures required by its limited liability company agreement are duly and validly taken. Without limiting the
foregoing, the Authorized Representative and each Originator will cause any financial statements consolidated with those of the Company to contain footnotes or other disclosures which describe the Company’s business and otherwise inform each
Originator’s creditors that the Company is a separate entity whose creditors have a claim on its assets prior to those assets becoming available to its equity holders and therefore to any creditors of an Originator or any of its Affiliates, to
the extent other treatment is not required by GAAP. 

  
 39 

 (g)      Change in Company
Name.   No Originator will make any change to its legal name unless it shall have, prior to the effectiveness of such name change: (i) given the Buyer prompt written notice thereof and (ii) delivered to the Buyer (in a manner
that will provide reasonable opportunity to allow the Buyer to make the filing thereof prior to or simultaneously with the effectiveness of such name change) all financing statements, instruments and other documents the Buyer determines are
necessary or appropriate to file under the UCC or that are otherwise necessary or appropriate for the Buyer to continue at all times following such change to have a valid, legal and perfected security interest in the Purchased Property of such
Originator. 
 (h)      Audits.   From time to time, but at least once
per calendar year, upon reasonable prior written notice from the Buyer during regular business hours, each Originator will permit the Buyer, or its agents or representatives, to (i) examine and make copies of and abstracts from all Records, (ii)
visit the offices and properties of each Originator for the purpose of examining such Records, and to discuss matters relating to the Receivables or each Originator’s performance hereunder with any of the officers or employees of such
Originator having knowledge of such matters and (iii) have access to its software for the purposes of examining such Records; provided that, in no event shall any Originator be required to allow examination of or access to “Protected Health
Information”, as such term is defined in regulations implementing HIPAA, where such examination or access is prohibited by Applicable Law without a Patient Consent Form that lists the Buyer and its specific agents or representatives who will
access “Protected Health Information”. Unless an Event of Termination or an “Event of Default” or a “Trigger Event” under the Contribution Agreement or the Loan Agreement has occurred and is continuing, only one such
examination and visit per calendar year shall be at the expense of the Originators. 

(i)       Keeping of Records and Books of Account.  Each Originator will
maintain (or cause to be maintained) and implement administrative and operating procedures (including an ability to recreate records evidencing the Receivables in the event of the destruction of the originals thereof) and keep and maintain, all
documents, books, records and other information reasonably necessary or advisable for the collection of all Purchased Property (including records adequate to permit the daily identification of each new Receivable and all collections of and
adjustments of each Receivable). Each Originator will indicate in its books and records that its Receivables have been transferred to CHS. 

(j)       Jurisdiction of Organization; Location of Records;
Structure.    Each Originator will keep its jurisdiction of incorporation or organization, principal place of business and chief executive office and the offices where it keeps its Records, in the jurisdictions and at the
addresses set forth on Schedule III, or, in any such case, upon prompt prior written notice to the Buyer in the manner provided in Section 6.08, at such other jurisdiction or locations within the United States where
all action required by Section 6.08 shall have been taken and completed, and will not change its structure or identity other than upon prior written notice to the Buyer and subject to the further requirement that all action
required by Section 6.08 shall have been taken and completed. 

(k)      Credit and Collection Policy.   Each Originator will, and will
cause the Collection Agent to, comply in all material respects with the Credit and Collection Policy in regard to each Receivable and the related Contract. No Originator shall, without the written 

  
 40 

 
consent of the Buyer and the Administrative Agent, (i) make any material change in the character of its business such that its principal business ceases to be a provider of healthcare
services, or (ii) make or agree to make or permit any material change in the Credit and Collection Policy other than in accordance with Section 6.02(c). 

(l)      Change in Payment Instructions to Obligors.  No Originator will (i)
add or terminate any bank as a Collection Account Bank, (ii) close any Lock-Box or any Collection Account or open any new lock-box or account to function as a Lock-Box or Collection Account, (iii) make any change to the instructions to the Obligors
that all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iv) make any change to the instructions to a Collection Account Bank as set forth in the applicable Deposit Account Notification Agreement
(Government Healthcare Receivables) requiring all available funds in each Collection Account to automatically sweep to the applicable Concentration Account at the end of each Business Day, in each case, without the prior written consent of the
Buyer, Administrative Agent and each of the Managing Agents in their sole discretion, which consent shall not be unreasonably withheld or delayed; provided, if any Originator violates any of the provisions under clauses (i) through (iv) above
with respect to any Lock-Box or Collection Account relating to such Originator without the prior knowledge or consent of the Buyer or the Collection Agent, the Originator (itself or through the Collection Agent) shall have the opportunity to cure
the violation of this clause (l) within 15 days of obtaining knowledge of such breach and, if such violation is cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or
warranty by any Originator under any Facility Document directly related to or directly arising from such violation without any further action. 

(m)     Taxes.  Each Originator will file or cause to be filed all federal and
other material tax returns which are required to be filed by it. Each Originator shall pay or cause to be paid all taxes shown to be due and payable on such returns or on any assessments received by it, other than any taxes or assessments, the
validity of which are being contested in good faith by appropriate proceedings and with respect to which such Originator shall have set aside or has caused to be set aside adequate reserves on its books (consolidated or otherwise) in accordance with
GAAP. 
 (n)      Originator Documents.    Each Originator will
comply in all material respects with the terms of this Agreement and employ the procedures outlined herein, enforce all of its other rights under each of the Originator Documents to which it is a party, take all such action to such end as may be
from time to time reasonably requested by the Buyer, and maintain all such Originator Documents and the UCC financing statements filed in connection with this Agreement in full force and effect. 

(o)      Segregation of Collections.  Each Originator will require the deposit
of all Collections into a Collection Account and the deposit of all Collections received in the Collection Accounts solely into the applicable Concentration Account, will prevent the deposit into any Concentration Account of any funds other than
Collections and proceeds of Self Pay Obligations and, with respect to proceeds of Self Pay Obligations, each Originator will hold all such proceeds in trust for the applicable Originator and promptly (and in any event within three Business Days)
identify such funds to the Collection Agent for segregation and remittance to the 

  
 41 

 
owner thereof; provided, that each Originator and the Collection Agent will use reasonable efforts to avoid deposit of the proceeds of Self Pay Obligations into any Collection Account or
Concentration Account if such parties determine in their reasonable business judgment that it is practical to do so, except to the extent requiring unreasonable additional effort or expense; provided further that the parties acknowledge that
each Originator and the Collection Agent have determined that such identification and segregation is impractical as of the Second Omnibus Amendment Effective Date. With respect to any funds other than Collections and proceeds of Self Pay Obligations
that are nevertheless deposited into such Concentration Account, each Originator will promptly identify any such funds to the Collection Agent for segregation and remittance to the owner thereof. 

(p)      Payment to Lenders.     The Originators (other than
any Specified Originator) will pay to the Buyer (and forward to the Administrative Agent) all amounts owing (i) by the Company to the Lenders under Article VIII of the Loan Agreement, or (ii) by Buyer to the Company under Article VII of the
Contribution Agreement. 
 (q)      Modifications to
Contracts.   Except as provided in Section 6.02, no Originator will, nor will it suffer or permit the Collection Agent to, extend, amend or otherwise modify the terms of any Eligible Receivable or any Contract related
thereto. 
 (r)       Sales Taxes.  Each Originator shall timely pay or
cause to be paid when due all sales, excise or personal property taxes payable in connection with the Receivables, other than any taxes or assessments, the validity of which are being contested in good faith by appropriate proceedings and with
respect to which the Originator has set aside or has caused to be set aside adequate reserves on its books (consolidated or otherwise) in accordance with GAAP. 

(s)       Deviation from Patient Consent Form.  At any time following
September 30, 2012, without the prior written consent of the Buyer, no Originator will, nor will it suffer or permit the Collection Agent to, substitute, alter, modify, or change in any way any of the Patient Consent Forms except in an Immaterial
Respect. 
 (t)       AccessOne Program Receivables.   After May
31, 2012, no Receivables will be sold pursuant to any agreement other than the Documents, and prior to May 31, 2012, the aggregate Expected Net Value of the AccessOne Program Receivables shall not exceed $500,000. 

(u)      Kay County Lien.  Kay County Oklahoma Hospital Company, LLC, as an
Originator (acting directly or through the Authorized Representative), will, and will cause the Collection Agent to, remove and terminate the Kay County Lien within six months of the Second Omnibus Amendment Effective Date and will utilize its best
efforts to remove and terminate such Kay County Lien as promptly as practicable, and the existence of the Kay County Lien shall not constitute a breach of this covenant or any other representation or covenant hereunder during the continuance of such
time period. 
 (v)      Anti-Corruption Laws and Sanctions – Policies and
Procedures.  Policies and procedures will be maintained and enforced by or on behalf of each Originator that are 

  
 42 

 
designed in good faith and in a commercially reasonable manner to promote and achieve compliance, in the reasonable judgment of such Originator, by such Originator and its directors, officers,
employees and agents with Anti-Corruption Laws and applicable Sanctions, in each case giving due regard to the nature of such Person’s business and activities. 

(w)      Anti-Corruption Laws and Sanctions – Requests for Advances and Uses of
Proceeds.  Each Originator and each of their Affiliates and its or their respective directors, officers, employees and agents shall not use, the proceeds of any Purchase (A) in furtherance of an offer, payment, promise to pay, or
authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (B) for the purpose of funding or financing any activities, business or transaction of or with any Sanctioned Person,
or in any Sanctioned Country, in each case to the extent doing so would violate any Sanctions, or (C) in any other manner that would result in liability to any party hereto under any applicable Sanctions or the violation of any Sanctions by any such
Person. 
 ARTICLE VI 

ADMINISTRATION, COLLECTION AND MONITORING OF ASSETS 

SECTION 6.01.  Appointment and Designation of the Collection Agent.   The Authorized
Representative and the Buyer may, from time to time, appoint one or more Persons as the Collection Agent of the Buyer to service, administer and collect the Receivables and otherwise to enforce its rights and interests in, to and under the
Receivables, the Related Security and the Contracts. The Collection Agent’s authorization under this Agreement shall terminate on the Collection Date. Until the Buyer, with the consent of the Administrative Agent as its assignee, gives notice
to the Authorized Representative of a designation of a new Collection Agent after the occurrence and during the continuance of a Servicer Termination Event, Professional Services is hereby designated as, and hereby agrees to perform the duties and
obligations of, the Collection Agent pursuant to the terms hereof. The Authorized Representative, the Buyer and the Collection Agent may from time to time agree in any collection agency or services agreement among them on the allocation of servicing
duties to be performed by the Collection Agent. Notwithstanding the foregoing, the Buyer may (with the approval of the Administrative Agent, as its assignee, and the Managing Agents), after the occurrence and during the continuance of a Servicer
Termination Event, designate as Collection Agent any Person to succeed Professional Services or any successor Collection Agent, on the condition in each case that any such Person so designated shall agree to perform the duties and obligations of the
Collection Agent pursuant to the terms hereof and of the Contribution Agreement and the Loan Agreement and in accordance with applicable Healthcare Laws. Each of the Originators hereby grants to the Collection Agent and any successor Collection
Agent, and the Collection Agent hereby grants to any successor Collection Agent, an irrevocable power of attorney, with full power of substitution, coupled with an interest, to take any and all steps in any Originator’s or the Collection
Agent’s name, as applicable, and on behalf of the Buyer, as may be necessary or desirable, in the determination of the Collection Agent or the successor Collection Agent, as the case may be, to collect all amounts due under any and all
Receivables, including endorsing such Originator’s name on checks and other instruments representing Collections and enforcing such Receivables and the related Contracts. The Collection Agent may subcontract the performance of its duties and
obligations to a third Person with the prior consent of Buyer, including with respect to Collection Agency Receivables. Any such 

  
 43 

 
subcontract shall not affect the Collection Agent’s liability for performance of its duties and obligations pursuant to the terms hereof, and any such subcontract shall automatically
terminate upon designation of a successor Collection Agent. Notwithstanding anything to the contrary contained in this Agreement, the Collection Agent, if not an Originator or an Affiliate thereof, shall have no obligation to collect, enforce or
take any other action described in this Article VI with respect to any Receivable that is not a Purchased Receivable other than to deliver to the Authorized Representative or at its direction, the Collections and documents
with respect to any such Receivable that is not a Purchased Property as described in Sections 6.03 and 6.07. 

SECTION 6.02.  Collection of Receivables by the Collection Agent; Extensions and Amendments of Receivables.

 (a)      The Collection Agent shall take or cause to be taken all such reasonable actions
as may be necessary or advisable to collect each Receivable from time to time, all in accordance with Applicable Law, with reasonable care and diligence, and in accordance with the Credit and Collection Policy; provided, however, that, if a
Servicer Termination Event shall have occurred and be continuing, (i) the Buyer shall have the right to direct the Collection Agent (whether the Collection Agent is an Originator or an Affiliate thereof or otherwise) to commence or settle any legal
action, to enforce collection of any Purchased Property or to foreclose upon or repossess any Related Security, and (ii) the Collection Agent shall not make the Buyer a party to any litigation without the express written consent of the Buyer, such
consent not to be unreasonably withheld or delayed. If the Termination Date shall not have occurred, Professional Services, while such Person is the Collection Agent, may, with respect to the Receivables and, with respect to any Eligible Receivable,
in accordance with the Credit and Collection Policy, (i) extend the maturity or adjust the Expected Net Value of any Defaulted Receivable as Professional Services may determine to be appropriate to maximize Collections thereof and (ii) adjust the
Expected Net Value of any Receivable to reflect (x) any reduction or adjustment as a result of any defective, rejected, returned, repossessed or foreclosed merchandise, any defective or rejected services, any failure to provide services, any
discount, rebate or any other adjustment made or performed by the Company or any other Person or (y) any reduction or cancelation as a result of a setoff in respect of any claim by the Obligor thereof against an Originator or an Affiliate of an
Originator or an Affiliate of an Originator, in each such case (except with respect to Receivables which are not Eligible Receivables) (x) in accordance with the requirements of the Credit and Collection Policy and (y) provided that such extension
or adjustment shall not alter the status of such Receivable as a Defaulted Receivable or limit the rights of the Buyer under this Agreement. Except as otherwise permitted pursuant to the immediately preceding sentence, neither the Collection Agent
nor any Originator will extend, amend, cancel or otherwise modify the terms of any Receivable without the prior written approval of the Buyer, or amend, modify, cancel or waive any term or condition of any Contract related to a Receivable, except to
the extent consistent with the Credit and Collection Policy or otherwise with the prior written approval of the Buyer. 

(b)      Notwithstanding anything else contained herein, neither the Collection Agent nor any
subcontractor or delegatee thereof is the agent of the Buyer, and they are not permitted to (nor do they have any authority to) (i) establish an office or other fixed place of business of the Buyer, or (ii) contract for, or conclude a contract in
the name of, the Buyer. 

  
 44 

 (c)      The Credit and Collection Policy may be
amended from time to time provided that (i) no change shall be made in the Credit and Collection Policy that would be adverse to any of the Buyer or its assignees, including by impairing the collectibility of any Receivable or the ability of the
Buyer or the Collection Agent to perform its obligations under this Agreement, the Contribution Agreement or the Loan Agreement and (ii) in the event that any change is made to the Credit and Collection Policy, promptly following such change and, in
any event within 30 days thereof, the Collection Agent shall provide the Buyer with an updated Credit and Collection Policy and a summary of all material changed. 

SECTION 6.03.  Distribution and Application of Collections.    The Collection Agent
shall set aside and segregate all Collections of Receivables from the other funds belonging to the Collection Agent. The Collection Agent shall as soon as practicable (and in any event within two Business Days) following receipt turn over to
the Authorized Representative or other Person entitled thereto the collections of any account receivable which is not a Purchased Property less, in the event neither Professional Services nor an Affiliate thereof is the Collection Agent, all
reasonable and appropriate out-of-pocket costs and expenses of the Collection Agent of servicing, collecting and administering the Receivables to the extent not covered by the Servicing Fee received by it. 

SECTION 6.04.  Other Rights of the Buyer.    At any time following the occurrence and
during the continuance of a Servicer Termination Event or the designation pursuant to Section 6.01 of a Collection Agent other than Professional Services, the Buyer or any Affiliate of either thereof, subject to Applicable
Law: 
 (a)      The Buyer may or, at the request of the Buyer, the Originators shall (in
either case, at the Originators’ expense) direct any or all of the Obligors to pay all amounts payable under any Receivable directly to the Buyer or its designee; 

(b)      The Buyer may or, at the request of the Buyer, the Originators shall (in either case,
at the Originators’ expense) give each of the Obligors notice of the Buyer’s interests in the Purchased Property; 

(c)      The Buyer may have a representative present during any or all business hours at each
office of the Collection Agent and the Originators involved in the administration, servicing and collections of the Receivables; 

(d)      The Buyer, or its representatives, may, during regular business hours, (i) review
any or all Records, computer programs and files related to the administration, servicing and collection of the Receivables and (ii) visit the offices of the Originators for the purpose of such review, and, at the Buyer’s request and at the
Originators’ expense, the Buyer shall (i) assemble all Records and make the same available to the Buyer or its designee at a place selected by the Buyer or its designee, and (ii) segregate all cash, checks and other instruments received by
it from time to time constituting Collections of Receivables in the manner provided herein or such other manner acceptable to the Buyer and, promptly following receipt, remit all such cash, checks and instruments, duly endorsed or with duly executed
instruments of transfer, to the Buyer or its designee; and 
 (e)      The Buyer shall have
all other rights and remedies provided under the UCC and other Applicable Law, which rights and remedies shall be cumulative. 

  
 45 

 SECTION 6.05.  Records. 

(a)      Each Originator will maintain and implement administrative and operating procedures
(including an ability to recreate records evidencing the Receivables in the event of the destruction of the originals thereof), and keep and maintain all documents, books, records and other information reasonably necessary or advisable for the
timely and full collection of all Receivables (including records adequate to permit the daily identification of each new Purchased Property and all Collections of and adjustments to each existing Purchased Property). Each Originator will
indicate in its books and records that its Receivables have been transferred to CHS. The Collection Agent will maintain access and copies of all such documents, books, records and other information of the Originators necessary to comply with
clause (b) below. 
 (b)      Each Originator and the Collection Agent, whether or not the
Buyer or an Affiliate thereof, shall hold all Records in trust for the Buyer and its assigns. Subject to the receipt of contrary instructions from the Buyer that are delivered following the occurrence and continuance of a Servicer Termination
Event, the Collection Agent and each Originator will deliver all Records to any new Collection Agent hereunder; provided, however, that such new Collection Agent, if other than an Affiliate of the Buyer, shall as soon as practicable upon
demand deliver to the Authorized Representative copies of Records in its possession relating to Purchased Property. 

SECTION 6.06.  Receivable Reporting.   On each Monthly Report Due Date, the Collection Agent
shall deliver to the Buyer a Monthly Report for the preceding Collection Period, which delivery may be in electronic form; provided, that so long as Professional Services is acting as Collection Agent, a Monthly Report delivered in a timely
fashion under the Loan Agreement shall constitute delivery of a Monthly Report under this Section 6.06. 
 SECTION
6.07.  Collections and Lock-Boxes.
 (a)      Each Originator and the
Collection Agent will instruct all Obligors to cause all Collections to be either (i) remitted to a Lock-Box to be retrieved therefrom by the applicable Collection Account Bank for prompt deposit to the applicable Collection Account or (ii) remitted
directly to a Collection Account. If the Collection Agent or any Originator receives any Collections, such Originator or the Collection Agent shall immediately remit such Collections to the applicable Collection Account within two Business Days
of receipt thereof and the Collection Agent or the applicable Originator will take all such actions as are reasonably necessary in the Collection Agent or Originator’s discretion or as reasonably requested by the Buyer to ensure that future
payments from any Obligor be made to a Collection Account or Lock-Box. If the applicable Originator or the Collection Agent does not promptly (and in any event within two Business Days from the Buyer’s request) take such actions as the
Buyer may reasonably request, then the Buyer, its assigns or designees, may, to the maximum extent permitted by law take such actions as the Buyer, its assigns or designees may, on its direction, deem appropriate. 

  
 46 

 (b)      The Collection Agent shall allocate and
remit Collections in accordance with the Loan Agreement; provided, however, that the Buyer may, at any time following a Trigger Event and shall, at the direction of the Administrative Agent, as its assignee, revoke the Collection Agent’s
authority with respect to each Concentration Account, direct each Concentration Account Bank to cease taking instructions from the Collection Agent or the Buyer and to thereafter take direction solely from the Administrative Agent, in each case by
delivery of a notice substantially in the form attached to the Control Agreement for such purpose. Neither any Originator nor the Collection Agent will (i) add or terminate any bank as a Collection Account Bank or a Concentration Account Bank,
(ii) close any Lock-Box, any Collection Account or any Concentration Account or open any new lock-box or account to function as a Lock-Box, Collection Account or Concentration Account, (iii) make any change to the instructions to the Obligors that
all payments with respect to the Receivables be made to a Lock-Box or Collection Account or (iv) make any change to the instructions to the Collection Account Bank set forth in the Deposit Account Notification Agreement (Government Healthcare
Receivables) requiring all available funds in each Collection Account to automatically sweep to the applicable Concentration Account at the end of each Business Day, in each case, without the prior written consent of the Buyer and the Administrative
Agent and each Managing Agent; provided, if any Originator violates any of the provisions under clauses (i) through (iv) above with respect to any Lock-Box or Collection Account relating to such Originator without the prior knowledge or
consent of the Buyer or the Collection Agent, the Originator (itself or through the Collection Agent) shall have the opportunity to cure the violation of this clause (b) within 15 days of obtaining knowledge of such breach and, if such violation is
cured within such 15 day period, the cure of such violation shall be effective to cure any breach of any covenant, representation or warranty by any Originator or the Collection Agent under any Facility Document directly related to or directly
arising from such violation without any further action. Each of the Originators and the Collection Agent each hereby agrees to take, or cause to be taken, any and all actions reasonably requested by the Buyer to protect and perfect the interest
of the Buyer in the event any such change is permitted. 
 SECTION 6.08.  UCC Matters; Protection and
Perfection of Purchased Property. Each Originator will keep its jurisdiction of incorporation or organization, principal place of business and chief executive office, and the offices where it keeps its Records, in the jurisdictions and at the
addresses set forth on Schedule III, or, in any such case, upon 30 days’ prior written notice to the Buyer, at such other jurisdictions or locations within the United States where all actions reasonably requested by the Buyer to protect
and perfect the interest of the Buyer in the Purchased Property have been taken and completed. Each of the Originators and the Collection Agent agrees that from time to time, at the Originators’ expense, it will promptly execute and deliver all
further instruments and documents, and take all further action that the Buyer may reasonably request in order to perfect, protect or more fully evidence the Purchased Property acquired by the Buyer hereunder, or to enable the Buyer to exercise or
enforce any of its rights hereunder. Without limiting the generality of the foregoing, each of the Originators and the Collection Agent agrees that it will, upon the request of the Buyer, execute and file such financing or continuation statements,
or amendments thereto or assignments thereof, and such other instruments or notices, as may be necessary or appropriate. Each Originator hereby authorizes the Buyer to file one or more financing or continuation statements, and amendments thereto and
assignments thereof, relative to all or any of the Purchased Property now existing or hereafter arising without the signature of such Originator where permitted by law. If an 

  
 47 

 
Originator or the Collection Agent fails to perform any of its agreements or obligations under this Section 6.08, the Buyer, or its assignee, may (but shall not be
required to) itself perform, or cause performance of, such agreement or obligation, and the reasonable expenses of the Buyer incurred in connection therewith shall be payable by the Originators upon the Buyer’s demand therefor. For purposes of
enabling the Buyer to exercise its rights described in the preceding sentence and elsewhere in this Article VI, each of the Originators and the Collection Agent hereby authorizes the Buyer to take any and all steps
following an Event of Termination in such Originator’s or the Collection Agent’s, as applicable, name and on behalf of the Originator necessary or desirable, in the determination of the Buyer, to collect all amounts due under any and all
Receivables, including endorsing such Originator’s or the Collection Agent’s name on checks and other instruments representing Collections and enforcing such Receivables and the related Contracts. 

SECTION 6.09.  Obligations With Respect to Receivables.     Each of the Originators
and the Collection Agent will (a) at the Originators’ expense, regardless of any exercise by the Buyer of its rights hereunder, timely and fully perform and comply with all material provisions, covenants and other promises required to be
observed by it under the Contracts related to the Purchased Property to the same extent as if Purchased Property therein had not been sold hereunder and (b) pay when due any taxes, including sales, excise or personal property taxes, payable in
connection with the Purchased Property. In no event shall the Buyer have any obligation or liability with respect to any Purchased Property or related Contracts, nor shall it be obligated to perform any of the obligations of the Collection Agent or
any Originator or any of their respective Affiliates thereunder. Each of the Originators and the Collection Agent agrees it will timely and fully comply in all material respects with the Credit and Collection Policy in regard to each Receivable and
the related Contract. 
 SECTION 6.10.  Applications of Collections.   Any payment by an
Obligor in respect of any indebtedness owed by it to any Originator shall, except as otherwise specified by such Obligor or otherwise required by contract or Applicable Law and unless otherwise instructed by the Buyer, be applied as a Collection of
any Receivables constituting Purchased Property of such Obligor, in the order of the age of such Receivables, starting with the oldest such Receivable, to the extent of any amounts then due and payable thereunder, before being applied to any other
indebtedness, account, general intangible or obligation of such Obligor. 
 SECTION 6.11.  Annual Servicing
Report of Independent Audit Firm.   On an annual basis on or before the date which is 90 days after the end of each fiscal year, beginning with the fiscal year ending December 31, 2012, the Collection Agent shall engage and cause
FTI Consulting, Inc. or another firm acceptable to the Buyer and its assigns, to provide the Collection Agent and the Buyer with a report setting forth the results of such firm’s review of the Receivables in form and in scope satisfactory to
the Buyer and the Collection Agent; provided that in no event shall such report include “Protected Health Information”, as such term is defined in regulations implementing HIPAA; provided further that such independent audit
firm shall be required to enter into a Business Associate Agreement with the Collection Agent. Each of the Originators hereby authorizes such firm to discuss such affairs, finances and performance with representatives of the Buyer and its designees.

  
 48 

 ARTICLE VII 

EVENTS OF TERMINATION 

SECTION 7.01.  Events of Termination.  If any of the following events (any such event, an
“Event of Termination”) shall occur: 
 (a)      The Collection Agent, the
Authorized Representative or any Originator shall fail to make any payment or deposit to be made by it hereunder when due and such failure shall remain unremedied for five Business Days; or 

(b)      Any representation or warranty made or deemed to be made by any Originator, the
Collection Agent or CHS (or any of their respective officers or agents) under or in connection with any Document, including any Monthly Report other than with respect to the status of a Receivable as an Eligible Receivable or any other information,
report or officer’s certificate delivered pursuant hereto, shall prove to have been false, incorrect or misleading in any material respect when made or deemed made, unless and solely to the extent (i) such representation or warranty does not
contain a grace period within such provision, and (ii) such misrepresentation is capable of being cured within 10 days, the Collection Agent, the Authorized Representative and any relevant Originator deliver a written certificate to the Buyer
certifying that such false, incorrect or misleading statement, and all ramifications thereof under this Agreement or any Document has been cured in full (together with such data demonstrating such cure) by earlier to occur of (x) the date on which
written notice shall have been given to the Authorized Representative and (y) the date on which a Responsible Officer of the Collection Agent, the Authorized Representative or the relevant Originator acquires knowledge thereof; or 

(c)      Any Originator, the Authorized Representative, CHS or the Collection Agent shall fail
to perform or observe, beyond the applicable grace or cure period therein, any term, covenant or agreement (other than any term, covenant or agreement described in another clause of this Section 7.01) contained in any
Document on its part to be performed or observed and any such failure (other than a failure with respect to any of Section 5.01(d), (g), (l), and (q), in each case, as to which no grace period shall apply) shall remain unremedied for
10 days after written notice thereof shall have been given by the Buyer to the Authorized Representative, or this Agreement or any other Document shall cease to be effective or be a legally valid, binding and enforceable obligation of the Buyer, any
Originator or the Collection Agent, as the case may be or any of their respective Affiliates shall contest in any manner the effectiveness, validity, binding nature or enforceability of this Agreement or any other Document; or 

(d)      (i) Any Originator, the Parent or the Collection Agent shall fail to pay any
principal, interest or other amount due in respect of any Material Indebtedness, when and as the same shall become due and payable (after giving effect to any grace period) or (ii) any other event or condition occurs that results in any Material
Indebtedness becoming due prior to its scheduled maturity or that enables or permits (after giving effect to any grace period) the holder or holders of any Material Indebtedness or any trustee or agent on its or their behalf to cause any Material
Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity or that results in the termination or permits any counterparty to terminate any interest rate protection
agreement, foreign currency exchange agreement, commodity price protection agreement or other interest or currency exchange rate or 

  
 49 

 
commodity price hedging arrangement, the obligations under which constitute Material Indebtedness; provided that this clause (ii) shall not apply to secured Debt that becomes due as a
result of the voluntary sale or transfer of the property or assets securing such Debt; or 

(e)      Either (i) any Purchase shall, for any reason, except to the extent permitted by the
terms hereof, cease to create a valid and perfected first priority ownership interest in each Purchased Property with respect thereto free and clear of any Lien (other than Permitted Liens referred to in clause (b) of the definition thereof and,
during the continuance of the time period specified in Section 5.01(u), the Kay County Lien), which shall remain unremedied for five Business Days after the earlier of delivery of notice thereof by the Buyer or discovery thereof by the Collection
Agent or any Originator or (ii) this Agreement shall for any reason cease to evidence the transfer to the Buyer of legal and equitable title to, and ownership of, the Purchased Property; or 

(f)      (i) Any Material Originator, the Parent, CHS or the Collection Agent shall (A) become
insolvent, generally not pay its debts as such debts become due, or shall admit in writing its inability to pay its debts generally or shall make a general assignment for the benefit of creditors; (B) any Insolvency Proceeding or any other
proceeding seeking the entry of an order for relief or the appointment of a receiver, receiver/manager, custodian, trustee, or other similar official for it or for any substantial part of its property shall be instituted by any Material Originator,
the Parent, CHS or the Collection Agent or (C) any Insolvency Proceeding or any other proceeding seeking the entry of an order for relief or the appointment of a receiver, receiver/manager, custodian, trustee, or other similar official for it or for
any substantial part of its property shall be instituted against any Material Originator, the Parent, CHS or the Collection Agent, and such other proceeding shall remain unstayed for a period of 60 days, or the requested adjudication, relief or
other action sought thereby shall have been made, granted or taken, or (ii) any Material Originator, the Parent, CHS or the Collection Agent shall take any corporate or entity-level action that authorizes any of the actions set forth above in this
Section 7.01(f); or 
 (g)      There shall have occurred and be
continuing an “Event of Default” under the Loan Agreement; or 
 (h)      There
shall have occurred and be continuing an “Event of Termination” under the Contribution Agreement; or 

(i)       There shall have occurred a Change in Control; or 

(j)       There shall have occurred any material adverse change in the business or
financial condition of CHS or the Originators taken as a whole since December 31, 2011, which could reasonably be expected to affect the value or collectability of the Receivables or the ability of the Buyer, the Collection Agent or any Originator
to collect the Receivables or otherwise perform its respective obligations under this Agreement or any other Document; or 

(k)      A Servicer Termination Event shall have occurred and be continuing; or 

(l)      The Buyer shall have become subject to registration as an “investment
company” within the meaning of the Investment Company Act; or 

  
 50 

 (m)     One or more judgments shall be rendered against
any Originator, the Collection Agent, the Company, CHS or the Parent or any combination thereof (to the extent not paid or fully covered by insurance) and the same shall remain undischarged for a period of 30 consecutive days during which execution
shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to levy upon assets or properties of any Originator, the Collection Agent, the Company, CHS or the Parent to enforce any such judgment and such judgment is
for the payment of money in an aggregate amount in excess of $50,000,000; or 
 (n)      An
ERISA Event shall have occurred that, in the opinion of the Buyer, when taken together with all other such ERISA Events, could reasonably be expected to result in liability of the Parent and its ERISA Affiliates in an aggregate amount exceeding
$50,000,000; 
 then, and in any such event, the Buyer may, by notice to the Authorized Representative (a “Termination Declaration
Notice”) declare the Termination Date to have occurred, except that, (i) in the case of any event described in clause (i)(B) or clause (i)(C) of Section 7.01(f)
above or any event described in Section 7.01(d) above, the Termination Date shall be deemed to have occurred automatically without notice upon the occurrence of such event, and (ii) in the case of any event described in
Sections 7.01(c) and (h) that relate to an Originator and not Material Originators, no Event of Termination shall be deemed to have occurred so long as the Buyer immediately ceases future purchases of Receivables
from such Originator. 
 Notwithstanding the foregoing, the occurrence of one or more events listed above that would otherwise constitute an
Event of Termination with respect to any Originator or Originators not constituting Material Originators (as calculated over any period of 30 consecutive days) shall not constitute an Event of Termination hereunder if such Originator or Originators
subject to such event are subject to a Removal (without consideration of the requirement for a 30 day prior written request as set forth in Section 9.14(b)) within 10 days of the occurrence of such event or events. 

ARTICLE VIII 
 INDEMNIFICATION 

SECTION 8.01.  Indemnities by the Originators. 

(a)      Without limiting any other rights which the Buyer may have hereunder or under
Applicable Law, each of the Collection Agent and the Originators hereby each agrees, jointly and severally, to indemnify the Buyer and its transfers and assigns, and each of their respective directors, officers, employees, agents and attorneys (all
of the foregoing being individually referred to as an “Indemnified Party” and being collectively referred to as “Indemnified Parties”) from and against any and all damages, losses, claims, liabilities and related
costs and expenses, including reasonable attorneys’ fees and disbursements (all of the foregoing being collectively referred to as “Indemnified Amounts”) awarded against or actually incurred by any of them arising out of or
resulting from this Agreement, the Contribution Agreement, the Loan Agreement or any other Document or the use of proceeds of any Purchase or in respect of any Purchased Property. Without limiting or being limited by the foregoing, each
Originator shall pay on demand to each Indemnified Party any and all amounts necessary to indemnify such Indemnified Party from and against any and all Indemnified Amounts relating to or resulting from any of the following: 

(i)       Any Receivable represented or deemed represented by an Originator
to be an Eligible Receivable which was not an Eligible Receivable as of the Purchase Date thereof; 

  
 51 

 (ii)       reliance on any
representation or warranty made or deemed made by any Originator, CHS, the Collection Agent or any of their respective officers under or in connection with this Agreement, the Contribution Agreement, the Loan Agreement or any other Document, which
shall have been false, incorrect or misleading in any material respect when made or deemed made or delivered; 

(iii)      the failure by any Originator, CHS or the Collection Agent to comply
with any term, provision or covenant contained in this Agreement, the Contribution Agreement, the Loan Agreement or any other Documents, or any Contract, or with any Applicable Law with respect to any Receivable, the related Contract or the Related
Security, or the nonconformity of any Receivable, the related Contract or the Related Security with any such Applicable Law; 

(iv)      the failure to (A) vest and maintain vested in the Buyer or to
transfer to the Buyer, legal and equitable title to and ownership of, the Receivables and the other Purchased Property which are, or are intended to be, sold by the Originators hereunder or (B) grant to the Buyer a valid and perfected first priority
“security interest” under Article 9 of the UCC in and to the Receivables which are, or are purported to be, Purchased Property, together with all Collections and Related Security, in each case free and clear of any Lien (other than
Permitted Liens referred to in clause (b) of the definition thereof) whether existing at the time of the Purchase of any such Receivable or at any time thereafter; 

(v)       the failure by any Originator to make any payment required on its
part to be made hereunder; 
 (vi)      the failure to file, or any delay in
filing, financing statements or other similar instruments or documents under the UCC of any applicable jurisdiction or other Applicable Law with respect to any Receivables and other Purchased Property which are, or are intended to be, sold by the
Originators hereunder, whether at the time of any Purchase or at any subsequent time; 

(vii)     any failure of any Originator, CHS or the Collection Agent to perform its
duties or obligations in accordance with the provisions of this Agreement or the other Documents or to perform its duties under the Contracts; 

(viii)    any products liability claim or personal injury or property damage suit or other
similar or related claim or action of whatever sort arising out of or in connection with merchandise or services which are the subject of any Receivable or Contract; 

  
 52 

 (ix)     any set-off by any Collection
Account Bank or any Concentration Account Bank against Collections; 

(x)      the failure to pay when due any taxes which are an Originator’s
responsibility, including sales, excise or personal property taxes payable in connection with the Purchased Property or the purchase thereof; 

(xi)     the commingling of Collections of Purchased Property at any time with other
funds; 
 (xii)    any investigation, litigation or proceeding related to this Agreement
or the use of proceeds of Purchases or the ownership by the Buyer of Purchased Property; 

(xiii)   any attempt by any Person to void or otherwise avoid any transfer of any Purchased
Property from an Originator to the Buyer under any statutory provision or common law or equitable action, including any provision of the Bankruptcy Law; or 

(xiv)   the inclusion in any Purchased Receivable any portion of the Expected Net Value of
which represents sales taxes.
 (b)      Any amounts subject to the indemnification
provisions of this Section 8.01 shall be paid by the Originators to the Buyer within 10 Business Days following the Buyer’s demand therefor. Notwithstanding any other provision of this Agreement to the contrary, the Originators shall not
indemnify any Indemnified Party for or with respect to any Indemnified Amounts (i) that would constitute recourse for uncollectible Receivables due to the bankruptcy or insolvency of the related Obligor or (ii) that arise solely from such
Indemnified Party’s gross negligence, bad faith or willful misconduct as determined in a final non-appealable judgment of a court of competent jurisdiction. 

(c)      Notwithstanding the foregoing, the liability of the Specified Originators shall be
limited to indemnification events relating to each such Specified Originator or the Purchased Property it has transferred under this Agreement. 

ARTICLE IX 
 MISCELLANEOUS 

SECTION 9.01.  Amendments and Waivers.   No amendment or modification of any provision of
this Agreement or any Document shall be effective without the written agreement of the parties hereto and, to the extent then required in the Loan Agreement, the written consent of the Administrative Agent and the Majority Lenders (or their
respective Managing Agents), and no termination or waiver of any provision of this Agreement or any Document or consent to any departure therefrom shall be effective without the written concurrence of the Company, the Administrative Agent and the
Majority Lenders (or their respective Managing Agents). Any waiver or consent shall be effective only in the specific instance and for the specific purpose for which given. 

  
 53 

 SECTION 9.02.  Notices, Etc. 

(a)      All notices, demands, requests and other communications required or expressly
authorized to be made by this Agreement shall be given in writing, unless otherwise expressly specified herein and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by facsimile or electronic
mail, and addressed to (i) if to an Originator, to the Authorized Representative at 4000 Meridian Boulevard, Franklin, TN 37067, to the attention of Rachel A. Seifert, Facsimile No.: 615-373-9704, Telephone No.: 615-465-7000, Email:
Rachel_Seifert@chs.net, (ii) if to the Collection Agent at 4000 Meridian Boulevard, Franklin, TN 37067, to the attention of Rachel A. Seifert, Facsimile No.: 615-373-9704, Telephone No.: 615-465-7000, Email: Rachel_Seifert@chs.net, and (iii) if to
the Buyer at 4000 Meridian Boulevard, Franklin, TN 37067, to the attention of Rachel A. Seifert, Facsimile No.: 615-373-9704, Telephone No.: 615-465-7000, Email: Rachel_Seifert@chs.net, or to such other address as shall be notified in writing to the
other parties hereto. 
 (b)      All communications described in
clause (a) above and all other notices, demands, requests and other communications made in connection with this Agreement shall be effective and be deemed to have been received (x) if delivered by hand or overnight courier
service or sent by facsimile or electronic mail, on the date of receipt or (y) if delivered by certified or registered mail, five Business Days after dispatch, in each case under clauses (x) and (y), delivered, sent, transmitted or mailed (properly
addressed) to such party as provided in this Section 9.02 or in accordance with the latest unrevoked direction from such party given in accordance with this Section 9.02. Notwithstanding the foregoing, no notice, demand, request or
other communication pursuant to Article II shall be effective until received. 
 SECTION
9.03.  Setoff and Counterclaim.   All payments to be made by any Originator or the Collection Agent under this Agreement shall be made free and clear and each of the Originators and the Collection Agent hereby
irrevocably and unconditionally waives all rights of any counterclaim, set-off, deduction or other defense, which such Originator or the Collection Agent may have against the Buyer, or against each other, whether under contract (including this
Agreement), Applicable Law, in equity or otherwise. The obligation of each Originator and the Collection Agent to make the payments and deposits contemplated by this Agreement is absolute and unconditional. 

SECTION 9.04.  No Waiver; Remedies.   No failure on the part of the Buyer to exercise, and no
delay in exercising, any right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any right hereunder preclude any other or further exercise thereof or the exercise of any other right. The remedies herein
provided are cumulative and not exclusive of any remedies provided by law. 
 SECTION 9.05.  Binding Effect;
Assignability; Third Party Beneficiary.    This Agreement shall be binding upon and inure to the benefit of the Originators, the Buyer, the Collection Agent and their respective successors and permitted assigns. No Originator
may assign its rights and obligations or any interest herein or delegate any of its duties hereunder or under the other Originator Documents, in each case, without the prior written consent of the Buyer. The Buyer may, subject to any restrictions in
the Loan Agreement, assign at any time all of its rights and obligations hereunder and interests herein without the consent of any Originator or the Collection Agent. All such assignees, including parties to the Loan Agreement, shall be third party
beneficiaries of, and shall be entitled to enforce the Buyer’s rights and remedies 

  
 54 

 
under, this Agreement to the same extent as if they were parties thereto, except to the extent specifically limited under the terms of their assignment. Without limiting the foregoing, each
of the Originators acknowledges (a) the assignment of Buyer’s rights and interests hereunder to the Administrative Agent (via the assignment by the Company to the Administrative Agent) pursuant to the Assignment of Agreements and agrees that,
subject to the terms set forth in the Assignment of Agreements, the Contribution Agreement and the Loan Agreement, the Administrative Agent (and any further assignee of any such assignee) shall have the right, as the assignee of the Buyer (or the
assignee of such assignee), to enforce the Buyer’s rights and remedies under this Agreement directly against such party (including the right (i) to appoint a successor Collection Agent and (ii) to give or withhold any and all consents,
requests, notices, directions, approvals, demands, extensions or waivers under or with respect to this Agreement or the obligations in respect of the Originators hereunder to the same extent as the Buyer may do), but without any obligation on the
part of any such assignee to perform any of the obligations of the Buyer hereunder and (b) that the Administrative Agent, each Managing Agent, each Lender and each other Secured Party (as defined in the Loan Agreement) is an intended third party
beneficiary of this Agreement to the same extent as if they were parties hereto, and that each of them is relying on, among other things, the representation and warranties of the Originators hereunder in entering into the Loan Agreement. Each
of the Originators, the Authorized Representative and the Collection Agent agrees that it shall send to the Administrative Agent and each Managing Agent (at the address set forth in the Loan Agreement) a copy of all written notices required to be
given by such Person to the Buyer hereunder. 
 SECTION 9.06.  Term of this
Agreement.    This Agreement, including each Originator’s and the Collection Agent’s obligation to observe its covenants set forth in Articles V and VI, shall remain in full force
and effect until the Collection Date; provided, however, that the rights and remedies with respect to any breach of any representation and warranty made or deemed made by the Originators pursuant to Article IV, the indemnification and
payment provisions of Article VIII and the provisions of Section 9.15 shall be continuing and shall survive any termination of this Agreement. 

SECTION 9.07.  GOVERNING LAW; CONSENT TO JURISDICTION; WAIVER OF OBJECTION TO VENUE; SERVICE OF
PROCESS.
 (a)      THIS AGREEMENT SHALL, IN ACCORDANCE WITH § 5-1401 OF THE GENERAL
OBLIGATIONS LAW OF THE STATE OF NEW YORK, BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. THE BUYER, EACH ORIGINATOR, AND THE COLLECTION AGENT EACH HEREBY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND
FEDERAL COURTS OF THE UNITED STATES AND THE NON-EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN NEW YORK COUNTY, NEW YORK IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OTHER ORIGINATOR DOCUMENT, ANY
OTHER DOCUMENT DELIVERED PURSUANT HERETO OR THERETO, OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH OF THE PARTIES HERETO HEREBY WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS, THE MAINTENANCE OF ANY SUCH ACTION OR PROCEEDING AND
CONSENTS TO THE GRANTING OF SUCH LEGAL OR EQUITABLE RELIEF AS IS DEEMED APPROPRIATE BY SUCH COURT. 

(b)      Each party hereto agrees that service of process may be effected by mailing a copy
thereof by registered or certified mail, postage prepaid, to it at its address specified in Section 9.02. Nothing in this Section 9.07 shall affect the right of any party to serve legal process in any other manner permitted by law.

  
 55 

 SECTION 9.08.  WAIVER OF JURY TRIAL.   TO
THE EXTENT PERMITTED BY APPLICABLE LAW, THE BUYER, EACH ORIGINATOR AND THE COLLECTION AGENT EACH WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT, OR OTHERWISE BETWEEN THE PARTIES HERETO
ARISING OUT OF, CONNECTED WITH, RELATED TO, OR INCIDENTAL TO THE RELATIONSHIP BETWEEN ANY OF THEM IN CONNECTION WITH THIS AGREEMENT, ANY OTHER ORIGINATOR DOCUMENT, ANY OTHER DOCUMENT DELIVERED PURSUANT HERETO OR THERETO, OR THE TRANSACTIONS
CONTEMPLATED HEREBY OR THEREBY. INSTEAD, ANY SUCH DISPUTE RESOLVED IN COURT WILL BE RESOLVED IN A BENCH TRIAL WITHOUT A JURY. 

SECTION 9.09.  Costs, Expenses and Taxes.    In addition to the rights of
indemnification granted to the Buyer and the other Indemnified Parties under Article VIII hereof, the Originators agree, jointly and severally, to pay on demand all reasonable out-of-pocket costs and expenses of the Buyer
and its assignee incurred in connection with the preparation, execution, delivery, administration (including periodic auditing permitted hereunder), amendment or modification of, or any waiver or consent issued in connection with, this Agreement and
the other documents to be delivered hereunder or in connection herewith, including rating agency fees, auditor fees, the annual servicing report referred to in Section 6.11 and out-of-pocket expenses and the reasonable fees and out-of-pocket
expenses of counsel for the Buyer and its assignee with respect thereto, and with respect to advising the Buyer and its assignee as to its rights and remedies under this Agreement and the other documents to be delivered hereunder or in connection
herewith, and all costs and expenses, if any (including counsel fees and expenses), incurred by the Buyer and its assignee in connection with the enforcement of this Agreement and the other documents to be delivered hereunder or in connection
herewith. 
 SECTION 9.10.  No Proceedings.   Each of the Originators, the Collection
Agent and the Administrative Agent each hereby agrees that it will not institute against, or join any other Person in instituting against, the Buyer any action, event or proceeding of the type referred to in Section 7.01(f) so long as there
shall not have elapsed one year plus one day since the later of (i) the Termination Date and (ii) the date on which all of the Purchased Receivables are either collected in full or become Defaulted Receivables. 

SECTION 9.11.  Execution in Counterparts; Severability; Integration.    This
Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same
agreement. In case any 

  
 56 

 
provision in or obligation under this Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or
obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. This Agreement, the Contribution Agreement, the Loan Agreement and the other Documents contain the final and
complete integration of all prior expressions by the parties hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof, superseding all prior oral or
written understandings. 
 SECTION 9.12.  Confidentiality.    Except to the extent
otherwise required by Applicable Law, unless the provider thereof shall otherwise consent in writing each of the Originators, the Buyer and the Collection Agent agrees that it shall maintain the confidentiality of (i) the Credit and Collection
Policy, and (ii) all other information obtained as a result of being a party hereto, to any related documents or to any of the transactions contemplated hereby or thereby (including the contents of any summary of indicative terms and conditions with
respect to such transactions, and the provisions of this Agreement and any of the other Originator Documents) other than information that was available to such Person on a non-confidential basis (“Confidential Information”);
provided, however, that the Originators and the Collection Agent may disclose any Confidential Information (w) to its and its Affiliates’ officers, directors, employees and agents, including accountants, legal counsel, administration and
service providers, and other advisors (it being understood that the persons to whom such disclosure is made will be informed of the confidential nature of such Confidential Information and instructed to keep such Confidential Information
confidential), (x) to the extent such disclosure may be required by Applicable Law, or by any court or administrative agency having jurisdiction over any party or as may be requested by any regulatory body, (y) to the extent an Originator, the Buyer
or the Collection Agent, as the case may be, consents in writing to the release of Confidential Information relating to it, (z) subject to a written confidentiality agreement having terms substantially similar to this
Section 9.11, to any financial institution or other party that extends or is considering the extension of debt or equity financing or swap or derivative arrangement to any Originator or any Affiliate thereof or (aa) as may
be required or appropriate in response to a court order or in connection with any litigation; provided further, however, that the Originators, the Buyer and the Collection Agent shall have no obligation of confidentiality whatsoever in
respect of any information which (i) may be generally available to the public or becomes available to the public other than as a result of a breach of this Section 9.12, (ii) is in the possession of an Originator, the Buyer or the Collection
Agent prior to the date hereof and receipt thereof from another party, and is not subject to a confidentiality agreement or legal or regulatory restriction on disclosure or (iii) is independently developed by the Company or the Collection Agent or
one or more of their respective representatives without violating the terms of this Section 9.12. 

SECTION 9.13.  Joint and Several Liability; Designation and Appointment of Authorized
Representative.
 (a)      Joint and Several Liability.   Each
Originator (other than any Specified Originator) agrees that each reference to “Originators” in this Agreement shall be deemed to refer to each such Originator, jointly and severally with the other Originators. Each Originator (other
than any Specified Originator) (i) shall be jointly and severally liable for the obligations, 

  
 57 

 
duties and covenants of each other Originator (other than any Specified Originator) under this Agreement and the acts and omissions of each other Originator (other than any Specified Originator)
and (ii) jointly and severally makes each representation and warranty for itself and each other Originator (other than any Specified Originator) under this Agreement. Notwithstanding the foregoing, if, in any action to enforce amounts payable
by any Originator (other than any Specified Originator) or any proceeding to allow or adjudicate a claim hereunder, a court of competent jurisdiction determines that enforcement of the joint and several obligations of all of the Originators (other
than any Specified Originator) against such Originator (other than any Specified Originator) for the full amount of such liabilities is not lawful under, or would be subject to avoidance under Section 548 of the Bankruptcy Law or any applicable
provision of Federal or state law, the liability of such Originator hereunder shall be limited to the maximum amount lawful and not subject to avoidance under such law. For the avoidance of doubt, notwithstanding anything in this Agreement or
any other document related hereto to the contrary, in no event shall any Specified Originator have any liability for the actions or inactions of any other Originator. 

(b)     Appointment of Authorized Representative.    Each Originator
hereby irrevocably designates and appoints Professional Services as its exclusive representative under this Agreement (the “Authorized Representative”) to deliver and receive all notices on behalf of such Originator and to receive
on behalf of such Originator, and distribute, all payments and distributions of Originators in accordance with the respective interests of Originators and to take such other actions as are set forth in this Agreement. Each Originator hereby
unconditionally releases the Buyer and its Affiliates with respect to any claims, obligations or duties that such Persons may otherwise have been deemed to possess absent the designation and appointment contained in this Section 9.13(b). 

SECTION 9.14.  Addition and Removal of Originators.

(a)     Additions.   Subject to satisfaction of the following conditions set
forth below and any other conditions required by the Buyer, upon 30-days’ prior written notice from the Collection Agent or the Authorized Representative, the Buyer hereby agrees to the adding of other Persons designated by the Collection Agent
or the Authorized Representative as an additional Originator hereunder (each such event, an “Addition”): 

(i)      the Buyer, in its sole discretion (and the Administrative Agent, as its
assignee under the Assignment of Agreements, in its sole discretion), shall have agreed in writing to such Addition; 

(ii)     the Termination Date shall have not occurred; 

(iii)    as of the effective date of such Addition, no Servicer Termination Event or Event
of Termination shall be continuing; 
 (iv)    as of the effective date of such
Addition, the conditions precedent applicable to such Person proposed as an Originator as set forth Article III shall have been fulfilled; 

  
 58 

 (v)       as of the effective
date of such Addition, the representations and warranties set forth in Article IV applicable to such Person proposed as an Originator shall be true and correct; 

(vi)      such Person proposed as an Originator shall execute such agreements,
instruments and documents (and issue such authorizations) as the Buyer may reasonably request, in each case, in form and substance satisfactory to the Buyer (and the Administrative Agent) to effectuate the Addition, including (x) a joinder agreement
to this Agreement whereby such Person agrees to be bound by the terms of this Agreement, and (y) financing statements covering the Receivables; 

(vii)     the Administrative Agent shall have received such opinions of counsel
(which may include corporate opinions from jurisdictions previously not required by the Administrative Agent) as it may reasonably request; and 

(viii)    the Buyer shall have been provided with such information (whether financial or
otherwise), documents or opinions as they may reasonably request. 
 Upon the effectiveness of any Addition, Schedule
I shall be deemed amended to add the name of the applicable Person. 

(b)       Removals.   Subject to satisfaction of the conditions set
forth below and any other conditions required by the Buyer, upon 30-days’ prior written request of the Collection Agent, the Buyer hereby agrees to the removal of any Originator designated by the Collection Agent (each such event, a
“Removal”): 
 (i)        no Termination or Event
of Termination shall have occurred and be continuing, or shall result from, or reasonably be expected to result from, such Removal or the Related Removals; 

(ii)       the Buyer shall have received a Monthly Report calculated on a
pro forma basis (after giving effect to such Removal and all Related Removals), which pro forma Monthly Report shall demonstrate compliance with all covenants hereunder and under the Loan Agreement, including the ratios set forth in Sections
7.01(h) and (i) of the Loan Agreement; 
 (iii)      as of the last
day of the Collection Period most recently ended prior to such Removal, the average Net Receivables Balance of all Receivables of the Originator(s) subject to such Removal and all Related Removals over the prior 3 Collection Periods shall not be
greater than (a) if such Removal and all Related Removals are effectuated at any time during the 2017 calendar year, 15% of the average Net Receivables Balance of Receivables of all Originators during the Collection Period 3 months prior to such
Collection Period and the two prior Collection Periods or (b) if such Removal and all Related Removals are effectuated at any other time, 7.5% of the average Net Receivables Balance of Receivables of all Originators during the Collection Period 3
months prior to such Collection Period and the two prior Collection Periods; provided, however, that the Removals of the Originators listed on Schedule VII hereto shall not be subject to this clause (iii) if the Net Receivables Balance
of Receivables of (a) all existing 

  
 59 

 
Originators that are not listed on Schedule VII hereto and (b) all new Originators to be added via an Addition concurrently with such Removals, as demonstrated on a Monthly Report calculated on a
pro forma basis (after giving effect to all such Additions and Removals), is equal to or greater than the Net Receivables Balance of Receivables of the Originators party hereto immediately prior to effecting such Additions and Removals, as
demonstrated on a Monthly Report calculated as of the same date (before giving effect to all such Additions and Removals); 

(iv)     such Originator shall execute such agreements, instruments and documents as
the Buyer and the Administrative Agent may reasonably request, in form and substance satisfactory to the Buyer and the Administrative Agent to effectuate the requested Removal, including an amendment to this Agreement effectuating such Removal; 

(v)      the Buyer shall have received all Collections pertaining to Purchased
Receivables (that have not become Defaulted Receivables) and all Noncomplying Receivables Adjustments, in each case, attributable to the Originator subject to the requested Removal; and 

(vi)     if such Removal is requested or to be effected during the Temporary Trigger
Relief Period (as defined in the Loan Agreement), the DSO (as defined in the Loan Agreement) reported on the most recently delivered Monthly Report shall not exceed 75 days; provided that, if no Monthly Report was delivered on the most recent
Monthly Report Due Date, the DSO shall be deemed to exceed 75 days. 
 Upon the effectiveness of any Removal, Schedule
I hereto shall be deemed amended to delete the name of the applicable Person. Authorized Representative shall promptly notify the Collection Agent of any Addition or Removal hereunder. 

(c)      Survival of Terms.   Notwithstanding any Removal of a Person as
an Originator in accordance with the terms hereof, the provisions of Article VIII (and the representations and warranties with respect thereto) shall, with respect to such Person, survive such Removal for all claims arising prior to such
Removal. 
 SECTION 9.15.  Waiver of Consequential Damages.   (a)  Each of the Originators and
the Collection Agent agrees that no Indemnified Party shall have any liability to them or any of their equity holders or creditors in connection with this Agreement, the other Facility Documents or the transactions contemplated thereby on any theory
of liability for any special, indirect, consequential or punitive damages (including any loss of profits, business or anticipated savings), and hereby waives any such claim. 

(b)      The Buyer agrees that none of the Originators, the Collection Agent or their
respective Affiliates shall have any liability to it or any of its equity holders or creditors in connection with this Agreement, the other Facility Documents or the transactions contemplated thereby on any theory of liability for any special,
indirect, consequential or punitive damages (including any loss of profits, business or anticipated savings), and hereby waives any such claim. 

(c)      The provisions of this Section 9.15 shall survive the termination of this
Agreement. 

  
 60 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective officers thereunto
duly authorized, as of the date first above written. 
  

									
	BUYER	 		 	CHS/COMMUNITY HEALTH SYSTEMS, INC.
			
		 		 	By:                                   
                               
		 		 	Name:	 	Edward W. Lomicka
		 		 	Title:	 	Vice President and Treasurer
			
	AUTHORIZED REPRESENTATIVE:	 		 	CHSPSC, LLC
			
		 		 	By:                                   
                               
		 		 	Name:	 	Edward W. Lomicka
		 		 	Title:	 	Vice President and Treasurer
			
	COLLECTION AGENT:	 		 	CHSPSC, LLC
			
		 		 	By:                                   
                               
		 		 	Name:	 	Edward W. Lomicka
		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Receivables Sale Agreement 

									
	ORIGINATORS:	 		 	
		 		 	AFFINITY HOSPITAL, LLC
		 		 	BERWICK HOSPITAL COMPANY, LLC
		 		 	BLUEFIELD HOSPITAL COMPANY, LLC
		 		 	BLUFFTON HEALTH SYSTEM LLC
		 		 	BULLHEAD CITY HOSPITAL CORPORATION
		 		 	CARLSBAD MEDICAL CENTER, LLC
		 		 	CLEVELAND TENNESSEE HOSPITAL COMPANY, LLC
		 		 	COATESVILLE HOSPITAL CORPORATION
		 		 	CRESTVIEW HOSPITAL CORPORATION
		 		 	DEACONESS HEALTH SYSTEM, LLC
		 		 	DUKES HEALTH SYSTEM, LLC
		 		 	DYERSBURG HOSPITAL CORPORATION
		 		 	EMPORIA HOSPITAL CORPORATION
		 		 	FOLEY HOSPITAL CORPORATION
		 		 	FRANKLIN HOSPITAL CORPORATION
		 		 	GADSDEN REGIONAL MEDICAL CENTER, LLC
		 		 	GRANBURY HOSPITAL CORPORATION
		 		 	GREENBRIER VMC, LLC
		 		 	HOSPITAL OF MORRISTOWN, INC.
		 		 	JACKSON, TENNESSEE HOSPITAL COMPANY, LLC
		 		 	JOURDANTON HOSPITAL CORPORATION
		 		 	KAY COUNTY OKLAHOMA HOSPITAL COMPANY, LLC
		 		 	LAKE WALES HOSPITAL CORPORATION
		 		 	LANCASTER HOSPITAL CORPORATION
		 		 	LAS CRUCES MEDICAL CENTER, LLC
		 		 	LEA REGIONAL HOSPITAL, LLC
		 		 	MARTIN HOSPITAL CORPORATION
		 		 	MARY BLACK HEALTH SYSTEM LLC
		 		 	MCNAIRY HOSPITAL CORPORATION
		 		 	MCSA, L.L.C.
		 		 	MOBERLY HOSPITAL COMPANY, LLC
		 		 	NATIONAL HEALTHCARE OF LEESVILLE, INC.
		 		 	NORTHAMPTON HOSPITAL COMPANY, LLC
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Receivables Sale Agreement 

									
		 		 	ORIGINATORS (CONT.):
			
		 		 	NORTHWEST HOSPITAL, LLC
		 		 	ORO VALLEY HOSPITAL, LLC
		 		 	PETERSBURG HOSPITAL COMPANY, LLC
		 		 	PHOENIXVILLE HOSPITAL COMPANY, LLC
		 		 	POTTSTOWN HOSPITAL COMPANY, LLC
		 		 	PORTER HOSPITAL, LLC
		 		 	QHG OF ENTERPRISE, INC.
		 		 	QHG OF SOUTH CAROLINA, INC.
		 		 	ROSWELL HOSPITAL CORPORATION
		 		 	RUSTON LOUISIANA HOSPITAL COMPANY, LLC
		 		 	SCRANTON HOSPITAL COMPANY, LLC
		 		 	SHELBYVILLE HOSPITAL CORPORATION
		 		 	SILOAM SPRINGS ARKANSAS HOSPITAL COMPANY, LLC
		 		 	SPOKANE VALLEY WASHINGTON HOSPITAL COMPANY, LLC
		 		 	SPOKANE WASHINGTON HOSPITAL COMPANY, LLC
		 		 	ST. JOSEPH HEALTH SYSTEM LLC
		 		 	TOMBALL TEXAS HOSPITAL COMPANY, LLC
		 		 	WARREN OHIO HOSPITAL COMPANY, LLC
		 		 	WARREN OHIO REHAB HOSPITAL COMPANY, LLC
		 		 	WARSAW HEALTH SYSTEM LLC
		 		 	WEATHERFORD TEXAS HOSPITAL COMPANY, LLC
		 		 	WESLEY HEALTH SYSTEM, LLC
		 		 	WEST GROVE HOSPITAL COMPANY, LLC
		 		 	WILKES-BARRE HOSPITAL COMPANY, LLC
		 		 	WOMEN & CHILDREN’S HOSPITAL, LLC
		 		 	YOUNGSTOWN OHIO HOSPITAL COMPANY, LLC
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Receivables Sale Agreement 

									
		 		 	ORIGINATORS (CONT.):
			
		 		 	KIRKSVILLE MISSOURI HOSPITAL COMPANY, LLC
		 		 	LUTHERAN MUSCULOSKELETAL CENTER, LLC
		 		 	OAK HILL HOSPITAL CORPORATION
		 		 	SALEM HOSPITAL CORPORATION
		 		 	SCRANTON QUINCY HOSPITAL COMPANY, LLC
		 		 	WOODWARD HEALTH SYSTEM, LLC
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  

Signature Page to Receivables Sale Agreement 

									
		 		 	ORIGINATORS (CONT.):
			
		 		 	AMORY HMA, LLC
		 		 	ANNISTON HMA, LLC
		 		 	BILOXI H.M.A., LLC
		 		 	BRANDON HMA, LLC
		 		 	CAMPBELL COUNTY HMA, LLC
		 		 	CARLISLE HMA, LLC
		 		 	CHESTER HMA, LLC
		 		 	CITRUS HMA, LLC
		 		 	CLARKSDARE HMA, LLC
		 		 	CLINTON HMA, LLC
		 		 	COCKE COUNTY HMA, LLC
		 		 	DURANT H.M.A., LLC
		 		 	EAST GEORGIA REGIONAL MEDICAL CENTER, LLC
		 		 	FORT SMITH HMA, LLC
		 		 	HAINES CITY HMA, LLC
		 		 	HERNANDO HMA, LLC
		 		 	HMA FENTRESS COUNTY GENERAL HOSPITAL, LLC
		 		 	HMA SANTA ROSA MEDICAL CENTER, LLC
		 		 	JACKSON HMA, LLC
		 		 	JEFFERSON COUNTY HMA, LLC
		 		 	KEY WEST HMA, LLC
		 		 	LANCASTER HMA, LLC
		 		 	LEBANON HMA, LLC
		 		 	MADISON HMA, LLC
		 		 	MARSHALL COUNTY HMA, LLC
		 		 	MELBOURNE HMA, LLC
		 		 	METRO KNOXVILLE HMA, LLC
		 		 	MIDWEST REGIONAL MEDICAL CENTER, LLC
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  
 Signature Page to

 Receivables Sale Agreement 

									
		 		 	ORIGINATORS (CONT.):
			
		 		 	NORTHWEST ARKANSAS HOSPITALS, LLC
		 		 	PASCO REGIONAL MEDICAL CENTER, LLC
		 		 	POPLAR BLUFF REGIONAL MEDICAL CENTER, LLC
		 		 	PORT CHARLOTTE HMA, LLC
		 		 	PUNTA GORDA HMA, LLC
		 		 	RIVER OAKS HOSPITAL, LLC
		 		 	ROCKLEDGE HMA, LLC
		 		 	ROH, LLC
		 		 	ROSE CITY HMA, LLC
		 		 	SEBASTIAN HOSPITAL, LLC
		 		 	SEBRING HOSPITAL MANAGEMENT ASSOCIATES, LLC
		 		 	SEMINOLE HMA, LLC
		 		 	STATESVILLE HMA, LLC
		 		 	TRIAD OF ALABAMA, LLC
		 		 	TULLAHOMA HMA, LLC
		 		 	TUNKHANNOCK HOSPITAL COMPANY LLC
		 		 	VENICE HMA, LLC
		 		 	VICKSBURG HEALTHCARE, LLC
		 		 	YAKIMA HMA, LLC
		 		 	YORK PENNSYLVANIA HOSPITAL COMPANY, LLC
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  
 Signature Page to

 Receivables Sale Agreement 

									
		 		 	 ORIGINATORS (CONT.):

			
		 		 	BROWNWOOD HOSPITAL, L.P.
		 		 	By: Brownwood Medical Center, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer
			
		 		 	COLLEGE STATION HOSPITAL, L.P.
		 		 	By: College Station Medical Center, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer
			
		 		 	IOM HEALTH SYSTEM, L.P.
		 		 	By: Lutheran Health Network Investors, LLC
		 		 	Its:   General Partner
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  
 Signature Page to

 Receivables Sale Agreement 

									
		 		 	ORIGINATORS (CONT.):
			
		 		 	LAREDO TEXAS HOSPITAL COMPANY, L.P.
		 		 	By: Webb Hospital Corporation
		 		 	Its: General Partner
				
		 		 	By:	 	
                                         
                       
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer
			
		 		 	LONGVIEW MEDICAL CENTER, L.P.
		 		 	By: Regional Hospital of Longview, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                             
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer
			
		 		 	NAVARRO HOSPITAL, L.P.
		 		 	By: Navarro Regional, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	
                                         
                       
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  
 Signature Page to

 Receivables Sale Agreement 

									
		 		 	ORIGINATORS (CONT.):
			
		 		 	PINEY WOODS HEALTHCARE SYSTEM, L.P.
		 		 	By: Woodland Heights Medical Center, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                            
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer
			
		 		 	REHAB HOSPITAL OF FORT WAYNE GENERAL PARTNERSHIP
		 		 	By: Lutheran Health Network Investors, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                            
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer
			
		 		 	SAN ANGELO HOSPITAL, L.P.
		 		 	By: San Angelo Community Medical Center, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                            
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer
			
		 		 	VICTORIA OF TEXAS, L.P.
		 		 	By: Detar Hospital, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                            
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  
 Signature Page to

 Receivables Sale Agreement 

									
		 		 	ORIGINATORS (CONT.):
			
		 		 	ARMC, L.P.
		 		 	By: Triad-ARMC, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                            
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer
			
		 		 	CRESTWOOD HEALTHCARE, L.P.
		 		 	By: Crestwood Hospital, LLC
		 		 	Its: General Partner
				
		 		 	By:	 	                                    
                            
		 		 		 	Name:	 	Edward W. Lomicka
		 		 		 	Title:	 	Vice President and Treasurer

  
 Signature Page to

 Receivables Sale Agreement 

 SCHEDULE I 

ORIGINATORS 
  

			
	1.  	  	Affinity Hospital, LLC
	2.  	  	Amory HMA, LLC
	3.  	  	Anniston HMA, LLC
	4.  	  	ARMC, L.P.
	5.  	  	Berwick Hospital Company, LLC
	6.  	  	Biloxi H.M.A., LLC
	7.  	  	Bluefield Hospital Company, LLC
	8.  	  	Bluffton Health System LLC
	9.  	  	Brandon HMA, LLC
	10.  	  	Brownwood Hospital, L.P.
	11.  	  	Bullhead City Hospital Corporation
	12.  	  	Campbell County HMA, LLC
	13.  	  	Carlisle HMA, LLC
	14.  	  	Carlsbad Medical Center, LLC
	15.  	  	Chester HMA, LLC
	16.  	  	Citrus HMA, LLC
	17.  	  	Clarksdale HMA, LLC
	18.  	  	Cleveland Tennessee Hospital Company, LLC
	19.  	  	Clinton HMA, LLC
	20.  	  	Coatesville Hospital Corporation
	21.  	  	Cocke County HMA, LLC
	22.  	  	College Station Hospital, L.P.
	23.  	  	Crestview Hospital Corporation
	24.  	  	Crestwood Healthcare, L.P.
	25.  	  	Deaconess Health System, LLC
	26.  	  	Dukes Health System, LLC
	27.  	  	Durant H.M.A., LLC
	28.  	  	Dyersburg Hospital Corporation
	29.  	  	East Georgia Regional Medical Center, LLC
	30.  	  	Emporia Hospital Corporation
	31.  	  	Foley Hospital Corporation
	32.  	  	Fort Smith HMA, LLC
	33.  	  	Franklin Hospital Corporation
	34.  	  	Gadsden Regional Medical Center, LLC
	35.  	  	Granbury Hospital Corporation
	36.  	  	Greenbrier VMC, LLC
	37.  	  	Haines City HMA, LLC

  
 Sch. I-1 

			
	38.  	  	Hernando HMA, LLC
	39.  	  	Hospital of Morristown, Inc.
	40.  	  	HMA Fentress County General Hospital, LLC
	41.  	  	HMA Santa Rosa Medical Center, LLC
	42.  	  	IOM Health System, L.P.
	43.  	  	Jackson HMA, LLC
	44.  	  	Jackson, Tennessee Hospital Company, LLC
	45.  	  	Jefferson County HMA, LLC
	46.  	  	Jourdanton Hospital Corporation
	47.  	  	Kay County Oklahoma Hospital Company, LLC
	48.  	  	Key West HMA, LLC
	49.  	  	Kirksville Missouri Hospital Company, LLC
	50.  	  	Lake Wales Hospital Corporation
	51.  	  	Lancaster Hospital Corporation
	52.  	  	Lancaster HMA, LLC
	53.  	  	Laredo Texas Hospital Company, L.P.
	54.  	  	Las Cruces Medical Center, LLC
	55.  	  	Lea Regional Hospital, LLC
	56.  	  	Lebanon HMA, LLC
	57.  	  	Longview Medical Center, L.P.
	58.  	  	Lutheran Musculoskeletal Center, LLC
	59.  	  	Madison HMA, LLC
	60.  	  	Marshall County HMA, LLC
	61.  	  	Martin Hospital Corporation
	62.  	  	Mary Black Health System LLC
	63.  	  	McNairy Hospital Corporation
	64.  	  	MCSA, L.L.C.
	65.  	  	Melbourne HMA, LLC
	66.  	  	Metro Knoxville HMA, LLC
	67.  	  	Midwest Regional Medical Center, LLC
	68.  	  	Moberly Hospital Company, LLC
	69.  	  	National Healthcare of Leesville, Inc.
	70.  	  	Navarro Hospital, L.P.
	71.  	  	Northampton Hospital Company, LLC
	72.  	  	Northwest Arkansas Hospitals, LLC
	73.  	  	Northwest Hospital, LLC
	74.  	  	Oak Hill Hospital Corporation
	75.  	  	Oro Valley Hospital, LLC
	76.  	  	Pasco Regional Medical Center, LLC
	77.  	  	Petersburg Hospital Company, LLC
	78.  	  	Phoenixville Hospital Company, LLC
	79.  	  	Piney Woods Healthcare System, L.P.
	80.  	  	Poplar Bluff Regional Medical Center, LLC

  
 Sch. I-2 

			
	81.  	  	Port Charlotte HMA, LLC
	82.  	  	Porter Hospital, LLC
	83.  	  	Pottstown Hospital Company, LLC
	84.  	  	Punta Gorda HMA, LLC
	85.  	  	QHG of Enterprise, Inc.
	86.  	  	QHG of South Carolina, Inc.
	87.  	  	Rehab Hospital of Fort Wayne General Partnership
	88.  	  	River Oaks Hospital, LLC
	89.  	  	Rockledge HMA, LLC
	90.  	  	ROH, LLC
	91.  	  	Rose City HMA, LLC
	92.  	  	Roswell Hospital Corporation
	93.  	  	Ruston Louisiana Hospital Company, LLC
	94.  	  	Salem Hospital Corporation
	95.  	  	San Angelo Hospital, L.P.
	96.  	  	Scranton Hospital Company, LLC
	97.  	  	Scranton Quincy Hospital Company, LLC
	98.  	  	Sebastian Hospital, LLC
	99.  	  	Sebring Hospital Management Associates, LLC
	100.  	  	Seminole HMA, LLC
	101.  	  	Shelbyville Hospital Corporation
	102.  	  	Siloam Springs Arkansas Hospital Company, LLC
	103.  	  	Spokane Valley Washington Hospital Company, LLC
	104.  	  	Spokane Washington Hospital Company, LLC
	105.  	  	St. Joseph Health System LLC
	106.  	  	Statesville HMA, LLC
	107.  	  	Tomball Texas Hospital Company, LLC
	108.  	  	Triad of Alabama, LLC
	109.  	  	Tullahoma HMA, LLC
	110.  	  	Tunkhannock Hospital Company LLC
	111.  	  	Venice HMA, LLC
	112.  	  	Vicksburg Healthcare, LLC
	113.  	  	Victoria of Texas, L.P.
	114.  	  	Warren Ohio Hospital Company, LLC
	115.  	  	Warren Ohio Rehab Hospital Company, LLC
	116.  	  	Warsaw Health System LLC
	117.  	  	Weatherford Texas Hospital Company, LLC
	118.  	  	Wesley Health System LLC
	119.  	  	West Grove Hospital Company, LLC
	120.  	  	Wilkes-Barre Hospital Company, LLC
	121.  	  	Women & Children’s Hospital, LLC
	122.  	  	Woodward Health System, LLC
	123.  	  	Yakima HMA, LLC

  
 Sch. I-3 

			
	124.  	  	York Pennsylvania Hospital Company, LLC
	125.  	  	Youngstown Ohio Hospital Company, LLC

  
 Sch. I-4 

 SCHEDULE II 

CONDITION PRECEDENT DOCUMENTS 

As required by Section 3.01 of the Agreement, each of the following items must be delivered to the Buyer prior to
the date of Initial Purchase: 

  
 Sch. II-1 

 SCHEDULE III 

LEGAL NAME, JURISDICTION OF ORGANIZATION, 

ORGANIZATIONAL ID NUMBER, PRINCIPAL PLACE OF BUSINESS, CHIEF 

EXECUTIVE OFFICE, LOCATION OF RECORDS AND REGISTERED NAMES 

The chief executive office of each Originator is 4000 Meridian Blvd., Franklin, TN 37067. 

Each Originator keeps its Records at such Originator’s principal place of business, as well as at its chief executive office. 

The legal name, jurisdiction of organization, organization ID number and principal place of business for each Originator are as follows: 

 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	1.  	  	Affinity Hospital, LLC	 	DE	 	 	 	4023245	 	 	  	 3690 Grandview Parkway

Birmingham, AL 35243

	2.  	  	Amory HMA, LLC	 	MS	 	 	 	938723	 	 	  	 1105 Earl Frye Blvd

Amory, MS 38821

	3.  	  	Anniston HMA, LLC	 	AL	 	 	 	425-743	 	 	  	 301 East 18th Street
 Anniston, AL 36207

	4.  	  	ARMC, L.P.	 	DE	 	 	 	3561898	 	 	  	 6250 Highway 83/84

Abilene, TX 79606

	5.  	  	Berwick Hospital Company, LLC	 	DE	 	 	 	4447833	 	 	  	701 E. 16th St, Berwick, PA 18603
	6.  	  	Biloxi H.M.A., LLC	 	MS	 	 	 	938583	 	 	  	 150 Reynoir Street

Biloxi, MS 39530

	7.  	  	Bluefield Hospital Company, LLC	 	DE	 	 	 	4812810	 	 	  	500 Cherry St, Bluefield, WV 24701
	8.  	  	Bluffton Health System, LLC	 	DE	 	 	 	3089523	 	 	  	303 S. Main Street, Bluffton, IN 46714
	9.  	  	Brandon HMA, LLC	 	MS	 	 	 	938712	 	 	  	 350 Crossgates Boulevard,

Brandon, MS 39042

	10.  	  	Brownwood Hospital, L.P.	 	DE	 	 	 	2967928	 	 	  	1501 Burnet Dr., Brownwood, TX 76801
	11.  	  	Bullhead City Hospital Corporation	 	AZ	 	 	 	09397220	 	 	  	2735 Silver Creek Rd, Bullhead City, AZ 86442
	12.  	  	Campbell County HMA, LLC	 	TN	 	 	 	660519	 	 	  	 923 East Central
Ave.,
 LaFollette, TN 37766

  
 Sch. III-1 

													
	  	  	Legal Name	 	 Jurisdiction of

Organization
	 	  	 	 Organization

ID #
	 	  	  	
Principal Place
 of
Business

	13.  	  	Carlisle HMA, LLC	 	PA	 	 	 	3870482	 	 	  	361 Alexander Spring Road, Carlisle, PA 17015
	14.  	  	Carlsbad Medical Center, LLC	 	DE	 	 	 	2964276	 	 	  	2430 W. Pierce, Carlsbad, NM 88220
	15.  	  	Chester HMA, LLC	 	SC	 	 	 	20328679-1	 	 	  	 One Medical Park Drive,

Chester, SC 29706

	16.  	  	Citrus HMA, LLC	 	FL	 	 	 	L08000108791	 	 	  	 6201 N. Suncoast Blvd.,

Crystal River, FL 34428

	17.  	  	Clarksdale HMA, LLC	 	MS	 	 	 	938727	 	 	  	 1970 Hospital Drive

Clarksdale, MS 38614

	18.  	  	Cleveland Tennessee Hospital Company, LLC	 	DE	 	 	 	4589625	 	 	  	2305 Chambliss Ave, Cleveland, TN 37311
	19.  	  	Clinton HMA, LLC	 	OK	 	 	 	3512339859	 	 	  	 100 North 30th Street
 Clinton, OK 73601

	20.  	  	Coatesville Hospital Corporation	 	PA	 	 	 	2987105	 	 	  	201 Reeceville Rd, Coatesville, PA 19320
	21.  	  	Cocke County HMA, LLC	 	TN	 	 	 	660506	 	 	  	 435 Second Street

Newport, TN 37821

	22.  	  	College Station Hospital, L.P.	 	DE	 	 	 	2967943	 	 	  	1604 Rock Prairie, College Station, TX 77845
	23.  	  	Crestview Hospital Corporation	 	FL	 	 	 	P93000087326	 	 	  	151 Redstone Ave, S.E., Crestview, FL 32539
	24.  	  	Crestwood Healthcare, L.P.	 	DE	 	 	 	2616459	 	 	  	 One Hospital Drive SW

Huntsville, AL 35801

	25.  	  	Deaconess Health System, LLC	 	DE	 	 	 	3918793	 	 	  	5501 N. Portland Ave, Oklahoma City, OK 73112
	26.  	  	Dukes Health System, LLC	 	DE	 	 	 	3575662	 	 	  	275 West 12th Street, Peru, IN 46970
	27.  	  	Durant H.M.A., LLC	 	OK	 	 	 	3512205738	 	 	  	 1800 University
Boulevard,
 Durant, OK 74701

  
 Sch. III-2 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	28.  	  	Dyersburg Hospital Corporation	 	TN	 	 	 	435828	 	 	  	400 Tickle St, Dyersburg, TN 38024
	29.  	  	East Georgia Regional Medical Center, LLC	 	GA	 	 	 	08050712	 	 	  	 1499 Fair Road

Statesboro, GA 30458

	30.  	  	Emporia Hospital Corporation	 	VA	 	 	 	0514489-4	 	 	  	727 N. Main St, Emporia, VA 23847
	31.  	  	Foley Hospital Corporation	 	AL	 	 	 	208-366	 	 	  	1613 N. McKenzie St, Foley, AL 36535
	32.  	  	Fort Smith HMA, LLC	 	AR	 	 	 	800164237	 	 	  	 1001 Towson Ave.

Fort Smith, AR 72902

	33.  	  	Franklin Hospital Corporation	 	VA	 	 	 	0529059-8	 	 	  	100 Fairview Dr., Franklin, VA 23851
	34.  	  	Gadsden Regional Medical Center, LLC	 	DE	 	 	 	4275573	 	 	  	1007 Goodyear Ave, Gadsden, AL 35903
	35.  	  	Granbury Hospital Corporation	 	TX	 	 	 	0142527600	 	 	  	1310 Paluxy Rd, Granbury, TX 76048
	36.  	  	Greenbrier VMC, LLC	 	DE	 	 	 	3249745	 	 	  	1320Maplewood Ave, Ronceverte, WV 24970
	37.  	  	Haines City HMA, LLC	 	FL	 	 	 	L08000107932	 	 	  	 40100 US Highway 27

Davenport, FL 33837

	38.  	  	Hernando HMA, LLC	 	FL	 	 	 	L08000108810	 	 	  	 17240 Cortez Blvd.

Brooksville, FL 34601
 and

10461 Quality Drive
 Spring Hill, FL 34609

	39.  	  	Hospital of Morristown, Inc.	 	TN	 	 	 	264618	 	 	  	726 McFarland St, Morristown, TN 37814
	40.  	  	HMA Fentress County General Hospital, LLC	 	TN	 	 	 	601484	 	 	  	 436 Central Avenue West

Jamestown, TN 38556

	41.  	  	HMA Santa Rosa Medical Center, LLC	 	FL	 	 	 	L08000118053	 	 	  	 6002 Berryhill Road

Milton, FL 32570

	42.  	  	IOM Health System, L.P.	 	IN	 	 	 	LP95090037	 	 	  	7950 W. Jefferson Blvd., Fort Wayne, IN 46804

  
 Sch. III-3 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	43.  	  	Jackson HMA, LLC	 	MS	 	 	 	938738	 	 	  	 1850 Chadwick Drive

Jackson, MS 39204

	44.  	  	Jackson, Tennessee Hospital Company, LLC	 	TN	 	 	 	435835	 	 	  	367 Hospital Blvd, Jackson, TN 38305
	45.  	  	Jefferson County HMA, LLC	 	TN	 	 	 	660508	 	 	  	 110 Hospital Drive

Jefferson City, TN 37660

	46.  	  	Jourdanton Hospital Corporation	 	TX	 	 	 	0800001865	 	 	  	1905 Hwy 97 E., Jourdanton, TX 78026
	47.  	  	Kay County Oklahoma Hospital Company, LLC	 	OK	 	 	 	3512092198	 	 	  	1900 North 14th Street, Ponca City, OK 74601
	48.  	  	Key West HMA, LLC	 	FL	 	 	 	L08000108767	 	 	  	 5900 College Road

Key West, FL

	49.  	  	Kirksville Missouri Hospital Co., LLC	 	MO	 	 	 	LC0043450	 	 	  	 315 S. Osteopathy

Kirksville, MO 63501

	50.  	  	Lake Wales Hospital Corporation	 	FL	 	 	 	P02000099846	 	 	  	410 S. 11th St, Lake Wales, FL 33853
	51.  	  	Lancaster Hospital Corporation	 	DE	 	 	 	2436981	 	 	  	800 W. Meeting Street, Lancaster, SC 29720
	52.  	  	Lancaster HMA, LLC	 	PA	 	 	 	5987673	 	 	  	 1500 Highlands Drive

Lititz, PA 17543

	53.  	  	Laredo Texas Hospital Company, L.P.	 	TX	 	 	 	0800237874	 	 	  	1700 E. Saunders, Laredo, TX 78041
	54.  	  	Las Cruces Medical Center, LLC	 	DE	 	 	 	3306969	 	 	  	4311 E. Lohman Ave, Las Cruces, NM 88011
	55.  	  	Lea Regional Hospital, LLC	 	DE	 	 	 	2964402	 	 	  	5419 N. Lovington Hwy, Hobbs, NM 88240
	56.  	  	Lebanon HMA, LLC	 	TN	 	 	 	453277	 	 	  	 1411 W. Baddour Parkway

Lebanon, TN 37087

	57.  	  	Longview Medical Center, L.P.	 	DE	 	 	 	2964553	 	 	  	2901 N. Fourth St, Longview, TX 75605
	58.  	  	Lutheran Musculoskeletal Center, LLC	 	DE	 	 	 	4463811	 	 	  	 7952 W. Jefferson
Blvd.
 Fort Wayne, IN 46804

  
 Sch. III-4 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	59.  	  	Madison HMA, LLC	 	MS	 	 	 	938594	 	 	  	 161 River Oaks Drive

Canton, MS 39046

	60.  	  	Marshall County HMA, LLC	 	OK	 	 	 	3512339852	 	 	  	 901 S.
5th Ave.
 Madill, OK 73446

	61.  	  	Martin Hospital Corporation	 	TN	 	 	 	435833	 	 	  	161 Mt. Pelia Rd, Martin, TN 38237
	62.  	  	Mary Black Health System, LLC	 	DE	 	 	 	2623318	 	 	  	1700 Skylyn Dr, Spartanburg, SC 29307
	63.  	  	McNairy Hospital Corporation	 	TN	 	 	 	435832	 	 	  	705 Poplar Ave, Selmer, TN 38375
	64.  	  	MCSA, LLC	 	AR	 	 	 	100129761	 	 	  	700 W. Grove St, El Dorado, AR 71730
	65.  	  	Melbourne HMA, LLC	 	FL	 	 	 	L10000078336	 	 	  	 250 N. Wickham Road

Melbourne, FL 32935

	66.  	  	Metro Knoxville HMA, LLC	 	TN	 	 	 	660505	 	 	  	 900 E. Oak Hill Ave.

Knoxville, TN 37917
 and

7565 Dannaher Drive
 Powell, TN 37894

and
 10820 Parkside Drive

Knoxville, TN 37943

	67.  	  	Midwest Regional Medical Center, LLC	 	OK	 	 	 	3512163140	 	 	  	 2825 Parklawn Drive

Midwest City, OK 73110

	68.  	  	Moberly Hospital Company, LLC	 	DE	 	 	 	4447851	 	 	  	1515 Union Ave, Moberly, MO 65270
	69.  	  	National Healthcare of Leesville, Inc.	 	DE	 	 	 	2101020	 	 	  	1020 Fertitta Blvd, Leesville, LA 71446
	70.  	  	Navarro Hospital, L.P.	 	DE	 	 	 	2964396	 	 	  	3201 W. Hwy 22, Corsicanna, TX 75110
	71.  	  	Northampton Hospital Company, LLC	 	DE	 	 	 	4442353	 	 	  	250 S. 21st Street, Easton, PA
18042

  
 Sch. III-5 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	72.  	  	Northwest Arkansas Hospitals, LLC	 	DE	 	 	 	4251378	 	 	  	 3000 Medical Center Pkwy

Bentonville, AR 72712
 and

609 W. Maple
 Springdale, AR 72764

and
 4301 Greathouse Springs Rd. Johnson, AR 72741

	73.  	  	Northwest Hospital, LLC	 	DE	 	 	 	2964436	 	 	  	6200 N. LaCholla Blvd, Tucson, AZ 85741
	74.  	  	Oak Hill Hospital Corporation	 	WV	 	 	 	46241	 	 	  	 430 Main Street

Oak Hill, WV 25901

	75.  	  	Oro Valley Hospital, LLC	 	DE	 	 	 	3575660	 	 	  	1551 E. Tangerine Rd, Oro Valley, AZ 85755
	76.  	  	Pasco Regional Medical Center, LLC	 	FL	 	 	 	L08000103539	 	 	  	 13100Fort King Road

Dade City, FL 33525

	77.  	  	Petersburg Hospital Company, LLC	 	VA	 	 	 	S096843-0	 	 	  	200 Medical Park Blvd, Petersburg, VA 23805
	78.  	  	Phoenixville Hospital Company, LLC	 	DE	 	 	 	3796044	 	 	  	140 Nutt Rd, Phoenixville, PA 19460
	79.  	  	Piney Woods Healthcare System, L.P.	 	DE	 	 	 	2964618	 	 	  	505 S. John Redditt Dr, Lufkin, TX 75904
	80.  	  	Poplar Bluff Regional Medical Center, LLC	 	MO	 	 	 	LC0961963	 	 	  	 3100 Oak Grove Road

Poplar Bluff, MO 63902

	81.  	  	Port Charlotte HMA, LLC	 	FL	 	 	 	L08000111185	 	 	  	 2500 Harbor Boulevard

Port Charlotte, FL 33952

	82.  	  	Porter Hospital, LLC	 	DE	 	 	 	4296736	 	 	  	814 LaPorte Avenue, Valparaiso, IN 46383
	83.  	  	Pottstown Hospital Company, LLC	 	DE	 	 	 	3657514	 	 	  	1600 E. High St, Pottstown, PA 19464

  
 Sch. III-6 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	
84.  
	  	Punta Gorda HMA, LLC	 	FL	 	 	 	L08000107920	 	 	  	 809 East Marion Avenue

Punta Gorda, FL 33950

	85.  	  	QHG of Enterprise, Inc.	 	AL	 	 	 	176-166	 	 	  	400 N. Edwards St, Enterprise, AL 36330
	86.  	  	QHG of South Carolina, Inc.	 	SC	 	 	 	N/A	 	 	  	 805 Pamplico Highway, Florence, SC 29505,

and
 2829 E Hwy 76, Mullins, SC 295741

	87.  	  	Rehab Hospital of Fort Wayne General Partnership	 	DE	 	 	 	N/A	 	 	  	7970 West Jefferson Blvd., Fort Wayne, IN 46804
	88.  	  	River Oaks Hospital, LLC	 	MS	 	 	 	939308	 	 	  	 1030 River Oaks Drive

Flowood, MS 33932

	89.  	  	Rockledge HMA, LLC	 	FL	 	 	 	L10000078587	 	 	  	 110 Longwood Avenue

Rockledge, FL 32955

	90.  	  	ROH, LLC	 	MS	 	 	 	938734	 	 	  	 1026 N. Flowood Drive

Flowood, MS 39232

	91.  	  	Rose City HMA, LLC	 	PA	 	 	 	3870485	 	 	  	 250 College Avenue

Lancaster, PA 17603

	92.  	  	Roswell Hospital Corporation	 	NM	 	 	 	1913540	 	 	  	405 West Country Club Road, Roswell, NM 88201
	93.  	  	Ruston Louisiana Hospital Company, LLC	 	DE	 	 	 	4270657	 	 	  	401 E. Vaughn Ave, Ruston, LA 71270
	94.  	  	Salem Hospital Corporation	 	NJ	 	 	 	0100863665	 	 	  	 310 Woodstown Road

Salem, NJ 08079

	95.  	  	San Angelo Hospital, L.P.	 	DE	 	 	 	2964591	 	 	  	3501 Knickerbocker Rd, San Angelo, TX 76904
	96.  	  	Scranton Hospital Company, LLC	 	DE	 	 	 	4927796	 	 	  	746 Jefferson Avenue, Scranton, PA 18510

 
  

	1 	These addresses represent the physical location of Carolinas Health System and Marion Regional Hospital, respectively. Records for Receivables are kept separately for each hospital at each of their respective physical
locations. 

  
 Sch. III-7 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	97.  	  	Scranton Quincy Hospital Company, LLC	 	DE	 	 	 	5005530	 	 	  	 700 Quincy Ave.

Scranton, PA 18510

	98.  	  	Sebastian Hospital, LLC	 	FL	 	 	 	L08000108770	 	 	  	 13695 US Highway 1

Sebastian, FL 32958

	99.  	  	Sebring Hospital Management Associates, LLC	 	FL	 	 	 	L08000110470	 	 	  	 3600 South Highlands Avenue

Sebring, FL 33870

	100.  	  	Seminole HMA, LLC	 	OK	 	 	 	3512339861	 	 	  	 2401 Wrangler Boulevard

Seminole, OK 74868

	101.  	  	Shelbyville Hospital Corporation	 	TN	 	 	 	494640	 	 	  	2835 Hwy 231 N., Shelbyville, TN 37160
	102.  	  	Siloam Springs Arkansas Hospital Company, LLC	 	DE	 	 	 	4617628	 	 	  	205 E. Jefferson St, Siloam Springs, AR 72761
	103.  	  	Spokane Valley Washington Hospital Company, LLC	 	DE	 	 	 	4447178	 	 	  	12606 East Mission Avenue, Spokane Valley, WA 99216
	104.  	  	Spokane Washington Hospital Company, LLC	 	DE	 	 	 	4436798	 	 	  	800 W. 5th Avenue, Spokane, WA 99204
	105.  	  	St. Joseph Health System, LLC	 	DE	 	 	 	2909376	 	 	  	700 Broadway, Fort Wayne, IN 46802
	106.  	  	Statesville HMA, LLC	 	NC	 	 	 	0557481	 	 	  	 218 Old Mocksville Road

Statesville, NC 28625

	107.  	  	Tomball Texas Hospital Company, LLC	 	DE	 	 	 	5017131	 	 	  	605 Holderrieth, Tomball, TX 77375
	108.  	  	Triad of Alabama, LLC	 	DE	 	 	 	2964867	 	 	  	 4370 West Main Street

Dothan, AL 36305

	109.  	  	Tullahoma HMA, LLC	 	TN	 	 	 	453279	 	 	  	 1801 N. Jackson Street

Tullahoma, TN 37388

	110.  	  	Tunkhannock Hospital Company LLC	 	DE	 	 	 	4927797	 	 	  	 880 SR 6 West

Tunkhannock, PA 18657

	111.  	  	Venice HMA, LLC	 	FL	 	 	 	L08000108774	 	 	  	 540 The Rialto

Venice, FL 34285

  
 Sch. III-8 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	112.  	  	Vicksburg Healthcare, LLC	 	DE	 	 	 	2939229	 	 	  	2100 Highway 61 North 
Vicksburg, MS 39183
	113.  	  	Victoria of Texas, L.P.	 	DE	 	 	 	2949026	 	 	  	 101 Medical Dr, Victoria, TX 77904,

and
 506 E. San Antonio St., Victoria, TX 779012

	114.  	  	Warren Ohio Hospital Company, LLC	 	DE	 	 	 	4856127	 	 	  	1350 E. Market St., Warren, OH 44484
	115.  	  	Warren Ohio Rehab Hospital Company, LLC	 	DE	 	 	 	4856131	 	 	  	 8747 Squires Lane Northeast, Warren, OH 44484

 

	116.  	  	Warsaw Health System, LLC	 	DE	 	 	 	2987604	 	 	  	2101 East DuBois Drive, Warsaw, IN 46580
	117.  	  	Weatherford Texas Hospital Company, LLC	 	TX	 	 	 	800718224	 	 	  	713 E. Anderson Street, Weatherford, TX 76086
	118.  	  	Wesley Health System, LLC	 	DE	 	 	 	2770969	 	 	  	5001 Hardy St, Hattiesburg, MS 39402
	119.  	  	West Grove Hospital Company, LLC	 	DE	 	 	 	4442356	 	 	  	1015 W. Baltimore Pike, West Grove, PA 19390
	120.  	  	Wilkes-Barre Hospital Company, LLC	 	DE	 	 	 	4617619	 	 	  	575 North River Street, Wilkes-Barre, PA 18764
	121.  	  	Women & Children’s Hospital, LLC	 	DE	 	 	 	2964655	 	 	  	4200 Nelson Rd, Lake Charles, LA70605
	122.  	  	Woodward Health System, LLC	 	DE	 	 	 	2964411	 	 	  	 900 17th Street

Woodward, OK 73801

  

 

	2 	These addresses represent the physical location of DeTar Hospital North, and DeTar Hospital Navarro, respectively. [Records for Receivables are kept separately for each hospital at each of their respective physical
locations.] 

  
 Sch. III-9 

													
	  	  	Legal Name	 	Jurisdiction of
Organization	 	  	 	 Organization

ID #
	 	  	  	Principal Place 
of Business
	123.  	  	Yakima HMA, LLC	 	WA	 	 	 	602882179	 	 	  	 502 W.
4th
 Toppendish, WA 98948

and
 110 S.
9th Avenue
 Yakima, WA 98902

	124.  	  	York Pennsylvania Hospital Company, LLC	 	DE	 	 	 	5069409	 	 	  	 325 S. Belmont St.

York, PA 17405

	125.  	  	Youngstown Ohio Hospital Company, LLC	 	DE	 	 	 	4848328	 	 	  	500 Gypsy Lane, Youngstown, OH 44501

  
 Sch. III-10 

 All currently registered trade names, fictitious names, assumed names or “doing business
as” names or other names under which it is doing business for each Originator are set forth on the following table: 
  

					
	  	  	Parties	  	Names
	1.  	  	 Affinity Hospital, LLC
	  	 - Grandview Medical
Center

	2.  	  	 Amory HMA, LLC
	  	 - Merit Health Gilmore
Memorial

	3.  	  	 Anniston HMA, LLC
	  	 - Stringfellow Memorial
Hospital

	4.  	  	 ARMC, L.P.
	  	 - David M. Collins WellHealth
Center
 - Abilene Regional Medical Center

	5.  	  	 Berwick Hospital Company, LLC
	  	 - Berwick Hospital Center

- Berwick Recovery Systems
 -
Berwick Retirement Village Nursing Home
 - Berwick Family Medicine and Obstetrics

- Berwick Hospital CRNA Group
 -
Berwick Orthopedics

	6.  	  	 Biloxi H.M.A., LLC
	  	 - Merit Health Biloxi

	7.  	  	 Bluefield Hospital Company, LLC
	  	 - Bluefield Regional Medical
Center

	8.  	  	 Bluffton Health System LLC
	  	 - Bluffton Regional Medical
Center

	9.  	  	 Brandon HMA, LLC
	  	 - Merit Health Rankin

	10.  	  	 Brownwood Hospital, L.P.
	  	 - Brownwood Regional Medical
Center
 - Brownwood Regional Rehab and Fitness Zone

- Brownwood Surgery Center
 -
Brownwood Regional Medical Center -Geriatric Psychiatric Unit
 - Brownwood Regional Medical Center - Skilled Nursing Facility

- Brownwood Regional Medical Center - Rehab Unit

- One Source Health Center - Lake Brownwood

- One Source Health Center - Comanche

- One Source Health Center - Cross Plains

- Brownwood Regional Medical Center Outpatient Imaging and Breast Center

	11.  	  	 Bullhead City Hospital Corporation
	  	 - Western Arizona Regional Medical
Center
 - W.A.R.M.C. Imaging Center

- W.A.R.M.C. Outpatient Rehabilitation Center

	12.  	  	 Campbell County HMA, LLC
	  	 - Tennova Healthcare –
LaFollette
 - Tennova Healthcare – LaFollette Medical Center

- Irene and Howard H. Baker Cancer Treatment Center

- Tennova LaFollette Geriatric Psyciatric Unit

- Tennova Infusion Center
 -
Tennova LaFollette Health & Rehabilitation Center
 - Tennova LaFollette Medical Center Clinic

- Tennova LaFollette Medical Center Clinic – Jacksboro

- Tennova LaFollette Outpatient Rehab Center

- Tennova LaFollette Sleep Disorders Clinic

	13.  	  	 Carlisle HMA, LLC
	  	 - Carlisle Regional Medical
Center
 - Carlisle Outpatient Surgery Center

	14.  	  	 Carlsbad Medical
Center, LLC
	  	 -
Carlsbad Medical Center

  
 Sch. III-11 

					
	     	  	
Parties
	  	
Names

	15.  	  	Chester HMA, LLC	  	 - Chester Regional Medical Center

- Chester Nursing Center
 - Neighbors Care Home Health Agency

- Church Street Clinic
 - Richburg Family Medical
Center

	16.  	  	CHS Receivables Funding, LLC	  	N/A
	17.  	  	CHS/Community Health Systems, Inc.	  	N/A
	18.  	  	Citrus HMA, LLC	  	 - Seven Rivers Regional Medical Center

- Seven Rivers Outpatient Laboratory
 - Dunnellon Diagnostic
Center
 - Seven Rivers Wound Center

	19.  	  	Clarksdale HMA, LLC	  	- Merit Health Northwest Mississippi
	20.  	  	Cleveland Tennessee Hospital Company, LLC	  	 - Tennova Healthcare - Cleveland

- Pine Ridge Treatment Center

	21.  	  	Clinton HMA, LLC	  	- AllianceHealth Clinton
	22.  	  	Coatesville Hospital Corporation	  	 - Brandywine Hospital

- Brandywine Health System
 - Brandywine School of Nursing

- Brandywine Hospital Home Health
 - Brandywine Hospital
Hospice
 - Brandywine Hospital Women’s Health-New Garden

- Brandywine Hospital Cardiothoracic Surgery
 - Brandywine
Behavioral Health Pavilion

	23.  	  	Cocke County HMA, LLC	  	 - Tennova Healthcare – Newport

- Tennova Healthcare – Newport Medical Center
 - Tennova
Newport Convalescent Center

	24.  	  	College Station Hospital, L.P.	  	 - College Station Medical Center

- The Heart Institute at College Station Medical Center
 - College
Station Orthopaedic Center

	25.  	  	CHSPSC, LLC	  	 - CHS Professional Services Corporation (AL)

- Community Health Systems PSC, Inc. (WA)
 - Trademark: Community
Health Systems, (TN)
 - CH Aviation (TN)

	26.  	  	Crestview Hospital Corporation	  	 - North Okaloosa Medical Center

- Hospitalist Services of Okaloosa County
 - Bluewater Bay Medical
Center
 - North Okaloosa Medical Center - Transitional Care Unit

- Gateway Medical Clinic
 - Gateway Medical Clinic - Laurel
Hill
 - Baker Clinic
 - Baker Medical Clinic

- Gateway Medical Clinic- Baker
 - North Okaloosa Medical Center
Surgery Center

	27.  	  	Crestwood Healthcare, L.P.	  	 - Crestwood Medical Center

- Columbia Homecare Huntsville
 - Columbia Medical Center of
Huntsville

	28.  	  	Deaconess Health System, LLC	  	- AllianceHealth Deaconess
	29.  	  	Dukes Health System, LLC	  	- Dukes Memorial Hospital
	30.  	  	Durant H.M.A., LLC	  	- AllianceHealth Durant

  
 Sch. III-12 

					
	     	  	
Parties
	  	
Names

	31.  	  	Dyersburg Hospital Corporation	  	 - Tennova Healthcare - Dyersburg Regional

- Riverside Surgery Center

	32.  	  	East Georgia Regional Medical Center, LLC	  	 - East Georgia Regional Medical Center

- Georgia One Call

	33.  	  	Emporia Hospital Corporation	  	 - Southern Virginia Regional Medical Center

- South Central Virginia Pain Center
 - Southern Virginia Pain
Management Center
 - Southern Virginia CompCare

	34.  	  	Foley Hospital Corporation	  	- South Baldwin Regional Medical Center
	35.  	  	Fort Smith HMA, LLC	  	 - Sparks Health System

- Sparks Regional Medical Center
 - PremierCare

	36.  	  	Franklin Hospital Corporation	  	 - Southampton Memorial Hospital

- New Outlook
 - Southampton Memorial Hospital Skilled Nursing
Facility
 - Southampton Memorial Hospital East Pavilion Nursing Facility

- Southampton Primary Care
 - Southampton Surgical Group

- Boykins Family Practice

	37.  	  	Gadsden Regional Medical Center, LLC	  	- Gadsden Regional Medical Center
	38.  	  	Granbury Hospital Corporation	  	 - Lake Granbury Medical Center

- Lake Granbury Sleep Disorders Center
 - Lake Granbury Open
MRI
 - Lake Granbury Physical Therapy
 - Lake Granbury
Fitness
 - Lake Granbury Imaging Center

	39.  	  	Greenbrier VMC, LLC	  	 - Greenbrier Valley Medical Center

- Greenbrier Valley Anesthesia
 - Greenbrier Thoracic and Vascular
Surgery
 - Jefferson Cardiology and Internal Medicine

	40.  	  	Haines City HMA, LLC	  	 - Heart of Florida Regional Medical Center

- Center for Healthy Workforce
 - Heart of Florida Therapy
Center

	41.  	  	Hernando HMA, LLC	  	 - Bayfront Health Brooksville

- Bayfront Health Spring Hill
 - Hernando Health Care

- Florida Sleep Institute
 - Good Shepard Medical Services

- Hernando Endoscopy & Surgery Center
 - Pinebrook Regional
Medical
 - Special Delivery Suites

	42.  	  	Hospital of Morristown, Inc.	  	 - Lakeway Regional Hospital

- Morristown Professional Building
 - Lakeway Regional
Women’s Imaging Center

	43.  	  	HMA Fentress County General Hospital, LLC	  	 - Tennova Healthcare - Jamestown

- Tennova Imaging - Jamestown

	44.  	  	HMA Santa Rosa Medical Center, LLC	  	 - Santa Rosa Medical Center

- Santa Rosa Primary Care Center

  
 Sch. III-13 

					
	     	  	
Parties
	  	
Names

	45.  	  	IOM Health System, L.P.	  	 - Lutheran Hospital of Indiana

- Lutheran Health Network
 - Lutheran Heart Center

- Lutheran Hospital Neurospine Center

	46.  	  	Jackson HMA, LLC	  	- Merit Health Central
	47.  	  	Jackson, Tennessee Hospital Company, LLC	  	 - Tennova Healthcare - Regional Jackson

- Sleep Diagnostics of Jackson

	48.  	  	Jefferson County HMA, LLC	  	 - Tennova Healthcare – Jefferson

- Tennova Healthcare – Jefferson Memorial Hospital
 - Tennova
Jefferson Memorial Rehabilitation Services East
 - Tennova Jefferson Memorial Rehabilitation Services Dandridge

- Tennova Jefferson Memorial Hospital Sleep Disorders Clinic

	49.  	  	Jourdanton Hospital Corporation	  	 - South Texas Regional Medical Center

- South Texas Regional Anesthesia

	50.  	  	Kay County Oklahoma Hospital Company, LLC	  	- AllianceHealth Ponca City
	51.  	  	Key West HMA, LLC	  	 - Lower Keys Medical Center

- Depoo Hospital

	52.  	  	Kirksville Missouri Hospital Company, LLC	  	 - Northeast Regional Medical Center

- Northeast Home Health Services
 - Northeast Regional Health and
Fitness Center
 - Northeast Regional Health System
 - Family
Health Center of Edina
 - A.T. Still Rehabilitation Center
 -
Missouri’s Choice Home Care
 - Northeast Regional Heart Center

- Northeast Regional Vein Center
 - Northeast Regional Medical
Group
 - Northeast Regional Home Health

	53.  	  	Lake Wales Hospital Corporation	  	- Lake Wales Medical Center
	54.  	  	Lancaster Hospital Corporation	  	 - Springs Memorial Hospital

- Lancaster Recovery Center
 - Kershaw Family Medicine Center

- Springs Business Health Services
 - Lancaster Rehabilitation

- Springs Wound Treatment Center
 - Springs Healthcare

- Rock Hill Rehabilitation

	55.  	  	Lancaster HMA, LLC	  	 - Heart of Lancaster Regional Medical Center

- Bariatric and Metabolic Institute of Lancaster
 - BMI of
Lancaster
 - Infusion Oncology Care of Heart of Lancaster Regional Medical Center

	56.  	  	Laredo Texas Hospital Company, L.P.	  	 - Laredo Medical Center

- LMC North
 - LMC South

	57.  	  	Las Cruces Medical Center, LLC	  	- Mountain View Regional Medical Center
	58.  	  	Lea Regional Hospital, LLC	  	- Lea Regional Medical Canter

  
 Sch. III-14 

					
	     	  	
Parties
	  	
Names

	59.  	  	Lebanon HMA, LLC	  	 - Tennova Healthcare - Lebanon

- Tennova Healthcare – McFarland Lebanon Campus
 - Cancer
Care Center
 - The Cancer Center at UMC

	60.  	  	Longview Medical Center, L.P.	  	 - Longview Regional Medical Center

- Longview Regional Medical Park Imaging Center
 -
The Heart and Vascular Institute of Longview
 - The Heart and Vascular Institute of Longview Regional

- The Vein Center of Longview Regional
 - Longview Regional
Quickcare
 - Family Care by Longview Regional
 - The Center for
Wound Healing & Hyperbaric Medicine at Longview Retional

	61.  	  	Lutheran Musculoskeletal Center, LLC	  	- The Orthopaedic Hospital of Lutheran Health Network
	62.  	  	Madison HMA, LLC	  	- Merit Health Madison
	63.  	  	Marshall County HMA, LLC	  	- AllianceHealth Madill
	64.  	  	Martin Hospital Corporation	  	 - Tennova Healthcare - Volunteer Martin

- Tennova Primary Care – Hillview South

	65.  	  	Mary Black Health System, LLC	  	- Mary Black Health System - Spartanburg
	66.  	  	McNairy Hospital Corporation	  	 - McNairy Regional Hospital

- Medical Associates of McNairy Regional Hospital
 - Tennova
Healthcare – McNairy Regional
 - Tennova Healthcare – McNairy Regional Hospital

- Tennova Family Medicine

	67.  	  	MCSA, L.L.C.	  	- Medical Center of South Arkansas
	68.  	  	Melbourne HMA, LLC	  	 - Wuesthoff Health System

- Wuesthoff Medical Center - Melbourne

	69.  	  	Metro Knoxville HMA, LLC	  	 - Tennova Healthcare – North Knoxville
Medical Center
 - Tennova Healthcare – Physicians Regional Medical Center

- Tennova Healthcare – Turkey Creek Medical Center
 - Tennova
Ambulatory Surgery Center South
 - Tennova Behavioral Services

- Tennova Diabetes Management Center
 - Tennova Health &
Fitness Center
 - Tennova Pain Management Center
 - Tennova
Physical Therapy and Sport Medicine North
 - Tennova Rehab Care Center

- Tennova Sleep Center North
 - Tennova Sleep Center South

- Tennova Sleep Center West
 - Tennova South Imaging Center

- Tennova Surgery Center West
 - Tennova Transitional Care
Unit
 - Tennova Women’s Care
 - Tennova Women’s
Pavillion
 - Tennova Wound Healing Center

	70.  	  	Midwest Regional Medical Center, LLC	  	 - AllianceHealth Midwest

- AllianceHealth Birth Center
 - AllianceHealth Midwest EMS

- AllianceHealth Midwest Birth Center

  
 Sch. III-15 

					
	     	  	
Parties
	  	
Names

	71.  	  	Moberly Hospital Company, LLC	  	 - Moberly Regional Medical Center,

- Moberly Rural Health Clinic
 - Charlton Valley Family
Medicine

	72.  	  	National Healthcare of Leesville, Inc.	  	 - Byrd Regional Hospital

- Leesville Diagnostic Center
 - Byrd Regional Hospital Outpatient
Surgery Center

	73.  	  	Navarro Hospital, L.P.	  	 - Navarro Regional Hospital

- Navarro Family Clinic
 - Navarro Pediatrics

	74.  	  	Northampton Hospital Company, LLC	  	 - Easton Hospital

- Outlook House
 - Easton Hospital Imaging

	75.  	  	Northwest Arkansas Hospitals, LLC	  	 - Northwest Medical Center – Willow Creek
Women’s Hospital
 - Northwest Medical Center
 - Northwest
Medical Center – Bentonville
 - Northwest Senior Health Centers

- Northwest Robotic Surgery Institute
 - Northwest Joint and Spine
Center
 - Northwest Sports Medicine Center
 - Smart Sports

- Northwest Wound Care
 - Northwest Medical Center Northwest Rehab
Therapy at the Agility Center
 - Northwest Medical Center Wound Care and Hyperbaric Center

- Northwest Medical Center Breast Imaging Center at Willow Creek

- Northwest Medical Center Cardiopulmonary Diagnostic and Rehabilitation Center

- Northwest Medical Center Bentonville Cardiopulmonary Diagnostic and Rehabilitation Center

- Northwest Medical Center Outpatient Surgery Department
 -
Northwest Medical Center Bentonville Outpatient Surgery Department
 - Northwest Medical Aquatic Therapy and Rehab Center

- Arkansas One Call Transfer Center
 - Northwest Health Diagnostic
Sleep Center

	76.  	  	Northwest Hospital, LLC	  	 - Northwest Medical Center

- The Women’s Health Center at Northwest Medical Center
 - La
Cholla Day Surgery at Northwest Medical Center
 - La Paloma Urgent Care

- Healthy Beginnings
 - The Wound Care Center at
Northwest
 - Continental Reserve Urgent Care
 - Northwest
Urgent Care at Duval Mine Road
 - Northwest Urgent Care at Orange Grove

- Northwest Balance Therapy Center

	77.  	  	Oak Hill Hospital Corporation	  	- Plateau Medical Center
	78.  	  	Oro Valley Hospital, LLC	  	 - Oro Valley Hospital

- Northwest Vein Center at Oro Valley Hospital
 - The Sleep
Centers of Oro Valley Hospital
 - Rancho Vistoso Urgent Care

  
 Sch. III-16 

					
	     	  	
Parties
	  	
Names

	79.  	  	Pasco Regional Medical Center, LLC	  	 - Bayfront Health Dade City

- Bayfront Health Diagnostics
 - Bayfront Health Sleep Lab

- Pasco Regional Medical Center
 - Pasco Medical Plaza
Condominium
 - Pasco Regional Diagnostic Center
 - Pasco
Regional Outpatient Center
 - The Center for Wound Healing and Hyperbaric

- Medicine of Pasco Regional Medical Center

	80.  	  	Petersburg Hospital Company, LLC	  	 - Southside Regional Medical Center

- Southside Regional Medical Center - Renal Services
 - Southside
Rehabilitation Services
 - Southside Behavioral Health Services

- Southside Industrial Medicine
 - Southside Regional Medical
Center School of Nursing
 - Southside Regional Medical Center School of Radiation Sciences

- Southside Regional Medical Center Professional Schools
 -
Colonial Heights Imaging Center

	81.  	  	Phoenixville Hospital Company, LLC	  	 - Phoenixville Hospital

- Phoenixville Hospital Therapy & Fitness
 - Limerick Medical
Center
 - Cardiothoracic Surgical Specialists
 - The Surgery
Center of the Main Line
 - Blue Bell Surgery Center
 - Surgery
Center at Limerick

	82.  	  	Piney Woods Healthcare System L.P.	  	 - Woodland Heights Medical Center

- The Surgery at Center at Gaslight Medical Park

	83.  	  	Poplar Bluff Regional Medical Center, LLC	  	 - Bloomfield Medical Center

- Dexter Medical Clinic
 - Malden Medical Clinic

- Piedmont Family Clinic
 - Piedmont Family Pharmacy

- Poplar Bluff Medical Clinic
 - Poplar Bluff Primary Care

- Poplar Bluff Regional Medical Center
 - Poplar Bluff Regional
Medical Center - North
 - Poplar Bluff Regional Medical Center - South

- Puxico Medical Clinic

	84.  	  	Port Charlotte HMA, LLC	  	 - Bayfront Health Port Charlotte

- Bayfront Baby Place
 - Bayfront Health Heart Institute

- Bayfront Health Neurosciences
 - Bayfront Health North Port

- Bayfront Health Orthopedics
 - Bayfront Health Robotics
Institute
 - Southwest Florida Heart Center

  
 Sch. III-17 

					
	     	  	
Parties
	  	
Names

	85.  	  	Porter Hospital, LLC	  	 - Porter Regional Hospital

- Porter Hospital
 - Portage Hospital

- Valparaiso Outpatient Center
 - Chesterton Medical Center

- DeMotte Medical Center
 - Hebron Medical Center

- Valparaiso Therapy Services
 - Glendale Medical Center

- Northwest Indiana PET/CT Center
 - Endo Labs at Porter

- Shoreline Surgery Center
 - Porter Regional Hospital Health at
Work

	86.  	  	Pottstown Hospital Company, LLC	  	 - Pottstown Memorial Medical Center

- Pottstown Memorial Medical Center Transitional Care Unit
 -
Pottstown Memorial Medical Center Renal Care Unit
 - Tri-County Medical Laboratory

- Schuylkill Valley Health System
 - Pottstown Obstetrical
Associates;
 - Pottstown Oncology Associates
 - Pottstown
Surgery Center
 - Commonwealth Health Cyberknife, a Department of Pottstown Memorial Medical Center

	87.  	  	Punta Gorda HMA, LLC	  	 - Bayfront Health Punta Gorda

- Bayfront Health Heart Institute
 - Bayfront Health Home
Infusion
 - Bayfront Health Wellness & Rehab
 - Bayfront
Health Wound Care & Hyperbaric Center
 - Bayfront Joint & Spine Academy

- Bayfront Health Neurosciences
 - Bayfront Health Orthopedics

- Bayfront Health Robotics Institute
 - Riverside Behavioral
Center
 - Sleep Center

	88.  	  	QHG of Enterprise, Inc.	  	- Medical Center Enterprise
	89.  	  	QHG of South Carolina, Inc.	  	 - Carolinas Hospital System;

- Physicians Surgery Center of Florence
 - Carolinas Hospital
System – Marion
 - Mullins Nursing Center
 - Carolinas
Neurology
 - Carolinas Oncology

	90.  	  	Rehab Hospital of Fort Wayne General Partnership	  	N/A
	91.  	  	River Oaks Hospital, LLC	  	- Merit Health River Oaks

  
 Sch. III-18 

					
	     	  	
Parties
	  	
Names

	92.  	  	Rockledge HMA, LLC	  	 - Wuesthoff Health System

- Wuesthoff Medical Center-Rockledge
 - Child Protection Team of
Brevard
 - Childrens Advocacy Center of Brevard
 - Wuesthoff
Cardiac Testing Center
 - Wuesthoff Health System at Port St. John

- Wuesthoff Hospital
 - Wuesthoff Medical Center at Merritt
Island
 - Wuesthoff Pain Management Center
 - Wuesthoff Pain
Management Center at Suntree
 - Wuesthoff Reference Lab
 -
Wuesthoff Rehabilitation Services

	93.  	  	ROH, LLC	  	- Merit Health Woman’s Hospital
	94.  	  	Rose City HMA, LLC	  	 - Lancaster Regional Medical Center

- Keystone Cancer Center
 - Regional Center for Cancer Care

- Willow Street Imaging

	95.  	  	Roswell Hospital Corporation	  	- Eastern New Mexico Medical Center
	96.  	  	Ruston Louisiana Hospital Company, LLC	  	 - Northern Louisiana Medical Center

- Northern Louisiana Oncology Associates

	97.  	  	Salem Hospital Corporation	  	 - The Memorial Hospital of Salem County

- Salem Medical Center
 - South Jersey Physical Therapy and Back
Rehabilitation Center
 - Beckett Diagnostic Center
 - Salem
Medical Imaging
 - Salem Surgical Weight Loss Center
 - Salem
Physical Therapy and Rehabilitation

	98.  	  	San Angelo Hospital, L.P.	  	 - San Angelo Community Medical Center

- Community Surgery Center

	99.  	  	Scranton Hospital Company, LLC	  	 - Commonwealth Healthcare Network

- Commonwealth Health Network
 - Commonwealth Health System

- Commonwealth Health Plan
 - Regional Hospital of Scranton

- Regional Hospital Surgery Center
 - Commonwealth Health Heart
and Vascular Institute

	100. 	  	Scranton Quincy Hospital Company, LLC	  	 - Moses Taylor Hospital

- Moses Taylor Apothecary
 - Commonwealth Health Carbondale
Outpatient Center
 - Advanced Imaging Specialists

	101. 	  	Sebastian Hospital, LLC	  	 - Sebastian River Medical Center

- Heart Center of the Treasure Coast

	102. 	  	Sebring Hospital Management Associates, LLC	  	 - Highlands Regional Medical Center

- Highlands Medical Group

	103. 	  	Seminole HMA, LLC	  	- AllianceHealth Seminole
	104. 	  	Shelbyville Hospital Corporation	  	- Tennova Healthcare - Shelbyville
	105. 	  	Siloam Springs Arkansas Hospital Company, LLC	  	- Siloam Springs Memorial Hospital
	106. 	  	Spokane Valley Washington Hospital Company, LLC	  	- Valley Hospital

  
 Sch. III-19 

					
	     	  	
Parties
	  	
Names

	107. 	  	Spokane Washington Hospital Company, LLC	  	 - Deaconess Hospital

- Deaconess Hospital Outpatient Cardiology
 - Deaconess North
Emergency Center

	108. 	  	St. Joseph Health System LLC	  	 - St. Joseph Hospital

- Dupont Ambulatory Surgery Center
 - Northeast Indiana
Rehabilitation Institute

	109. 	  	Statesville HMA, LLC	  	- Davis Regional Medical Center
	110. 	  	Tomball Texas Hospital Company, LLC	  	 - Tomball Regional Medical Center

- Texas Sports Medicine Center
 - Tomball Regional Cancer
Center
 - Tomball Regional Heart and Vascular Center
 - Tomball
Regional Surgery Center
 - Tomball Regional Skilled Nursing
 -
Tomball Regional Medical Center Spring Creek Imaging
 - Affinity Imaging Center at Magnolia, a department of Tomball Regional Medical Center

- Affinity Emergency Center, a department of Tomball Regional Medical Center

	111. 	  	Triad of Alabama, LLC	  	- Flowers Hospital
	112. 	  	Tullahoma HMA, LLC	  	 - Tennova Healthcare - Harton

- Tullahoma Family Medical Center

	113. 	  	Tunkhannock Hospital Company LLC	  	 - Tyler Memorial Hospital

- Tyler OccuCare

	114. 	  	Venice HMA, LLC	  	 - Venice Regional Bayfront Health

- Venice Regional Medical Center
 - Bayfront Health Laboratory
Services
 - Venice Health Park-Bayfront Health
 - Venice
Regional Bayfront Heart Institute
 - Venice Regional Bayfront Home Health

- Venice Regional Bayfront Joint Academy
 - Venice Regional
Bayfront Neurosciences
 - Venice Regional Bayfront Robotics Institute

- Venice Regional Bayfront Spine Academy
 - Venice Regional
Bayfront Woundcare & Hyperbaric Center
 - Venice Regional Weight Management

	115. 	  	Vicksburg Healthcare, LLC	  	 - Merit Health River Region

- Merit Health River Region West

	116. 	  	Victoria of Texas, L.P.	  	 - DeTar Hospital

- DeTar Hospital Navarro
 - DeTar Hospital North;

- DeTar Healthcare System
 - DeTar Hospital After Hours Center

- Crossroads Physical Therapy Center

	117. 	  	Warren Ohio Hospital Company, LLC	  	 - Trumbull Memorial Hospital

- Trumbull Memorial Hospital Cancer Care Center
 - TMH Center for
Surgery
 - TMH Center for Radiology
 - TMH Center for
Rehabilitation
 - TMH Diagnostic Center
 - TMH Sleep
Center

  
 Sch. III-20 

					
	     	  	
Parties
	  	
Names

	118. 	  	Warren Ohio Rehab Hospital Company, LLC	  	- Hillside Rehabilitation Hospital
	119. 	  	Warsaw Health System LLC	  	 - Kosciusko Community Hospital

- Provident Imaging Center

	120. 	  	Weatherford Texas Hospital Company, LLC	  	 - Weatherford Regional Medical Center

- Willow Park Physical Therapy

	121. 	  	Wesley Health System LLC	  	- Merit Health Wesley
	122. 	  	West Grove Hospital Company, LLC	  	 - Jennersville Regional Hospital

- HealthTech
 - Jennersville Pediatrics

- Jennersville OB Associates
 - Home Health of Brandywine;

- Hospice of Brandywine

	123. 	  	Wilkes-Barre Hospital Company, LLC	  	 - Wilkes-Barre General Hospital

- Commonwealth Health Laboratory Services
 - Commonwealth Health
School of Nurse Anesthesia
 - Center for Same Day Surgery at Wilkes-Barre General Hospital

- Commonwealth Health Diagnostic Imaging; Center for Advanced Surgery

- Wellspring
 - Wilkes-Barre General Hospital Sleep Disorder
Center
 - Center for Advanced Rehabilitation
 - Commonwealth
Health
 - Commonwealth Health Cancer Center

	124. 	  	Women & Children’s Hospital, LLC	  	- Lake Area Medical Center
	125. 	  	Woodward Health System, LLC	  	 - AllianceHealth Woodward

- AllianceHealth Woodward Woodward Clinic Family Medicine
 -
AllianceHealth Woodward Woodward Clinic Family Medicine and Obstetrics
 - AllianceHealth Woodward Woodward Clinic Primary Care

- AllianceHealth Woodward Woodward Clinic Urology
 -
AllianceHealth Woodward Woodward Clinics

	126. 	  	Yakima HMA, LLC	  	 - Yakima Regional Medical and Heart Center

- Yakima Regional Medical and Cardiac Center
 - Yakima Regional
Home Health
 - Yakima Regional Hospice
 - Yakima Regional
Medical Center Pharmacy
 - Toppenish Regional Medical Center
 -
Toppenish Regional Medical Center Pharmacy
 - Toppenish Community Hospital

	127. 	  	York Pennsylvania Hospital Company, LLC	  	 - Memorial Hospital

- Memorial Hospital Outpatient Surgery Center
 - Memorial Hospital
Outpatient Endoscopy Center
 - Greenbriar Medical Center
 - The
Breast Center at Memorial Hospital

  
 Sch. III-21 

					
	     	  	
Parties
	  	
Names

	128. 	  	Youngstown Ohio Hospital Company, LLC	  	 - Northside Medical Center

- Austintown Rehabilitation Services
 - Center for Breast
Health
 - ValleyCare Health System (OH and PA)
 - ValleyCare
Health System of Ohio (OH and PA)
 - Austintown Imaging Center

- MRI at Northside Medical Center

  
 Sch. III-22 

 SCHEDULE IV 

[INTENTIONALLY OMITTED] 

  
 Sch. IV-1 

 SCHEDULE V 

SPECIFIED ORIGINATORS 
  

					
	  	  	Originator	  	CHS %
	1.	  	ARMC, L.P.	  	87.577
	2.	  	Crestview Hospital Corporation	  	97.6393
	3.	  	Deaconess Health System, LLC	  	98.13
	4.	  	Durant H.M.A., LLC	  	92.249
	5.	  	East Georgia Regional Medical Center, LLC	  	89.25
	6.	  	Greenbrier VMC, LLC	  	96.0
	7.	  	Haines City HMA, LLC	  	97.894
	8.	  	Hernando HMA, LLC	  	98.85
	9.	  	IOM Health System, L.P.	  	86.30
	10.	  	Jackson, Tennessee Hospital Company, LLC	  	96.94
	11.	  	Kirksville Missouri Hospital Co., LLC	  	88.10
	12.	  	Lake Wales Hospital Corporation	  	96.8178
	13.	  	Lancaster HMA, LLC	  	98.73
	14.	  	Lutheran Musculoskeletal Center, LLC	  	60.00
	15.	  	Midwest Regional Medical Center, LLC	  	98.6
	16.	  	Petersburg Hospital Company, LLC	  	99.3
	17.	  	Piney Woods Healthcare System, L.P.	  	96.4985
	18.	  	Porter Hospital, LLC	  	91.17
	19.	  	Rehab Hospital of Fort Wayne General Partnership	  	86.30
	20.	  	Rose City HMA, LLC	  	89.9
	21.	  	San Angelo Hospital, L.P.	  	94.318
	22.	  	St. Joseph Health System LLC	  	86.30
	23.	  	Warsaw Health System LLC	  	99.08

  
 Sch. V-1 

 SCHEDULE VI 

TAX LIENS 

  
 Sch. VI-1 

 EXHIBIT A 

FORM OF ASSIGNMENT OF AGREEMENTS 

Attached. 

  
 Ex. A-1 

 EXHIBIT B 

FORM OF ORIGINATOR NOTE 

Attached. 

  
 Ex. B-1 

 EXHIBIT C 

FORM OF BUSINESS ASSOCIATE AGREEMENT 

Attached. 

  
 Ex. C-1 

 EXHIBIT D 

FORM OF MONTHLY REPORT 

Separately provided. 

  
 Ex. D-1EX-10.1

 Exhibit 10.1 

Execution Version 

SECURITIES PURCHASE AGREEMENT 

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 18, 2016 by and among Spring Bank
Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”). 

RECITALS 
 A. The Company
and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the provisions of Regulation D (“Regulation D”), as promulgated by the U.S. Securities and Exchange
Commission (the “SEC”) under the Securities Act of 1933, as amended; and 
 B. The Investors wish to purchase from the Company, and
the Company wishes to sell and issue to the Investors, upon the terms and subject to the conditions stated in this Agreement, (i) shares (the “Shares”) of the Company’s Common Stock, par value $0.0001 per share (the “Common
Stock”) and (ii) warrants in the form attached hereto as Exhibit B to purchase Common Stock (each, a “Common Warrant” and collectively, the “Common Warrants”). 

C. Contemporaneously with the sale of the Shares and Common Warrants, the parties hereto will execute and deliver a Registration Rights
Agreement, in the form attached hereto as Exhibit C (the “Registration Rights Agreement”), pursuant to which the Company will agree to provide certain registration rights in respect of the Shares and the Common
Warrant Shares (as defined below) under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, and applicable state securities laws. 

In consideration of the mutual promises made herein and for other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties hereto agree as follows: 
 1. Definitions. For the purposes of this Agreement, the following
terms shall have the meanings set forth below: 
 “Affiliate” means, with respect to any Person, any other Person which
directly or indirectly through one or more intermediaries Controls, is controlled by, or is under common Control with, such Person. 

“Business Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general
transaction of business. 
 “Closing” has the meaning set forth in Section 3.1. 

“Closing Bid Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if
the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market as reported by Bloomberg Financial L.P. (based on a
Trading Day from 9:30 a.m. Eastern Time to 4:02 p.m. Eastern Time); (b) the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the OTC Bulletin Board or (c) if the Common Stock is not then listed or
quoted on the OTC Bulletin Board and if prices for the Common Stock are then reported in the “Pink Sheets” published by the Pink Sheets, LLC (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported; or (d) in all other cases, the fair market value of a share of Common Stock as determined by a good faith determination of the Company’s Board of Directors 

 “Closing Date” has the meaning set forth in Section 3.1. 

“Closing Securities” means the Shares and the Common Warrants. 

“Common Stock Equivalents” means any securities of the Company which would entitle the holder thereof to acquire at any time
Common Stock, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. 

“Common Warrants” has the meaning set forth in the recitals to this Agreement. 

“Common Warrant Shares” means the shares of Common Stock issuable upon exercise of the Common Warrants. 

“Company Intellectual Property” has the meaning set forth in Section 4.14. 

“Company’s Knowledge” means the actual knowledge of the executive officers (as defined in Rule 405 under the 1933
Act) of the Company. 
 “Control” (including the terms “controlling”, “controlled by” or “under
common control with”) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 

“Disclosure Schedules” has the meaning set forth in Section 4. 

“Environmental Laws” has the meaning set forth in Section 4.15. 

“FDA” has the meaning set forth in Section 4.30. 

“GAAP” has the meaning set forth in Section 4.17. 

“IPO Registration Statement” means the Company’s registration statement (File No. 333-208875), including a
prospectus, as amended at the time it became effective on May 5, 2016, including the information deemed pursuant to Rule 430A, 430B or 430C under the 1933 Act to be part of such registration statement at the time of its effectiveness. 

“Losses” has the meaning set forth in Section 8.2. 

“Material Adverse Effect” means a material adverse effect on (i) the assets, liabilities, results of operations,
financial condition or business of the Company and its subsidiary taken as a whole, (ii) the legality or enforceability of any of the Transaction Documents or (iii) the ability of the Company to perform its obligations under the
Transaction Documents. 

  
 2 

 “Material Contract” means any contract, instrument or other agreement to which
the Company is a party or by which it is bound that has been filed or was required to have been filed as an exhibit to the SEC Filings pursuant to Item 601(b)(4) or Item 601(b)(10) of Regulation S-K. 

“Nasdaq” means The Nasdaq Capital Market. 

“Person” means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint
stock company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed herein. 

“Placement Agent” means William Blair & Company, L.L.C. 

“Press Release” has the meaning set forth in Section 9.7. 

“Principal Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading,
which, as of the date of this Agreement and the Closing Date, shall be The Nasdaq Capital Market. 
 “Registration Rights
Agreement” has the meaning set forth in the recitals to this Agreement. 
 “Required Investors” has the meaning
set forth in the Registration Rights Agreement. 
 “SEC Filings” has the meaning set forth in Section 4. 

“Securities” means the Shares, the Common Warrants and the Common Warrant Shares. 

“Shares” has the meaning set forth in the recitals to this Agreement. 

“Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the 1934 Act (but shall not be
deemed to include the location and/or reservation of borrowable shares of Common Stock). 
 “Subscription Amount” means, as
to an Investor, the aggregate amount to be paid for the Closing Securities purchased hereunder as specified opposite such Investor’s name on Exhibit A attached hereto, under the column entitled “Aggregate Purchase Price of Closing
Securities,” in U.S. Dollars and in immediately available funds. 
 “Subsidiary” of any Person means another Person,
an amount of the voting securities, other voting ownership or voting partnership interests of which is sufficient to elect at least a majority of its Board of Directors or other governing body (or, if there are no such voting interests, 50% or more
of the equity interests of which) is owned directly or indirectly by such first Person. 

  
 3 

 “Trading Day” means (i) a day on which the Common Stock is listed or quoted and
traded on its Principal Trading Market (other than the OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board), a day on which the Common Stock is traded in the over-the-counter
market, as reported by the OTC Bulletin Board, or (iii) if the Common Stock is not quoted on any Trading Market, a day on which the Common Stock is quoted in the over-the-counter market as reported in the “pink sheets” by Pink Sheets LLC
(or any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business
Day. 
 “Trading Market” means whichever of the New York Stock Exchange, the NYSE Amex Equities (formerly the American
Stock Exchange), the NASDAQ Global Select Market, the NASDAQ Global Market, the NASDAQ Capital Market or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. 

“Transfer Agent” has the meaning set forth in Section 7.4(a). 

“Transaction Documents” means this Agreement, the Common Warrants and the Registration Rights Agreement. 

“1933 Act” means the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated
thereunder. 
 “1934 Act” means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules
and regulations promulgated thereunder. 
 2. Purchase and Sale of the Shares and Common Warrants. On the Closing Date, upon the terms
and subject to the conditions set forth herein, the Company will issue and sell, and the Investors will purchase, severally and not jointly, for a price per Share and associated Common Warrant of $9.12 (i) the number of Shares set forth opposite the
name of such Investor under the heading “Number of Shares to be Purchased” on Exhibit A attached hereto and (ii) a Common Warrant to purchase one share of Common Stock for every one Share purchased at Closing. The Common
Warrants shall have an exercise price equal to $10.79 per Common Warrant Share (subject to adjustment as provided therein).
 3.
Closing. 
 3.1. Upon the satisfaction of the conditions set forth in Section 6, the completion of the purchase and sale of the
Closing Securities (the “Closing”) shall occur remotely via exchange of documents and signatures at a time (the “Closing Date”) to be agreed to by the Company and the Investors but in no event later than the third
Business Day after the date hereof, and of which the Investors will be notified in advance by the Placement Agent.
 3.2. On the Closing
Date, each Investor shall deliver or cause to be delivered to the Company the Subscription Amount via wire transfer of immediately available funds pursuant to the wire instructions delivered to such Investor by the Company on or prior to the Closing
Date. 
 3.3. At or before the Closing, the Company shall deliver or cause to be delivered to each Investor the following: 

(a) a number of Shares, registered in the name of the Investor, equal to the number of Shares set forth opposite the name of such Investor
under the heading “Number of Shares to be Purchased” on Exhibit A attached hereto; and 

  
 4 

 (b) a Common Warrant, registered in the name of such Investor, to purchase up to the number of
Common Warrant Shares set forth opposite the name of such Investor under the heading “Number of Common Warrant Shares Underlying Common Warrant Purchased” on Exhibit A attached hereto. 

4. Representations and Warranties of the Company. The Company hereby represents and warrants to the Investors that, except as set
forth in the schedules delivered herewith (collectively, the “Disclosure Schedules”) or as otherwise described in the Company’s filings pursuant to the 1934 Act (collectively, the “SEC Filings”), which qualify
these representations and warranties in their entirety: 
 4.1. Organization, Good Standing and Qualification. The Company is a
corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation and has all requisite corporate power and authority to carry on its business as now conducted and to own or lease its
properties. The Company is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property makes such qualification or leasing
necessary unless the failure to so qualify has not had and would not reasonably be expected to have a Material Adverse Effect. The Company’s subsidiary is duly organized, validly existing and in good standing under the laws of its
jurisdiction of its incorporation and has all requisite power and authority to carry on its business as now conducted and to own or lease its properties. The Company’s subsidiary is duly qualified to do business as a foreign corporation
and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property makes such qualification or leasing necessary unless the failure to so qualify has not had and would not reasonably be expected
to have a Material Adverse Effect. 
 4.2. Authorization. The Company has the requisite corporate power and authority and has
taken all requisite corporate action necessary for, and no further action on the part of the Company, its officers, directors and stockholders is necessary for, (i) the authorization, execution and delivery of the Transaction Documents,
(ii) the authorization of the performance of all obligations of the Company hereunder or thereunder, and (iii) the authorization, issuance (or reservation for issuance) and delivery of the Closing Securities. The Transaction Documents
constitute the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general
applicability, relating to or affecting creditors’ rights generally and to general equitable principles. 
 4.3.
Capitalization. The Company is authorized under its Certificate of Incorporation to issue 200,000,000 shares of Common Stock. The Company’s disclosure of its issued and outstanding capital stock in its most recent SEC Filing
containing such disclosure was accurate in all material respects as of the date indicated in such SEC Filing. All of the issued and outstanding shares of the Company’s capital stock have been duly authorized and validly issued and are
fully paid and nonassessable; none of such shares were issued in violation of any pre-emptive rights; and such shares were issued in compliance in all material respects with applicable state and federal securities law and any rights of third
parties. No Person is entitled to pre-emptive or similar statutory or contractual rights with respect to the issuance by the Company of any securities of the Company. There are no outstanding warrants, options, convertible securities or
other rights, agreements or arrangements of any character under which the Company is or may be obligated to issue any equity securities of any kind and except as contemplated by this Agreement. Except for the Registration Rights Agreement,
there are no voting agreements, buy-sell agreements, option or right of first purchase agreements or other agreements of any kind among the Company and any of the securityholders of the Company relating to the securities of the Company held by
them. Except as provided in the Registration Rights Agreement, no Person has the right to require the Company to register any securities of the Company under the 1933 Act, whether on a demand basis or in connection with the registration of
securities of the Company for its own account or for the account of any other Person. 
 The issuance and sale of the Closing Securities
hereunder will not obligate the Company to issue shares of Common Stock or other securities to any other Person (other than the Investors) and will not result in the adjustment of the exercise, conversion, exchange or reset price of any
outstanding security. 

  
 5 

 The Company does not have outstanding stockholder purchase rights or “poison pill” or
any similar arrangement in effect giving any Person the right to purchase any equity interest in the Company upon the occurrence of certain events. 

4.4. Valid Issuance. The Shares have been duly and validly authorized and, when issued and paid for pursuant to this Agreement,
will be validly issued, fully paid and nonassessable, and shall be free and clear of all encumbrances and restrictions (other than those created by the Investors), except for restrictions on transfer set forth in the Transaction Documents or imposed
by applicable securities laws. The Common Warrants have been duly and validly authorized and, when issued and paid for pursuant to this Agreement, will be validly issued. The Common Warrant Shares have been duly and validly authorized and
reserved for issuance and, upon exercise of the Common Warrants in accordance with their terms, including the payment of any exercise price therefor, will be validly issued, fully paid and nonassessable and will be free and clear of all encumbrances
and restrictions (other than those created by the Investors), except for restrictions on transfer set forth in the Transaction Documents or imposed by applicable securities laws.

4.5. Consents. The execution, delivery and performance by the Company of the Transaction Documents and the offer, issuance and sale
of the Closing Securities require no consent of, action by or in respect of, or filing with, any Person, governmental body, agency, or official other than filings that have been made pursuant to applicable state securities laws and post-sale filings
pursuant to applicable state and federal securities laws and the rules and regulations of Nasdaq which the Company undertakes to file within the applicable time periods and other than the registration statement required to be filed by the
Registration Rights Agreement. Subject to the accuracy of the representations and warranties of each Investor set forth in Section 5 hereof, the Company has taken all action necessary to exempt (i) the issuance and sale of the Closing
Securities and (ii) the other transactions contemplated by the Transaction Documents from the provisions of any stockholder rights plan or other “poison pill” arrangement, any anti-takeover, business combination or control share law
or statute binding on the Company or to which the Company or any of its assets and properties is subject that is or could reasonably be expected to become applicable to the Investors as a result of the transactions contemplated hereby, including
without limitation, the issuance of the Closing Securities and the ownership, disposition or voting of the Shares or the Common Warrant Shares by the Investors or the exercise of any right granted to the Investors pursuant to this Agreement or the
other Transaction Documents. 
 4.6. Use of Proceeds. The net proceeds of the sale of the Closing Securities hereunder shall be
used by the Company for working capital and general corporate purposes.
 4.7. No Material Adverse Change. Since December 31,
2015, except as identified and described in the SEC Filings, there has not been: 
 (i) any change in the assets, liabilities, financial
condition or operating results of the Company from that reflected in the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, except for changes in the ordinary course of business which
have not had and would not reasonably be expected to have a Material Adverse Effect, individually or in the aggregate; 
 (ii) any
declaration or payment by the Company of any dividend, or any authorization or payment by the Company of any distribution, on any of the capital stock of the Company, or any redemption or repurchase by the Company of any securities of the Company;

 (iii) any material damage, destruction or loss, whether or not covered by insurance, to any assets or properties of the Company; 

  
 6 

 (iv) any waiver, not in the ordinary course of business, by the Company of a material right or
of a material debt owed to it; 
 (v) any satisfaction or discharge of any lien, claim or encumbrance or payment of any obligation by the
Company, except in the ordinary course of business and which is not material to the assets, properties, financial condition, operating results or business of the Company (as such business is presently conducted); 

(vi) any change or amendment to the Company’s Certificate of Incorporation or By-laws, or material change to any material contract or
arrangement by which the Company or is bound or to which any of its assets or properties is subject; 
 (vii) any material labor
difficulties or, to the Company’s Knowledge, labor union organizing activities with respect to employees of the Company; 
 (viii) any
material transaction entered into by the Company other than in the ordinary course of business; 
 (ix) the loss of the services of any key
employee, or material change in the composition or duties of the senior management of the Company; 
 (x) the loss or, to the Company’s
Knowledge, threatened loss of any customer which has had or would reasonably be expected to have a Material Adverse Effect; or 
 (xi) any
other event or condition of any character that has had or would reasonably be expected to have a Material Adverse Effect. 
 4.8. SEC
Filings. 
 (a) The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company
under the 1934 Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material). At the time of filing thereof, the
SEC Filings complied as to form in all material respects with the requirements of the 1934 Act. 
 4.9. No Conflict, Breach, Violation or
Default. The execution, delivery and performance of the Transaction Documents by the Company and the issuance and sale of the Closing Securities in accordance with the provisions thereof will not, except for such violations, conflicts or
defaults as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect, (i) conflict with or result in a breach or violation of (a) any of the terms and provisions of, or constitute a default
under, the Company’s Certificate of Incorporation or the Company’s By-laws, both as in effect on the date hereof (true and complete copies of which have been made available to the Investors through the Electronic Data Gathering, Analysis,
and Retrieval system (the “EDGAR system”)), or (b) assuming the accuracy of the representations and warranties in Section 5, any applicable statute, rule, regulation or order of any governmental agency or body or any court,
domestic or foreign, having jurisdiction over the Company or its subsidiary, or any of their assets or properties, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default)
under, result in the creation of any lien, encumbrance or other adverse claim upon any of the properties or assets of the Company or its subsidiary or give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any Material Contract. This Section does not relate to matters with respect to tax status, which are the subject of Section 4.10, employee relations and labor matters, which are the subject of
Section 4.13, and environmental laws, which are the subject of Section 4.15. 

  
 7 

 4.10. Tax Matters. The Company and its subsidiary have timely prepared and filed all
tax returns required to have been filed by them with all appropriate governmental agencies and timely paid all taxes shown thereon or otherwise owed by them. The charges, accruals and reserves on the books of the Company in respect of taxes for
all fiscal periods are adequate in all material respects, and there are no material unpaid assessments against the Company nor, to the Company’s Knowledge, any basis for the assessment of any additional taxes, penalties or interest for any
fiscal period or audits by any federal, state or local taxing authority except for any assessment which is not material to the Company. All taxes and other assessments and levies that the Company is required to withhold or to collect for
payment have been duly withheld and collected and paid to the proper governmental entity or third party when due. There are no tax liens or claims pending or, to the Company’s Knowledge, threatened against the Company or any of its assets
or property. There are no outstanding tax sharing agreements or other such arrangements between the Company and any other corporation or entity. 

4.11. Title to Properties. The Company and its subsidiary have good and marketable title to all real properties and all other
properties and assets owned by them, in each case free from liens, encumbrances and defects, except such as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; and the Company and its subsidiary
hold any leased real or personal property under valid and enforceable leases with no exceptions, except such as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

4.12. Certificates, Authorities and Permits. The Company and its subsidiary possess adequate certificates, authorities or permits
issued by appropriate governmental agencies or bodies necessary to conduct the business now operated by them, except where failure to so possess would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse
Effect. The Company and its subsidiary have not received any written notice of proceedings relating to the revocation or modification of any such certificate, authority or permit that would reasonably be expected to have a Material Adverse Effect,
individually or in the aggregate, on the Company. 
 4.13. Labor Matters. 

(a) Neither the Company nor its subsidiary is party to or bound by any collective bargaining agreements or other agreements with labor
organizations. To the Company’s knowledge, Company and its subsidiary have not violated in any material respect any laws, regulations, orders or contract terms, affecting the collective bargaining rights of employees, labor organizations
or any laws, regulations or orders affecting employment discrimination, equal opportunity employment, or employees’ health, safety, welfare, wages and hours. 

(b) No material labor dispute with the employees of the Company or its subsidiary, or with the employees of any principal supplier,
manufacturer, customer or contractor of the Company, exists or, to the knowledge of the Company, is threatened or imminent.
 4.14.
Intellectual Property. Except as expressly contemplated by the SEC Filings, the Company and its subsidiary own, possess, license or have other rights to use, the patents and patent applications, copyrights, trademarks, service marks,
trade names, service names and trade secrets described in the SEC Filings as necessary or material for use in connection with their business and which the failure to so have would have or reasonably be expected to result in a Material Adverse Effect
(collectively, the “Company Intellectual Property”). There is no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by any Person that the Company’s business or the business of its
subsidiary as now conducted infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of another. To the Company’s Knowledge, there is no existing infringement by another Person of any of
the Intellectual Property Rights that would have or would reasonably be expected to have a Material Adverse Effect. The Company and its subsidiary have taken reasonable security measures to protect the secrecy, confidentiality and value of all of
their Intellectual Property Rights, except where failure to do so would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

  
 8 

 4.15. Environmental Matters. Neither the Company nor its subsidiary is in violation
of any statute, rule, regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the
environment or human exposure to hazardous or toxic substances (collectively, “Environmental Laws”), has released any hazardous substances regulated by Environmental Law on to any real property that it owns or operates, has received any
written notice or claim it is liable for any off-site disposal or contamination pursuant to any Environmental Laws, which violation, release, notice, claim, or liability would reasonably be expected, individually or in the aggregate, to have a
Material Adverse Effect,; and to the Company’s Knowledge, there is no pending or threatened investigation that would reasonably be expected to lead to such a claim. 

4.16. Legal Proceedings. There are no legal, governmental or regulatory investigations, actions, suits or proceedings pending to
which the Company or its subsidiary is or may reasonably be expected to become a party or to which any property of the Company or its subsidiary is or may reasonably be expected to become the subject that, individually or in the aggregate, would
reasonably be expected to have a Material Adverse Effect. 
 4.17. Financial Statements. The financial statements included in
each SEC Filing comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing (or to the extent corrected by a subsequent restatement) and
present fairly, in all material respects, the financial position of the Company as of the dates shown and its results of operations and cash flows for the periods shown, subject in the case of unaudited financial statements to normal, immaterial
year-end audit adjustments, and such financial statements have been prepared in conformity with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”) (except as may be
disclosed therein or in the notes thereto, and except that the unaudited financial statements may not contain all footnotes required by GAAP, and, in the case of quarterly financial statements, as permitted by Form 10-Q under the 1934
Act). Except as set forth in the financial statements of the Company included in the SEC Filings filed prior to the date hereof, the Company has not incurred any liabilities, contingent or otherwise, except those incurred in the ordinary course
of business, consistent (as to amount and nature) with past practices since the date of such financial statements, none of which, individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect. 

4.18. Insurance Coverage. The Company and its subsidiary maintain in full force and effect insurance coverage that is customary for
comparably situated companies for the business being conducted and properties owned or leased by the Company and its subsidiary, and the Company reasonably believes such insurance coverage to be adequate against all liabilities, claims and risks
against which it is customary for comparably situated companies to insure. 
 4.19. Compliance with Nasdaq Continued Listing
Requirements. The Company is in compliance with applicable Nasdaq continued listing requirements. There are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of
the Common Stock on Nasdaq and the Company has not received any notice of, nor to the Company’s Knowledge is there any reasonable basis for, the delisting of the Common Stock from Nasdaq. 

4.20. Brokers and Finders. Other than the Placement Agent, no Person will have, as a result of the transactions contemplated by the
Transaction Documents, any valid right, interest or claim against or upon the Company or an Investor for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company.
No Investor shall have any obligation with respect to any fees, or with respect to any claims made by or on behalf of other Persons for fees, in each case of the type contemplated by this Section 4.20 that may be due in connection with the
transactions contemplated by this Agreement or the Transaction Documents. 

  
 9 

 4.21. No Directed Selling Efforts or General Solicitation. Neither the Company nor
any Person acting on its behalf has conducted any general solicitation or general advertising (as those terms are used in Regulation D) in connection with the offer or sale of any of the Closing Securities. 

4.22. No Integrated Offering. Neither the Company nor its subsidiary nor any Person acting on their behalf has, directly or
indirectly, made any offers or sales of any Company security or solicited any offers to buy any Company security, under circumstances that would adversely affect reliance by the Company on Section 4(2) for the exemption from registration for
the transactions contemplated hereby or would require registration of the Closing Securities under the 1933 Act. 
 4.23. Private
Placement. Assuming the accuracy of the representations and warranties of the Investors set forth in Section 5, the offer and sale of the Closing Securities to the Investors as contemplated hereby is exempt from the registration
requirements of the 1933 Act. The issuance and sale of the Closing Securities does not contravene the rules and regulations of Nasdaq. 

4.24. Questionable Payments. Neither the Company nor its subsidiary nor, to the Company’s
Knowledge, any of their current or former directors, officers, employees, agents or other Persons acting on behalf of the Company or its subsidiary, has on behalf of the Company or its subsidiary in connection with its business: (a) used any
corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity; (b) made any direct or indirect unlawful payments to any governmental officials or employees from corporate funds;
(c) established or maintained any unlawful or unrecorded fund of corporate monies or other assets which is in violation of law; (d) made any false or fictitious entries on the books and records of the Company; or (e) made any unlawful
bribe, rebate, payoff, influence payment, kickback or other unlawful payment of any nature. 
 4.25. Transactions with
Affiliates. None of the executive officers or directors of the Company or its subsidiary and, to the Company’s Knowledge, none of the employees of the Company or its subsidiary is presently a party to any transaction with the Company
(other than as holders of stock options and/or warrants, and for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real
or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the Company’s Knowledge, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee or partner. 
 4.26. Internal Controls. The Company has established and maintains disclosure
controls and procedures (as defined in Rules 13a-15 and 15d-15 under the 1934 Act), which are designed to ensure that material information relating to the Company, including its subsidiary, is made known to the Company’s principal executive
officer and its principal financial officer by others within those entities. Since the end of the Company’s most recent audited fiscal year, there have been no significant deficiencies or material weakness in the Company’s internal
control over financial reporting (whether or not remediated) and no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal
control over financial reporting. The Company is not aware of any change in its internal controls over financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial reporting. 
 4.27. Disclosures. Neither the Company nor any Person
acting on its behalf has provided the Investors or their agents or counsel with any information that constitutes or would reasonably be expected to constitute material, non-public information which according to applicable law, rule or regulation was
required to have been disclosed publicly by the Company or its subsidiary, but which has not been so disclosed, other than with respect to the transactions contemplated hereby and except as will be disclosed in the 8-K Filing (as defined
below). The SEC Filings and the slide presentation presented to the Investors by the Company in connection with the offer and sale of the Closing Securities, when considered together, do not contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements contained therein, in light of the circumstances under which they were made, not misleading. The Company understands and confirms that the Investors will rely on the
foregoing representations in effecting transactions in securities of the Company.

  
 10 

 4.28. Required Filings. Except for the transactions contemplated by this Agreement,
including the acquisition of the Closing Securities contemplated hereby, no event or circumstance has occurred or information exists with respect to the Company or its business, properties, operations or financial condition, which, under applicable
law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed (assuming for this purpose that the SEC Filings are being incorporated by reference into an effective
registration statement filed by the Company under the 1933 Act).
 4.29. Investment Company. The Company is not required to be
registered as, and is not an Affiliate of, and immediately following the Closing will not be required to register as, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 

4.30. Tests and Preclinical and Clinical Trials. The studies, tests and preclinical and clinical trials conducted by or, to the
Company’s Knowledge, on behalf of the Company that are described in the SEC Filings were and, if still pending, are being, conducted in all material respects in accordance with the protocols submitted to the U.S. Food and Drug Administration
(the “FDA”) or any foreign governmental body exercising comparable authority, procedures and controls pursuant to, where applicable, accepted professional and scientific standards, and all applicable laws and regulations; the descriptions
of the studies, tests and preclinical and clinical trials conducted by or, to the Company’s Knowledge, on behalf of the Company, and the results thereof, contained in the SEC Filings are accurate and complete in all material respects; the
Company is not aware of any other studies, tests or preclinical and clinical trials, the results of which call into question the results described in the SEC Filings; and the Company has not received any notices or correspondence from the FDA, any
foreign, state or local governmental body exercising comparable authority or any Institutional Review Board requiring the termination, suspension, material modification or clinical hold of any studies, tests or preclinical or clinical trials
conducted by or on behalf of the Company. 
 4.31. Manipulation of Price. The Company has not, and, to the Company’s
Knowledge, no Person acting on its behalf has taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the
Securities. 
 4.32. Anti-Bribery and Anti-Money Laundering Laws. Each of the Company, its subsidiary and any of their respective
officers, directors, supervisors, managers, agents, or employees, are and have at all times been in compliance with and its participation in the offering will not violate: (A) anti-bribery laws, including but not limited to, any applicable law,
rule, or regulation of any locality, including but not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, signed December 17,
1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any other law, rule or regulation of similar purposes and scope or (B) anti-money laundering laws, including but not limited to, applicable
federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money laundering, including, without limitation, Title 18 US. Code section 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and
international anti-money laundering principles or procedures by an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which the United States is a member and with which designation the United
States representative to the group or organization continues to concur, all as amended, and any Executive order, directive, or regulation pursuant to the authority of any of the foregoing, or any orders or licenses issued thereunder. 

5. Representations and Warranties of the Investors. Each of the Investors hereby severally, and not jointly, represents and
warrants to the Company that: 
 5.1. Organization and Existence. Such Investor is a validly existing corporation, limited
partnership or limited liability company and has all requisite corporate, partnership or limited liability company power and authority to enter into and consummate the transactions contemplated by the Transaction Documents and to carry out its
obligations hereunder and thereunder, and to invest in the Securities pursuant to this Agreement. 

  
 11 

 5.2. Authorization. The execution, delivery and performance by such Investor of the
Transaction Documents to which such Investor is a party have been duly authorized and each has been duly executed and when delivered will constitute the valid and legally binding obligation of such Investor, enforceable against such Investor in
accordance with their respective terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating to or affecting creditors’ rights generally. 

5.3. Purchase Entirely for Own Account. The Securities to be received by such Investor hereunder will be acquired for such
Investor’s own account, not as nominee or agent, and not with a view to the resale or distribution of any part thereof in violation of the 1933 Act, and such Investor has no present intention of selling, granting any participation in, or
otherwise distributing the same in violation of the 1933 Act without prejudice, however, to such Investor’s right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable federal and state
securities laws. Nothing contained herein shall be deemed a representation or warranty by such Investor to hold the Securities for any period of time. Such Investor is not a broker-dealer registered with the SEC under the
1934 Act or an entity engaged in a business that would require it to be so registered. 
 5.4. Investment Experience. Such
Investor acknowledges that it can bear the economic risk and complete loss of its investment in the Securities and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the
investment contemplated hereby. 
 5.5. Disclosure of Information. Such Investor has had an opportunity to receive, review and
understand all information related to the Company requested by it and to ask questions of and receive answers from the Company regarding the Company, its business and the terms and conditions of the offering of the Securities, and has conducted and
completed its own independent due diligence. Such Investor acknowledges that copies of the SEC Filings are available on the EDGAR system. Based on the information such Investor has deemed appropriate, and without reliance upon any
Placement Agent, it has independently made its own analysis and decision to enter into the Transaction Documents. Such Investor is relying exclusively on its own sources of information, investment analysis and due diligence (including
professional advice it deems appropriate) with respect to the execution, delivery and performance of the Transaction Documents, the Securities and the business, condition (financial and otherwise), management, operations, properties and prospects of
the Company, including but not limited to all business, legal, regulatory, accounting, credit and tax matters. Neither such inquiries nor any other due diligence investigation conducted by such Investor shall modify, limit or otherwise affect
such Investor’s right to rely on the Company’s representations and warranties contained in this Agreement. 
 5.6. Restricted
Securities. Such Investor understands that the Securities are characterized as “restricted securities” under the U.S. federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a
public offering and that under such laws and applicable regulations such securities may be resold without registration under the 1933 Act only in certain limited circumstances. 

5.7. Legends. It is understood that, except as provided below, certificates evidencing the Securities may bear the following or any
similar legend: 
 (a) “The securities represented hereby have not been registered with the Securities and Exchange Commission or the
securities commission of any state in reliance upon an exemption from registration under the Securities Act of 1933, as amended, and, accordingly, may not be transferred unless (i) such securities have been registered for sale pursuant to the
Securities Act of 1933, as amended, (ii) such securities may be sold pursuant to Rule 144, or (iii) the Company has received an opinion of counsel reasonably satisfactory to it that such transfer may lawfully be made without
registration under the Securities Act of 1933, as amended.” 

  
 12 

 (b) If required by the authorities of any state in connection with the issuance of sale of the
Securities, the legend required by such state authority. 
 5.8. Accredited Investor. Such Investor is (a) an “accredited
investor” within the meaning of Rule 501 under the 1933 Act and has executed and delivered to the Company a questionnaire in substantially the form attached hereto as Exhibit D (the “Investor Questionnaire”), which such
Investor represents and warrants is true, correct and complete. Such investor is (b) a sophisticated institutional investor with sufficient knowledge and experience in investing in private equity transactions to properly evaluate the risks and
merits of its purchase of the Securities. Such Investor has determined based on its own independent review and such professional advice as it deems appropriate that its purchase of the Securities and participation in the transactions
contemplated by the Transaction Documents (i) are fully consistent with its financial needs, objectives and condition, (ii) comply and are fully consistent with all investment policies, guidelines and other restrictions applicable to such Investor,
(iii) have been duly authorized and approved by all necessary action, (iv) do not and will not violate or constitute a default under such Investor’s charter, by-laws or other constituent document or under any law, rule, regulation, agreement or
other obligation by which such Investor is bound and (v) are a fit, proper and suitable investment for such Investor, notwithstanding the substantial risks inherent in investing in or holding the Securities.

5.9. Placement Agent. Such Investor hereby acknowledges and agrees that (a) the Placement Agent is acting solely as placement agent
in connection with the execution, delivery and performance of the Transaction Documents and is not acting as an underwriter or in any other capacity and is not and shall not be construed as a fiduciary for such Investor, the Company or any other
person or entity in connection with the execution, delivery and performance of the Transaction Documents, (b) the Placement Agent has not made and will not make any representation or warranty, whether express or implied, of any kind or character and
has not provided any advice or recommendation in connection with the execution, delivery and performance of the Transaction Documents, (c) the Placement Agent will not have any responsibility with respect to (i) any representations, warranties or
agreements made by any person or entity under or in connection with the execution, delivery and performance of the Transaction Documents, or the execution, legality, validity or enforceability (with respect to any person) thereof, or (ii) the
business, affairs, financial condition, operations, properties or prospects of, or any other matter concerning the Company, and (d) the Placement Agent will not have any liability or obligation (including without limitation, for or with respect to
any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements incurred by such Investor, the Company or any other person or entity), whether in contract, tort or otherwise, to such Investor, or
to any person claiming through it, in respect of the execution, delivery and performance of the Transaction Documents. 
 5.10. No General
Solicitation. Such Investor did not learn of the investment in the Securities as a result of any general solicitation or general advertising. 

5.11. Brokers and Finders. No Person will have, as a result of the transactions contemplated by the Transaction Documents, any
valid right, interest or claim against or upon the Company or an Investor for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of such Investor. 

5.12 Short Sales and Confidentiality Prior to the Date Hereof. Other than consummating the transactions contemplated hereunder, such
Investor has not, nor has any Person acting on behalf of or pursuant to any understanding with such Investor, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period
commencing as of the time that such Investor was first contacted by the Company, the Placement Agent or any other Person regarding the transactions contemplated hereby and ending immediately prior to the date hereof. Notwithstanding the
foregoing, in the case of an Investor that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Investor’s assets and the portfolio 

  
 13 

 
managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Investor’s assets, the representation set forth above shall only
apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement, such Investor has
maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall
constitute a representation or warranty, or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future. 

5.13 No Government Recommendation or Approval. Such Investor understands that no United States federal or state agency, or similar
agency of any other country, has reviewed, approved, passed upon, or made any recommendation or endorsement of the Company or the purchase of the Securities. 

5.14 No Intent to Effect a Change of Control. Such Investor has no present intent to effect a “change of control” of the
Company as such term is understood under the rules promulgated pursuant to Section 13(d) of the 1934 Act. 
 5.15 No Rule 506
Disqualifying Activities. Such Investor has not taken any of the actions set forth in, and is not subject to, the disqualification provisions of Rule 506(d)(1) of the 1933 Act. 

5.16 Residency. Such Investor is a resident of the jurisdiction specified below its address on the Schedule of Investors. 

6. Conditions to Closing. 

6.1. Conditions to the Investors’ Obligations. The obligation of each Investor to purchase Closing Securities at the Closing
is subject to the fulfillment to such Investor’s satisfaction, on or prior to the Closing Date, of the following conditions, any of which may be waived by such Investor (as to itself only): 

(a) The representations and warranties made by the Company in Section 4 hereof shall be true and correct in all material respects as of
the date hereof and on the Closing Date, except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and correct in all material respects as of such
earlier date. The Company shall have performed in all material respects all obligations and covenants herein required to be performed by it on or prior to the Closing Date. 

(b) The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary for consummation of the
purchase and sale of the Closing Securities and the consummation of the other transactions contemplated by the Transaction Documents, all of which shall be in full force and effect. 

(c) The Company shall have executed and delivered the Registration Rights Agreement. 

(d) The Company shall have filed with Nasdaq a Notification Form: Listing of Additional Shares for the listing of the Shares and the Common
Warrant Shares. 

  
 14 

 (e) No judgment, writ, order, injunction, award or decree of or by any court, or judge, justice
or magistrate, including any bankruptcy court or judge, or any order of or by any governmental authority, shall have been issued, and no action or proceeding shall have been instituted by any governmental authority, enjoining or preventing the
consummation of the transactions contemplated hereby or in the other Transaction Documents. 
 (f) The Company shall have delivered a
Certificate, executed on behalf of the Company by its Chief Executive Officer or its Chief Financial Officer, dated as of the Closing Date, certifying to the fulfillment of the conditions specified in subsections (a), (b), (d), (e) and
(i) of this Section 6.1. 
 (g) The Company shall have delivered a Certificate, executed on behalf of the Company by its Secretary,
dated as of the Closing Date, certifying the resolutions adopted by the Board of Directors of the Company approving the transactions contemplated by this Agreement and the other Transaction Documents and the issuance of the Closing Securities,
certifying the current versions of the Certificate of Incorporation and By-laws of the Company and certifying as to the signatures and authority of persons signing the Transaction Documents and related documents on behalf of the Company. 

(h) The Investors shall have received an opinion from Wilmer Cutler Pickering Hale and Dorr LLP, the Company’s counsel, dated as of the
Closing Date, in form and substance reasonably acceptable to the Placement Agent and addressing such legal matters as the Investors may reasonably request. 

(i) No stop order or suspension of trading shall have been imposed by Nasdaq, the SEC or any other governmental or regulatory body with respect
to public trading in the Common Stock. 
 6.2. Conditions to Obligations of the Company. The Company’s obligation to sell
and issue Closing Securities at the Closing is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any of which may be waived by the Company: 

(a) The representations and warranties made by the Investors in Section 5 hereof shall be true and correct in all material respects as of
the date hereof, and shall be true and correct in all material respects on the Closing Date with the same force and effect as if they had been made on and as of said date. The Investors shall have performed in all material respects all
obligations and covenants herein required to be performed by them on or prior to the Closing Date. 
 (b) The Investors shall have executed
and delivered the Registration Rights Agreement and each Investor Questionnaire. 
 (c) Any Investor purchasing Closing Securities at the
Closing shall have paid in full its Subscription Amount to the Company. 
 6.3. Termination of Obligations to Effect Closing; Effects.

 (a) The obligations of the Company, on the one hand, and the Investors, on the other hand, to effect the Closing shall terminate as
follows: 

  
 15 

 (i) Upon the mutual written consent of the Company and Investors that agreed to purchase a
majority of the Closing Securities to be issued and sold pursuant to this Agreement; 
 (ii) By the Company if any of the conditions set
forth in Section 6.2 shall have become incapable of fulfillment, and shall not have been waived by the Company;
 (iii) By an Investor
(with respect to itself only) if any of the conditions set forth in Section 6.1 shall have become incapable of fulfillment, and shall not have been waived by the Investor; or 

(iv) By either the Company or any Investor (with respect to itself only) if the Closing has not occurred on or prior to November 30, 2016;

 provided, however, that, except in the case of clause (i) above, the party seeking to terminate its obligation to effect the Closing shall not then
be in breach of any of its representations, warranties, covenants or agreements contained in this Agreement or the other Transaction Documents if such breach has resulted in the circumstances giving rise to such party’s seeking to terminate its
obligation to effect the Closing. 
 (b) In the event of termination by the Company or any Investor of its obligations to effect the Closing
pursuant to this Section 6.3, written notice thereof shall be given to the other Investors by the Company and the other Investors shall have the right to terminate their obligations to effect the Closing upon written notice to the Company and
the other Investors. Nothing in this Section 6.3 shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents or to impair the right
of any party to compel specific performance by any other party of its obligations under this Agreement or the other Transaction Documents. 

7. Covenants and Agreements of the Company. 

7.1. No Conflicting Agreements. The Company will not take any action, enter into any agreement or make any commitment that would
conflict or interfere in any material respect with the Company’s obligations to the Investors under the Transaction Documents. 
 7.2.
Nasdaq Listing. The Company will use commercially reasonable efforts to continue the listing and trading of its Common Stock on Nasdaq and, in accordance, therewith, will use commercially reasonable efforts to comply in all respects with
the Company’s reporting, filing and other obligations under the bylaws or rules of such market or exchange, as applicable. 
 7.3.
Termination of Covenants. The provisions of Sections 7.1 and 7.2 shall terminate and be of no further force and effect on the date on which the Company’s obligations under the Registration Rights Agreement to register or
maintain the effectiveness of any registration covering the Registrable Securities (as such term is defined in the Registration Rights Agreement) shall terminate. 

7.4. Removal of Legends.

(a) In connection with any sale, assignment, transfer or other disposition of the Shares by an Investor pursuant to Rule 144 or pursuant
to any other exemption under the 1933 Act such that the purchaser acquires freely tradable shares and upon compliance by the Investor with the requirements of this Agreement, if requested by the Investor, the Company shall cause the transfer agent
for the Common Stock (the “Transfer Agent”) to remove any 

  
 16 

 
restrictive legends related to the book entry account holding such Shares and make a new, unlegended entry for such book entry Shares sold or disposed of without restrictive legends, provided
that the Company has received from the Investor customary representations and other documentation reasonably acceptable to the Company in connection therewith.

(b) Subject to receipt from the Investor by the Company and the Transfer Agent of customary representations and other documentation reasonably
acceptable to the Company and the Transfer Agent in connection therewith, upon the earliest of such time as the Shares (i) have been sold or transferred pursuant to an effective registration statement, (ii) have been sold pursuant to
Rule 144, or (iii) are eligible for resale under Rule 144(b)(1) or any successor provision (such earliest date, the “Effective Date”), the Company shall (A) deliver to the Transfer Agent irrevocable instructions that the
Transfer Agent shall make a new, unlegended entry for such book entry Shares, and (B) cause its counsel to deliver to the Transfer Agent one or more opinions to the effect that the removal of such legends in such circumstances may be effected
under the 1933 Act if required by the Transfer Agent to effect the removal of the legend in accordance with the provisions of this Agreement. The Company agrees that following the Effective Date or at such time as such legend is no longer required
under this Section 7.4, it will, within three Trading Days of the delivery by an Investor to the Company or the Transfer Agent of a certificate representing shares issued with a restrictive legend and receipt from the Investor by the Company and the
Transfer Agent of customary representations and other documentation reasonably acceptable to the Company and the Transfer Agent in connection therewith (the “Share Delivery Date”) deliver or cause to be delivered to such Investor a
certificate representing such Shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this
Section 7.4.Shares subject to legend removal hereunder may be transmitted by the Transfer Agent to the Investor by crediting the account of the Investor’s prime broker with the DTC System as directed by such Investor. The Company shall be
responsible for the fees of its Transfer Agent and all DTC fees associated with such issuance. If the Company fails to effect delivery of any such Shares on or before the applicable Share Delivery Date and if after such date, due to the
Company’s continuing failure to deliver such Shares, such Investor purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the holder of shares of Common Stock that such Investor
anticipated receiving from the Company without any restrictive legend (a “Buy-In”), then the Company shall, within three (3) Trading Days after such Investor’s request and in such Investor’s sole discretion, either (i) pay
cash to the Investor in an amount equal to such Investor’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased, at which point the Company’s obligation to deliver such Shares shall
terminate, or (ii) promptly honor its obligation to deliver to such Investor such shares of Common Stock and pay cash to the Investor in an amount equal to the excess (if any) of such Investor’s total purchase price (including brokerage
commissions, if any) for the shares of Common Stock so purchased in the Buy-In over the product of (a) such number of shares of Common Stock purchased in the Buy-in, times (b) the Closing Bid Price on the Share Delivery Date. 

(c) Each Investor, severally and not jointly with the other Investors, agrees with the Company (i) that such Investor will sell any Shares
pursuant to either the registration requirements of the 1933 Act, including any applicable prospectus delivery requirements, or an 

  
 17 

 
exemption therefrom, (ii) that if Shares are sold pursuant to a registration statement, they will be sold in compliance with the plan of distribution set forth therein and (iii) that if, after
the effective date of the registration statement covering the resale of the Shares, such registration statement is not then effective and the Company has provided notice to such Investor to that effect, such Investor will sell Shares only in
compliance with an exemption from the registration requirements of the 1933 Act. 
 7.5. Subsequent Equity Sales. 

(a) From the date hereof until sixty (60) days after the effective date of the registration statement covering the resale of the Shares,
without the consent of the Required Investors, the Company shall not (A) issue shares of Common Stock or Common Stock Equivalents or (B) file with the SEC a registration statement under the 1933 Act relating to any shares of Common Stock or Common
Stock Equivalents, except pursuant to the terms of agreements to which the Company is currently a party. Notwithstanding the foregoing, the provisions of this Section 7.5(a) shall not apply to (i) the issuance of the Securities
hereunder, (ii) the issuance of Common Stock or Common Stock Equivalents upon the conversion or exercise of any securities of the Company outstanding on the date hereof or outstanding pursuant to clause (iii), (iv) or (v) below, (iii) the
issuance of any Common Stock or Common Stock Equivalents pursuant to any Company stock-based compensation plans, (iv) the issuance of any Common Stock or Common Stock Equivalents in connection with a transaction with an unaffiliated third party that
includes a bona fide commercial relationship with the Company (including any joint venture, marketing or distribution arrangement, strategic alliance, collaboration agreement or corporate partnering, intellectual property license agreement or
acquisition agreement with the Company); provided, however, that the aggregate number of shares of Common Stock issued pursuant to clause (iv) during the ninety (90) day restricted period shall not exceed 10% of the total number of shares of Common
Stock issued and outstanding immediately following the Closing. 
 (b) The Company shall not, and shall use its commercially reasonable
efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the 1933 Act) that will be integrated with the offer or sale
of the Securities in a manner that would require the registration under the 1933 Act of the sale of the Securities to the Investors, or that will be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any
trading market such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction. 

7.6. Short Sales and Confidentiality After the Date Hereof. Each Investor covenants that neither it nor any Affiliates acting on
its behalf or pursuant to any understanding with it will execute any Short Sales during the period from the date hereof until the earlier of such time as (i) the transactions contemplated by this Agreement are first publicly announced or (ii) this
Agreement is terminated in full. Each Investor covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company, such Investor will maintain the confidentiality of all disclosures made to
it in connection with this transaction (including the existence and terms of this transaction). Each Investor understands and acknowledges that the SEC currently takes the position that coverage of Short Sales of shares of the Common Stock
“against the box” prior to effectiveness of a resale registration statement with securities included in such registration statement would be a violation of Section 5 of the 1933 Act, as set forth in Item 239.10 of the Securities Act
Rules Compliance and Disclosure Interpretations compiled by the Office of Chief Counsel, Division of Corporation Finance. 

  
 18 

 8. Survival and Indemnification. 

8.1. Survival. The representations, warranties, covenants and agreements contained in this Agreement shall survive the Closing of
the transactions contemplated by this Agreement for the applicable statute of limitations. 
 8.2. Indemnification. The Company
agrees to indemnify and hold harmless each Investor and its Affiliates and their respective directors, officers, trustees, members, managers, employees and agents, and their respective successors and assigns, from and against any and all losses,
claims, damages, liabilities and expenses (including without limitation reasonable attorney fees and disbursements and other expenses reasonably incurred in connection with investigating, preparing or defending any action, claim or proceeding,
pending or threatened and the costs of enforcement thereof) (collectively, “Losses”) to which such Person may become subject as a result of any breach of representation, warranty, covenant or agreement made by or to be performed on the
part of the Company under the Transaction Documents, and will reimburse any such Person for all such amounts as they are incurred by such Person. 

8.3. Conduct of Indemnification Proceedings. Any person entitled to indemnification hereunder shall
(i) give prompt notice to the indemnifying party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the
indemnified party; provided that any person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the
expense of such person unless (a) the indemnifying party has agreed to pay such fees or expenses, (b) the indemnifying party shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory to such person or
(c) in the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies the
indemnifying party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such person); and
provided, further, that the failure of any indemnified party to give notice as provided herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that such failure to give notice shall
materially adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or
expenses of more than one separate firm of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party, which consent shall not be unreasonably withheld, conditioned or
delayed, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such claim
or litigation. No indemnified party will, except with the consent of the indemnifying party, consent to entry of any judgment or enter into any settlement. 

9. Miscellaneous. 
 9.1.
Successors and Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of the Company or each of the Investors, as applicable, provided, however, that an Investor may assign its rights and delegate
its duties hereunder in whole or in part to an Affiliate or to a third party acquiring some or all of its Securities in a transaction complying with applicable securities laws without the prior written consent of the Company or the other Investors,
provided such assignee agrees in writing to be bound by the provisions hereof that apply to Investors. The provisions of this Agreement shall inure to the benefit of and be binding upon the respective permitted successors and assigns of the
parties. Without limiting the generality of the foregoing, in the event that the Company is a party to a merger, consolidation, share exchange or similar business combination transaction in which the Common Stock is converted into the equity
securities of another Person, from and after the effective time of such transaction, such Person shall, by virtue of such transaction, be deemed to have assumed the obligations of the Company hereunder, the term “Company” shall be deemed
to refer to such Person and the term “Securities” shall be deemed to refer to the securities received by the Investors in connection with such transaction. Nothing in this Agreement, express or implied, is intended to confer upon
any party other than the parties hereto or their respective permitted successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

  
 19 

 9.2. Counterparts; Faxes; E-mail. This Agreement may be executed in one or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Agreement may also be executed via facsimile or e-mail, which shall be deemed an original. 

9.3. Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be
considered in construing or interpreting this Agreement. 
 9.4. Notices. Unless otherwise provided, any notice required or
permitted under this Agreement shall be given in writing and shall be deemed effectively given as hereinafter described (i) if given by personal delivery, then such notice shall be deemed given upon such delivery, (ii) if given by facsimile,
then such notice shall be deemed given upon receipt of confirmation of complete transmittal, (iii) if given by mail, then such notice shall be deemed given upon the earlier of (A) receipt of such notice by the recipient or (B) three
days after such notice is deposited in first class mail, postage prepaid, and (iv) if given by an internationally recognized overnight air courier, then such notice shall be deemed given one Business Day after delivery to such carrier. All
notices shall be addressed to the party to be notified at the address as follows, or at such other address as such party may designate by ten days’ advance written notice to the other party: 

If to the Company: 
 Spring Bank
Pharmaceuticals, Inc. 
 113 Cedar Street 

Milford, Massachusetts 01757 

Attention: Chief Financial Officer 

Fax: (508) 381-0347 

Email: jfreve@springbankpharm.com 

With a copy to: 
 Wilmer Cutler
Pickering Hale and Dorr LLP 
 60 State Street 

Boston, Massachusetts 02109 

Attention: Stuart M. Falber 

Fax: (617) 526-5000 
 If to the
Investors: 
 to the addresses set forth on the signature pages hereto. 

9.5. Expenses. The parties hereto shall pay their own costs and expenses in connection herewith regardless of whether the
transactions contemplated hereby are consummated; it being understood that each of the Company and each Investor has relied on the advice of its own respective counsel.

9.6. Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be
waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and (a) prior to the Closing, Investors that agreed to purchase a majority of the Shares to be issued and
sold pursuant to this Agreement and (b) following the Closing, the Required Investors. Notwithstanding the foregoing, this Agreement may not be amended and the 

  
 20 

 
observance of any term of this Agreement may not be waived with respect to any Investor without the written consent of such Investor unless such amendment or waiver applies to all Investors in
the same fashion. Any amendment or waiver effected in accordance with this paragraph shall be binding upon (i) prior to Closing, each Investor and (ii) following the Closing, each holder of any Securities purchased under this Agreement at the time
outstanding, and in each case, each future holder of all such Securities and the Company. 
 9.7. Publicity. Except as set forth
below, no public release or announcement concerning the transactions contemplated hereby shall be issued by the Investors without the prior consent of the Company (which consent shall not be unreasonably withheld), except as such release or
announcement may be required by law or the applicable rules or regulations of any securities exchange or securities market, in which case the Investors shall allow the Company, to the extent reasonably practicable in the circumstances, reasonable
time to comment on such release or announcement in advance of such issuance. The Company shall not include the name of any Investor in any press release or public announcement (which, for the avoidance of doubt, shall not include any SEC
Filing) without the prior written consent of such Investor. By 8:30 a.m. (New York City time) on the Business Day immediately following the date this Agreement is executed, the Company shall issue a press release disclosing all material terms
of transactions contemplated by this Agreement (the “Press Release”). No later than 5:30 p.m. (New York City time) on the first Business Day following the date this Agreement is executed, the Company will file a Current Report on Form
8-K (the “8-K Filing”) attaching the press release described in the foregoing sentence as well as copies of the Transaction Documents. In addition, the Company will make such other filings and notices in the manner and time required
by the SEC or Nasdaq. The parties acknowledge that from and after the issuance of the Press Release, no Investor shall be in possession of any material, nonpublic information received from the Company or any of its respective officers,
directors, employees or agents, with respect to the transactions contemplated hereby that is not disclosed in the Press Release. The Company shall not, and shall cause each of its officers, directors, employees and agents, not to, provide any
Investor with any such material, nonpublic information regarding the Company from and after the filing of the Press Release without the express prior written consent of such Investor. 

9.8. Severability. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such
jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall be interpreted as if it were written so as to be enforceable to the maximum extent permitted by
applicable law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. To the extent permitted by applicable law, the parties hereby waive any
provision of law which renders any provision hereof prohibited or unenforceable in any respect. 
 9.9. Entire Agreement. This
Agreement, including the signature pages, Exhibits and the Disclosure Schedules, and the other Transaction Documents constitute the entire agreement among the parties hereof with respect to the subject matter hereof and thereof and supersede all
prior agreements and understandings, both oral and written, between the parties with respect to the subject matter hereof and thereof. 

9.10. Further Assurances. The parties shall execute and deliver all such further instruments and documents and take all such other
actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained. 

9.11. Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in
accordance with, the internal laws of the State of New York without regard to the choice of law principles thereof. Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the courts of the State of New York located in
New York County and the United States District Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated
hereby. Service of process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the
parties hereto irrevocably consents to the jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue of any such
suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been 

  
 21 

 
brought in an inconvenient forum. EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS
BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.  
 9.12. Independent Nature of Investors’ Obligations and Rights. The
obligations of each Investor under any Transaction Document are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any
Transaction Document. The decision of each Investor to purchase Closing Securities pursuant to the Transaction Documents has been made by such Investor independently of any other Investor. Nothing contained herein or in any Transaction
Document, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its
investment hereunder and that no Investor will be acting as agent of such Investor in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction Documents. Each Investor shall be entitled to
independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Investor to be joined as an additional party
in any proceeding for such purpose. The Company acknowledges that each of the Investors has been provided with the same Transaction Documents for the purpose of closing a transaction with multiple Investors and not because it was required or
requested to do so by any Investor. 
 9.13. Limitation of Liability. Notwithstanding anything herein to the contrary, the
Company acknowledges and agrees that the liability of an Investor arising directly or indirectly under any Transaction Document of any and every nature whatsoever shall be satisfied solely out of the assets of such Investor and that no trustee,
officer, other investment vehicle or any other Affiliate of such Investor or any investor, shareholder or holder of shares of beneficial interest of such Investor shall be personally liable for any liabilities of such Investor. 

[remainder of page intentionally left blank] 

  
 22 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

							
	COMPANY:	 		 	SPRING BANK PHARMACEUTICALS, INC.
				
		 		 	By:	 	 /s/ Martin Driscoll

		 		 		 	Name: Martin Driscoll
		 		 		 	Title: Chief Executive Officer

							
	INVESTOR:	 		 	
		 		 	By:	 	 /s/ Ansbert Gadicke

		 		 		 	 Ansbert Gadicke
  

on behalf of
 MPM ONCOLOGY IMPACT

MANAGEMENT GP LLC
  

in its capacity as general partner of
 MPM ONCOLOGY IMPACT

MANAGEMENT LP
  

in its capacity as general partner of
 ONCOLOGY IMPACT FUND

(CAYMAN) MANAGEMENT L.P.
  

in its capacity as general partner of
 UBS ONCOLOGY IMPACT FUND
L.P.

							
	INVESTOR:	 		 	
		 		 	By:	 	Baker Bros. Advisors LP, Management Company and Investment Adviser to Baker Brothers Life Sciences, L.P., pursuant to authority granted to it by Baker Brothers Life Sciences Capital, L.P., general partner to Baker Brothers Life
Sciences, L.P. and not as the general partner
				
		 		 	By:	 	 /s/ Scott L. Lessing

		 		 		 	Scott L. Lessing, President

					
	 INVESTOR:
	  	
		  	By:	  	Baker Bros. Advisors LP, Management Company and Investment Adviser to 667, L.P., pursuant to authority granted to it by Baker Biotech Capital, L.P., general partner to 667, L.P. and not as the general partner
			
		  	By:	  	 /s/ Scott L. Lessing

		  		  	Scott L. Lessing, President

					
	INVESTOR: Alyeska Master Fund, LP	  	
	                      Alyeska Master Fund 2, LP	  	By:	  	 /s/ Jason Bragg

		  		  	 Name: Jason Bragg
 Title: CFO

					
	 INVESTOR: The E. Burke Ross Jr. Descendants’

GST Investment Trust 2014
	  	
		  	By:	  	 /s/ Peter Lacaillade

		  		  	 Name: Peter Lacaillade
 Title:
Trustee

					
	INVESTOR: EBR Ventures, LLC	  	
		  	By:	  	 /s/ E. Burke Ross Jr.

		  		  	 Name: E. Burke Ross Jr.
 Title: Manager, EBR
Ventures, LLC

					
	INVESTOR: CVI Investments, Inc.	  	
		  	By:	  	 /s/ Martin Kobinger

		  		  	 Name: Martin Kobinger
 Title: Investment
Manager

							
	INVESTOR: Burrage Capital Healthcare Fund I, LP	 		 		 	
		 		 	By:	 	 /s/ Chris Bardon

		 		 		 	Chris Bardon

					
	 INVESTOR:
	  	
		  	By:	  	 /s/ Kurt Eichler

		  		  	 Name: Kurt Eichler

Title: Director

							
	INVESTOR:	 	 Marilyn E. Tenzer
 Declaration of
Trust
 u/a/d 10/7/98
	  	
		 	  	By:	  	 /s/ Marilyn E. Tenzer

		 	  		  	 Name: Marilyn E. Tenzer
 Title: Trustee for the
Marilyn E. Tenzer Declaration of Trust

					
	INVESTOR: Iroquois Master Fund Ltd.	  	
		  	By:	  	 /s/ Richard Abbe

		  		  	 Name: Richard Abbe
 Title:
Director

					
	INVESTOR: Iroquois Capital Investment Group LLC	  	
		  	By:	  	 /s/ Richard Abbe

		  		  	 Name: Richard Abbe
 Title:
Director

					
	 INVESTOR: DAFNA LifeScience LP
	  	
		  	 By:
	  	 /s/ Nathan Fischel

		  		  	 Name: Nathan Fischel

Title: CEO

					
	 INVESTOR: DAFNA LifeScience Select LP
	  	
		  	 By:
	  	 /s/ Nathan Fischel

		  		  	 Name: Nathan Fischel

Title: CEO

					
	INVESTOR: Intracoastal Capital, LLC	  	
		  	By:	  	 /s/ Keith A. Goodman

		  		  	 Name: Keith A. Goodman
 Title: Authorized
Signatory

					
	INVESTOR: MLPF&S Custodian FBO	  	
	                      Anthony Argyrides IRRA	  	By:	  	 /s/ Anthony Argyrides

		  		  	 Name: Anthony Argyrides 11/16/2016

Title:

					
	 INVESTOR:
	  	
		  	 By:
	  	 /s/ Todd Brady

		  		  	 Todd Brady

					
	INVESTOR:	  	
		  	By:	  	 /s/ Nezam Afdhal

		  		  	Nezam Afdhal

					
	 INVESTOR: Parallax Biomedical Fund, LP
	  		  	
		  	 By:
	  	 /s/ Marc Pentopoulos

		  		  	Name: Marc Pentopoulos
		  		  	Title:   Managing Partner

					
	INVESTOR:	  	
		  	By:	  	 /s/ Martin Driscoll

		  		  	 Name: Martin Driscoll
 Title: CEO

					
	INVESTOR: Cynergy Healthcare Investors	  	
	                      Emerging Bridge, LLC	  	By:	  	 /s/ Patrick Adams

		  		  	 Name: Patrick Adams
 Title: Managing
Member

					
	INVESTOR:	  	
		  	By:	  	 /s/ Jonathan Freve

		  		  	 Name: Jonathan Freve
 Title: CFO

					
	INVESTOR:	  	
		  	By:	  	 /s/ David Arkowitz

		  		  	 Name: David Arkowitz
 Title: Director, Spring
Bank Pharma

 EXHIBIT A 

Schedule of Investors 
  

													
	 Investor Name and Address
	  	Number of
Shares to be
Purchased	 	  	Number of
Common Warrant
Shares
Underlying
Common Warrant
Purchased	 	  	Aggregate
Purchase Price
of Closing
Securities	 
	 UBS Oncology Impact Fund L.P.

UBS Trustees (Cayman) Ltd.,

5th Floor, Cayman Corporate Center, 27 Hospital Road

Georgetown, Grand Cayman KY1-1003
	  	 	603,070	  	  	 	603,070	  	  	$	5,499,998.40	  
	 Baker Brothers Life Sciences, L.P.

667 Madison Ave, 21st Flr

New York, NY 10065
	  	 	198,642	  	  	 	198,642	  	  	$	1,811,615.04	  
	 667, L.P.

667 Madison Ave, 21st Flr

New York, NY 10065
	  	 	20,656	  	  	 	20,656	  	  	$	188,382.72	  
	 Alyeska Master Fund, LP

77 W Wacker

Chicago, IL 60601
	  	 	116,000	  	  	 	116,000	  	  	$	1,057,920.00	  
	 Alyeska Master Fund 2, LP

77 W Wacker

Chicago, IL 60601
	  	 	84,000	  	  	 	84,000	  	  	$	766,080.00	  
	 The E. Burke Ross Jr. Descendants’

GST Investment Trust 2014

c/o SCS Financial,

One Winthrop Square, 4th Floor

Boston, MA 02110
	  	 	26,455	  	  	 	26,455	  	  	$	241,269.60	  
	 EBR Ventures, LLC

172 S. Ocean Boulevard

Palm Beach, FL 33480
	  	 	118,550	  	  	 	118,550	  	  	$	1,081,176.00	  

  
 47 

													
	 CVI Investments, Inc.

c/o Heights Capital Management

101 California Street, Suite 3250

San Francisco, CA 94111
	  	 	109,645	  	  	 	109,645	  	  	$	999,962.40	  
	 Burrage Capital Healthcare Fund I, LP

314 Commonwealth Ave.

Boston, MA 02115
	  	 	54,824	  	  	 	54,824	  	  	$	499,994.88	  
	 Kurt Eichler
	  	 	64,100	  	  	 	64,100	  	  	$	584,592.00	  
	 Marilyn E. Tenzer Declaration of Trust

u/a/d 10/7/98

111 W. Jackson Blvd., Ste. 115B

Chicago, IL 60604
	  	 	54,824	  	  	 	54,824	  	  	$	499,994.88	  
	 Iroquois Master Fund Ltd.

c/o Iroquois Capital Management, LLC

205 East 42nd Street, 20th Floor
 New York, NY 10017
	  	 	13,706	  	  	 	13,706	  	  	$	124,998.72	  
	 Iroquois Capital Investment Group LLC

c/o Iroquois Capital Management, LLC

205 East 42nd Street, 20th Floor
 New York, NY 10017
	  	 	24,671	  	  	 	24,671	  	  	$	224,999.52	  
	 DAFNA LifeScience LP

10990 Wilshire Blvd. #1400

Los Angeles, CA 90024
	  	 	16,447	  	  	 	16,447	  	  	$	149,996.64	  
	 DAFNA LifeScience Select LP

10990 Wilshire Blvd. #1400

Los Angeles, CA 90024
	  	 	10,965	  	  	 	10,965	  	  	$	100,000.80	  
	 Intracoastal Capital, LLC

245 Palm Trail

Delray Beach, FL 33483

w/ Notice to:

Intracoastal Capital LLC

2211A Lakeside Drive

Bannockburn, IL 60015
	  	 	27,410	  	  	 	27,410	  	  	$	249,979.20	  
	 MLPF&S Custodian FBO Anthony Argyrides IRRA
	  	 	21,930	  	  	 	21,930	  	  	$	200,001.60	  
	 Todd Brady
	  	 	10,964	  	  	 	10,964	  	  	$	99,991.68	  
	 Nezam Afdhal
	  	 	13,150	  	  	 	13,150	  	  	$	119,928.00	  
	 Parallax Biomedical Fund, LP

342 E. 67th St. 4B

New York, NY 10065
	  	 	12,000	  	  	 	12,000	  	  	$	109,440.00	  
	 Martin Driscoll
	  	 	21,900	  	  	 	21,900	  	  	$	199,728.00	  

  
 48 

													
	 Cynergy Healthcare Investors Emerging Bridge, LLC

6898 S. University Blvd, Suite 100

Centennial, CO 80122
	  	 	10,960	  	  	 	10,960	  	  	$	99,955.20	  
	 Jonathan Freve
	  	 	5,482	  	  	 	5,482	  	  	$	49,995.84	  
	 David Arkowitz
	  	 	4,386	  	  	 	4,386	  	  	$	40,000.32	  
	 TOTAL
	  	 	1,644,737	  	  	 	1,644,737	  	  	$	15,000,001.44	  

  
 49 

 EXHIBIT B 

Form of Common Warrant 

 EXHIBIT C 

Registration Rights Agreement 

 EXHIBIT D 

Investor Questionnaire 

 Disclosure Schedules 

None.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00264-of-00352.parquet"}]]